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Abstract 
Mounting evidence suggests prenatal stress can affect child development.   
Clinical studies of this concept, termed fetal programming, focus predominantly on 
early childhood. Also, little is known about the mechanisms underlying how maternal 
stress is transmitted to the fetus.  This thesis will test if maternal anxiety during 
pregnancy is associated with (1) behavioural outcomes from childhood to early 
adolescence, (2) cortisol output in adolescence and (3) an altered placental 
phenotype. 
For Studies 1 and 2 participants were drawn from the Avon Longitudinal Study 
of Parents and Children (ALSPAC).  Psychometric data from 9,871 mother child 
pairs (5,098 males, 4,773 females) were analysed using latent growth curve 
analysis. A subsample of the ALSPAC children aged 15 years (n = 899) provided 
saliva samples on three days at waking, +35mins, after school and before bed, for 
later cortisol analysis.   
For Study 3 a new cohort of women (n= 73) was recruited.  Maternal 
psychometric data was collected one day prior to elective caesarean section, and the 
placenta collected after delivery.   
Study 1 showed that maternal prenatal anxiety was associated with conduct 
and emotional problems, and symptoms of ADHD at age 13 years, after allowing for 
a range of confounders, including postnatal anxiety. There were marked sex 
differences in the developing patterns. Saliva cortisol demonstrated a marked diurnal 
profile with a clear sex difference at age 15.  Higher maternal prenatal anxiety was 
associated with a reduced cortisol awakening response. High levels of maternal 
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prenatal anxiety were associated with reduced placental expression and activity of 
the cortisol metabolising enzyme 11β-Hydroxy steroid dehydrogenase 2 (11β-HSD2) 
and also with reduced placental weight. 
 This thesis provides evidence that maternal prenatal anxiety can affect 
behavioural and neuroendocrine outcomes in adolescence.  It also provides 
preliminary evidence that maternal anxiety is associated with alterations in the 
function of the placenta, which may underlie some aspects of fetal programming. 
 These findings have public health implications.  Increasing awareness about 
the lasting effects of prenatal anxiety may ultimately benefit mothers, the care they 
receive and their families.  
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Chapter 1:  Introduction 
 1.6 Background 
Adapting to the environment is key to an organism’s survival.  Developmental 
plasticity provides a mechanism to achieve this change. Environmental cues, 
signalled to fetus via the mother, affect the development of target organs and 
structures. This process is termed fetal programming.
  Environment-dependent patterns of development are found in a range of 
species.  The fur of the adult meadow vole 
melatonin (Lee and Zucker, 1988)
presence of a predator results in offspring with a defensive helmet structure 
1.1.1;Agrawal et al., 1999). Another example comes from amphibian species.  When 
the water-level of a pond threatens the survival of a tadpole, a 
like terrestrial phenotype is triggered 
plasticity provides a mechanism for rapid adaptation to changes in the environment.  
Such changes may persist across the lifespan of the organism and re
phenotype.  
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is influenced prenatally by maternal 
, while in the fresh water crustacean 
transition to an adult
(Crespi and Denver, 2005). Developmental 
Figure 1.6.1: Electron micrograph of the 
inducible helmet structure (left) versus control 
(right) following exposure to chemical predatory 
signals during pregnancy in Daphnia C
(From Agwaral et al., 1999).    
 
  
 
 
Daphnia the 
(Figure 
-
sult in a distinct 
ucullatta  
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This thesis will explore fetal programming in the context of maternal prenatal 
emotional state and potential programming effects on the child. There is good 
evidence from several independent prospective studies that maternal stress, anxiety 
or depression during pregnancy is associated with adverse neurodevelopmental 
outcomes in the child.  Less is known about the effect of the maternal prenatal 
emotional state on outcomes in older children or the potential mediating 
mechanisms.   
This thesis will begin by reviewing the fetal programming literature.  This 
background will include a description of the conceptual framework underpinning fetal 
programming (Section 1.2).  Background will also be provided on studies of child 
emotional/behavioural development (Section 1.3) and also the hypothalamic pituitary 
adrenal (HPA) axis (Section 1.4), topics which will later be evaluated in the context of 
the maternal prenatal emotional state.  This will be followed by the introduction of 
altered placental function as a potential programming mechanism (Section 1.5).  
Finally a description of the current study’s aims and hypotheses will be provided 
(Sections 1.6-7).   
1.6.1 Teratology and insights from the past 
Teratology provides clear evidence that the fetus is sensitive to environmental 
insults (for comprehensive review see Katler, 2003).  A number of interesting 
examples come from the work of Charles Stockard (Stockard and Papanicolaou, 
1916 and Stockard, 1921).  Stockard’s work on birth defects discusses important 
concepts cited in modern studies of fetal programming. 
Stockard’s (1916) study of alcohol exposure in guinea pigs provides evidence 
for germ line transmission across generations.  Alcohol exposures in the parental 
 generation, with no further manipulations in subsequent generations, affected fertility 
and birth defects up to the third (F3) generation 
Stockard offers this insightful explanation for such transgenerational effects:
“...probably due to modifications of the chromatin or carriers of the hereditary 
qualities within the germ cells.” From Stockard and Papanicolaou (1916) 
TRANSMISSION OF DEGENERACY
The epigenetic regulation of gene expression is emerging as an important 
mechanism for the transmission of early life stress (see section 1.4.10). However 
these observations provide early evidence for such processes.  Interestingly a recent 
study in mice supports Stockard’s observations finding epigenetic changes following 
prenatal alcohol exposure (Kaminen
craniofacial dysmorphogensis in treated offspring in line with Stockard’s description 
of a distinct ‘alcoholized’ phenotype (Figure 1.1.2) (Stockard and Papanicolaou, 
1916)  
Figure 1.6.2: Illustration of germline transmission of alcohol
Image is of a female guinea pig with alcoholic grandparents born  with a one normal 
(1A) and one deformed eye (1B) (From Stockard 
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(Stockard and Papanicolaou, 1916)
, p 171. 
-Ahola et al., 2010).  The authors also describe 
-related birth defects.  
and Papanicolau, 1916). 
.  
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Stockard (1921) illustrates another important concept in fetal programming, 
that of timing.  Using fertilised eggs of the Mud Minnow brief exposure to 
hypothermia resulted in severe birth defects (Stockard, 1921).  Such abnormalities 
were exclusively confined to the pre-gastrulation period.  This led Stockard to 
propose that there are ‘critical moments’ of vulnerability in development; a concept 
cited in modern theories of fetal programming (see 1.7.3 and Hanson and Gluckman, 
2005).   
From this work it appears that timing can determine whether an environmental 
insult affects an organism.  This point is also emphasised in clinical studies of 
teratogens.  
1.6.2 Clinical studies of teratogens 
Other well known examples of teratogens include rubella, and the 
antiemetic/sedative medication thalidomide (Kalter, 2003).  In line with Stockard’s 
work both of these teratogens have the greatest effect during specific periods of 
development.  Sheridan (1964) reported that deafness occurred in children exposed 
to rubella in the first 16 weeks of pregnancy (Sheridan, 1964).  Similarly the severe 
limb defects associated with the prenatal use of the thalidomide were confined to 21-
36 days post-conception (Kalter, 2003).  These studies demonstrate that specific 
targets are sensitive to insults at different stages of gestation. 
Teratology illustrates how an environmental insult can disrupt fetal 
development with the adverse consequences evident at birth.  Conversely, the work 
which gained much attention for the fetal programming hypothesis examined causes 
of mortality in later life.   
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1.7 Fetal programming and cardiovascular disease 
Evidence that prenatal period was related to risk of cardiovascular disease 
(CVD) came from the observation that CVD was associated with rates of infant 
mortality (see Barker, 2007).  Stronger evidence came from the work of David Barker 
and colleagues using a cohort of British men and women (Hales et al., 1991, Barker 
et al., 1993a, Barker et al., 1993c, Barker et al., 1993d, Osmond et al., 1993).  Using 
birthweight as a marker for fetal growth, a U shaped association between death from 
CVD and birthweight was observed (Figure 1.2.1), with increased mortality from CVD 
at low and high birthweight (Barker et al., 1993d, Osmond et al., 1993).  
 
Figure 1.7.1: Birthweight and mortality ratios related to coronary heart disease (from 
Osmond et al, 1993) 
 
These studies also established a link between impaired fetal growth and a 
range of related risk factors including type-2 diabetes and the metabolic syndrome 
(Hales et al., 1991, Barker et al., 1993a, Barker et al., 1993b).  It has been estimated 
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that the metabolic syndrome (if defined by glucose intolerance, high blood pressure 
and dyslipidemia) was between 6-10 times more common in men born below men 
born ≤ 6.5lbs (2.9kg) versus those born ≥ 9.5lbs (4.31kg) (Barker et al., 1993a, 
Phillips et al., 2006). Similar findings relating indices of fetal growth to cardio-
metabolic risk factors have been reported in cohorts from Europe, the United States 
and India (Phillips et al., 2006, Barker, 2007). 
Such findings lend support to what has been termed the ‘Barker hypothesis’ 
or the developmental origins of health and disease (DOHaD) model.  A series of 
systematic reviews and meta-analyses report that suboptimal fetal growth is 
associated with; type 2 diabetes (Harder et al., 2007, Whincup et al., 2008), raised 
blood pressure (Huxley et al., 2000, Gamborg et al., 2007),  raised cholesterol 
(Lawlor et al., 2006) the metabolic syndrome (Nobili et al., 2008) and CVD (Huxley et 
al., 2007).  Despite these associations it is as yet undetermined if birthweight is 
causally related to the disease process.  
Poor nutrition is a key aspect of the Barker hypothesis.  Barker and Hales 
proposed that poor conditions during pregnancy, especially malnutrition may 
ultimately affect obstetric outcomes such as birthweight (Hales and Barker, 2001).  A 
fetus exposed to malnutrition in utero becomes ‘programmed’ to conserve nutrients 
in later life, the so called ‘thrifty phenotype’.  Yet given the proposed adaptive value 
of phenotypic plasticity why should changes to in utero environment lead to such 
pathological outcomes in humans?  
1.7.1 The predictive adaptive response (PAR) 
From the examples provided earlier in this chapter it is clear how 
developmental plasticity can be adaptive; the meadow vole will have thicker fur in 
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winter and Daphnia will be larger in a predatory environment.  Cues received during 
development provide information about the future environment.  By responding to 
such information an organism can alter their phenotype accordingly; such changes 
are termed predictive adaptive responses (PARs).   
Gluckman and Hanson (2005) propose PARs as an extension of the thrifty 
phenotype, which places greater emphasis on small size at birth.  PARs are distinct 
from immediately adaptive responses which confer advantage in the short term.  An 
example of such a short term response is preterm labour following intrauterine 
infection; this response limits fetal exposure to the pathogen and may promote 
survival.  Conversely the increased mortality and morbidity seen in preterm infants 
may be the trade off for this survival in the short term.  By definition PARs are 
predictive with their advantage often evident only later in life (Gluckman et al., 2005).    
High glucose levels in maternal circulation for instance may indicate that the 
environment into which the fetus will be born is glucose-rich.  Thus, it may be in the 
interests of the fetus (and its descendents) to adapt its development to match the 
requirements of such a postnatal environment (Gluckman and Hanson, 2005).  PARs 
give direction and purpose to phenotypic changes.  The evolutionary advantage of 
PARs is illustrated in Figure 1.2.2.  
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Figure 1.7.2: Evolutionary advantage of the predictive adaptive response ensuring 
genotype transmission across generations (From Gluckman et al., 2005). 
 
1.7.2 Mismatch 
Inconsistency between the predicted and the actual environment a fetus is 
born into is termed ‘mismatch’.  Mismatch is thought to explain the link between a 
potentially adaptive response and a pathological outcome such as CVD.  If the 
maternal environment does not match the external postnatal environment (e.g. due 
to poor maternal diet or conditions such as diabetes), or the external environment 
changes postnatally, then the fetus may make non-beneficial and even 
disadvantageous adaptations. 
  Some good evidence linking mismatch to adverse outcomes come from a 
number of rodent studies (Thompson et al., 2007, Howie et al., 2009).  Maternal 
nutrition during pregnancy may be a determinant of later obesity and risk of CVD.  
High fat feeding during pregnancy increases obesity in offspring raised on a normal 
diet (Howie et al., 2009).  A similar pattern is seen in offspring from calorie restricted 
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pregnancies.  The strongest effects on obesity are seen in offspring calorie restricted 
in utero but fed a high fat diet postnatally (Thompson et al., 2007).  There is also 
support for mismatch from clinical studies of famine exposure during pregnancy.  
Rates of CVD were greatly increased in adults born following 1st trimester exposure 
to famine (Roseboom et al., 2000).  As the famine ended abruptly maternal nutrition 
would have improved rapidly in subsequent trimesters.   Interestingly these results 
were independent of birthweight suggesting that environmental insults may not affect 
birthweight but may still impact on future health.  
1.7.3 Critical windows of vulnerability  
Together with PARs and mismatch, timing is another central theme of the 
DOHaD model.  As different tissues develop, they pass through periods of increased 
sensitivity to stimuli and insults from the in utero and fetal environments (Drake and 
Walker, 2004; Seckl, 2004).  During these ‘windows of sensitivity’ the tissues can be 
affected by nutrition, hormonal signalling and other factors which may influence their 
development (Drake and Walker, 2004; Seckl, 2004).  The idea that structures 
undergoing rapid growth are most vulnerable to environmental insults is not new 
(Stockard, 1921).  However it is these structures which are likely demonstrate PARs.  
An example comes from the study of cited above (Roseboom et al., 2000) where 
rates of CVD were highest in those exposed to famine only in the first trimester of 
pregnancy when key stages of heart development occur (Kiserud, 2005).   
The DOHaD provides a conceptual framework with supportive evidence from 
animal and clinical studies.  Given the associations described between the prenatal 
period and later physical health, are similar associations observed with mental 
health?  
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1.8 The developing brain 
The Barker hypothesis emphasises that periods of rapid growth can be critical 
periods of vulnerability.  Fetal Magnetic Resonance Imaging (MRI) studies illustrate 
that the fetal brain undergoes rapid proliferation across gestation with an 
approximate 17-fold change in relative size from mid to late gestation. This contrasts 
with the 4-fold change observed from birth to early childhood (Huang et al., 2006).  
Figure 1.3.1 shows the changes seen in the fetal brain from mid to late gestation. 
Note the increased sulci and gyri formation and decrease in ventricle volume at term. 
In addition to this gross increase in size, diffusion tensor imaging, a form of MRI, 
reveals the formation of white matter tracts across gestation between a number of 
neural structures (Huang, 2010).  These studies illustrate the marked growth of the 
fetal brain across gestation.  In parallel with this structural development aspects of 
function are acquired over the prenatal period.   
Figure 1.8.1:  
 
 
 
 
 
 
 
 
MRI acquired images used to 
generate 3D models of the 
cortex (grey: a, f, k), brain stem 
(blue) and cerebellum (beige, 
b, g, l), ventricle (light blue), 
caudate nucleus (green), basal 
ganglia (red: c, h, m), 
hippocampus (pink: d, i, n), 
thalamus (yellow), and 
ganglionic eminence (orange; 
e, j, o) of a 19 gestational week 
fetal brain (a–e), newborn baby 
brain (f–j), and 5-year-old 
paediatric brain (k–o) (from 
Huang et al., 2006). 
 
37 
 
The study of the fetus in utero demonstrates its sensitivity to changes in the 
environment.  Human fetal endocrine responses to stress have been demonstrated 
from 18 weeks gestation. An increase in fetal plasma concentrations of cortisol and 
β-endorphin are observed in response to needling of the intrahepatic vein (IHV) for 
intrauterine transfusion (Giannakoulopoulos et al., 1994). The magnitude of these 
stress responses correlated with the duration of the procedure.  Fetuses receiving 
the same procedure of transfusion, but via the non-innervated placental cord 
insertion, failed to show these hormonal responses. This result was replicated in a 
larger study confirming a stress response at 18 weeks gestation (Gitau et al., 2001). 
The fetal cortisol response was observed from 20 weeks gestation, but increased 
with gestational age, independent of the maternal response (Giannaloulopoulos et 
al., 1999).  The presence of a fetal response may not be surprising given the direct 
nature of fetal blood sampling; however the fetus is responsive to an array of stimuli 
from mid-gestation onwards. 
Distinct fetal behaviours, such as changes in fetal heart rate in response to 
maternal psychological functioning, begin to emerge from 24 weeks (DiPietro et al., 
2003).  Increases in fetal heart rate in the final trimester, following exposure to a 
cognitive stressor such as the Stroop test, were found to be greatest in mothers 
reporting increased anxiety symptoms (Monk et al., 2004), and increased with 
gestational age. Paradoxically, this increase in the fetal response is in contrast to the 
progressive blunting of the maternal stress response to such stressors (DiPietro et 
al., 2005).  Both the maternal hypothalamic-pituitary-adrenal (HPA) axis and 
sympathetic system are found to become hyporesponsive to acute physical and 
psychological stressors toward the latter stages of pregnancy (Kammerer et al., 
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2002, DiPietro et al., 2005). But as gestation advances, and the fetus matures, an 
increased sensitivity to maternal input is observed.  
Taken together these data demonstrate that the fetal brain, which undergoes 
rapid growth and development, does so in an environment sensitive to a range of 
stimuli.  The maternal emotional state is one such stimulus which can have lasting 
effects. 
1.8.1 Fetal programming and mental health 
The mental health of a woman can be important not only for herself but also 
for her child.  An early observational study linking prenatal stress with longer term 
effects on the child was published by DH Stott in 1973. Information was collected 
from 200 women in Scotland in 1965–6, at the end of their pregnancy (Stott, 1973).  
The questions asked of the mother concerned her physical and mental health, the 
course of the pregnancy, and her social circumstances. The health, development, 
and behaviour of the child were followed for the next four years. Stott’s major 
conclusion was that stresses during pregnancy involving severe and continuing 
personal tensions, in particular marital discord, were closely associated with child 
morbidity in the form of ill health, neurological dysfunction, developmental delays and 
behaviour disturbance (Stott, 1973). 
 Another early study was that of Meijer (1985) which examined the outcome 
for two cohorts of boys, one group consisting of those born in the year of the Israeli 
Six-Day War and a second group born two years later. The children from the ‘war-
exposed pregnancies’ had significant developmental delays and showed regressive 
behaviour (Meijer, 1985). However, these studies, although pioneering, did not 
control for possible confounding factors such as smoking or postnatal mood.  
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More evidence for neurodevelopmental programming comes from 
retrospective cohorts. Exposure to war and famine, during the prenatal period, have 
been associated with an increased risk for affective disorders in later life (van Os and 
Selten, 1998, Brown et al., 2000).  Indeed, more recently a retrospective study 
supports an association between length of gestation and depressive symptoms in 
late-adulthood (Raikkonen et al., 2007). 
In the last fifteen years, several independent prospective, and better 
controlled, studies have examined the effects of prenatal stress, anxiety, or 
depression on social/emotional and cognitive outcomes during childhood. 
Outcomes so far linked with prenatal stress or anxiety include autism, 
schizophrenia, emotional/behavioural problems, and reduced cognitive abilities 
especially with language development (see Table 1.3.1).  Such effects have been 
demonstrated early in postnatal period and across childhood. 
1.8.2 Clinical studies of maternal prenatal stress and child outcome 
Studies of newborns provide evidence for the effects of prenatal stress, 
anxiety or depression, which must be independent of postnatal experience. Two 
studies report impairment in the newborns using the Brazelton scale (Brouwers et 
al., 2001, Field et al., 2002) and one study used the Prechtl neurological assessment 
(Lou et al . 1994 ).  Interestingly in the study of Brouwers and colleagues prenatal 
anxiety resulted in group differences on the Brazelton scale at three weeks but more 
pronounced effects on child development when measured at age 2.  At this stage 
children born to more anxious mother were three times more likely to demonstrate a 
developmental delay.   
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Table 1.8.1 Examples of the types of stress exposure during pregnancy and association with a range of neurodevelopmental outcomes 
Abbreviations: v = amount of variance explained, OR = Odds Ratio, ADHD = Attention Deficit and Hyperactivity Disorder, DSM - R = 
Diagnostic and Statistical Manual - Revised, CBCL = Child Behaviour Checklist, TRF = Teachers Report Form, CPT = Continuous 
Performance Task, CDI = Child Depression Inventory, BSID = Bayleys Scale of Infant Development, MDI= Mental Development Index, 
ICQ = Infant Characteristics Questionnaire, NBAS = Brazelton Neonatal Behavioral Assessment Scale, SDQ = Strengths and Difficulties 
Questionnaire, TOMAL = Test Of Memory And Learning, Lab-TAB = Laboratory Temperament Assessment Battery, ICD = International 
Classification of Diseases, MCDI = MacArthur Communicative Development Inventory, IQ = Intelligence Quotient, WPPSI = Wechsler 
Preschool and Primary Scale of Intelligence, MDD = Major Depressive Disorder, IBQ = Infant Behaviour Questionnaire, wks = weeks, 
mths = months yrs = years, † in boys only, # in girls only, - = not reported, ++ = most significantly 
Type of exposure Prenatal 
Timing 
Outcome Age Magnitude Citation 
Perceived Stress 10wks ADHD (DSM-IV) 7-8yrs 23% (v) † (Rodriguez and Bohlin, 
2005) 
Anxiety (State) 
″ 
Anxiety (Trait) 
12-22 wks 
″ 
″ 
ADHD (CBCL, TRF) 
Sustained attention (CPT) 
Depression (CDI) 
8-9yrs 
15yrs 
15yrs 
22% (v) 
-† 
-# 
(Van den Bergh et al., 
2004, 2006, 2008) 
Perceived stress 15-38wks Behavioral Problems 
(CBCL) 
2yrs 1.12-
1.17(OR) 
(Gutteling et al., 2005) 
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Daily hassles 15-17wks Mental development (MDI) 8mths 1.1 (OR) (Huizink et al., 2003) 
Pregnancy related anxiety 
Pregnancy-related anxiety 
15-38wks 
″ 
Temperament (ICQ) 
Attention regulation (BSID) 
2yrs 
″ 
1.39 (OR) 
1.46 (OR) 
(Gutteling et al., 2005) 
(Gutteling et al., 2005) 
ʺ 19wks Reduced Grey matter 
density 
(prefrontal cortex) 
6-9yrs - (Buss et al., 2009) 
Depression - Attentiveness (NBAS) Neonate - (Hernandez-Reif et al., 
2006) 
Depression/ 
Maternal cortisol 
18-32wks Infant temperament  2-5mths 7%(v) (Davis and Sandman, 
2010) 
Anxiety 32wks Attentiveness (NBAS) 
Cognitive Development 
(MDI) 
3 wks 
2yrs 
- 
3 month delay 
(Browers et al., 2001) 
ʺ 
ʺ 32 wks Emotional & Behavioural 
problems (SDQ) 
4 & 7yrs 1.9-2.2 (OR) (O’Connor et al 2002, 
2003) 
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ʺ ~18wks Attention problems (CBCL) 4 & 14yrs 3.5 (OR) (Clavarino et al., 2010) 
Life events stress 15-17wks Memory (TOMAL) 6yrs - (Gutteling et al., 2006) 
Life events stress 
(++relationship problems) 
- Cognitive Development 
(MDI) 
Fear reactivity (Lab-TAB) 
1.5yrs 
″ 
17% (v) 
10% (v) 
(Bergman et al., 2007) 
Death of a close relative 0-12wks Schizophrenia 
(ICD8/ICD10) 
- 1.67 (OR) (Khashan et al., 2008) 
Hurricane 24-40wks Autism (DSM-III-R/DSM-
IV) 
- 10.12-43.05 
(OR) 
(Kinney et al., 2008) 
Ice storm 
″ 
″ 
4-24wks 
″ 
- 
Cognitive developmental 
(BSID-MDI) 
Language production 
(MCDI) 
IQ (WISC) 
2yrs 
″ 
5.5yrs 
11.4% (v) 
17.3% (v) 
15.3 (v) 
 (Laplante et al., 2004, 
2008) 
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Chernobyl 
″ 
14wks  
″ 
Depression/MDD  
ADHD 
14yrs 
″ 
2.48 (OR) 
2.01 (OR) 
(Huizink et al., 2007) 
9/11 - Temperament (IBQ) 9mths - (Brand et al., 2006) 
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Field et al., (2002) reported that the newborns of mothers with high anxiety 
had greater relative right frontal brain activation (as measured by 
electroencephalogram) and lower vagal tone (Field et al., 2002). The babies also 
spent more time in deep sleep and less time in quiet and active alert states, and 
showed more state changes and less optimal motor maturity, autonomic stability, 
and withdrawal.  
Lou et al (1994) proposed there may be a ‘fetal stress syndrome’ analogous 
to the ‘fetal alcohol syndrome’, on the basis of their study which showed that prenatal 
life events resulted in a smaller head circumference, lower birthweight, and lower 
neurological scores on the Prechtl scale (Lou et al., 1994).  
As shown in Table 1.3.1 the maternal prenatal emotional state has been 
associated with a number of adverse neurodevelopmental outcomes.  Findings 
which have been replicated in a number of samples include problems with 
temperament, cognitive development and most commonly symptoms related to 
emotional and behavioural development. 
Some of the strongest evidence of a specific prenatal effect on child 
development comes from large epidemiological analyses which can adequately 
control for the postnatal environment.  The lasting effects of maternal prenatal 
anxiety on child emotional and behavioural development are illustrated by O’Connor 
and colleagues (O'Connor et al., 2002, O'Connor et al., 2003).  Using a large UK 
based cohort the authors found higher levels of prenatal anxiety, particularly in late 
pregnancy, were associated with a two-fold increased risk of problem behaviour in 
children aged four.  The stability of these findings were demonstrated when the 
children were assessed at seven and a robust association observed between 
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prenatal anxiety and child outcomes.  Importantly these effects were independent of 
a range of covariates including postnatal maternal anxiety.  
More recently a study has shown that maternal pregnancy related anxiety is 
associated with brain morphology.  Reductions in grey matter density in cortical 
regions, including the prefrontal cortex, were seen in children prenatally exposed to 
higher levels of maternal pregnancy related anxiety (Buss et al., 2009).  Similarly 
dermatoglyphic asymmetry, a feature also seen in schizophrenia, has also been 
reported in children exposed to high levels of maternal prenatal stress following an 
ice storm (King et al., 2009).  This especially interesting fingerprint pattern develops 
at the same time as the hippocampus, and may be a physical marker for  altered 
development of this region, which is important in both cognition, and feedback 
control of the function of the hypothalamic pituitary adrenal (HPA) axis (see Section 
1.4) (Cottrell and Seckl, 2009). 
A common feature of most of the studies listed above is their focus on 
outcomes in childhood.  To date only three prospective studies have examined the 
long-term effects of maternal prenatal stress/anxiety on outcomes in adolescence.   
Using a small group of 14-15 year olds van den Bergh has found symptoms of 
impulsivity and attention problems in children exposed to maternal prenatal anxiety.   
More supportive evidence for comes from a recent study from a large Australian 
cohort.  In line with van den Bergh and colleagues, attention problems in 
adolescence were observed in participants exposed to maternal prenatal anxiety 
(Clavarino et al., 2010).  Moreover, this study found that maternal prenatal anxiety 
was associated with persisting attention problems from age 4 to age 14, suggesting 
impairments in attention were stable across childhood. 
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The possibility that maternal prenatal anxiety is associated with persistent 
behavioural problems is also supported by the work of Barker and Maughan (2009).  
Focusing on conduct problems the authors demonstrate that maternal prenatal 
anxiety predicts higher rates of conduct problems across childhood to age 13 (Barker 
and Maughan, 2009).   
Collectively the studies described above provide good evidence that the 
maternal prenatal emotional state can influence child development.  Less is known 
about the stability of such effects as children transition to adolescence.  A limited 
number of studies indicate that prenatal effects on child attention and conduct 
problems may lead to stable impairment into early adolescence.  However, even less 
is known about other outcomes such as emotional difficulties.  The importance of the 
findings described above is evident when placed in the context of current prevalence 
estimates of child mental health problems. 
1.8.3 The prevalence of child mental health problems in the UK 
In the UK it is estimated that over 1,000,000 young people suffer from some 
form of mental illness, or behavioural problems (Meltzer et al., 2003).  As many as 
one in five children and young people experience some form of mental health 
problem in any one year (Patel and Goodman, 2007).  The Office of National 
Statistics (ONS) carried out one of the most comprehensive surveys of child and 
adolescent mental health in the UK in 1999 (Meltzer et al., 2000).  This survey of 
over 10,000 5-15 year olds reported a prevalence of around 10% for any mental 
health disorder.  Conduct disorders were reported in 5% of the population with an 
additional 4% reporting an emotional disorder.  Diagnoses related to hyperactivity 
were observed in approximately 1% of the children adolescents surveyed.   
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The stability of these diagnoses is of interest from an interventional and health 
economics perspective.  Kessler et al (2005) found 75% of all adult mental health 
disorders were evident before 24 years of age (Kessler et al., 2005).  In another 
prospective cohort study, 50% of adults diagnosed with a psychiatric disorder 
(average age 26 years) had experienced a psychiatric disorder by age 15 (Kim-
Cohen et al., 2003).  These studies suggest a large proportion of adult service users 
are identifiable as young people and indicate that identifying the antecedents of child 
mental health will ultimately benefit adult mental health. This point is emphasised by 
a study, based on the ONS survey, which found that those with a diagnosis in 1999 
had poorer outcomes on emotional and behavioural assessments three years later 
(Ford et al., 2007). 
It is currently unknown what proportion of child mental health problems is 
attributable to the maternal prenatal emotional state.  One estimate, based on the 
epidemiological studies carried out to date, suggests between 10-15% of 
neurodevelopmental problems may be explained by maternal prenatal anxiety or 
stress (Talge et al., 2007).  Thus, determining which types of stress, the gestation of 
greatest vulnerability and the potential mediating mechanisms become issues 
weighted with public health importance. 
1.8.4 Stressors associated with ‘programming’ effects 
The range of prenatal maternal stressors that predict child outcomes is quite 
wide and includes minor stresses such as daily hassles (Huizink et al., 2003), more 
severe traumas (Khashan et al., 2008), and symptoms and disorders of anxiety and 
depression (Field et al., 2010).   
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These studies show that the nature of the risk can be quite varied, and that 
many neurodevelopmental effects can be observed with non-clinical levels of anxiety 
or stress (O'Connor et al., 2002, O'Connor et al., 2003).  There is evidence from one 
study that the effect on the child derives more from prenatal anxiety than depression 
(O'Connor et al., 2002); another study found  that the life events most closely linked 
with both low scores on the Bayley Mental Developmental Index and increased fear 
reactivity were “separation/divorce” and “cruelty by the partner” (Bergman et al., 
2007).  Nevertheless, as noted, the nature of the “risk phenotype” is unclear and 
most studies have focused on non-diagnostic levels of anxiety and depression or life 
events. 
In contrast to most of the findings described above, two studies report 
enhanced development following exposure to prenatal stress. In a cohort of 
financially and stable middle to upper class sample of  women, there was a small but 
significant positive association between prenatal stress and both the mental and 
physical development) of the child (DiPietro et al., 2006).  A similar trend was 
observed by Laplante  et al (Laplante et al., 2008) on child IQ  The authors suggest 
that a small to moderate amount of prenatal stress may actually promote an 
accelerated rate of brain development, although this remains to be confirmed.  
1.8.5  Gestational ages of vulnerability 
More needs to be understood about the periods of gestation which are most 
sensitive for all the effects described here.  Different studies have found different 
periods of vulnerability.   In the study of O’Connor et al (2002) anxiety was measured 
at 18 and 32 weeks gestation, and the associations with behavioural/emotional 
problems in the child were stronger with the latter time point (O'Connor et al., 2002). 
49 
 
However, in the study showing that a life event, the death of a relative, was 
associated with an increased risk of schizophrenia, the risk was confined to the first 
trimester (Khashan et al., 2008). It is likely that the gestational age of vulnerability is 
different for different outcomes. Brain systems underlying different aspects of 
cognition or behaviour mature at different stages. It is unknown why some children 
are affected but not others. Possible explanations include specific genetic 
vulnerabilities in both mother and child, timing of the prenatal exposures, and the 
nature of the postnatal care.   
It is clear from the studies described above that a range of stressors can 
result in a diverse range of adverse outcomes in the child.  The specific outcome is 
most likely related to the magnitude of the stress experienced and the prenatal 
period of stress exposure.  Given the diverse range of outcomes associated with 
prenatal stress exposure what biological mechanism(s) mediate these effects? 
1.8.6 Fetal programming and the hypothalamic pituitary adrenal 
(HPA) axis 
Altered HPA axis function is both a potential mediator and outcome 
associated with maternal prenatal stress or anxiety.  The following section will review 
the animal and clinical evidence to suggest the maternal HPA axis may be a 
programming agent.  This will be followed by a discussion of studies which suggest 
that HPA axis function in the child may be ‘reprogrammed’ following exposure to 
maternal prenatal stress or anxiety.  Firstly, given the central role of the HPA axis 
function in the programming hypothesis a general introduction to its function will be 
provided below.  
 
  
1.9 The HPA axis 
 
Figure 1.9.1 The hypothalamic pituitary adrenal axis. modified from Lupien et al.,2009 
with additional data from O'Donnell et al., 2009
 
The hypothalamus–pituitary
involved in a range of physiological processes including metabolism, development 
and reproduction (Michael and Papageorghiou, 2008)
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–adrenal (HPA) axis is a major endocrine system 
.  An important function of the 
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HPA axis is the stress response.  When faced with a threat to homeostasis or 
‘stress’,  whether real or perceived, activation of the HPA axis induces physiological 
changes which help an organism meet the needs of a challenge (Tsigos and 
Chrousos, 2002).  The glucocorticoid cortisol is the end product of a hormonal 
cascade following activation of the HPA axis in humans (corticosterone in rodent 
species) (See Figure 1.4.1).  Stimulatory input to the paraventricular nucleus (PVN) 
of the hypothalamus increases synthesis and release of corticotropin-releasing-
hormone (CRH) into the portal blood circulation via the median eminence.  Together 
with vasopressin, CRH stimulates the secretion of adrenocorticotropic hormone 
(ACTH) from the anterior pituitary. This glucocorticoid secretagogue travels to the 
adrenal cortex via the systemic blood flow where it results in glucocorticoid 
production from the adrenal cortex.  Once released cortisol exerts its actions, in part, 
by binding glucocorticoid receptors (GR) which are found in most tissues in the body 
and throughout the brain (Anacker et al., 2010, Lupien et al., 2009).   
The acute cortisol stress response has been well characterised. Increases are 
consistently reported in response to pharmacological (Wetherell et al., 2006, Schlotz 
et al., 2008), psychosocial and physical stressors, (Kammerer et al., 2002, McRae et 
al., 2006, Jones et al., 2007, Entringer et al., 2009). Cortisol levels peak generally 
10-20 minutes post-stress followed by a return to baseline level (Figure 1.4.1).  A 
prolonged recovery phase is thought to reflect dysregulation of the HPA axis, 
specifically impaired negative feedback, and has been associated with early 
adversity and depression (e.g. Heim et al., 2000, Weaver et al., 2004).   
Both the GR and mineralocorticoid receptor (MR) are abundant in the 
hippocampus, and are involved in the control of the HPA axis.  Low affinity GRs are 
largely unoccupied under basal conditions but thought to regulate the HPA under 
52 
 
conditions of stress or when cortisol levels are high.  Conversely the high affinity MR 
is saturated when cortisol levels are high but controls the HPA axis when cortisol 
levels are lower (Spencer et al., 1998).  Evidence for the role of the GR and MR in 
regulating the circadian rhythm of cortisol comes from clinical studies using 
antagonists such as spironolactone (MR selective) or mifesprestone (GR selective).  
Blocking the GR can result in elevated cortisol levels in the morning, when levels are 
already high (Bertagna et al., 1994).  Similarly inhibiting the MR increases, while 
treatment with an MR agonist (fludrocortisone), decreases in basal cortisol levels 
(Otte et al., 2010).  This view of GR and MR regulation of HPA axis is perhaps an 
oversimplification.  It is more likely that both receptors are involved in the regulation 
of cortisol across the day.  Evidence to support this comes from a study using 
antagonists of both receptors.  Basal evening cortisol levels were enhanced only 
when both mifepristone and spironolactone were co-administered with little effect of 
either drug alone (Mattsson et al., 2009).  
In general cortisol production follows a distinctive circadian cycle (see Figure 
1.4.1).  Animal (Windle et al., 1998) and clinical studies (Russell et al., 2010) 
demonstrate the circadian cycle is composed of pulsatile bursts of cortisol in humans 
and corticosterone in rodents, which increase in amplitude towards the active period.  
In human lowest levels are seen in the late evening.  Cortisol levels increase towards 
the end of the sleep-cycle, a period associated with hippocampal inactivation, 
peaking approximately thirty minutes post-waking.  This discrete portion of the 
diurnal profile, termed the cortisol awakening response (CAR), is followed by 
declining levels across the day (Pruessner et al., 1997).   
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An increasing number of studies have focused specifically on the CAR as a 
potentially informative component of the HPA axis (Clow et al., 2004, Chida and 
Steptoe, 2009, Clow et al., 2009, Fries et al., 2009).  
1.9.1 HPA axis function: focus on the CAR 
The CAR appears to be an independent function of the cortisol diurnal profile 
(Clow et al., 2009). The CAR has been studied extensively over the past two 
decades, not only in healthy populations, but also in relation to many disorders 
including cardiovascular, autoimmune, atopic, allergic, and psychiatric diseases, 
among others (see Clow et al., 2004). 
The CAR is sensitive to pharmacological manipulation as demonstrated by 
the dexamethasone suppression test (DST).  Administering this GR selective agonist 
results in a reduced CAR, a response which is often abnormal in depressed patients 
(Pariante and Lightman, 2008).   
A CAR is observed in approximately 75% of adults with evidence to suggest 
larger CARs on weekdays versus weekend, and in women compared to men (Kunz-
Ebrecht et al., 2004).  The CAR also demonstrates stronger intra-individual stability 
across days (Wust et al., 2000b).  Accordingly there appears to be a genetic 
component to the CAR with moderate heritability estimate (30-45%) between twin 
pairs, but not for cortisol levels later in the day (Wust et al., 2000a, Kupper et al., 
2005).  The CAR has been reported in a range of age groups (Pruessner et al., 
1997) most consistently in adults but also seen in some (Matchock et al., 2007, 
Oskis et al., 2009) but not all studies of children (O'Connor et al., 2005). 
Strong evidence that the CAR is a response to waking and distinct from the 
underlying diurnal profile comes from the work of Wilhelm et al (2007).  By using 
repeated blood sampling and a sleep lab design the authors demonstrated that the 
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CAR was non-linearly associated with the steadily increasing cortisol levels in the 
pre-wake stage.  In addition by monitoring sleep patterns the authors could directly 
link this increase in cortisol to wakefulness.  It has been suggested that cognitive 
processes activated upon waking are necessary for induction of the CAR (Fries et 
al., 2009, Stalder et al., 2009).   
The importance of the hippocampus for CAR regulation is strengthened by 
data from patients with severe hippocampal damage who have greatly diminished 
CARs (Buchanan et al., 2004).  Similarly a group of severely amnesic patients 
showed a reduced CAR (Wolf et al., 2005) which contrasts with studies in healthy 
controls reporting a positive association between the CAR and hippocampal volume 
(Pruessner et al., 2010).  Such findings are of interest given the wealth of literature 
describing the negative feedback inhibition of the HPA axis mediated by activation of 
hippocampal GR (Anacker et al., 2010).  In contrast these studies indicate that the 
hippocampus may have a stimulatory role on the CAR.  One possibility is the 
switching of hippocampal function observed from late stage sleep to wakefulness.  
This period associated with a transient inactivation of the hippocampus post-waking 
may facilitate the CAR (Clow et al., 2009).   Indirect support for this hypothesis 
comes from a recent study of acute stress in which hippocampal inactivation was 
associated with higher cortisol levels (Khalili-Mahani et al., 2010).  Other neural 
structures may also be involved in the regulation of the CAR. 
1.9.2 HPA axis function and other neural structures 
1.9.2.1 The suprachiasmatic nucleus 
The suprachiasmatic nucleus (SCN) which has a central role in the 
maintenance of biological rhythms may be of importance for the CAR (Clow et al., 
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2009). The SCN is sensitive to light which also affects the CAR.  Using a dawn 
stimulation lamp Thorn et al., (2004) demonstrated a positive association with light 
stimulation (Thorn et al., 2004).  A direct effect of the SCN on the CAR is feasible 
given the direct neural projections from the SCN to the PVN in the hypothalamus 
(Buijs et al., 2003).  In addition to input to the PVN the SCN is connected to the 
adrenal via the splanchnic nerve.  These neural circuits provide tentative evidence of 
an association between the HPA axis and SCN.  Stronger evidence of a direct effect 
of the SCN on HPA axis regulation comes from studies of targeted lesions to the 
SCN.  While lesions to the pineal gland or the PVN had little effect, damage to the 
SCN significantly decreased circulating ACTH indicating a direct effect of the SCN 
on ACTH release from the pituitary (Sage et al., 2001).  The SCN has also been 
shown to modulate the adrenal sensitivity to ACTH, affecting circulating 
corticosterone (Ulrich-Lai et al., 2006, Clow et al., 2009).  Taken together these data 
highlight the role the SCN may play in moderating the HPA axis and potentially the 
CAR. 
In addition to the SCN there are a number of other neural structures which 
may regulate the CAR or HPA axis function.   
1.9.2.2 The amygdala 
The amygdala is an important neural structure for the processing of emotional 
stimuli.  The appraisal of a situation as threatening is associated with activation of 
the amygdala when imaged using functional MRI (fMRI) (Taylor et al., 2008, Gregory 
et al., 2010).  Animal studies demonstrate that lesions to the medial amygdala 
nucleus result in reduced corticosterone release following acute stress (Solomon et 
al., 2010).  The amygdala also has reciprocal projections to the hypothalamus.  In 
addition the amygdala is rich in GR and MR and sensitive to circulating 
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glucocorticoids.  Clinical studies have yet to clarify the role of the amygdala in HPA 
axis regulation, however one fMRI study demonstrates decreased amygdala activity 
is associated with lower cortisol levels in response to a stress task (see Dedovic et 
al., 2009).   
1.9.2.3 The prefrontal cortex: 
The prefrontal cortex (PFC) acts in a similar manner to the hippocampus 
exerting a negative control on HPA axis activity (Herman et al., 2005). Importantly 
these effects are observed for both stress induced and basal HPA axis function 
indicating the CAR may also be affected.  A recent study does demonstrate a link 
between the PFC and HPA axis regulation.  Participants with a history of trauma had 
both reduced PFC volume and increased evening cortisol levels (Carrion et al., 
2010).  Currently there is little clinical evidence associating the CAR with the PFC 
however the study of Carrion et al provides initial evidence that the PFC could have 
a regulatory role.  In addition, the reductions in grey matter seen in this area 
following exposure to maternal prenatal anxiety may prove relevant for future studies 
of the reprogramming of HPA axis function (Buss et al., 2009).   
In summary the HPA axis receives input from multiple brain regions which can 
modulate its action.  From an evolutionary perspective this level of control seems 
important given the wide ranging effects of glucocorticoids.  In addition to 
endogenous control, other factors can regulate the function of the HPA axis. 
1.9.3 HPA axis function and psychosocial factors 
A recent meta-analysis combing 62 studies indicates that psychosocial factors 
are associated with the CAR (Chida and Steptoe, 2009).  Most consistently, work 
and general life stress were associated with a larger CAR.  Conversely post 
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traumatic disorder (PTSD) and fatigue were negatively correlated with the CAR.  
Despite a large literature on depression and HPA axis dysregulation this study did 
not find a main effect of depression on the CAR.  The authors discuss differences in 
study design and symptom severity to explain the often conflicting results of positive 
and negative associations with the CAR (Chida and Steptoe, 2009).  Another 
possibility is that the HPA axis responds differentially to subtypes of 
psychopathology. 
Disorder-specific cortisol profiles have been reported, at least in relation to 
depression.  Participants with more atypical symptoms of depression (e.g. mood 
reactivity, hyperphagia, rejection sensitivity, hypersomnia) were found to have lower 
cortisol levels in the morning relative to control (Anisman et al., 1999, Stewart et al., 
2009).  This contrasts with a recent study of over 1,500 participants with major 
depressive disorder (MDD) and with a history of MDD (Figure 1.4.2) where the CAR 
was enhanced in the patient groups.  Comorbid anxiety is also associated with an 
enhanced CAR (Vreeburg et al., 2009).  Recently this group have published data on 
individuals with different anxiety disorders.  The authors indicate that comorbidity 
may be an influencing factor with the highest CAR in panic disorder patients with 
comorbid agoraphobia or depression (Vreeburg et al., 2010).  These studies 
highlight that both hypo and hyper arousal of the HPA axis are associated with 
psychopathology.   
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Figure 1.9.2: The CAR in participants with current major depressive disorder (MMD, 
diamonds) remitted MMD (squares) and controls (triangles).  From Vreeburg et al., 
2009. 
In addition to dysfunction to basal activity of the HPA axis, a number of 
studies report a dysregulated stress response in those with depression (see Burke et 
al., 2005) a finding also seen in adolescence (Lopez-Duran et al., 2009).  Taken 
together these studies provide evidence that the HPA axis can be affected by 
depression and anxiety disorders.  Symptoms severity, and diagnoses specificity 
may influence the direction of this association.  State factors have been reported to 
have a significant impact on the function of the HPA axis, which may explain some of 
the inconsistencies reported in the cortisol literature. 
1.9.3.1 Psychological states 
A considerable proportion of variance in HPA axis function is specific to state 
factors.  This is particularly relevant for studies of the CAR, one study estimates that 
40-60% of the variance in the CAR may be due to state factors (Hellhammer et al., 
2007, Stalder et al., 2010a,b).  In a single case study design Stadler reports marked 
variation in the magnitude of the CAR.  On days when anticipatory arousal was high 
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the CAR was found to be much larger than on rest days, in line with studies finding 
an enhanced CAR on work days (e.g. Kunz-Ebrecht et al., 2004).  A modulatory 
effect of emotional states on the day prior to sampling has also been reported 
(Adam, 2006, Doane and Adam, 2010). 
In addition to the psychological factors described above a number of other 
factors can affect HPA axis function. 
1.9.4 Genetic determinants of HPA axis function 
A number of functional polymorphisms have been identified which affect the 
HPA axis response to stress (DeRijk and de Kloet, 2008).  These include four single 
nucleotide polymorphisms (SNPs) in NR3C1, the gene encoding the GR.  Of these 
SNPs, male carriers homozygous for the 9β AA SNP, associated with reduced GR 
availability, had the highest cortisol response following psychosocial stressor 
(Kumsta et al., 2007).  This contrasted with carriers homozygous for BclI GG, 
associated with increased sensitivity to glucocorticoids, demonstrated diminished 
response.  In females an opposite stress by genotype interaction was observed with 
the highest serum cortisol levels found in female carrier of the BclI GG SNP (Kumsta 
et al., 2007).  
A genotype by sex interaction has also been observed in relation to the CAR.  
Two functional SNPs in NR3C2 (the gene encoding the MR) affect the CAR following 
a DST (van Leeuwen et al., 2010).  
The serotonergic system influences the function of the HPA axis.  An 
investigation of the serotonin transporter (5HTT), a regulator of cellular serotonin 
uptake, found sex specific interactions with the CAR.  Females homozygous for short 
allelic repeats within the the 5-HTT gene-linked polymorphic region (5-HTTLPR), 
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associated with decreased 5HTT transcription, had markedly increased CARs. Males 
demonstrated an opposite pattern. The largest CAR was seen in males homozygous 
for long allelic repeats within 5-HTTLPR, associated with increased availability of the 
5HTT (Wüst et al., 2009).   
This work indicates that the contribution of individual polymorphisms to the 
function of the HPA axis may be sex-specific.  These genetic interactions may 
explain some of the sex differences observed in the cortisol literature. 
1.9.5 Sex differences in HPA axis function 
Aspects of HPA axis function are sexually dimorphic.  The stress response in 
particular shows sex differences which have been comprehensively reviewed  (see 
Kajantie and Phillips, 2006).  In general pre-menopausal women show lower cortisol 
responses to stress relative to males.  This sex-effect varies throughout the 
menstrual cycle with lower responses observed in the luteal phase.  This sex 
difference diminishes in post menopausal women but is re-established through the 
use of hormone replacement therapy (Kajantie and Phillips, 2006).  A related point is 
the use of oral contraceptives (OC).  Studies examining the effect of such medication 
have yielded inconsistent results with some evidence to suggest a smaller CAR in 
women using OC’s.  The size of the effect is thought to be small accounting for 
approximately 4% of the variance in the CAR (Fries et al., 2009).   
In younger children there is less evidence of sex differences.  A series of 
studies with participants ranging in age from 16 months to early adolescence shows 
little difference between the sexes for basal or stress induced cortisol levels 
(O'Connor et al., 2005, Gunnar et al., 2009b, Sumner et al., 2010). 
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 There is conflicting reports of sex differences in the CAR.  A larger CAR has 
been reported in females (Pruessner et al., 1997, Wust et al., 2000b, Kunz-Ebrecht 
et al., 2004, Adam et al., 2010) but this is not consistently found across studies 
(Kudielka and Kirschbaum, 2003, van Leeuwen et al., 2010).  In a recent review of 
the CAR Fries and colleagues (2009) conclude that sex differences probably account 
for a small proportion (1-3%) of the variance in the CAR (Fries et al., 2009). 
1.9.6 Age and the HPA axis 
A recent study of nearly one thousand participants ranging in age from 45-84 
years revealed a positive association between cortisol output and advancing age 
(Hajat et al., 2010).  At younger ages there is some evidence that basal level of 
cortisol increase across childhood and into adolescence (Gunnar et al., 2009b).  The 
CAR may also be affected by age.  O’Connor et al (2005) do not report a CAR in 
their sample of 10 year old children.  Similarly Kudlieka et al 2003 report a significant 
positive association between age and the CAR in a sample of individuals between 4 
and 64 years (Kudielka and Kirschbaum, 2003).  These findings contrast with a 
larger study by Wust et al (2000) who report no effect of age on the CAR (Wust et 
al., 2000b).  It is interesting to note that those studies reporting an age-effect include 
a greater proportion of adolescent participants. 
1.9.7 Puberty and HPA axis function 
A number of studies suggest that puberty is associated with changes to the 
function of the HPA axis.  Basal cortisol levels are seen to increase across stages of 
puberty (Adam, 2006, Gunnar et al., 2009b).  In addition there is some evidence that 
the CAR is also affected by pubertal stage, particularly in females.  Netherton et al., 
(2006) report the emergence of a sex differences in the CAR between pre and mid-
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puberty in morning cortisol.  This difference was not seen in prepubescent children 
but has been reported in adult samples (Kunz-Ebrecht et al., 2004, Netherton et al., 
2004).  More supportive evidence a puberty effect comes from Oskis et al (2009).  
The authors report a main effect of menarche, with a more sustained elevation in 
cortisol levels between waking and 45 minutes post-waking in post-menarchal 
females (Oskis et al., 2009).  These studies contrast with one report of a decreasing 
CAR across stages of puberty (Adam, 2006). 
In addition to effects on basal function the HPA axis becomes more reactive 
to a range of laboratory stressors from childhood to adolescence.  The emergence of 
this reactive HPA axis as a child transitions through puberty points to a maturation of 
the HPA axis during this period (Gunnar et al., 2009a, Gunnar et al., 2009b).    
1.9.8 Ethnic differences in HPA axis function 
There is some evidence for ethnic differences in the function of the HPA axis.  
Ethnic minority groups such as African Americans and Hispanics have been found to 
have an altered diurnal profile relative to Caucasians.  Hajat et al (2010) report lower 
waking levels and CARs in these minority groups (See Figure 1.4.3a ) followed by a 
flatter diurnal profile in Blacks and a steeper decline in Hispanics (Hajat et al., 2010).  
A similar flattened profile has been reported in adolescents of Hispanic and Black 
ethnicity suggesting an early on-set of ethnic differences in HPA axis function 
(DeSantis et al., 2007).  
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Figure 1.9.3 Diurnal cortisol profiles by race (a) and income (b) (from Hajat et al., 2010) 
1.9.9 Socioeconomic status 
Good evidence for an association between SES and HPA axis function comes 
from the UK based Whitehall cohort.  Kumari and colleagues (2010) describe a 
flattened profile among low SES participants (Kumari et al., 2010).  These findings 
are consistent with those of Hajat et al., (2010) who report a flatter diurnal profile in 
lower income groups (Figure 1.4.3b).  Conversely a recent study describes an 
enhanced CAR in low SES participants (Gustafsson et al., 2010).  In this study the 
strongest effect was observed for earlier assessments of SES.  This is in line with an 
earlier study finding an effect of childhood poverty on morning cortisol.  This inverse 
association between SES and cortisol was observed between 6-10 years of age but 
disappeared in adolescence (Lupien et al., 2001).  An interesting observation is that 
in the work of DeSantis et al., (2007), carried out with adolescent participants, no 
effect of SES was observed despite significant differences in relation to ethnicity.  It 
is possible that the effects of SES may be absent in adolescence and re-emerge in 
adulthood. This possibility of a ‘sleeper effect’ is suggested by the work of Miller and 
Chen (2007).  The authors report childhood (between 2-6 years of age) SES to 
a b 
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predict GR mRNA levels in peripheral blood.  This study found early, rather than 
current SES was more closely associated with this index of HPA axis function (Miller 
and Chen, 2007). 
1.9.10 The effects of early adversity on HPA axis function 
The lasting effect of early exposure to low SES is comparable to the literature 
on early life adversity and HPA axis function.  A number of studies have now 
demonstrated a link between childhood trauma and later HPA axis function (Heim et 
al., 2001, Tarullo and Gunnar, 2006, Heim et al., 2008).  In general childhood abuse 
is associated with a blunted HPA response to pharmacological challenges (Heim et 
al., 2001, Tyrka et al., 2009).  Conversely when combined with comorbid depression 
HPA axis out is significantly increased (Heim et al., 2000, Heim et al., 2001, Heim et 
al., 2008) .  Exposure to childhood trauma has been linked to the later on-set of 
chronic fatigue syndrome (CFS).  When combined with CFS early childhood trauma 
is associated with a reduced CAR (Heim et al., 2009).  A study of adoptee’s indicates 
that HPA axis output may be increased or decreased depending on the severity of 
childhood abuse experienced (Figure 1.4.4)(van der Vegt et al., 2009).     
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Figure 1.9.4: Diurnal salivary cortisol profiles in adoptees exposed to severe (dark 
grey) moderate (light grey) or no childhood abuse (black). From van der Vegt et al., 
2009. 
There is some evidence for a moderating role of genetic variants of the CRH1 
receptor in relation to childhood maltreatment (Heim et al., 2009, Tyrka et al., 2009), 
while the role of epigenetic change to HPA axis function is suggested by a recent 
study in adult suicide victims with a history of childhood abuse (McGowan et al., 
2009).  
The studies described above demonstrate how the early environment can 
impact on later HPA axis function.  There is growing evidence that adverse events in 
the earliest stage of human development can have similar consequences.  
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1.9.11  Prenatal stress and programming of the HPA axis: 
animal studies 
It has been known for over five decades from animal studies that maternal 
stress during pregnancy can have a range of long-term effects on the offspring 
(Weinstock, 2001). These include learning deficits, more anxious behaviour, reduced 
attention, altered immune function, as well as altered cardiovascular responses to 
stress (Igosheva et al., 2007) and  glucose intolerance (Lesage et al., 2004).  These 
effects are can be different in male and female offspring (Darnaudery and Maccari, 
2008).  
An advantage of the animal model is the ability to cross foster the prenatally-
stressed pups to control mothers after birth, or nursery rear in the case of monkeys 
(Schneider et al., 2002), and thus establish that the origin of these effects is prenatal 
rather than postnatal.  
In the animal work much research has shown how prenatal stress can alter 
the function of the HPA axis in the offspring.  These effects have been found in a 
range of species.  Variation in the responsiveness of the HPA axis plays an adaptive 
role, and it is plausible that the prenatal reprogramming has evolutionary significance 
and is part of the predictive adaptive response (Love and Williams, 2008).  
Weinstock (Weinstock 2005, 2007, 2008), has reviewed this comprehensively for the 
rodent.  She discusses the variability in results and the many parameters that may 
affect this: the nature and the timing of the stress exposure during pregnancy, the 
age of testing of the offspring, the genetic strain of rat or mouse used, the sex of the 
offspring, the time of day of testing the offspring HPA axis, and whether basal or 
stress induced corticosterone levels were measured.  Despite the variability many of 
the studies have found that prenatal stress did cause both an increase in basal 
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levels and an increase in corticosterone response in the offspring. However several 
others showed a decrease in the corticosterone stress response, and others still 
showed no change.  She concludes that to have an effect the prenatal stress needs 
to be of sufficient intensity, be administered daily in the last week of gestation, and 
that female offspring are more sensitive than males.  Different rat strains appear to 
respond in different ways.  There has been little study of whether the changes in the 
function of the HPA axis underlie the behavioural changes induced by prenatal 
stress, although both have been shown to occur in the same model (Abe et al., 
2007).  
Animal studies have also identified brain structures altered by prenatal stress.  
For example, Coe et al (2003), studying non-human primates, have shown that 
exposure to unpredictable noise, either early or late in pregnancy, resulted in 
reduced neurogenesis and volume of the hippocampus in the offspring (Coe et al., 
2003). This is a part of the brain that is important both for memory and the control of 
the HPA axis.  In rodents prenatal stress has been shown to reduce the number of 
both GR and MR in the hippocampus (Henry et al., 1994). This could explain why the 
corticosterone response to a new stressor is both increased and prolonged: there is 
less feedback inhibition via corticosterone acting on its receptors.  
Another finding in the animal research is that programming effects can last 
until the F2 generation. In one experiment in which the pregnant female was treated 
with dexamethasone,  reduced birthweight and glucose intolerance were transmitted 
to the second generation by both the first generation female and male offspring 
(Drake et al., 2005) This suggests the possibility that epigenetic changes/prenatal 
stress effects can affect both oocyte and sperm.   
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Rodent experiments have shown that the effects of prenatal stress may be 
moderated and even reversed by positive postnatal rearing (Maccari et al., 1995).  
Similarly environment enrichment can buffer against the effects of prenatal stress 
(Welberg et al., 2006).  This indicates that although there can be persisting effects of 
prenatal stress, it is not inevitable, and that the period of sensitivity or programming 
extends beyond the prenatal period.  Meaney and his group have shown how 
variation in the nature of maternal care can have long lasting effects on both the 
behaviour and function of the HPA axis of the offspring. Offspring of mothers 
showing more maternal care are both less anxious and have a less pronounced 
corticosterone response to a new stressor (Liu et al., 1997).  Interestingly, this group 
has shown that prenatal stress interacts with postnatal care.  Levels of maternal care 
were significantly reduced by prenatal stress.  Previously ‘high care’ mothers gave 
rise to offspring with a HPA axis profile similar to those from ‘low care’ backgrounds 
(Champagne and Meaney, 2006).  This group is also uncovering some of the 
epigenetic changes in the brain, altered methylation in the promoter region of the 
glucocorticoid receptor in the hippocampus, which underlie this (Weaver et al., 
2004).   
Additional support for epigenetic regulation of HPA axis activity comes from 
Murgatroyd et al., (2009).  Rodents exposed to early life stress had elevated 
corticosterone across the lifespan and demonstrated depressive-like behaviours 
(passive coping strategies).  These outcomes were associated with decreased 
methylation of a regulatory sequence of the Avp gene, which regulates production of 
arginine vasopressin.  Accordingly, these effects of early life stress were largely 
abolished when rodents were treated with an Avp receptor antagonist (Murgatroyd et 
al., 2009). 
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Although many of the same mechanisms may well occur in humans, there are 
many physiological and other differences between humans and animal models.  For 
example, rodents are born at a much less developed stage than humans.  There are 
differences in the nature and regulation of maternal-placental-fetal neuroendocrine 
processes underlying development and birth across mammals, even between 
nonhuman primates and humans (Smith and Nicholson, 2007). Nevertheless, and 
despite the caveats about the animal findings cited above, animal experiments have 
provided strong evidence that prenatal stress can have long lasting and varied 
effects on the offspring, including the function of the HPA axis. 
1.9.12 Fetal programming and the maternal HPA axis 
The potentially widespread role for exposure to increased cortisol in human 
fetal brain development is strengthened by a microarray analysis that showed that 
increased cortisol exposure affects the expression of over a thousand genes in fetal 
brain cells (Salaria et al., 2006).  The hypothesis that stress causes an increase in 
prenatal maternal cortisol (corticosterone in rodents), which in turn has a range of 
long term effects on fetal development, is cited frequently in the programming 
literature.  It has support from rodent and primate studies, in which the effects of 
prenatal stress are mimicked by administering exogenous glucocorticoids or ACTH, 
and abolished by adrenalectomy (Barbazanges et al., 1996, Schneider, 1999). 
Several animal studies have also shown an effect of prenatal stress in 
reprogramming the function of the HPA axis in the offspring, often resulting in a more 
prolonged and greater cortisol/corticosterone response to stressors later in 
development (Henry et al., 1994, Kapoor and Matthews, 2005).This has lead to a 
model of fetal programming by exposure to excess maternal glucocorticoids (Seckl 
and Holmes, 2007). 
 Figure 1.9.5 Schematic describing the excess maternal glucocorticoid h
fetal programming 
The application of this ‘excess maternal glucocorticoid’ model (Figure 1.4.5) to 
programming in humans has attracted considerable attention.  One set of studies 
has assessed the link between maternal stress/mood symptoms in p
cortisol, a readily observed index of HPA
correct, then we would find elevated levels of cortisol in anxious, depressed, and/or 
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and Trait anxiety and only a modest one with State anxiety (r =0.18), despite high 
levels of State anxiety; there was no significant association between State anxiety 
and plasma cortisol in women for whom samples were taken after 17 weeks 
gestation.  The lack of association in that study may be attributed to sampling cortisol 
only in the morning. 
More recently Davis and Sandman (2010) report a similar lack of association 
between the maternal psychological state and saliva cortisol collected at 5 time-
points across gestation (Davis and Sandman, 2010).  This was despite significant 
associations with child outcome.  While no relationship was observed these data 
require cautious interpretation as saliva samples were collected at one time-point per 
day but not adjusted for time of waking (Davis and Sandman, 2010). 
Few studies have assessed diurnal variation in cortisol in pregnancy in 
relation to maternal stress and mood symptoms.  In their study of 8am and 8pm 
cortisol levels, Obel et al. (2005) reported higher evening cortisol in late pregnancy 
(~30 weeks gestation) in women who had experienced a major life event or had high 
levels of pregnancy specific anxiety (Obel et al., 2005).  Another study (Kivlighan et 
al., 2008) found trait anxiety was associated with a flattened afternoon decline in 
cortisol, which is also consistent with elevated afternoon levels. 
One factor that may confound the links between maternal prenatal emotional 
state and cortisol is a dampening of the HPA axis responsiveness in late pregnancy.  
This has been demonstrated in response to a simple physical stress, the cold hand 
test  (Kammerer et al., 2002), and CRH challenge (Schulte et al., 1990).  Maternal 
cortisol also increases to term under the drive of placental CRH, and the maternal 
adrenal cortex, already producing high levels of cortisol, may have a reduced 
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capacity to respond to psychosocial stress or the maternal emotional state.  This 
could be especially true in the morning when basal levels are already high (de 
Weerth et al., 2007).  It is not known at what gestational age the maternal HPA axis 
starts to lose its responsiveness, or how much individual variability there is in this 
respect.  It is notable that some studies have shown that the greatest effect of 
prenatal stress for child development is in late pregnancy (O'Connor et al., 2002, 
O'Connor et al., 2003). 
It is significant that each of the above studies employed a different 
measurement strategy for assessing cortisol.  That, along with greater attention to 
gestational age, is clearly a matter that requires further attention.  
However, while the link between prenatal stress/distress symptoms and 
maternal HPA functioning may be weak, the evidence that maternal HPA axis 
functioning mediates the association between prenatal stress/anxiety and child 
outcomes is even weaker.  Thus, the few studies that measured both maternal 
cortisol and emotional state failed to find any evidence that maternal cortisol 
mediated the effects of stress or anxiety on child outcomes (Gutteling et al., 2006, 
Davis et al., 2007).  In both studies, the authors reported that maternal cortisol 
predicted outcomes in the infant independently from prenatal stress/mood 
symptoms.  In contrast only the recent study of Davies and Sandman (2010) reports 
an association between higher maternal salivary cortisol in late gestation and child 
outcome.  Exposure to both maternal depression and higher levels of cortisol 
accounted for 7% of the variance in negative infant temperament (Davis and 
Sandman, 2010). 
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1.9.13 Prenatal stress and the function of the HPA axis in 
humans 
In the last ten years there have been a limited number of studies which have 
examined the association between prenatal maternal mood or stress and the 
function of the HPA axis in the child.  They all have different designs and are mostly 
small in terms of their sample sizes.  Most are from Europe, one is from Canada, one 
from Australia, and two from the USA.   The type of prenatal stress studied varies 
from self-rated anxiety (O'Connor et al., 2005, Van den Bergh et al., 2008),  anxiety 
diagnosed by a clinical interview (Grant et al., 2009),  daily hassles and fear of 
bearing a handicapped child  (Gutteling et al., 2004; Gutteling et al., 2005) 
depression , (Brennan et al., 2008, Oberlander et al., 2008) to severe life events 
(Entringer et al., 2009)  or experience of an acute disaster, Chernobyl (Huizink et al., 
2008) or 9/11 (Yehuda, et al 2005). The method of measuring outcome also varies 
from diurnal salivary cortisol to single basal samples, from saliva to plasma cortisol 
and ACTH response to a stressor. The age at which the offspring was assessed 
varied from 3 months to young adults.  
All the studies found that there were associations between prenatal stress and 
some aspect of HPA axis function in the child. However, perhaps unsurprisingly, the 
nature of this association varied and we do not yet have any solid replications.  As in 
the case of the studies of cognitive and behavioural outcomes, the studies on the 
HPA axis are not specific to one type of stress or anxiety.  Further confounding the 
HPA axis findings is that different forms of anxiety – generalized anxiety, panic, 
specific phobia, and posttraumatic stress –  may involve quite different, or even 
opposite, physiological processes.  Whereas anxiety in general is associated with 
raised cortisol, PTSD is associated with reduced cortisol (Tsigos and Chrousos, 
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2002).  It is notable that whereas prenatal maternal anxiety and depression  have in 
general been found to be associated with raised cortisol in the child , the  infants of 
mothers exposed to the trauma of 9/11, who themselves developed symptoms of 
PTSD,  had lower cortisol levels (Yehuda et al., 2005).  The fact that the effect was 
particularly apparent in the children of mothers exposed in the third, rather than 
earlier trimesters, supports the possibility of fetal programming, rather than a shared 
genetic vulnerability.  
O’Connor et al, (2005) and Van den Bergh et al (2008) both examined diurnal 
cortisol levels and found increased basal levels in the child associated with prenatal 
anxiety. O’Connor et al found raised morning and afternoon levels (O'Connor et al., 
2005), whereas Van den Bergh et al (2008) found raised evening levels and a flatter 
curve. Gutteling et al (2004) studying children of mothers reporting more daily 
hassles and Huizink et al (2008) studying children born to mothers exposed to 
Chernobyl, had raised baseline cortisol levels.  Gutteling (2005) also showed that 
prenatal fear of bearing a handicapped child was associated with raised diurnal 
cortisol in the 4 year old child.  Entringer et al (2009) carried out the most 
comprehensive study to date.  They retrospectively identified pregnant women who 
had been exposed to a severe life event such as the death of someone close or had 
experienced severe relationship problems, and recruited the young adult offspring of 
these mothers for their study (prenatal stress group) and a matched non-exposed 
comparison group.  They examined both the diurnal cortisol pattern and the 
response to the Trier Social Stress Test and to a pharmacological challenge of 
ACTH1-24 stimulation in the young adult offspring.  They found no differences in the 
diurnal patterns. However the exposed group had a lower serum cortisol pre-stress 
test level and, perhaps relatedly, a higher cortisol stress response.  In addition ACTH 
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levels were higher in the exposed group during the stress task.  Conversely, 
exposed subjects showed significantly lower cortisol levels during the ACTH 
challenge. 
A study by Grant and colleagues (Grant et al., 2009) found that prenatal 
anxiety was associated with an increased cortisol after the stressor of the “still face” 
procedure in 7 month old infants. They also found that this response was moderated 
by the sensitivity of the mother-infant interaction. This was a small study, with quite 
complex analyses, and certainly warrants replication.  
Van den Bergh and colleagues (Van den Bergh et al., 2008) have provided 
the only evidence that an altered cortisol diurnal profile associated with prenatal 
anxiety was also associated with an altered behavioural phenotype, depressive 
symptoms in adolescent girls.  It is unlikely that alterations in the function of the HPA 
axis underlie all, or even most, of the neurodevelopmental outcomes found to be 
affected by prenatal stress, but more studies of this type are needed.  It is important 
to note that studies have often found little correlation between various psychological 
measures and cortisol levels (Teixeira et al., 2005).   
Most studies did described above do not examine mode of delivery as a 
covariate, although there is some evidence that a more stressful delivery is 
associated with an altered cortisol response to the stress of inoculation, at least for 
the first two months  (Miller et al., 2005). This effect of delivery on infant cortisol level 
was also found by Brennan et al (2008).  Other evidence that early exposure to 
stress can have an effect on the cortisol response of the infant later comes from 
examining stress responses of babies born preterm, who have much higher levels of 
cortisol than a fetus of similar gestational age (Glover et al., 2005). This study 
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showed that the magnitude of glucocorticoid exposure, both endogenous and 
exogenous, was associated with the magnitude of the later cortisol response to 
inoculation.  
Another factor which should be taken into account is birth weight.  Low birth 
weight, an index of impaired fetal growth, which can have a variety of causes 
including increased in utero exposure to cortisol, has been shown to be associated 
with altered function of the HPA axis (Seckl, 2004).  In 7-9 year old children, birth 
weight has been reported to be inversely related to the saliva cortisol response to 
stress in boys, but not morning diurnal cortisol levels. In girls birth weight was 
inversely correlated with morning peak cortisol (Jones et al., 2006), but not to the 
stress response.  
As described above there is starting to be some evidence that the nature of 
the stress response can be modified by sensitive early mothering (Grant et al., 
2009), as in the animal literature.  This has also been shown in a recent study of 
women undergoing amniocentesis and their children.  Despite higher levels of in 
utero cortisol being associated with poorer neurodevelopmental outcomes, good 
parenting buffered against these negative effects (Bergman et al., 2010).  In contrast 
there is also evidence that early exposure to childhood abuse or trauma can be 
associated with later alterations in both stimulated and basal diurnal cortisol patterns 
(Heim et al., 2009). 
In summary animal studies provide good evidence that the maternal HPA axis 
is involved in the transmission of prenatal stress to the fetus.  The evidence from 
clinical studies is less clear cut.  Associations between the maternal emotional state 
and her own cortisol levels are not consistently found.  If maternal cortisol output is 
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not increased in relation to prenatal stress then how does this stress alter the in 
utero environment?  
1.10 Fetal programming and the placenta 
The biological mechanisms which underlie the association between prenatal 
stress and the reprogramming of the function of the HPA axis remain to be 
determined. One possibility is that there is an alteration in the function of the 
placenta, which allows a greater passage of cortisol and other factors from mother to 
fetus. 
The placenta plays a crucial role in moderating fetal exposure to maternal 
factors (Jansson and Powell, 2007), including cortisol and in preparing the fetus for 
the environment in which it is going to find itself (Gluckman et al., 2005).  
Understanding the impact of prenatal stress/anxiety and maternal HPA axis 
functioning on child outcomes requires a careful consideration of the role of the 
placenta, which has so far been largely absent.  However, that is starting to change.  
1.10.1 Placental 11β-hydroxy steroid dehydrogenase type 2 in 
animal models  
The developing fetus is normally protected from the high levels of circulating 
maternal cortisol by the placental barrier enzyme 11β-hydroxy steroid 
dehydrogenase type 2 (11β-HSD2), which converts cortisol to the inactive cortisone 
(Benediktsson et al., 1997).  Localised to the syncytiotrophoblast, the placental 
interface with the maternal circulation, this enzyme normally excludes the large 
majority of maternal cortisol from the fetus (Shams et al., 1998).  This is supported 
by the finding that fetal blood has a 13-fold lower cortisol concentration than 
maternal (Gitau et al., 2001). 
78 
 
Several animal studies support downregulation of placental 11β-HSD2, and 
thus a greater fetal exposure to maternal cortisol/corticosterone, as a possible 
component of programming mechanisms.  For example, pharmacological blockage 
of 11β-HSD2 by carbenoxolone during pregnancy caused an upregulation of 
glucocorticoid receptors in basolateral, central and medial nuclei of the amygdala in 
adult offspring, together with increased basal corticosterone (Welberg et al., 2000).  
A more direct targeting of enzyme activity has been achieved by a pregnant 11β-
HSD2 mouse knock-out model, which affected the fetus/placenta rather than the 
mother (Holmes et al., 2006).  The adult offspring in this model were more anxious 
than controls; their adrenals were also smaller, but basal and stress-induced 
corticosterone levels were unaffected (Holmes et al., 2006).   
Maternal diet may also affect 11β-HSD2 activity. Reducing protein intake by 
50% in pregnant rats decreased placental 11β-HSD2 activity by 33% (Langley-Evans 
et al., 1996); there was also a reduction in birthweight and increased blood pressure 
at 7 weeks in both male and female offspring.  These effects were abolished by 
blocking maternal corticosterone production by metyrapone (Langley-Evans, 1997) 
and restoring corticosterone to physiological levels caused the re-emergence of the 
low-protein phenotype in females only, perhaps suggestive of a sexually dimorphic 
sensitivity to this manipulation.  However, the role of fetal sex, which controls the sex 
of the placenta, remains largely unexplored in animal studies.   
Prenatal stress has also been shown to influence placental 11β-HSD2 activity 
in rats.  In one study placental 11β-HSD2 activity was unchanged relative to controls 
in the chronic stress condition, but markedly increased in the acute stress condition 
(Welberg et al., 2005).  However, when the chronically stressed animals were 
exposed to an acute stressor this potentially protective upregulation of 11β-HSD2 
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activity was absent (Welberg et al., 2005).  In contrast, another study has found 
markedly reduced both placental 11β-HSD2 mRNA expression and activity in rats 
subjected to stress in the last week of pregnancy (Mairesse et al., 2007).  The 
fetuses of these pregnancies were smaller and, as in the knock-out mice, had 
reduced adrenal size.  Circulating fetal corticosterone levels were similar to controls, 
despite lower fetal ACTH (Mairesse et al., 2007).   
These rodent studies indicate that levels of placental 11β-HSD2 activity and 
expression can be regulated by maternal stress. Yet there is a discrepancy between 
these studies regarding the effect of chronic stress on enzyme activity. This may be 
explained by the use of a more potent stressor, incorporating bright lights in 
conjunction with restraint, over a more protracted period (Mairesse et al., 2007). 
Alternatively the use of different inbred lines (Sprague-Dawley versus Long-Evans) 
may influence the result obtained, as demonstrated in other strains of rat (Stohr et 
al., 1998). 
A more recent study has shown that Wistar rats selectively bred for high 
anxiety and exposed to prenatal stress had significantly lower placental 11β-HSD2 
activity than prenatally stressed low anxiety animals (Lucassen et al., 2008).  These 
animals also demonstrated decreased hippocampal neurogenesis, an effect also 
seen in primates exposed to prenatal stress (Coe et al., 2003).  Together these 
studies suggest that the response of placental 11β-HSD2 activity to stress may also 
depend on the genetic vulnerability of the mother but can have lasting effects on key 
neural processes.  
In summary, rodent studies have shown that placental 11β-HSD2 activity is 
sensitive to a range of manipulations, including maternal prenatal stress.  Reducing 
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enzyme activity can alter the neuroendocrine, structural and behavioural phenotype 
of the offspring.   
1.10.2 11β-HSD2 in the human placenta 
In general, human 11β-HSD2 gene expression increases to term and remains 
relatively stable in late gestation (Stewart et al., 1995, McTernan et al., 2001, Schoof 
et al., 2001, Staud et al., 2006).  However, reduced placental 11β-HSD2 activity has 
been found in a range of pathological conditions, which may involve fetal exposure to 
elevated cortisol.  These include preeclampsia (McCalla et al., 1998), maternal 
asthma (Murphy et al., 2003), preterm birth (Kajantie et al., 2006) and intrauterine 
growth restriction (Shams et al., 1998, Dy et al., 2008).  Lower enzyme activity has 
also been associated with poorer clinical outcome, and symptoms of adrenal 
insufficiency, in extremely low birthweight neonates (Kajantie et al., 2006).  
Additionally a congenital deficiency of 11β-HSD2 has been reported to result in 
reduced birthweight and increased susceptibility to hypertension in later life (White, 
2001). 
In contrast a recent study found no differences in placental 11β-HSD2 activity 
or gene expression from small for gestational age neonates when compared to 
appropriate or large for gestational age comparison groups (Mericq et al., 2009).  
There was also some evidence for a sex difference in placenta from the 
appropriately grown group.  Placental 11β-HSD2 activity was significantly higher in 
males in this group.  An additional finding of interest related to placental weight.  
Placental weight was inversely correlated with cord blood cortisol providing evidence 
that placental size may affect steroid levels in the fetus (Mericq et al., 2009).   
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The findings of Mericq et al., (2009) highlight an interesting feature of human 
placental 11β-HSD2 activity is its apparent sexual dimorphism.  One previous report 
indicates higher levels of 11β-HSD2 activity in female placenta (Murphy et al., 2003), 
which contrasts with the findings of Mericq and colleagues.  In response to maternal 
asthma, female fetuses demonstrated decreased placental enzyme activity than 
males, whose levels remained unchanged. Despite these differences in activity 
levels, cortisol concentrations in cord blood were similar in males and females 
(Murphy et al., 2003). This is in agreement with work by Kajantie et al who also failed 
to find an association between enzyme activity and cortisol concentration in cord 
blood (Kajantie et al., 2003, Kajantie et al., 2006). 
These findings suggest that human placental 11β-HSD2 activity may be 
sensitive to certain medical disorders, and that reduction in its activity may affect 
fetal development. It is thus plausible human placental 11β-HSD2 activity may also 
be affected by the maternal emotional state and affect fetal neurodevelopment.  
The results from Glover et al., (2009) suggest that maternal anxiety may 
indeed increase the permeability of the placenta to cortisol.   The authors found a 
strong positive correlation between maternal plasma and fetal amniotic cortisol in 
women with the highest quartile of anxiety; no relationship was found in women with 
the lowest levels of anxiety (Glover et al., 2009). 
Despite this stronger correlation in women with highest anxiety, there was no 
difference in the absolute levels of amniotic fluid cortisol between groups of anxious 
women.  This possibly surprising finding is similar to those of Kajantie et al (2006, 
2003), who found no association between cord blood cortisol and placental 11β-
HSD2 activity (Kajantie et al., 2003, Kajantie et al., 2006), and those of the Mairesse 
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et al (2007) who found no difference in cord blood corticosterone associated with 
prenatal stress induced reduction of placental 11β-HSD2 activity in the rat (Mairesse 
et al., 2007).  
Thus prenatal stress may cause a down regulation of placental 11β-HSD2 
activity, as shown by Mairesse and colleagues in rats (Mairesse et al., 2007) and 
suggested by Glover et al in humans. This may allow more cortisol to cross from the 
maternal to fetal blood and cause a decrease of fetal ACTH and impede fetal adrenal 
growth and maturation.  A smaller, or less mature, fetal adrenal has been shown by 
Holmes et al using a knockout mouse model (Holmes et al., 2006) and suggested by 
Kajantie et al in extremely low birth weight neonates (Kajantie et al., 2006). Thus, 
while the maternal contribution to circulating fetal cortisol may be increased, the fetal 
contribution may be decreased.  This could explain the finding of unchanged cortisol 
in fetal blood despite decreased placental 11β-HSD2 activity (Kajantie et al., 2003, 
Kajantie et al., 2006, Glover et al., 2009).  However the net effect may vary at 
different gestational ages.  It is important to note that the study of cord blood or 
amniotic fluid cortisol is a very crude index of fetal exposure to cortisol in specific 
tissues, although it is the best currently available.  Studies of fetal levels have been 
conducted during brief time windows, either early in gestation at time of 
amniocentesis, or at term.   
For this to help explain the mediating mechanism between prenatal stress and 
child neurodevelopmental outcome one would need to establish that the proposed 
increases in exposure to maternal cortisol, or changes in the function of the fetal 
HPA axis, have long term effects on the function of the HPA axis and behaviour of 
the child.  Specifically, it remains to be seen if the results of Holmes et al (2006) 
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using the knock out mouse model, which showed increased anxiety in the offspring, 
translate to human development.  
1.10.3  Other placental factors 
Reduction in 11β-HSD2 activity may affect other aspects of placental structure 
and function, which in turn affect fetal development.  The 11β-HSD2 knock-out mice 
demonstrated significant placental pathology (Holmes et al., 2006).  These animals 
were found to have a smaller placenta and a 53% decrease in glucose transport 
(Wyrwoll et al., 2009).  
The emotional state of the mother may also alter the function of the placenta 
in other ways, independent of cortisol.  There is some evidence for effects on uterine 
blood supply and nutrient transport, which could affect the neurodevelopment of the 
fetus.  For example, some studies have shown that maternal prenatal anxiety in late 
pregnancy is associated with reduced blood flow in umbilical or uterine arteries 
(Sjostrom et al., 1997, Teixeira et al., 1999), and altered fetal cerebral circulation 
(Sjostrom et al., 1997), although others have not found this earlier in gestation (e.g. 
Kent et al., 2002).  A direct effect of maternal stress on placental nutrient transport 
has also been observed in the rat (Mairesse et al., 2007).  
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1.11 Aims of the current study 
The studies described above provide an overview of the existing evidence 
linking the prenatal environment to biobehavioural outcomes in the child.  A large 
number of prospective studies have reported on outcomes in childhood but there is 
little evidence for effects beyond childhood.  Furthermore, while animal studies 
provide insights into potential mediating mechanisms, clinical studies of this kind are 
in their infancy.  This thesis will attempt to address these key issues by addressing 
the following research questions: 
1) Can the maternal prenatal emotional state affect emotional and 
behavioural development into later childhood or adolescence?   
2) Can the HPA axis of the child be reprogrammed by the maternal emotional 
state during pregnancy?   
3) Is altered placental function a potential programming mechanism? 
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1.11.1 Primary hypotheses to be tested in this study 
1. Maternal prenatal anxiety will predict emotional/behavioural problems in late 
childhood independent of socioeconomic and obstetric risk factors 
 
2. There will be a significant positive correlation between maternal prenatal 
anxiety and diurnal levels of cortisol in their adolescent offspring. 
 
3. Maternal prenatal anxiety will be negatively associated with 11β-HSD2 gene 
expression. 
 
1.11.2 Secondary hypotheses 
1a)  ADHD-related, conduct and emotional development, as described using 
growth models, will be associated with maternal prenatal anxiety.  
2a)  Maternal prenatal anxiety will predict higher waking cortisol in adolescence. 
3a)  Lower gene expression will be associated with increased fetal cord blood 
cortisol 
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2 Chapter 2:  MATERIALS AND 
METHODS 
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2.1 Study design and contributions 
The work described in this thesis can be divided into three studies (1-3).  
Collectively these studies test the association between the maternal prenatal 
emotional state and markers of fetal programming.  Studies 1 and 2 are large 
epidemiological studies, initially designed by V Glover and T O’Connor, using 
mothers and their children from the Avon Longitudinal Study of Parents and Children 
(ALSPAC).  There were two main aims of these studies 1) to determine if the effects 
of the maternal prenatal emotional state on child emotional and behavioural 
development persist across childhood and 2) to determine if maternal prenatal 
anxiety/depression can alter the function of the HPA axis in the child.  These studies 
were designed prior to my appointment and were funded by the National Institutes of 
Health (NIH).  Ethical approval was granted through the local ethics committee at 
Bristol University, where ALSPAC is based. 
As Study 1 (Chapter 3) consisted of analysis of existing data my contribution 
was data management and statistical analysis.  Additional support was provided by 
ED Barker for the growth curve modelling. 
Study 2 required the collection and analysis of saliva samples from the 
ALSPAC cohort.  Recruitment of study participants was carried out locally by 
ALSPAC clinic staff.  I processed the saliva samples returned to the lab by study 
participants, with the help of D Adams.  I carried out all of the salivary cortisol assays 
which form the basis of Chapter 4.  I ensured the method was reliable given the large 
volume of samples and resultant assays.  I then carried out the statistical analyses of 
the cortisol data, with the exception of the multi-level modelling analysis, which was 
carried out by T O’Connor. 
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I initiated and helped to design Study 3 (Chapter 5), under the supervision of 
V Glover, with additional input from L Freeman, to determine if altered placental 
function is a potential programming mechanism.  I carried out recruitment of this 
cohort with additional support from N Khalife.  I was responsible for determining the 
placental sampling procedure and initiating/optimising all placental assays described 
in chapter 5.  Additional support with tissue collection/dissection was provided by N 
Khalife, M Yu and A Jensen, working under the joint supervision of myself and V 
Glover.   In addition to helping with sample collection, A Jensen also completed half 
of the gene expression analyses and all of the cord blood cortisol assays discussed 
in Chapter 5, working under my supervision in the laboratory.  I carried out all the 
statistical analysis of this data with additional advice from T O’Connor.  Funding for 
this study was provided by the Medical Research Council (MRC) with additional 
funding from the Genesis Research Trust. 
Throughout this study V Glover was my primary supervisor responsible for the 
day-to-day supervision of the project, including all writing and analyses undertaken.  
T O’Connor, based at the University of Rochester Medical Centre in New York, acted 
as my secondary supervisor.  Supervision was provided through quarterly meetings 
in London and regular email and telephone communication. 
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2.2 Sample    
The findings discussed in this thesis come from two samples.  The first is a 
large epidemiological sample which was used for studies discussed in chapter 3 and 
4 (Study 1 and 2).  The second sample, for Study 3, is a new cohort established 
specifically to determine the effects of the maternal emotional state on placental 
function (see chapter 5). 
2.2.1 The Avon Longitudinal Study of Parents and Children 
(ALSPAC) 
The ALSPAC cohort was established in the early nineties and continues to be 
one of the oldest prospective cohorts with psychometric data on mothers from 
pregnancy and beyond.  To be eligible for the study, pregnant mothers had to be 
resident in Avon, an area near Bristol, UK. In addition, their expected date of delivery 
had to lie between 1st April 1991 and 31st December 1992. Mothers who were 
resident in the area but left shortly after enrolment were omitted from further follow-
up.  
Self-selecting pregnant women contacted the study team to participate in the 
ALSPAC study.  Those women eligible for participation were sent a general 
information pack and a questionnaire collecting demographic information at 
approximately 12 weeks gestation.  Two additional prenatal questionnaire 
assessments were completed at approximately 18 and 32 weeks gestation.  Events 
such as miscarriage, perinatal death or infant death were notified to the study centre 
by a number of different organisations.  
The core ALSPAC sample consists of 14,541 pregnancies, of which 69 had 
no known outcome. Of the remaining 14,472 pregnancies, 195 were twin, 3 were 
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triplet and 1 was quadruplet, meaning that there are 14,676 children in the ALSPAC 
core sample (Golding, 1990, Golding et al., 2001). 
For surviving children, notification of the birth of the child initiated the timing of 
the postnatal questionnaires to be sent out. As well as date of birth, this notification 
included the birthweight and sex of the child. It also stated whether the child was a 
singleton, a twin or one of a higher order multiple birth pregnancy.  
Following the birth of the study child maternal questionnaire packs were sent 
out at the when children were aged: 8 weeks, 8 months, 2, 3 and 8 years of age.  In 
addition to these maternal assessments, questionnaires about the development of 
their child were sent to mothers at: 4, 7, 9, 11 and 13 years of age.  Finally at age 15 
ALSPAC children were invited to participate in a clinic based assessment called 
Teen Focus 3.  A total of 5,501 participants attended Teen Focus 3. 
All maternal and child-based questionnaire packs described above are 
accessible online at: http://www.bristol.ac.uk/alspac/sci-com/quests/. 
2.2.1.1 The maternal emotional state and child emotional and behavioural 
development (Study 1) 
Maternal ratings of child emotional and behavioural development formed the 
basis for Study 1.  This was assessed five times from childhood to age 13 using the 
Strengths and Difficulties Questionnaire (SDQ) (See section2.3.6).  At age four, the 
first time point, data was available for 9,457 participants (4,895 Males, 4,562 
Females).  In contrast at age 13 data was available for 6,316 participants (3,172 
males, 3,144 females).  The analyses presented in Study 1 are based on participants 
contributing at least one SDQ assessment over the study period.  After exclusions 
(see below) a total of 9,871 (5,098 males, 4, 773, females) remained in the final 
cohort. 
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2.2.1.2 The maternal emotional state and hypothalamic pituitary adrenal (HPA) axis 
function at age 15 (Study 2) 
ALSPAC participants attending the Teen Focus 3 clinic formed the sample for 
Study 2.  This study assessed the contribution of the maternal prenatal emotional 
state to the function of the HPA axis in adolescents.  HPA axis function was indexed 
by salivary cortisol (See section 2.3.8.1).   
Of the 10, 472 participants invited to the ALSPAC clinic approximately half 
attended (n = 5,501).   Recruitment within the clinic commenced in October 2006 and 
continued until March 2008.  In this period 3,020 participants were approached and 
1,175 declined to take part in the study.  Of the participants agreeing to take part 
1,035 returned a total of 9,935 individual samples for analysis.  A final sample of 899 
participants was available for the cortisol analysis following application of exclusion 
criteria (Section 2.2.3.2). 
2.2.2 Maternal emotional state and placental function (Study 3) 
 To test if the maternal emotional state during pregnancy affects placental 
function a second cohort was established based at Queen Charlottes and Chelsea 
Hospital (QCCH), London. 
Women scheduled for a Caesarean section (C-section), attending a pre-
assessment appointment at QCCH were approached for the current study.  Study 
participants with singleton pregnancies, older than 18 years and with no known 
medical disorder were eligible for inclusion. The study was described to all eligible 
participants and an information sheet provided for their consideration (see appendix 
A).   Women wishing to take part were provided with a study pack which included a 
consent form (see appendix B) and a questionnaire pack (see Measures below). 
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Women were asked to fill out the questionnaires when alone that evening and return 
it the following morning prior to their section. A total of 73 women agreed to take part 
in the current study.   
Ethical permission for this study was approved by the local ethics committee 
(REC: No: 08/H0708/126) 
2.2.3 Sample exclusion criteria 
All studies (1-3) were based on singleton pregnancies free from any known 
medical disorder.  In addition it was decided a priori to exclude participants born very 
premature (<32 weeks gestational age) or of very low birthweight (<1500g).  These 
exclusion criteria were adopted to ensure that effects of prematurity or very low 
birthweight did not confound the results of the present analyses.  In addition, there 
were a number of study-specific exclusions. 
2.2.3.1 Study 1 exclusions 
Participants were required to have at least one SDQ assessment for inclusion 
in the analysis of emotional and behavioural difficulties across childhood.  At least 
two SDQ assessments were available for the majority of the cohort with ≥2 
assessments available for 55% of males and 53% of females. 
2.2.3.2 Study 2 exclusions 
All participants taking part in Study 2 returned saliva samples for determining 
salivary cortisol.  These samples were visually inspected and those found with overt 
signs of contamination (e.g. blood, fluorescent colours) were immediately excluded.  
Following the cortisol assay (see section 2.3.1) it became apparent that a number of 
samples had unphysiologically high cortisol concentrations (see Figure 2.2.1).  Any 
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samples with a cortisol concentration greater than 4 standard deviations (SD) above 
or below the mean were excluded from the current analyses. 
2.3 Measures 
2.3.1 Maternal characteristics 
In all studies maternal age in years at time of pregnancy was recorded.  
Similarly in all studies the number of previous pregnancies was recorded through 
maternal self-report.  In addition, a measure of pre-pregnancy body mass index 
(BMI) was available for participants in all studies.  
2.3.1.1 Maternal smoking and alcohol use during pregnancy 
In the ALSPAC studies data on smoking and alcohol use during pregnancy 
was collected through maternal self-report from the prenatal assessment at 18 
weeks.  Smoking was assessed by asking mothers ‘have you smoked during the last 
two weeks?’ with responses coded as yes/no.  Maternal responses to alcohol 
consumption during pregnancy were coded as 1) none, 2) less than 1 glass of 
alcohol per day and 3) more than one glass of alcohol per day. 
In Study 3 maternal smoking during pregnancy was recorded by asking ‘Are 
you currently smoking?’ with a yes/no response.  If participants responded positively 
to this question they were asked to estimate their daily cigarette intake.  With regard 
to alcohol intake, mothers were asked to estimate their weekly unit-alcohol intake 
using the prompt ‘One unit is equivalent to a small glass of wine/a glass of beer’.  
Response categories were: None, 1-5, 5-10 and greater than 10 units per week.  
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Figure 2.2.2.3.1 Examples of individuals with cortisol 
levels outside of normal range (mean values over 3 days 
are inset. Extreme scores were not limited to the 
awakening response (a-b) and were not consistent over 
the three days (a-c). Individual days not exceeding 4SD 
from the overall mean were also evident in these 
participants (c) 
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2.3.2 Obstetric outcomes 
2.3.2.1 Study 1 and 2 
The obstetric outcomes birthweight and gestational age were included in all 
analyses using the ALSPAC cohort.  These measures were recorded and verified 
from a number of sources.  Any pregnancies ending prior to 37 weeks gestation 
were verified from obstetric case notes by an ALSPAC clinician.  Similarly 
birthweight was recorded from multiple sources including maternal self-report and 
obstetric notes.  Cases in which there was a significant discrepancy between 
maternal estimates and obstetric records are not included in the current analysis.    
2.3.2.2 Study 3 
Both the clinical indication for C-section and gestational age was recorded 
from maternal self-report and verified from obstetric records.  Similarly birthweight 
was obtained from delivery records held at QCCH.  
2.3.3 Maternal psychometric questionnaires 
2.3.3.1 Study 1 and 2 
Maternal anxiety was assessed at seven timepoints starting in pregnancy at 
18 weeks and continuing until eight years postpartum.  Self-report maternal anxiety 
was measured used the anxiety subscale of the Crown-Crisp Experiential index 
(Crown and Crisp, 1966) (see appendix C).   This eight item index with four response 
categories results in ratings ranging from zero (not anxious) to 16 (very anxious).  
This measure of anxiety was employed in the prenatal period (18 and 32 weeks 
gestation) and then at eight weeks, eight months, two and three years’ postpartum.  
The final assessment of maternal anxiety occurred when children were aged eight.  
At this time-point the Spielberger trait anxiety inventory (STAI) was used to assess 
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maternal anxiety (Spielberger et al., 1970) (see appendix D).  The STAI correlates 
well with both the CCEI and other clinical assessments of anxiety.  This 20-item 
questionnaire has four responses categories with total scores ranging from 20 (not 
anxious) to 80 (very anxious).  The STAI requires respondents to answer individual 
items with respect to how they generally feel.  Trait anxiety, as measured by the 
STAI is indicative of stable dimension of personality and general feelings of anxiety.  
Maternal depression was measured in parallel with assessments of maternal 
anxiety.  The Edinburgh Postnatal Depression Scale (EPDS) was used to assess 
depressive symptoms (Cox et al., 1996).  This ten item screening questionnaire, 
validated for use in pregnancy, as well as postnatally,  gives scores ranging from 0 
(not depressed) to 30 (very depressed)(see appendix E).  As such, data on maternal 
anxiety and depression was available at the from two timepoints pregnancy (8 and 
32 weeks) and then postnatally at 8 weeks, 8 months, 2, 3 and 8 years. 
2.3.3.2 Study 3  
Two different assessments of maternal anxiety were used in Study 3.  All 
women completed the STAI, to measure trait-like anxiety, but also the Spielberger 
state anxiety inventory (SSAI)(Appendix F).  This 20-item scale is comparable to the 
STAI however respondents are asked to response to questionnaire items ‘at the 
present moment’.  This scale is useful for assessing transitory or momentary anxiety.   
In line with Study 1 and 2, the EPDS was used to measure maternal prenatal 
depression scores. 
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2.3.4 Indicators of socioeconomic status (SES) 
In all studies indices of SES were recorded and covaried in subsequent 
analyses.  The measures of SES used differed between the ALSPAC studies and 
Study 3.  
In the ALSPAC studies maternal education was assessed during pregnancy 
and used a proxy for maternal SES.  Three categories were formed on the basis of 
maternal responses ranging from lowest to highest educational achievement 1) 
Certificate of secondary education/vocational training, 2) O-level, 3) A-level/Third 
level education.   
A household crowding index was calculated and served as an additional 
measure of SES.  The crowding index was given by dividing the number of persons 
per household by the number of rooms.  Responses to this assessment resulted in 
four categories 1) Low: crowding index ≤0.50; 2) 0.50-0.75; 3) 0.76-1.0 and 4) High: 
values >1. 
In Study 3 annual household income served as a marker of SES.   
Respondents were asked to report their monthly household income which was 
converted to household income per annum.  The following income brackets were 
established:  less than £18,000, £18,000-£25,000, £25,000-£43,000, greater than 
£43,000. 
2.3.5 Study child ethnicity 
Child ethnicity was recorded in all studies by maternal self-report.  In the 
ALSPAC cohort a limited response category of ‘White/Non-white’ was employed to 
describe child ethnicity. 
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In Study 3 mothers were asked to report their child’s ethnicity.  Mothers 
selected their child’s ethnicity from one of the following categories: Caucasian, 
African/Afro-Caribbean, Indian/Pakistani and Middle Eastern.  Alternatively mothers 
could record a non-listed ethnic group in a free-format response section.   
2.3.6 Child emotional and behavioral development 
Child emotional and behavioural development was measured using the SDQ 
(Goodman et al., 1998).  This brief screening questionnaire can be used in 3-16 year 
olds to assess emotional and behavioural development.  The full questionnaire 
consists of 5 subscales assessing 1) Attention deficit and Hyperactivity (ADHD) 
related problems 2) Emotional problems 3) Conduct 4) Peer relations 5) Prosocial 
behaviour, and a Total score composed of subscales 1-4 (see appendix G).  The 
SDQ is robust screening tool and demonstrates both good psychometric properties 
and cross-cultural sensitivity (Goodman et al., 2000b, Goodman, 2001).  
For these analyses the three ‘problem’ scales (1-3) were assessed.  Each of 
these subscales show good discriminatory and predictive validity for ADHD, 
emotional problems (Anxiety/Depression) and Conduct Disorder (CD) respectively 
(Goodman et al., 2000b, Blom et al., 2010). 
2.3.7 Markers of pubertal development 
Data on puberty in the ALSPAC cohort were available at 14.5 years of age 
(175 months) using the Tanner stages (Marshall and Tanner, 1969, 1970).  Data 
were self-report collected by study child.  From males data on the presence and 
pattern of pubic hair and voice change were available.  For females details on breast 
development, pubic hair, and age of menarche were available.  This data was used 
as a covariate for the cortisol analyses presented in chapter 4. 
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2.3.8 Biological measures 
2.3.8.1 Saliva sampling (Study 2) 
Participants attending Teen Focus 3 clinic who took take part in Study 2 were 
given detailed instructions and provided with a saliva sampling pack.  This pack 
contained 12 saliva sampling tubes/Salivettes (Starsteadt, Germany), an information 
sheet and a sampling time record form (see appendix H).  Participants were 
instructed to provide saliva samples at waking, then thirty minutes post-waking, after 
school and before bed to capture the diurnal profile of salivary cortisol.  Participants 
were asked to refrain from eating or brushing their teeth 30 minutes prior to 
sampling. Participants were asked to record the date and timing of each sample on 
their daily record sheet.  The times given on these sheets were used as an index of 
compliance with sampling procedure and to ensure samples were taken on school 
versus non-school days.  Participants were asked to store their samples in the fridge 
until all three sampling days had been completed.  Samples were then returned to 
the laboratory by post.  Saliva samples were checked for quantity and quality and 
archived at -20C until the day of assay.  All samples were assayed for salivary 
cortisol (see section 2.4.1). 
2.3.8.2 Placental and fetal cord blood (Study 3) 
Following each C-section, the attending midwife removed the placenta 
checked for any abnormalities and collected fetal cord blood samples.  Arterial and 
venous cord blood samples were collected into ethylenediaminetetracetic acid 
(EDTA)-free vacutainers (Becton-Dickinson, UK).  The placenta and cord blood 
samples were immediately returned to the laboratory and processed as described 
below. 
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2.3.8.2.1 Placental sampling 
All placenta were collected and processed less than one hour post-delivery.  
All placental data were collected on individual proformas (see appendix I).  
Firstly, the umbilical cord was trimmed to approximately one inch and the 
placental weight was recorded. Tissue samples were then taken from the maternal 
side of the placenta, at 5 random sampling sites (across the placenta). To ensure the 
tissue was fetal in origin, the uppermost surface of the cotyledon was removed and 
trophoblast tissue collected from the central part of the placenta.  The tissue samples 
were washed (x3) in phosphate buffered saline (PBS) to remove excess blood. Each 
sample was then finely dissected in ice cold PBS. Samples from all 5 sites were 
pooled to account for any intraplacental variation in measure of interest (e.g. gene 
expression).   
Tissue used for RNA analyses was first treated with the RNA stabilising 
solution RNAlater (Applied Biosystems, UK).  Approximately 0.2g of pooled placental 
tissue was added to a 1.5ml microcentrifuge tube containing 1ml RNAlater.  Tissue 
samples were kept in solution at 4C overnight before removal of RNAlater and 
transfer of sample to -80C.  
Tissue for 11β-HSD2 activity analyses were collected in a 1.5ml 
microcentrifuge tube, placed on dry ice and then stored at -80C. 
2.3.8.2.2 Fetal cord blood sample processing 
Matched arterial and venous cord blood samples in EDTA-free vacutainers 
were allowed to clot at room temperature (RT) for 10minutes.  Samples were then 
centrifuged at RT for 10 minutes at 1500 x g. The sample serum was removed and 
aliquots of 200ul stored at-80C. 
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2.4 Biochemical Assays 
2.4.1 Salivary cortisol 
Saliva samples were assayed for cortisol using a standard commercial 
enzyme linked immuno-sorbent assay (ELISA) (Salimetrics, UK). This is a 
competitive binding assay in which the cortisol in saliva samples and standards, 
compete with horseradish peroxidise-linked for antibody biding sites. The protocol 
described by the manufacturer was adhered to with minor amendments. 
The assay requires 25µl of saliva which is incubated for one hour with 
horseradish peroxidise-linked cortisol in phosphate buffer. Bound cortisol remains 
following a series of washes with a phosphate buffer. A second incubation (30mins) 
with tetramethybezidene results in a colour change (blue) based on presence of 
peroxidise-linked cortisol. This reaction is stopped by the addition of 50 µl 2M 
sulphuric acid giving rise to a second colour change (blue to yellow). This is 
measured spectrophotometrically at 450nm (with correction at 650nm) in a standard 
laboratory plate reader (Tecan sunrise, Tecan, UK). A standard curve was generated 
and the concentration of unknowns calculated (Figure 2.4.1). Standards from a 
pooled stored saliva sample were included in each assay batch as an internal 
standard.   This assay has good sensitivity with a lower detection threshold of 
0.05nmol/L.  The intra and inter-assay coefficients of variance (CV) were 7.9 and 
8.9% respectively.  
   
Figure 2.4.1: A salivary cortisol standard curve
samples was determined with reference to the optical density (Y axis) of the 
standards of known concentration (X axis).
2.4.2 Fetal cord blood cortisol analysis
Serum cortisol from fetal cord blood samples was measured using a serum 
ELISA kit (R&D systems, UK). 
Serum samples were thawed at RT prior to assaying and diluted 20
calibrator diluent to a total volume of 200µl. Each assay included 7 pairs of cortisol 
standards (at concentrations of 10, 8, 5, 4, 2.5, 1.25 and 0.31ng/ml). These were 
used to generate the standard curve. In addition, each assay included two blank 
wells (where no sample was a
included. 
Briefly, 100µl of each standard and sample was pipetted into individual wells 
of the antibody coated microplate. 150µl and 100µl of calibrator diluent was added to 
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the NSB and blank wells respectively. 50µl cortisol conjugate was added to all wells 
using a multi-channel pipette. Subsequently 50µl primary antibody solution was 
added to all but the NSB wells. The plate was covered with an adhesive strip and 
incubated for 2 hours at RT. Any unbound material was then removed and the plate 
washed (x4) using assay buffer. The plate was inverted and blotted dry. Colour 
reagents A and B were mixed to give the substrate solution which was protected 
from light and used within 15 minutes of preparation. 200µl substrate solution was 
added to each well and the time taken between addition to the first and last row of 
wells was noted. A 30minute incubation at RT followed, with the plate protected from 
light.  The assay was terminated by the addition of 50µl stop solution was then 
added to each well.  The plate was then agitated on a plate-shaker at 500rpm for 2 
minutes, the plate was read three (within 30 minutes) using a plate reader set at 
450nm.  The standard curve was generated and cortisol determined in the cord 
blood samples. 
  The intra-assay coefficient of variation was 7.8% (n=22) and the inter-assay 
coefficient of variation was 12.7% (n=16). 
2.4.3 Placental 11β-HSD2 gene expression 
2.4.3.1 Placental RNA extraction  
A sample of RNAlater treated placenta tissue (approximately 50-100mg) was 
homogenized in 1ml of TRIzol reagent (Invitrogen, UK). Each sample was then 
transferred to a 1.5ml RNase-free microcentrifuge tube. The homogeniser was 
cleaned between samples using RNaseZap (Invitrogen, UK) to avoid RNase and 
cross-sample contamination. Samples were incubated at RT for 5 minutes before 
addition of 0.2ml chloroform to each tube. Tubes were shaken vigorously by hand for 
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15 seconds before incubation at RT for 2-3 minutes. Samples were then centrifuged 
at 13,266xg for 15 minutes (at 4C) resulting in each separation to give an upper 
aqueous phase which was removed and aliquoted into a new 1.5ml tube. To each 
tube, 0.5ml isopropyl-alcohol was added and incubated for 10minute at RT.  
Samples were then centrifuged at 13,226 x g for 10 minutes (at 4C). The 
supernatant was removed from each tube leaving a gel-like RNA pellet which were 
washed with 1ml 75% ethanol before vortexing and then centrifuging at 3,306 x g for 
5 minutes (at 4C). The ethanol was removed and the pellets dried for 15 minutes at 
RT. The pellets were then re-dissolved in 60µl RNase-free water and the samples 
heated at 55-60C for 10 minutes to promote solubilisation into water.  
The RNA concentration (in ng/µl) of each sample was measured using a 
NanoDrop ND-1000 spectrophotometer. The ratio of sample absorbance at 260 
versus 280nm was noted to assess the concentration and purity of the RNA sample. 
A 260/280 ratio between 1.7 and 2.0 was deemed acceptable (see: 
http://nanodrop.com/Library/CPMB-1st.pdf). 
2.4.3.1.1 Assessing RNA integrity  
The integrity of the RNA extracted from each placenta sample was assessed 
using the Agilent 2100 Bioanalyzer (Agilent Technologies, UK) and following the 
protocol for the RNA6000 Nano-Assay. Using electrophoretic separation the Agilent 
Bioanalyzer separates the RNA samples on a microfabricated chip and then detects 
them using laser induced fluorescence detection (Fleige and Pfaffl, 2006). An RNA 
ladder is used as a standard to determine the mass and size of the RNA bands 
present in the samples (Fleige and Pfaffl 2006). Electropherograms are produced for 
each sample which can be used to assess the RNA quality. In addition, an RNA 
integrity number (RIN) is determined by the Bioanalyzer based on the 
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electropherogram produced.  Those samples with an RNA integrity number (RIN) ≥5 
were used for subsequent cDNA synthesis and qPCR (as recommended by Fleige 
and Pfaffl 2006). 
2.4.3.2 Reverse Transcriptase polymerase chain reaction (RT-PCR): cDNA 
synthesis 
First, genomic DNA was removed from the RNA sample using a DNase 
treatment (DNase I, Invitrogen, UK). Subsequently, the RNA template is incubated 
with the deoxynucleoside triphosphates (dNTPs) from which a DNA template will be 
synthesised using the reverse transcriptase SuperScript III, and using random 
hexamers as a primer (all reagents Invitrogen, Paisley, UK).  
cDNA synthesis was carried out for all samples with a RIN value ≥5 using the 
Invitrogen Superscript III First-Strand synthesis system for quantitative PCR (qPCR) 
(Invitrogen, UK). Firstly, DNase treatment for each sample was carried out by mixing 
2µg of RNA (in a total volume of 16µl) with 2µl DNase I and 2µl 10X DNase I 
reaction buffer. After incubation at RT for 15 minutes, 1µl EDTA was added before a 
further incubation for 10 minutes at 65C. From this reaction 16µl was then 
transferred to a new 0.2ml tube. To this, 2µl dNTP mix and 2µl Random hexamers 
was added before incubation at 65C for 5 minutes followed by 4C for at least 1 
minute. Subsequently, a cDNA synthesis mix was prepared comprised of 4µl 10X RT 
Buffer, 8µl 2.5mM MgCl2, 0.1M Dithiothreitol (DTT) and 2µl 40U/µl RNase OUT, per 
sample. 18µl of the cDNA synthesis mix was added to the RNA/random hexamer 
mixture before a 2 minute RT incubation. The content of the sample was 
subsequently split into two 19µl aliquots.  To the first 1µl 200U/µl SuperScript III RT 
was added to initate reverse transcription and cDNA synthesis. Following incubation 
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of all tubes at RT for 10 minutes, 50C for 50 minutes and 85C for 5 minutes, samples 
were stored at -20C.  To the second tube 1ul of water was added followed by the 
incubation described above.  The sample serve as the no reverse transcriptase 
controls (-RT) which are used to determine genomic DNA contamination during 
qPCR.   
2.4.3.3 Primer sequences (L19 and 11β-HSD2) 
The large ribosomal protein L19 was the housekeeping gene used to 
normalize for differences in input RNA. Both forward and reverse primers were used 
at a concentration of 400nm per reaction.  The primer sequences were as follows: 
L19 forward: 5’ GGGCTGTTCAACTCCAATACG 3’  
L19 reverse: 5’ GCTCATCACCGGGTGTGACT 3’  
Similarly a primer concentration of 400nM per reaction was used for 11β-
HSD2 gene expression analysis.  The following primer sequences were used:  
11β-HSD2 forward: 5' GCTCATCACCGGGTGTGACT 3’  
11β-HSD2 reverse (5’ GCTCATCA CCGGGTGTGACT 3’ 
2.4.3.4 qPCR: measursing 11β-HSD2 gene expression 
An individual MicroAmp Optical 96 well reaction qPCR plate (Applied 
Biosystems) was prepared for determining L19, and 11β-HSD2 gene expression 
respectively. In each well the final assay volume consisted of: 12.5µl SYBR Green 
ReadyMix, 5.5µl DEPC-treated water, 1µl forward and 1µl reverse (diluted to give 
final concentration of 400nM).  The principle of this assay is based on the covalent 
bonding of SYBR green reagent to double-stranded DNA giving rise to fluorescence.  
The point at which fluorescence becomes detectable is termed the cycle threshold 
(Ct) and is directly proportional to the concentration of cDNA in the sample. 
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For each gene of interest 5µl of sample cDNA was added. No template control 
(NTC) samples were run (with 5µl water instead of cDNA) on each plate to check for 
primer-dimer artefacts and assay contamination.  A number of –RT samples were 
added to each plate to assess genomic DNA contamination.  In addition a  selection 
of L19 and 11 β-HSD2 internal standards was also added to each plate (using 5µl 
pooled cDNA), thus allowing for cross plate comparison. The cross plate coefficient 
of variation was 4% (n=4). qPCR was performed using the Applied Biosystems 
StepOne Real-Time PCR systems. The cycling parameters were 1) 50C for 2 
minutes, 2) 95C for 10 minutes, 3) 95C for 15 seconds and 4) 60C for 1 minute. 
Steps 3 and 4 were repeated for a total of 40 cycles.  Data for 11β-HSD2 are 
presented as the ∆CT, target gene expression normalised to the housekeeping gene 
(11β-HSD2 Ct – L19 Ct) and as the fold change in expression. The fold change is 
calculated using the 2-∆∆CT method (Schmittgen and Livak, 2008) where the ∆∆CT is 
the ∆CT from the control group is subtracted from the ∆CT of the experimental group 
e.g. the high prenatal anxiety group.  
2.4.4 Placental 11β-HSD2 activity 
2.4.4.1 Placental 11β-HSD2 activity: tissue homogenization 
Frozen placental samples were dissected on dry ice.  Approximately 0.2g of 
tissue was dissected into a sterile 4ml polypropylene tube (Becton-Dickinson, UK).  
To this, 500ul of homogenisation buffer was added (250mM Sucrose and 10mM 
HEPES, pH: 7.4).  This homogenate was spun at 134g for 10 minutes at 4C to pellet 
nuclear debris.  The supernatant was removed, divided into aliquots and then stored 
at -80C. 
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2.4.4.2 Placental 11β-HSD2 activity: protein estimation (Bradford assay) 
Protein was estimated by method of Bradford (Bradford, 1976).This assay is 
based on the colorimetric conversion of Bradford reagent (Coomasie blue, Sigma-
Aldrich, UK) from blue (low protein) to dark brown (high protein).  Protein standards 
were prepared at a range of 2.00, 1.75, 1.5, 1.25, 1.0, 0.75, 0.5, 0.25mg/ml using 
Bovine Serum Albumin (Sigma-Aldrich, UK) dissolved in the sucrose/HEPES buffer 
(see above).  In addition a blank control (assay buffer) was prepared.  5µl of the 
standards, blanks and unknown samples were plated in duplicate into a 96-well flat 
bottomed plate. 250µl of Bradford reagent was added to each well. The plate was 
agitated for 10 minutes on a bench-top shaker before reading in a standard 
laboratory plate reader (Tecen Sunrise, Tecan, UK) at 595nm.  The standard curve 
was determined and the protein content of placental samples calculated.  
2.4.4.3 Activity assay 
Placental 11β-HSD2 activity was determined using a high performance liquid 
chromatography (HPLC) based radiometric conversion assay (Brown et al., 1996).  
The principle is based on measuring the percentage conversion of tritiated cortisol to 
tritiated cortisone under standard conditions as an index of enzyme activity. This 
method was modified from Brown et al (1996).  The final optimised assay of 250µL 
consisted of 1.5mg/ml protein (excluding nuclear protein), 400uM of Nicotinamide 
dinucleotide (NAD) and 2.3uM cortisol prepared in Phosphate Buffer (10% glycerol, 
300 mM NaCl, 1 mM EDTA, 0.02 M Tris}HCl, pH 7.7).  Substrate was a mix of non-
tritiated and tritiated cortisol at a ratio of 22:1, dried down under oxygen-free 
Nitrogen (OFN) and reconstituted in 25% ethanol and 75% Phosphate Buffer.  The 
incubation was performed at 37C for 30minutes. The reaction was stopped by the 
addition of 1ml of ice-cold ethyl acetate and removing the reaction tube into ice.  
 500µl of organic layer containing the steroids was pu
and dried down under OFN at 60C before being re
phase (25% Methanol (MeOH), 15% Acetonitrile (ACN), 60% HPLC grade water) 
2.4.4.3.1 HPLC separation of cortisol and cortisone: chromatography conditions
Reverse phased HPLC was used for steroid separation.  This was carried out 
using a Perkin Elmer 200 series HPLC system fitted with a C18
pore size: 5µm; 46x150mm) with the column temperature held constant at 35C.  
Mobile phase (25% MeOH, 15% AC
to equilibrate for 30 minutes prior to the first run.  
Figure 2.4.2 HPLC steroid separation.  Data from placental 11
Following efficient HPLC separation (
of tritiated cortisone was determined by measuring scintillation events/counts per 
seconds (CPS) using a Berthol
attached to a scintillation pump (Perkin Elmer 200 series).  Ultima Gold liquid 
scintillant was pumped at 2ml per min through the radio
converted to Volts per second and this information u
using TotalChrom HPLC software (TotalChrom Version 6, Perkin
area was used as a marker of analyte concentration.  
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2.5 Statistical analyses 
In all studies, numeric data were tested for normality using probability-
probability (P-P) plots.  Data which was skewed appeared normal after ln 
transformation (Figure 2.5.1).  In cases where data did not benefit from ln 
transformation non-parametric tests were used. 
  
 
Descriptive statistics are presented as mean and standard deviation (SD) or 
median and range where appropriate. 
The correlation between variables of interest was measured using Pearson 
product moment (r(p)) or Spearman rank order (r(s)) tests of association for parametric 
and non-parametric data respectively.   
In addition, univariate and multivariate linear regression was used to 
determine any independent linear relationships between covariates and outcomes of 
interest.  These analyses were all carried out using SPSS version 18 (SPSS, UK). 
Finally a number of study-specific analyses were carried out which are 
detailed below.  
Figure 2.5.1: An example of non-normally distributed evening cortisol sample 
(left) which normalised following Ln transformation (right) 
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2.5.1 Study 1: Growth curve analysis of child emotional and behavioural 
development 
Growth curve analysis has been used for a wide range of studies which 
attempt to identify the predictors of outcomes with differing developmental 
trajectories.  Examples include the predictors of alcohol use across adolescence 
(Harford and Muthen, 2000), risky sexual behaviours (Mason et al., 2010) and peer 
victimisation (Troop-Gordon and Ladd, 2005). 
A novel aspect of this methodology is its ability to combine data from multiple 
timepoints within a single framework.  This data is used to generate latent growth 
factors.  Predictors of interest can be tested for an association with each aspect of 
growth.  As such a predictor may account for variance in the starting point 
(intercept), the positive or negative change over time (slope) or non-linear patterns of 
growth (quadratic). 
In the context of this study child SDQ scores from multiple assessments were 
used to model ADHD-related, conduct or emotional development.   
A robust maximum likelihood estimator (MLR) was used in these analyses to 
account for the non-normal distributions of the repeated measures data. 
First an unconditional model was fit to the data to assess if a two (intercept, 
slope) or three factor solution (intercept, slope, quadratic) best described the data.  
Model fit was assessed by three parameters: the comparative fit index (CFI <.95), 
the Tucker Lewis Index (TLI > .95) and the root mean squared estimate of 
approximation (RMSEA < .06) (Hu and Bentler, 1999).   
Sex differences in growth factors were tested using the Satorra-Bentler 
Scaled Chi-Square test, analogous to a t-test for nested models.  Subsequently 
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measures of maternal anxiety from pregnancy and beyond were added to the model 
together with obstetric, pregnancy related and SES-related factors.  These 
covariates were regressed on each growth factor simultaneously and the 
independent effect established.  Finally missing data were accommodated by full 
information maximum likelihood (FIML) which uses the available data to derive 
estimates for missing data. 
2.5.2 Study 2: Cortisol analysis 
The research literature does not yet provide a coherent or consistent manner 
for analyzing diurnal cortisol data.  As such a number of different methodologies 
were employed.  The findings from conventional forms of analysis were assessed 
using these different forms of analysis providing a robust test of the study’s findings.  
2.5.2.1 Repeated measures multivariate analysis of variance (MANOVA)  
In line with the previous work from within this cohort data were analysed using 
multivariate analysis of variance (O'Connor et al., 2005).  This analysis extends the 
ANOVA model to include multiple dependent variables (outcome measures). In the 
context of this study, the mean cortisol value (day 1-3) was entered into the 
MANOVA model.  Covariates were then tested for main effects (an effect on the 
overall diurnal profile) before reporting specific effects of covariates of interest on 
individual cortisol measures. 
2.5.2.2 Cluster analysis 
Cluster analysis is an exploratory data analysis tool which can use a number 
of algorithms to determine similarity between data-points (Jain et al., 1999).  Cluster 
analysis can be used to discover structures within cortisol data grouping participants 
with similar cortisol diurnal profiles into groups or ‘clusters’.  As such cluster analysis 
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is a data driven or ‘bottom-up’ form of data analysis (Jain et al., 1999).  Using this 
analytical approach Lasikiewicz et al., (2008) describe two distinct clusters of cortisol 
profiles in their study of adults and metabolic risk factors.  The cluster associated 
with the highest number of metabolic risk factors had a blunted cortisol diurnal profile 
(Lasikiewicz et al., 2008).  More specifically, the Ward linkage method of cluster 
analysis uses the variance in data to determine which patterns of data-points are 
grouped together (Ward, 1963).  Each data point is plotted in a three dimensional 
space, points that fall closest together are grouped together.  It is then possible to 
assess if a predictor of interest is more closely associated with one group/cluster 
using chi-square (χ2) tests of distribution.  In the context of this study the mean 
cortisol diurnal profile represents the data patterns and the clusters are formed of 
participants with the most similar cortisol profiles. Cluster analysis was used to 
determine if there was a specific cortisol diurnal profile which showed a strong 
association with maternal prenatal anxiety.  Cluster analysis and subsequent chi-
square testing were carried out in SPSS version 18 (SPSS, UK).  
2.5.2.3 Multi-level modelling 
Data were analyzed using multilevel modelling (random effects models).   A 
novel aspect of this form of analysis is its ability to model nested data.  Typically 
sample samples are collected on a number of occasions (e.g., wake-up, 30minutes 
following wake-up, 4pm, 9pm) that is nested within days (day 1-3) that is nested with 
subject.  Total variance in cortisol can be partitioned into these three levels; the 
variance at each level relative to the total variance can be computed giving an 
estimate of the relative contribution of each level to the total variance in cortisol data. 
An additional strength of this model is to use all the available data rather than 
relying on means values. 
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First, a basic model containing the three parameters of interest (intercept, 
CAR and slope) and time of waking was constructed (model 1).  Subsequently 
obstetric and sociodemographic data were added to this model (Model 2).  Measures 
of maternal anxiety from pregnancy, at 8 weeks post-partum and at 8 years post-
partum were added to the final model (Model 3).  Finally all predictors of interest 
were regressed on the intercept, CAR and slope.  All MLM analyses were carried out 
in MLwin version 2.21.   
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3 Chapter 3:  The maternal emotional 
state in pregnancy and child 
emotional and behavioural 
development 
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3.1 The role of maternal prenatal emotional state and child 
behavioural and emotional development 
Attention deficit and Hyperactivity Disorder (ADHD), conduct and emotional 
problems such as anxiety and depression are among the most common forms of 
childhood psychopathology (Ford et al., 2003).  The presence of mental health 
problems in childhood remains a risk factor across the lifespan.  Approximately 50% 
of adults with a psychiatric diagnosis report a mental health problem by age 15 (Kim-
Cohen et al., 2003), and adolescence is a period marked by an increased 
prevalence of psychiatric disorders.  Females are more at risk from internalising 
problems (e.g. depression and anxiety disorders) while males have a higher rate of 
externalising problems, such as delinquency and conduct disorder (Clements et al., 
2008).  Hence, determining the protective and risk-factors for child mental health 
may have long term benefits for later mental health. 
Maternal prenatal stress is a potential risk factor for adverse emotional and 
behavioural development.  More specifically within this cohort maternal prenatal 
anxiety at 32 weeks was associated with approximately a two-fold increased risk of 
emotional and behavioural problems at age four and seven years (O'Connor et al., 
2002, O'Connor et al., 2003).   
Work from this cohort has also demonstrated that maternal prenatal anxiety is 
a specific risk factor for behavioural problems.  Using growth curve models Barker 
and Maughan (2009) demonstrated that children exposed to maternal prenatal 
anxiety were more likely to report more persistent conduct problems across 
childhood to age 13.  Similarly problems with attention associated with prenatal 
anxiety have been found to persist across childhood (Clavarino et al., 2010).  These 
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studies and one other, represent what is known about the long-term effects of 
maternal prenatal stress or anxiety beyond childhood (Van den Bergh et al., 2006, 
2008).  Determining if maternal prenatal anxiety is an independent risk factor for 
impaired emotional and behavioural development, and its association between the 
sexes will give us more understanding of the contribution of fetal programming to 
child development.   
3.1.1 Primary Hypothesis to be tested 
 
1) Maternal prenatal anxiety will predict emotional/behavioural problems in 
late childhood independent of socioeconomic and obstetric risk factors 
3.1.1.1 Secondary hypothesis 
a. ADHD-related, conduct and emotional development, as described 
using growth models, will be associated with maternal prenatal 
anxiety.  
3.2 Methods 
3.2.1 Participants 
Participants were drawn from the Avon Longitudinal Study of Parents and 
Children (ALSPAC: see section 2.2.1).  Maternal ratings of child emotional and 
behavioural development were carried out at ages 4, 7, 9, 11 and 13 using the 
Strengths and Difficulties Questionnaire (SDQ: see section 2.3.6).  Inclusion criteria 
for the current analyses were 1) the availability of (at least) one SDQ assessment, 2) 
a singleton pregnancy, 3) gestation greater than 32 weeks, 4) birthweight greater 
than 1500g and 5) one or more assessments of maternal prenatal anxiety.  This 
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resulted in a final sample of 9,871 participants (5,098 Males, 4773 Females).  These 
participants were used for correlation and growth-curve analyses (see section 2.5).   
A subgroup of interest comprises participants with an SDQ assessment at age 
13.  At this time-point data were available on 6,316 participants (3,172 Males, 3,144).  
Data from these participants were used for regression analyses to determine if 
maternal prenatal anxiety predicted child SDQ score at age 13. 
3.2.2 Measures: 
3.2.2.1 The strengths and difficulties questionnaire (SDQ)  
Child emotional and behavioural development as the outcome of interest was 
measured using the SDQ (Goodman et al., 1998).  The full questionnaire consists of 
5 subscales assessing symptoms relating to1) Attention deficit and hyperactivity 
(ADHD) 2) Emotional difficulties 3) Conduct disorder 4) Peer relations 5) Prosocial 
behaviour, and a Total score composed of subscales 1-4.  However for these 
analyses emphasis was placed on the three ‘problem’ scales (1-3).  Each of these 
subscales show discriminatory and predictive validity for ADHD, emotional problems 
(Anxiety/Depression) and Conduct Disorder respectively (Goodman et al., 2000b, 
Blom et al., 2010). 
3.2.2.2 Obstetric outcomes 
Birthweight measured in grams was recorded and verified from three sources 
(medical records, ALSPAC researchers and maternal report).  Gestational age in 
weeks was calculated from maternal last menstrual period.  All gestations which 
appeared preterm (<37weeks) were verified by review of medical notes including 
ultrasound-based estimates.  Birthweight for gestational age (BwGa) was calculated 
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by using centred values (each value minus mean) for birthweight and gestational age 
then correcting for length of gestation. 
Maternal substance use during pregnancy was also recorded.  Maternal 
smoking during pregnancy was assessed by asking ‘have you smoked during the 
last two weeks?’ with responses coded as yes/no.  Maternal responses to alcohol 
consumption during pregnancy were coded as 1) none, 2) less than one unit of 
alcohol per day and 3) more than one unit of alcohol per day. 
3.2.2.3 Indicators of Socioeconomic status (SES) 
Maternal education was assessed during pregnancy and used a proxy for 
maternal SES.  Three categories were formed on the basis of maternal responses 
ranging from lowest to highest educational achievement 1) Certificate of secondary 
education/vocational training, 2) O-level, 3) A-level/Third level education.   
A crowding index was implemented as an additional measure of SES.  The 
crowding index was calculated by dividing the number of persons per household by 
the number of rooms.  Responses to this assessment resulted in the formation of 
four categories 1) Low: crowding index ≤0.50; 2) 0.50-0.75; 3) 0.76-1.0 and 4) High: 
values >1. 
3.2.2.4 Other covariates 
Maternal age at time of pregnancy was calculated from maternal self report 
and recorded in years. 
Study child ethnicity was determined by maternal report and recorded as 
white/non-white. 
120 
 
3.2.2.5 Maternal psychometric data 
Maternal anxiety was recorded at 7 time-points across the study period.  Two 
of these assessments occurred in the prenatal period, the first at 18 weeks gestation 
and the second at 32.  Postnatal assessments were carried out at eight weeks and 
eight months postpartum.  Subsequently maternal anxiety was assessed when 
children were aged approximately two, three and eight years of age. 
Maternal anxiety was measured using the anxiety subscale of the self-report 
Crown-Crisp Experiential index (CCEI, Crown and Crisp, 1966).   This eight item 
index with four response categories results in ratings ranging from zero (not anxious) 
to 16 (very anxious).  As there are no prescribed ‘cut-off’s’ for clinically relevant 
anxiety for this index, where cut-offs are presented these are based on the top 15% 
of anxious women, in line with previous publications (O’Connor et al., 2002).  The 
CCEI was used at the first 4 time-points (pregnancy to age 3), while at the final 
assessment point (age 8) the Spielberger Trait Anxiety Inventory (STAI) was used to 
assess maternal anxiety (Spielberger et al., 1970).  This 20-item questionnaire has 
four responses categories with total scores ranging from 20 (not anxious) to 80 (very 
anxious). 
In conjunction with maternal anxiety, maternal depression was assessed at 
each timepoint using the Edinburgh postnatal depression survey (EDPS).  This ten 
item screening questionnaire, validated for use in pregnancy, gives scores ranging 
from 0 (not depressed) to 30.  A cut-off of 13 is used as an indicator of clinical 
depression. 
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3.2.3 Analyses 
All data were tested for normality using P-P plots.  Due to the skewed nature 
of child SDQ scores and the presence of zero values non-parametric Spearman’s 
rank order correlations (r(s)) were used for all correlation analyses.   
To determine if maternal prenatal anxiety was predictive of child SDQ score at 
age 13, linear regression models were used.   
3.2.3.1 The regression model 
Linear regression models determine the proportion of variance accounted for 
by each predictor independently.  We found maternal self-report of anxiety ratings 
were highly inter-correlated (r(s)’s = 0.39-0.64), with associations highest for 
consecutive time-points.   Multicollinearity (a linear association between predictor 
variables) can affect prediction estimates from correlated parameters in a regression 
model.  Specifically, multicollinearity can result in (1) unreasonably large variances 
(2) non-significant findings (3) an inverse sign for prediction estimates of the related 
variables (Lin, 2008).  To reduce such effects we selected three of the seven 
maternal assessments of anxiety for inclusion in the regression model.  As there was 
no strong a priori rationale for selecting a specific assessment of prenatal anxiety we 
tested the prediction from both 18 and 32 weeks anxiety.  These preliminary 
analyses found maternal anxiety at 32 weeks was a consistent predictor of child 
outcome.  To control for postnatal effects maternal postnatal anxiety at eight weeks 
was added to the model.  Similarly to control for effects later in childhood maternal 
anxiety at eight years was included in the regression model.   
The final regression model also included: birthweight for gestational age 
(BwGa) and gestational age.  Indicators of maternal SES were maternal education, 
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age and a crowding index.  Using an identical model the effects of maternal 
depression were assessed results are given where significant. 
The regression proceeded in two stages.  First, all obstetric, socioeconomic 
and pregnancy related factors were entered into the regression model for each SDQ 
outcome for males and females separately.  In the next step, maternal anxiety at 3 
timepoints were entered into the model and regression coefficients reported from this 
model (see section 3.2.3.1).  All correlation and regression analyses were carried out 
using SPSS. 
The final set of analyses describes how maternal anxiety can affect the 
developmental trajectory of emotional and behavioural problems in childhood.  This 
expands the focus from one time-point (e.g. age 13 SDQ) to examine the 
relationship between maternal anxiety and SDQ score across all time-points.  Using 
latent growth models it is possible to a) describe the different profiles of emotional 
and behavioural development between participants and b) determine if maternal 
anxiety influences the rate of development of emotional and behavioural problems.  
All latent trajectory models (LTM) were built using Mplus version 5.2 (California, US). 
3.2.3.2 Attrition 
A comparison between participants providing data at age 13 and those lost to 
follow-up revealed selective attrition within this sample.  Children with data available 
at age 13 come from a subgroup of mothers who on average were significantly less 
anxious (Table 3.3.1).  These effects were modest but most marked for maternal 
anxiety at 32 weeks (Cohen’s δ = .17).  A similar pattern of missing data was 
observed for all other maternal covariates.  Missing data were more likely on children 
born to younger mothers with lower levels of education, from higher levels of 
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household crowding.  Similarly women who did not complete the age 13 child 
assessment were more likely to have consumed more alcohol and smoked more 
heavily during pregnancy.  In terms of obstetric outcomes only birthweight for 
gestation age differed significantly between the groups while no difference was 
observed in birthweight or gestational age alone (Table 3.3.1).  
The SDQ outcomes at earlier assessments also differed for these children. 
Children from the missing data group at age 13 had significantly higher scores 
across all ages for the attention/hyperactivity and conduct subscale of the SDQ (all p 
<.01).  There was a less marked difference for the emotional subscale of the SDQ 
with significant difference only emerging at ages 9 and 11 (p <.01). 
3.3 Results 
Table 3.3.1 provides information on the ALSPAC cohort used for these 
analyses.  Overall there were a higher proportion of males in the group included for 
the longitudinal analyses (age 4-13).  These males were 100g heavier at birth 
relative to females in the same sample. When birthweight was corrected for 
gestational age these group differences were no longer significant (t =-0.38, p = 
0.71).  Significant sex differences were observed between males and females for 
length of gestation and maternal age.  Longer gestations in females contrasted with 
increased maternal age in the male group. Although significant these differences are 
very small representing an increase of one day in gestational age and a four-month 
difference in maternal age in the female group. No sex differences were observed in 
relation to maternal education, crowding, ethnicity, smoking or alcohol use during 
pregnancy in the total cohort or the age 13 subgroup. 
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Table 3.3.1:  Information on participants included for analyses of child emotional and 
behavioural development.  Mean (SD) values are given on the overall cohort (no shading) 
and those with data at age 13 (grey shading).  a. significant within-group differences 
(males versus females) in overall cohort, b. significant within-group differences (males 
versus females) in age 13 cohort, c.  significant between-group differences (overall cohort 
versus age 13 cohort). *p<.05, **p<.01, ***p<.001.  SDQ = Strengths and difficulties 
questionnaire, wks = weeks, yrs = years, edu = education, CSE/Vocat = Certificate of 
secondary education/vocational training, preg = pregnancy 
 
SDQ data availability ≥1 SDQ subscale 
(4yrs-13yrs) 
≥1 SDQ subscale  
(at age 13) 
 
Sex***c. 
***a.Males 
n = 5098 
Females 
n = 4773 
***b.Males 
n = 3172 
Females  
n = 3144 
Obstetric factors     
Gestation wks ***a.39.5 (1.6) 39.6 (1.5) ***b39.5 (1.6) 39.6 (1.5) 
Birthweight g ***a. 3495 
(523) 
3389 (475) ***b 3502 
(518) 
3394 (471) 
-Corrected for GA*c. 
Missing  
1.00 (.12) 
1038 
1.0 (.12) 
901 
1.00 (.12) 
544 
1.00 (.12) 
508 
Maternal factors     
Maternal age yrs***c. **a. 28.0 (4.7) 27.7 (4.6) **b 28.6 (4.6) 28.2 (4.5) 
     
Crowding index ***c.     
≥0.5 2219 2103 1559 1520 
>0.5 - 0.75 1594 1453 977 955 
>0.75-1.0 877 837 443 481 
>1 253 229 113 106 
Missing N:  173  111  180 82 
Maternal edu.***c.     
CSE / Vocat. 1298 1199 650 653 
O-Level  1786 1647 1110 1063 
A-Level/ Higher degree 1882 1808 1360 1371 
Missing: 132 119 52 57 
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Table 3.3.1 contd ≥1 SDQ subscale 
(4yrs-13yrs) 
≥1 SDQ subscale  
(at age 13) 
 Males Females Males Females 
Smoking in preg. ***c.     
Yes 877 777 437 426 
No 
Missing N: 
4161 
50 
3955 
41 
2718 
17 
2696 
22 
     
Alcohol in preg. *c.     
None 354 297 191 194 
< 1 Glass per day 4077 3884 2570 2568 
>1 glass per day 
Missing N: 
595 
72 
534 
58 
380 
31 
350 
32 
Ethnicity **c.     
White 4662 4390 2958 2931 
Other 206 175 105 115 
Missing N: 230 208 112 98 
Maternal Anxiety     
18 weeks prenatal***c  
Missing N: 
4.75 (3.45) 
572 
4.83 (3.50) 
587 
4.61 (3.38) 
284 
4.71 (3.42) 
342 
32 weeks prenatal***c 
Missing N: 
4.96 (3.56) 
484 
5.02 (3.52) 
453 
4.76 (3.46) 
236 
4.89 (3.40) 
232 
8 weeks postnatal***c 
Missing N: 
3.30 (3.25) 
427 
3.40 (3.30) 
359 
3.24 (3.16) 
184 
3.27 (3.17) 
160 
8 months postnatal*c 
Missing N: 
3.55 (3.28) 
459 
3.60 (3.35) 
396  
3.50 (3.26) 
198 
3.52 (3.23) 
183 
2 years***c 
Missing N: 
3.73 (3.29) 
695 
3.77 (3.35) 
658  
3.67 (3.20) 
282 
3.68 (3.27) 
283 
3 years***c 
Missing N: 
4.71 (3.59) 
792 
4.64 (3.52) 
734 
4.56 (3.46) 
304 
4.52 (3.38) 
310 
8 years (STAI)*c 
Missing N: 
39.37 ( 9.02) 
1907 
39.33 (9.20) 
1676 
39.17 (8.87) 
628 
39.24 (9.16) 
635 
Table contd     
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3.3.1 ADHD-related, Conduct and Emotional SDQ scores: mean 
values and correlations across childhood 
Table 3.3.2a presents the means, standard deviations and Spearman 
correlation coefficients for ADHD-related scores on the SDQ in boys and girls across 
childhood.  
Maternal estimates of ADHD-related scores were higher for males at each 
assessment from 4 through to age 13.  The correlations between assessments 
showed moderate stability (r(s) ≥ .4) in both males and females (Table 3.3.2a). 
A similar pattern was observed for conduct problem scores across childhood 
(Table 3.3.2b).  Males were rated higher on the conduct subscale for each 
Table 3.3.1 contd ≥1 SDQ subscale 
(4yrs-13yrs) 
≥1 SDQ subscale  
(at age 13) 
Maternal Depression Males Females Males Females 
18 weeks prenatal***c 
Missing N: 
6.72 (4.76) 
538 
6.68 (4.66) 
495 
6.46 (4.61) 
255 
6.48 (4.61) 
279 
32 weeks prenatal***c 
Missing N: 
6.82 (5.01) 
376 
6.84 (4.93) 
338 
6.54 (4.93) 
172 
6.65 (4.89) 
164 
8 weeks postnatal***c 
Missing N: 
5.94 (4.66) 
347 
5.90 (4.70) 
329 
5.78 (4.53) 
138 
5.74 (4.61) 
146 
8 months postnatal***c 
Missing N: 
5.30 (4.61) 
434 
5.33 (4.64) 
400 
5.17 (4.54) 
187 
5.20 (4.54) 
185 
2 years***c 
Missing N: 
5.64 (4.72) 
625 
5.64 (4.76) 
606 
5.50 (4.61) 
244 
5.48 (4.68) 
252 
3 years***c 
Missing N: 
6.24 (4.93) 
790 
6.19 (5.03) 
734 
6.07 (4.80) 
305 
6.00 (4.94) 
313 
8 years**c 
Missing N: 
6.06 (5.15) 
3659 
6.08 (5.22) 
3555 
5.96 (5.01) 
2810 
5.98 (5.15) 
2783 
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assessment.  For both males and females correlation coefficients increased across 
time-points with the strongest association seen between age 11 and age 13 
assessments (males: r(s) = .70; females: r(s) = .62, all p < .001). 
Emotional scores on the SDQ also showed sex differences.  With the 
exception of the age 4 assessment females were rated significantly higher on the 
emotional subscale of the SDQ (Table 3.3.2c).  Emotional scores in both males and 
females demonstrated modest to moderate stability across time with the strongest 
association seen at ages 11 to 13 (r(s) = .61, p <.01, in both sexes) and the weakest 
association seen between age4 and age 13 (r(s) = .26, p < .01, in both sexes). 
3.3.2 Maternal anxiety and ADHD-related SDQ scores across 
childhood (correlation analyses) 
Modest but significant positive associations (all p<0.001) were observed 
between maternal prenatal anxiety and ADHD-related scores on the SDQ (Table 
3.3.3).  Correlations were comparable between maternal pre and postnatal 
assessments of maternal anxiety.  A similarly consistent, but weaker, pattern of 
association was observed with maternal depression and SDQ outcomes (see 
appendix J).   
 
128 
 
Table 3.3.2 Spearman (rs) correlations between assessments of the 
attention/hyperactivity (a) conduct (b) and emotional (c) subscales of the SDQ for 
males (below the line) and females (above the line) all p < .001.  Descriptive statistics 
and significant sex differences are given in the right hand column. 
†  
p for trend < .08, * 
p< .05, *p<.01, **p<.001. 
   
      ADHD-related  SDQ subscale 
Males 
na = 4,518 
Females 
n =4,200 
 4yrs  7yrs  9yrs  11yrs  13yrs  Mean (SD)  Mean (SD) 
4yrs  r(s) =   0.55  0.49  0.43  0.40  4.23 (2.4)**  3.66 (2.2)  
7yrs  0.57   0.69  0.60  0.55  3.80 (2.5)**  3.00 (2.2)  
9yrs  0.51  0.70   0.69  0.63  3.34 (2.3)**  2.55 (2.0)  
11yrs  0.45  0.64  0.74   0.71  3.24 (2.3)**  2.33 (2.0)  
13yrs  0.44  0.60  0.69  0.75   3.38  (2.3)**  2.56 (2.0)  
       Conduct SDQ subscale  
Males 
n
a
 = 4534   
Females 
n 
 
= 4210   
 4yrs  7yrs  9yrs  11yrs  13yrs  Mean (SD) Mean (SD)  
4yrs  r(s) =   0.47 0.42 0.36 0.35 2.01 (1.4)** 1.88 (1.4) 
7yrs  0.50  0.58 0.49 0.46 1.67 (1.4)** 1.50 (1.4) 
9yrs  0.46 0.60  0.61 0.56 1.34 (1.4)** 1.17 (1.3) 
11yrs  0.39 0.54 0.66  0.62 1.27 (1.4)** 1.12  (1.3) 
13yrs  0.39 0.48 0.61 0.70  1.32 (1.4)* 1.23 (1.4) 
       Emotional SDQ subscale  
Males 
 n
a
 = 4539  
Female  
n = 4267  
 4yrs  7yrs  9yrs  11yrs  13yrs  Mean (SD)  Mean (SD)  
4yrs   r(s) =  0.43 0.36 0.31 0.26 1.43 (1.5) 1.48 (1.5)
 †
 
7yrs  0.45  0.53 0.48 0.44 1.44 (1.7) 1.58 (1.7)** 
9yrs  0.32 0.53  0.55 0.50 1.36 (1.7) 1.61 (1.8)** 
11yrs  0.29 0.49 0.56  0.61 1.31 (1.6) 1.60 (1.7)** 
13yrs  0.26 0.44 0.52 0.61  1.24 (1.6) 1.62 (1.8)** 
a: N based on participants providing data on at least one occasion across assessments 
a
b
c.
129 
 
  Maternal Anxiety 
.  Prenatal  Postnatal 
a. ADHD-related SDQ male 18 wks 32wks 8wks 8mths 2yrs 3yrs 8yrs 
 4yrs r(s)= .12 .15 .13 .14 .15 .15 .20 
 (4051) (4051) (3851) (3844) (3703) (3701) (2836) 
7yrs  .13 .13 .15 .15 .16 .16 .22 
 (3495) (3495) (3333) (3335) (3231) (3203) (2695) 
9yrs  .12 .12 .15 .15 .18 .15 .23 
 (3155) (3155) (2996) (3002) (2894) (2876) (2599) 
11yrs  .11 .11 .12 .14 .15 .12 .19 
 (2870) (2870) (2734) (2744) (2650) (2622) (2382) 
13yrs  .11 .13 .15 .14 .15 .13 .19 
 (2885) (2885) (2747) (2741) (2670) (2645) (2379) 
b. ADHD-related SDQ female 18 wks 32wks 8wks 8mths 2yrs 3yrs 8yrs 
 4yrs r(s)= .13 .16 .14 .15 .16 .15 .18 
 (3718) (3718) (3553) (3553) (3408) (3410) (2689) 
7yrs  .15 .15 .16 .18 .16 .16 .24 
 (3256) (3256) (3142) (3129) (3002) (3004) (2582) 
9yrs  .15 .17 .15 .16 .17 .15 .25 
 (2995) (2995) (2896) (2879) (2785) (2748) (2501) 
11yrs  .15 .16 .16 .15 .16 .17 .22 
 (2797) (2797) (2708) (2690) (2594) (2583) (2317) 
13yrs  .15 .18 .15 .15 .16 .17 .23 
 (2815) (2815) (2714) (2693) (2609) (2594) (2309) 
Table 3.3.3 Spearman correlations between maternal anxiety and outcomes for males (a) and 
females (b) on the attention/hyperactivity subscale of the Strengths and Difficulties 
questionnaire (SDQ).  All p<.001, (n) yrs = years. 
3.3.2.1 Other factors and child ADHD-related SDQ scores 
Of the SES indices assessed maternal education was the only variable which 
showed an association with ADHD-related score comparable to maternal anxiety.  
For both boys and girls lower maternal education was associated with higher ADHD-
related scores across time-points (males: all r’s ≥ .10; females all r’s ≥ .12, all p 
<.001).  This association was strongest for ratings of ADHD-related scores at 4years 
(males: r(s) = -.17, p <.001, n = 4,025; females r(s) = -.19, p <.001, n = 3,699).  A 
second index of SES, crowding, demonstrated a less consistent association with 
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ADHD-related score.  In males crowding was positively associated with each 
assessment of ADHD-related score.  Conversely in females crowding was 
associated with raised ADHD-related score at ages 4, 7, 9, 13 but not 11 years.  The 
reverse was observed in relation to maternal age.  In females lower maternal age at 
time of pregnancy was associated with higher ADHD-related scores at each time-
point however in males an inverse association was observed at all time-points 
except at age 11. 
Maternal smoking during pregnancy was consistently associated with 
increased ADHD-related score at each time-point for both males and girls (males 
and females all r(s) ≤ .10, all p < .01). Conversely maternal alcohol intake during 
pregnancy was not associated with ADHD-related score at any time-point.   
Of the obstetric variables assessed birthweight corrected for gestational age 
was most consistently associated with ADHD-related score.  This relationship was 
significant across all assessments in females (all r(s) ≤ -.07, all p < .05) but only at 4, 
7, and 9 years in males (all r(s) ≤ -.07 p <.02). Gestational age at birth (GA) did not 
correlate with ADHD-related score at age 4 through to age 11, however a weak 
inverse association was observed at age 13 (males r(s) = -.04, p = .04, n = 2688; 
females r(s) = -.04, p = .04, n = 2808). 
In summary, correlational analyses demonstrate a consistent positive 
association between ADHD-related scores and maternal anxiety.  Lower maternal 
education shows a similar association while other sociodemographic and obstetric 
outcomes show some but not consistent associations with ADHD-related score in 
males and females. 
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It has been previously shown that maternal prenatal anxiety predicts 
increased ADHD-related scores in childhood independent of obstetric and 
sociodemographic factors.  To extend these findings to age 13 regression models 
were constructed (see equation 3.1). 
Equation 3.1: Regression model for ADHD-related problems at age 13 in the ALSPAC 
cohort 
y = β1(BwGa)x+ β2(Gestational age)x + β3(Smoking in preg)x + β4(Alcohol in preg)x+         
β5(Maternal age)x + β6(Maternal education)x + β7(Crowding)x + β8(Prenatal anxiety at 
32weeks)x + β9(Postnatal anxiety at 8 weeks)x + β10(Maternal anxiety at 8years)x + 
constant. 
x = SD of ADHD-related score at 13 years, males = 2.3, females = 2.0,  
y = ADHD-related score at age 13 
ADHD = Attention deficit and hyperactivity disorder, BwGa = Birthweight for gestational 
age, preg = pregnancy 
 
3.3.2.2 Does maternal prenatal anxiety predict Attention/Hyperactivity scores on the 
SDQ at age 13 (regression analyses)?  
The regression model accounted for a similar portion of the variance (9%) in 
ADHD related score in both males (F = 35.5, p< .001, Adjusted R2 = .09) and 
females (F = 36.81, p <.01, adjusted R2 = .09) at age 13 (Table 3.3.4).  A plot of the 
standardised residuals from this regression model indicated a normal distribution in 
both sexes (see appendix K).  
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In both sexes maternal prenatal anxiety was a significant predictor of child 
ADHD-related scores at age 13.  This finding was independent of postnatal and later 
maternal anxiety, obstetric and SES covariates.  An increase of one SD in maternal 
prenatal anxiety (32 weeks) was associated with an increase of 4% and 6.5% in 
ADHD-related SDQ subscale (males) 
Covariate B β p 
Birthweight for gestational age -0.79 -0.04 0.00 
Gestational age -0.04 -0.02 0.28 
Smoking during pregnancy 0.10 0.01 0.45 
Alcohol use in pregnancy 0.11 0.02 0.28 
Maternal age -0.03 -0.06 0.00 
Maternal education -0.10 -0.06 0.00 
Crowding 0.22 0.08 0.00 
Prenatal anxiety at 32 weeks 0.04 0.06 0.02 
Postnatal anxiety at 8 weeks 0.05 0.07 0.00 
Maternal anxiety at 8 years 0.04 0.27 0.00 
ADHD-related SDQ subscale (females) 
Covariate B β p 
Birthweight for gestational age -0.36 -0.02 0.28 
Gestational age 0.05 0.03 0.11 
Smoking during pregnancy 0.24 .05 0.02 
Alcohol use in pregnancy 0.05 0.01 0.57 
Maternal age -0.01 -0.03 0.11 
Maternal education -0.14 -0.09 0.00 
Crowding 0.05 0.02 0.34 
Prenatal anxiety at 32 weeks 0.05 0.08 0.00 
Postnatal anxiety at 8 weeks 0.04 0.06 0.02 
Maternal anxiety at 8 years 0.03 0.28 0.00 
Table 3.3.4: Multiple regression analysis of ADHD-related score at 
age 13. B = unstandardised regression coefficient, β = standardised 
coefficient. 
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ADHD-related score in males and females respectively (Table 3.3.4). The effect of 
maternal prenatal anxiety was comparable to that of anxiety in the early postnatal 
period.  The standardised model revealed maternal anxiety at eight years to have the 
strongest effect of any of the maternal predictors.  For every SD increase in maternal 
anxiety at eight years child ADHD-related score increased by approximately 19% in 
males and 23% in females.  
The analyses described above were repeated replacing maternal anxiety with 
maternal depression.  These models accounted for a smaller proportion of the 
variance in ADHD-related SDQ score (Males: F = 14.73, p <.001, adjusted R2 = .05; 
Females: F = 17.36, p <.001, adjusted R2 = .06).  Overall maternal depression gave 
similar results to that of maternal anxiety but with less marked effects on child 
ADHD-related SDQ score.   
3.3.2.2.1 Other predictors of child ADHD-related SDQ score 
In males other significant predictors of child ADHD-related score included 
proxy indicators of SES maternal education, maternal age and crowding.  Per SD 
increase in maternal education and age ADHD-related scores decreased by 3.2% 
while scores increased by 4.3% per SD increase in crowding.  
There was a significant effect of birthweight for gestational age.  For every SD 
increase in BwGa ADHD-related scores decreased by approximately 3%.   
In females maternal education and maternal smoking during pregnancy were 
significant predictors of ADHD-related scores at age 13.  Maternal education was 
significant determinant of female ADHD-related score.  For each unit increase in 
maternal education ADHD-related scores fell by 6%.  Conversely smoking in 
pregnancy was associated with a 10% increase in ADHD-related scores in females. 
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3.3.3 Maternal anxiety and conduct SDQ scores across childhood 
(correlation analyses) 
 Maternal Anxiety 
  Prenatal  Postnatal 
 
a. Conduct SDQ male 18 wks 32wks 8wks 8mths 2yrs 3yrs 8yrs 
 4yrs r(s)= .15 .17 .17 .19 .20 .22 .22 
 (4087) (4087) (3879) (3870) (3729) (3729) (2854) 
7yrs  .15 .17 .16 .17 .17 .20 .23 
 (3570) (3570) (3399) (3406) (3298) (3264) (2746) 
9yrs  .14 .16 .14 .17 .18 .18 .23 
 (3129) (3129) (2972) (2985) (2879) (2850) (2567) 
11yrs  .11 .13 .12 .13 .14 .13 .17 
 (2886) (2886) (2755) (2761) (2674) (2633) (2387) 
13yrs  .14 .15 .13 .16 .15 .14 .19 
 (2882) (2882) (2743) (2739) (2666) (2642) (2377) 
b. Conduct SDQ female 
18 wks 32wks 8wks 8mths 2yrs 3yrs 8yrs 
 4yrs r(s)= .14 .15 .15 .17 .18 .19 .20 
 (3745) (3745) (3579) (3576) (3431) (3435) (2702) 
7yrs  .13 .13 .14 .13 .15 .14 .21 
 (3326) (3326) (3206) (3197) (3066) (3070) (2630) 
9yrs  .10 .13 .13 .11 .13 .14 .20 
 (3029) (3029) (2925) (2907) (2802) (2767) (2519) 
11yrs  .12 .16 .14 .12 .14 .14 .19 
 (2791) (2791) (2698) (2685) (2583) (2576) (2309) 
13yrs  .14 .15 .16 .15 .15 .16 .19 
 (2818) (2818) (2716) (2696) (2612) (2596) (2310) 
Table 3.3.5 Spearman correlations between maternal anxiety and outcomes for males 
(a) and females (b) on the conduct subscale of the Strengthens and Difficulties 
Questionnaire (SDQ).  All p<.001, (n) yrs = years. 
Maternal anxiety from pregnancy to age 8 was positively associated with 
ratings of conduct scores on the SDQ (all p<0.001) in males and females (Table 
3.3.5).  In general, correlation coefficients were similar for each assessment of 
maternal anxiety and child conduct score. 
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3.3.3.1 Other factors and child conduct SDQ scores 
The SES indicators were also significantly associated with conduct score 
across childhood.  Maternal education was inversely associated with child conduct 
score.  This association was strongest at age 4 (Males r(s) = -.18, p<.001, n = 4574, 
Females r(s) = -.19, p <.001, n = 4208) but maintained across childhood (Males: all r(s) 
≥ -.11; Females: all r(s) ≥ -.10, all p <.001).  Similarly, maternal age was inversely 
associated with conduct scores (Males r(s) ≥ -.11, all p <.001; Females: r(s) ≥ -.14, all 
p <.001).  Higher levels of crowding were also associated with higher conduct 
problem scores. In keeping with both maternal age and education the strongest 
association was observed for crowding and the age 4 SDQ assessment (Males: r(s) = 
.10, p <.001, n = 4478; Females: r(s) = .08, p <.001, n = 4176) but remained 
significant across subsequent assessments (Males: all r(s) ≤ .09, all p ≤ .001; 
Females: all r(s) ≤ .06, all p ≤ .01).  
Maternal smoking during pregnancy was positively correlated with child 
conduct scores.  This modest association was significant across all time-points for 
both males and females (Males all r(s) ≤ .11, all p <.001; Females: all r(s) ≤ .09, all p 
<.001).  Conversely alcohol consumption was not consistently associated with child 
conduct score.  Of the 5 SDQ assessments, alcohol use in pregnancy was 
marginally associated with child conduct score at age 4 in males only (Males r(s) = -
.03, p = .08, n = 4557) indicating lower scores following higher alcohol intake. 
Of the obstetric variables tested, birthweight for gestational age (BwGa) 
showed the strongest association with child conduct problems.  In females there was 
a modest inverse association between BwGa and conduct scores (all r(s) ≥ -.08, all p 
≤ .02).  In males a similar association was observed (all r(s) ≥ -.07, all p ≤ .02) with 
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the exception of the age 11 assessment which was non-significant (r(s) = -.02, p = 
.27, n = 2662). 
In keeping with the previous analysis a regression model predicting conduct 
scores at age 13 used a range of covariates described in equation 3.2 below. 
Equation 3.2: Regression model for conduct problems at age 13 in the ALSPAC 
cohort 
y = β1(BwGa)x+ β2(Gestational age)x + β3(Smoking in preg)x + β4(Alcohol in preg)x+         
β5(Maternal age)x + β6(Maternal education)x + β7(Crowding)x + β8(Prenatal anxiety at 
32weeks)x + β9(Postnatal anxiety at 8 weeks)x + β10(Maternal anxiety at 8years)x + 
constant. 
x = SD of conduct problem score at age 13: males = 1.4, females = 1.4,  
y = Conduct problem score at age 13 
BwGa = Birthweight for gestational age, preg = pregnancy 
 
3.3.3.2 Does maternal prenatal anxiety predict conduct scores on the SDQ at age 
13 (regression analyses)?  
This model accounted for approximately 7% of the variance in conduct 
score at age 13 in males (F = 15.80, p<.001, Adjusted R2 = .07) and 6% in females 
(F = 13.10, p < .001).  A plot of the standardised residuals revealed a distribution 
which approached normality in both sexes (see appendix K). 
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Maternal prenatal anxiety was a significant predictor of conduct score at this 
time-point independent of later maternal anxiety.  For each SD increase in maternal 
anxiety conduct scores increased by 10%.  A similar increase in maternal anxiety at 
Conduct SDQ subscale (males) 
Covariate B β p 
Birthweight for gestational age -0.20 -0.02 0.37 
Gestational age -0.01 -0.01 0.52 
Smoking during pregnancy 0.26 0.06 0.00 
Alcohol use in pregnancy -0.04 -0.01 -0.51 
Maternal age -0.03 -0.09 0.00 
Maternal education -0.02 -0.02 0.41 
Crowding 0.10 0.06 0.00 
Prenatal anxiety at 32 weeks 0.03 0.07 0.00 
Postnatal anxiety at 8 weeks 0.03 0.06 0.02 
Maternal anxiety at 8 years 0.03 0.30 0.00 
Conduct SDQ subscale (females) 
Covariate B β p 
Birthweight for gestational age -0.26 -0.02 0.27 
Gestational age -0.00 -0.00 0.92 
Smoking during pregnancy 0.19 0.06 0.01 
Alcohol use in pregnancy -0.04 0.01 0.55 
Maternal age -0.02 -0.05 0.01 
Maternal education -0.00 -0.00 0.93 
Crowding 0.07 0.04 0.03 
Prenatal anxiety at 32 weeks 0.02 0.06 0.01 
Postnatal anxiety at 8 weeks 0.04 0.10 0.00 
Maternal anxiety at 8 years 0.02 0.24 0.00 
Table 3.3.6 Multiple regression analysis of conduct problem score at 
age 13. B = unstandardised regression coefficient, β = standardised 
coefficient. 
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eight weeks was associated with a 6% and 12% increase in conduct score in males 
and females respectively.  Finally maternal anxiety at eight years was the strongest 
predictor of later conduct score.  In males there was an increase of 34% per SD 
increase in maternal anxiety at eight years.  This was in line with findings of a 28% 
increase in females per SD increase in maternal anxiety at this time-point. 
Replacing maternal anxiety with maternal depression gave comparable 
results for child conduct score at age 13 (Males: F = 16.67, p <.001, adjusted R2 = 
.06; Females: F = 14.97, p <.001, adjusted R2 = .06).  One exception was maternal 
postnatal depression at eight weeks which was not a significant predictor of conduct 
scores in males. 
3.3.3.2.1 Other predictors of child conduct SDQ scores at age 13  
In both sexes maternal age and the crowding index were significant 
predictors of child conduct score at age 13.  In males and females each unit increase 
in maternal age was associated with an approximate 2% decrease in conduct score.  
Conversely a one unit increase in the crowding index was associated with an 8% 
and 6% increase in conduct score in males and females respectively.  A one unit 
increase in smoking (indicating heavy smoking during pregnancy) was associated 
with between 20% (males) and 16% (females) increases in conduct score. 
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3.3.4 Maternal anxiety and emotional SDQ scores across childhood 
(correlation analyses) 
 Maternal Anxiety 
  Prenatal  Postnatal 
a. Emotional SDQ male 18 wks 32wks 8wks 8mths 2yrs 3yrs 8yrs 
 4yrs r(s)= .15 .19 .18 .20 .19 .18 .18 
 (4096) (4096) (3890) (3880) (3738) (3739) (2859) 
7yrs  .19 .18 .20 .22 .23 .20 .23 
 (3598) (3598) (3431) (3433) (3324) (3293) (2767) 
9yrs  .21 .22 .22 .22 .24 .21 .26 
 (3180) (3180) (3022) (3032) (2926) (2898) (2608) 
11yrs  .22 .22 .21 .22 .23 .21 .28 
 (2887) (2887) (2750) (2756) (2671) (2632) (2387) 
13yrs  .18 .20 .20 .20 .21 .17 .23 
 (2886) (2886) (2747) (2742) (2670) (2646) (2380) 
b. Emotional SDQ female 18 wks 32wks 8wks 8mths 2yrs 3yrs 8yrs 
 4yrs r(s)= .14 .18 .17 .17 .18 .19 .18 
 (3742) (3742) (3577) (3572 (3427) (3434) (2698) 
7yrs  .18 .19 .22 .21 .23 .236 .27 
 (3327) (3327) (3209) (3198) (3070) (3072) (2633) 
9yrs  .22 .19 .21 .23 .23 .22 .28 
 (3043) (3043) (2937) (2924) (2825) (2783) (2530) 
11yrs  .22 .22 .23 .21 .20 .22 .26 
 (2815) (2815) (2720) (2706) (2606) (2598) (2334) 
13yrs  .21 .19 .21 .19 .22 .23 .25 
 (2819) (2819) (2718) (2696) (2612) (2597) (2313) 
Table 3.3.7: Spearman correlations (r s) between maternal anxiety and scores for 
males (a) and females (b) on the emotional subscale of the Strengthens and 
Difficulties Questionnaire (SDQ).  All p<.001, (n) yrs = years. 
The relationship between maternal anxiety and child emotional SDQ rating 
are presented in Table 3.3.7.  Across childhood there was a modest positive 
association between maternal anxiety and emotional score on the SDQ.  Correlation 
estimates from the prenatal period were comparable to those observed later in 
infancy and were similar in boys and girls. 
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3.3.4.1 Other factors and child emotional SDQ scores 
In contrast to the relationship between maternal anxiety and child outcome 
few consistent associations were observed for other the other covariates.  The 
correlations which reached significance were weak and often sex-specific.   
Maternal age and education were associated with some but not all 
assessments of child emotional difficulties.  For example in males maternal age was 
inversely correlated with emotional SDQ score at ages 4 and 11, with trend 
associations at age 7 and 9.  Conversely in females maternal age was inversely 
associated with emotional score at age 4, 7, 11 and 13 but not at 9 years.  Maternal 
education was inversely associated with emotional scores in males at ages 4, 11 and 
13 (all r(s) ≤.06 , all p≤ .03) but not at ages 7 (r(s) = -.03, p = .06, n = 4008) and 9 (r(s) = 
-.02, p = .32, n = 3552).  In contrast maternal education was not associated with 
emotional scores in females from ages 4-11 with a weak positive correlation 
observed at age 13 (r(s) = -.04, p = .03, n = 3173).  Levels of crowding were not 
related to child emotional scores at any time-point in male or females. 
Maternal alcohol use during pregnancy was not related to later emotional 
difficulties in the child.  This was true for maternal smoking at ages 4-11 however at 
age 13 a weak positive association was observed between maternal smoking during 
pregnancy and child emotional score (males: r(s) .04, p = .02, n = 3234; females: r(s) 
.03, p = .05, n = 3212). 
A similarly inconsistent pattern of association was observed between obstetric 
covariates and child emotional score.  For males BwGa was inversely associated 
with emotional difficulties at age 4 only (r(s) = -.04, p = .02, n = 3766).  A trend for a 
similar inverse association was observed in females for emotional difficulties but at 
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age 13 only (r(s) = -.04, p = .07, n = 2681).  In males gestational age was inversely 
correlated with emotional difficulties at age 9 (r(s) = -.05, p < .01, n = 3650) with a 
trend for a similar association at age 13 (r(s) = -.03, p = .07, n = 3284). In females 
gestational age at birth was not associated with later emotional difficulties at any 
time-point. 
Following these correlational analyses a regression model was constructed 
using the predictors detailed in equation 3. 
Equation 3.3: Regression model for emotional difficulties at age 13 in the ALSPAC 
cohort 
y = β1(BwGa)x+ β2(Gestational age)x + β3(Smoking in preg)x + β4(Alcohol in preg)x+         
β5(Maternal age)x + β6(Maternal education)x + β7(Crowding)x + β8(Prenatal anxiety at 32weeks)x 
+ β9(Postnatal anxiety at 8 weeks)x + β10(Maternal anxiety at 8years)x + constant. 
x = SD of emotional problem score at 13 years, males = 1.6, females = 1.8,  
y = Emotional problem score at age 13 
BwGa = Birthweight for gestational age, preg = pregnancy 
 
3.3.4.2 Does maternal prenatal anxiety predict conduct scores on the SDQ at age 
13 (regression analyses)?  
This model accounted for 6% of the variance in emotional scores at age 13 in 
males (F = 14.31, p < .001, adjusted R2 = .06) and 8% of the variance in females (F 
= 56.01, p <.001, Adjusted R2 = .08).  An analysis of the residuals in this model 
revealed a distribution approaching normality in both males and females (see 
appendix K). 
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Maternal prenatal anxiety was predictive of emotional SDQ at 13 in both 
sexes independent of additional assessments of maternal anxiety, SES, obstetric 
outcomes and smoking and alcohol use in pregnancy (Table 3.3.8).  An increase of 
13% in males and 7% in females was observed per one SD increase in maternal 
Emotional SDQ subscale (males) 
Covariate B β p 
Birthweight for gestational age 0.08 0.01 0.36 
Gestational age -0.06 -0.05 0.01 
Smoking during pregnancy -0.06 -0.01 0.53 
Alcohol use in pregnancy -0.09 -0.02 0.21 
Maternal age 0.01 0.03 0.17 
Maternal education -0.04 0.03 0.13 
Crowding 0.05 0.03 0.19 
Prenatal anxiety at 32 weeks 0.05 0.10 0.00 
Postnatal anxiety at 8 weeks 0.04 0.08 0.00 
Maternal anxiety at 8 years 0.02 0.24 0.00 
Emotional SDQ subscale (females) 
Covariate B β P 
Birthweight for gestational age -0.22 -0.01 0.46 
Gestational age 0.02 0.01 0.50 
Smoking during pregnancy 0.07 0.02 0.44 
Alcohol use in pregnancy -0.02 -0.00 0.86 
Maternal age -0.01 -0.04 0.08 
Maternal education -0.01 -0.01 0.82 
Crowding 0.01 0.00 0.84 
Prenatal anxiety at 32 weeks 0.03 0.06 0.01 
Postnatal anxiety at 8 weeks 0.08 0.13 0.00 
Maternal anxiety at 8 years 0.04 0.34 0.00 
Table 3.3.8 Multiple regression analysis of emotional problem scores 
at age 13. B = unstandardised regression coefficient, β = 
standardised coefficient. 
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prenatal anxiety.  A similar effect of postnatal anxiety was observed with increases of 
10% (males) and 15% (females) per SD increase at eight weeks.  Finally in line with 
both ADHD-related and conduct problem models, maternal anxiety at eight years 
was a significant predictor of emotional difficulties.  For every one SD increase in 
maternal anxiety increases of 31% and 38% in emotional score were observed in 
males and females at age 13. 
The analysis of this model with maternal depression gave similar results 
accounted for marginally less proportion of the variance (Males: F = 15.13, p <.001, 
adjusted R2= .05; Females: F = 19.62, p <.001, adjusted R2 = .07).  Similarly the 
prediction from maternal prenatal depression was significant but less marked than 
for that of maternal prenatal anxiety in males and females. 
3.3.4.2.1 Other predictors of child emotional score at age 13 
In males, of the additional covariates, only gestational age predicted 
emotional scores.  Each SD increase in gestational age was associated with a 6% 
decrease in emotional SDQ score. 
In females maternal age was the only additional covariate which reached 
significance.  Each SD increase in maternal age (5 years) was associated with a 6% 
decrease in emotional difficulties. 
3.3.5 Conclusions regarding maternal prenatal anxiety and SDQ 
regression analyses at age 13 
These analyses demonstrate that the effects of maternal prenatal anxiety on 
child ADHD-related score persist across childhood and into early adolescence.  The 
consistent positive association seen in correlational analyses was further supported 
by regression models at age 13.  In line with previous findings at ages 4 and 7, 
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maternal prenatal anxiety was associated with increases in ADHD-related scores in 
both males and females.  An independent effect of the postnatal environment and 
anxiety later in childhood were also observed. 
These findings indicate that maternal anxiety is positively associated with 
child conduct problem scores across childhood to age 13.  Specifically maternal 
prenatal anxiety was predictive of increased conduct scores at age 13 in both males 
and females, independent of a range of covariates.  This extends previous work from 
the ALSPAC cohort and demonstrates the robust nature of this finding (Barker and 
Maughan, 2009). 
In line with the other SDQ subscales maternal anxiety was positively 
correlated with rating of child emotional scores.  These correlations demonstrate 
stability across childhood.  In both males and females maternal prenatal anxiety was 
predictive of emotional score at age 13.  Adolescence is a period marked by 
increased prevalence of psychiatric disorders (Clements et al., 2008).  These 
analyses indicate that maternal prenatal anxiety has a persisting affect on emotional 
problems in both males and females. 
Taken together the results of these multiple regression models support this 
study’s primary hypothesis that maternal prenatal anxiety predicts higher 
emotional/behavioural problems at age 13. 
3.3.5.1 Other factors and SDQ regression analyses at age 13 
At age 13 ADHD-related scores were associated with measures of SES.  In 
males, maternal age, maternal education and levels of crowding were significant 
predictors of ADHD-related scores.  While in females a link with maternal education 
was predictive of ADHD-related problem scores. This is in line with previous work 
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demonstrating a link between SES and the incidence of ADHD (Biederman and 
Faraone, 2005).  
Similarly the role of SES and conduct problems at age 13 emerged from these 
analyses.  In both males and females maternal age and levels of crowding as 
measures of SES were significantly associated with conduct score.  This is in line 
with previous work linking lower SES to conduct problems in adolescence (Odgers et 
al., 2008). 
Obstetric factors showed the strongest association with ADHD-related 
problem scores.  The finding that ADHD-related scores were inversely associated 
with BwGa agrees with several reports linking birthweight to ADHD (Indredavik et al., 
2004, Boulet et al., 2009).  However this association was not observed in females.  
While surprising, this result is in line with a female twin study showing no association 
between birthweight and risk of ADHD, possibly indicating sex-specific associations 
between risk of ADHD and birthweight (Knopik et al., 2009).  
Similarly the effects of smoking on ADHD scores seen in females is supported 
by previous work, however the lack of association in males conflicts with other 
studies (Biederman et al., 2009).  A similarly inconsistent pattern of association was 
observed between maternal smoking and conduct problem scores.  This contrasts 
with a previous study showing effects of maternal smoking in both males and 
females (Monuteaux et al., 2006). 
There were fewer significant predictors of emotional problems at age 13. 
Gestational age was predictive of emotional score in males, but not females.  
Interestingly the size of this effect was comparable to Raikkonnen and colleagues 
who report a 7% decrease in depressive score per week increase in gestation 
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(Raikonnen et al., 2007).  However in this study the authors did not observe the sex 
difference reported here. 
3.3.6 Growth curve modelling of child emotional and behavioural 
development 
A variable centred approach, such as regression, provides a snapshot of 
fixed-effects on an outcome variable at a specific point in time.  To make best use of 
the repeated measures of child emotional/behavioural development we used latent 
trajectory models/growth curves. In the context of this thesis LTM or growth curves 
describes the pattern of development of emotional and behavioural problems across 
childhood. This form of analysis has been successfully applied to a range of 
outcomes with often divergent developmental pathways (Curran and Willoughby, 
2003).    
A simple model of growth is linear growth.  A child may achieve a certain mark 
on an examination and in each subsequent exam this mark may increase or 
decrease.  In this linear model the starting point, termed the intercept, is the child’s 
score on the first exam.  The second factor, which describes the child performance, 
is whether the marks increase or decrease, this positive or negative change over 
time can be described by a slope function.  From this model there are now two 
(growth) factors which describe academic performance 1) intercept/starting point, 2) 
slope/positive or negative change over time.  It is then possible to test how different 
covariates e.g. tuition may influence school performance by assessing whether they 
affect the starting point or rate of increase or decrease over time.   
In a linear model an intercept (starting point) and slope function (positive or 
negative) describe the pattern of change over time, however not all growth is linear.  
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A third growth factor can be used to describe non-linear growth i.e. growth that 
changes direction over time. In a quadratic model the intercept and slope are used in 
conjunction with a quadratic term. In the context of academic achievement a 
quadratic term may be useful when student’s marks begin to slip, the student’s 
success in early examinations will be described by a positive slope while later poor 
performance will result in a negative quadratic term.  
In the present analyses growth factors describe child emotional/behavioural 
development.  These models were tested for an association with maternal anxiety 
and 1) the intercept; representing baseline levels of problem scores, 2) the slope; 
reflecting increases or decreases over time and 3) a quadratic function; to capture 
non-linear change across later assessments. 
3.3.6.1 Growth curves: model fitting 
The first step was to fit an appropriate model to the data i.e. determine if a 
linear or quadratic model was best for each SDQ subscale.  This was done by 
entering the data from each time-point for each participant and assessing the 
different profiles that emerged over time.  This is termed the unconditional growth 
model as no covariates are entered at this stage.  The goal of this initial stage of the 
analyses is to determine if a two (intercept and slope) or three (intercept, slope, 
quadratic) factor model best describe the patterns of data.  Goodness of fit is 
indexed by 4 indicators 1) a comparative fit index (CFI) >0.95, 2) a Tucker Lewis 
Index (TFI) >.95, 3) a root mean squared estimate of approximation (RMSEA) <.06 
(Hu and Bentler, 1999).   
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For all three problem scales a three factor model (intercept, slope and 
quadratic) fit the data best indicating both increases and decreases in SDQ score 
over time (Attention/Hyperactivity: χ2 (20) = 12531.15, p< .001, CFI/TLI = .99/.99, 
RMSEA = .04, 90% CI = .04, .05, Conduct: χ2(20) =7424.26, p < .001, CFI/TLI = 
.99/.98, RMSEA = .04, 90% CI = .04, .05, Emotional subscale: χ2(20) =5742.12, p < 
.001, CFI/TLI = .99/.99, RMSEA = .02, 90% CI = .01, .04;).  Table 3.3.9 gives the 
mean, variance and standard error estimates of the three latent factors for males and 
females across each problem scale.  The mean intercept corresponds to the SDQ 
score at age 4. The slope value describes the rate of positive or negative change 
over time and is expressed in SDQ score per assessment over time.  Finally the 
quadratic term reflects changes in direction of linear growth such that a positive 
slope (increasing SDQ scores) followed by a negative quadratic reflects a downward 
trend in later SDQ scores. 
The next stage of the analyses was to determine if the models differed 
between the sexes and if so, which if the three growth factors were significantly 
different.  This was done by restraining (making equal) each growth factor 
consecutively in males and females for each SDQ model one at a time.  For example 
if the intercept (starting point) for ADHD scores is comparable in males and females 
then restraining the intercept (making equal) will not significantly affect model fit.  If 
however there is a difference in the starting point between males and females the 
model fit will be impaired resulting in a significant difference.  The Satorra-Bentler 
scaled chi-square test is the significance test used for determining changes in model 
fit and can be conceptualised as a t-test for growth factors.  
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 Males  Females     Males  Females 
ADHD-
related: 
 
Estimate  
 
SE 
 
Estimate 
 
SE 
 
†Sex difference 
 
Variance 
  
SE 
 
Variance 
 
Intercept 4.26** 0.0
4 
3.68**     0.03 Yes 4.21**      0.55 3.41**     0.50 
Slope -.67**     0.0
3 
-0.87**   0.03 Yes 1.55**     0.29 1.05**      0.27 
Quadratic  0.11* *    0.0
1 
0.15**      0.01 Yes 0.04** 0.01 0.02*  0.01 
Conduct:         
Intercept 2.03**      0.0
2 
1.90**     0.02 Yes 1.90**      0.28 1.11**      0.07 
Slope -0.48*      0.0
2 
-0.55**     0.02 Yes 0.39**      0.15 0.35**     0.06 
Quadratic 0.08**     0.0
0 
0.10**      0.01 Yes 0.02**      0.01 0.01       0.01 
Emotional:         
Intercept 1.44** .02 1.49**      0.02 No (p = .09) 0.81*       0.35 1.23**      0.38 
Slope .01 .02 0.09**     0.02 Yes 0.47*    0.18 0.57* *  0.19 
Quadratic -.01* .01 -0.02**     0.01 No 0.02*       0.01 0.01       0.01 
Table 3.3.9 Individual growth curve estimates, standard errors and variation of estimates for 
boys and girls on subscales of the Strengths and Difficulties Questionnaire (SDQ), SE = 
Standard error, †Sex difference calculated using the Satorra-Bentler Scaled χ2 difference test. 
*p<.05, **p <.01, ***p<.001. 
 3.3.6.1.1 ADHD-related SDQ model fit
Figure 3.3.1 ADHD-related growth curve in the ALSPAC cohort.  male
in blue (n = 4539) females in red (n = 4217 )
The growth curves for ADHD
differences were observed for each growth factor related to the 
Attention/Hyperactivity subscale
intercepts (∆χ2(1) = 155.23, 
Attention/Hyperactivity scores decreased across assessments.  This decreases was 
significantly slower in males (∆
function was significantly higher in females relative to males, indicating a non
increase in scores across assessments (
estimates observed for each growth factor indicate significant inter
variation in each growth factor (
This analysis indicates that males have higher ADHD
These high scores are followed by decreasing ADHD
assessments in both sexes, with a slower decline in males.  Finally in later 
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-related problems are presented above.  Sex 
 (Figure 3.3.1).  Males had significantly higher 
p <.01) relative to females.  Overall 
χ
2(1) = 23.14, p <.01).  In contrast the q
∆χ2(1) = 12.43, p < .01).  The variance 
-individual 
Table 3.3.9). 
-related scores at age 4.  
-related scores across 
 
s presented are 
uadratic 
-linear 
 assessments ADHD-related scores begin to increase an effect which is more 
pronounced in females.    
3.3.6.1.2 Conduct SDQ model fit
Figure 3.3.2: Conduct problem growth curves. Males are presented in blue (n = 4534) 
Conduct problem growth curves showed significant sex differences.  All three 
latent factors related to conduct problems showed significant sex differences 
(intercept: ∆χ2(1)= 24.27, p<.01
8.26, p <.01).  The starting level of conduct difficulties (intercept) was higher in males 
than females (Figure 3.3.2 
with a slower decline in conduct score in males.  There was also a small but 
significant non-linear change in score for both males and females indicating an 
increase in conduct score towards age 13.  This effect was observed in both sexes 
was stronger in females than males.
 Variance estimates for the intercept and slope were significant in males and 
females indicating different starting points and rates of decrease between 
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females are in red (n = 4210) 
, slope: ∆χ2(1) = 5.83, p = .02, quadratic: ∆
Table 3.3.9).  This higher starting point was associated 
 
 
χ
2(1) = 
 individuals.  In contrast the variance estimate for the quadratic function was only 
significant in males, indicating greater inter
at later time-points. 
The pattern of growth seen in this model is comparable to that of ADH
related scores.  Males had a higher starting point for conduct scores at age 4.  In 
both males and females these initial higher scores were followed by a decline across 
assessments.  Finally as with ADHD
in SDQ scores in later assessments.  Taken together the results of the model fitting 
above replicate well established sex differences in externalising problem behaviours 
in males and females (Zahn
extend previous cross-sectional work to show that there are significant sex 
differences both in the initial levels of externalising behaviours (ADHD/conduct 
problems) and in the rate of decline in these problems across childhood.
3.3.6.1.3 Emotional SDQ model fit
Figure 3.3.3 Emotional difficulties growth curves. Males are presented in blue (n = 
4539) and females in red (n = 4217)
152 
-individual differences in conduct scores 
-related scores there was a significant increase 
-Waxler et al., 2008).  The results of these analyses 
 
 
D-
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There was a trend for a higher intercept in females (∆χ2(1)  = 2.80, p = .09) 
with significant variance estimates suggesting heterogeneity in this starting point for 
both males and females (Figure 3.3.3, Table 3.3.9).   
There was a significant difference in the increase in emotional difficulties 
(slope) between males and females (∆χ2(1) = 8.02, p <.01).  Emotional scores in 
females increased across assessments. Conversely males slope function was non-
significant indicating little increase or decrease over time.  This pattern of consistent 
scores across childhood was not seen in all males as the slope variance estimate 
was highly significant.  Finally there was no sex difference with respect to the 
quadratic term (∆χ2(1) = .15, p = 0.7) but again variance estimates were significant in 
both sexes (Table 3.3.9). 
The pattern of growth in this model is consistent with higher rates of emotional 
problems in females.  There was trend for higher scores at age 4 followed by a 
significant positive increase in females but not males across childhood.  These 
increases were associated with a small but significant decrease in later assessments 
in females.  Similarly males were found to have a modest but significant decrease in 
emotional scores in later assessments.  
These analyses revealed clear sexes differences in SDQ growth curves.  For 
each subsequent analysis data on males and females will be presented separately. 
Having established models with a good fit the next step was to test if prenatal 
maternal anxiety was associated with the growth curves for each SDQ subscale.  
This was achieved by using the intercept (initial levels) slope (positive or negative 
growth) and quadratic (non-linear change over time) as three dependent variables.  
These three outcomes were entered into a regression model in one step and the 
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relationship with maternal anxiety at 32 weeks anxiety assessed together with 
obstetric and other maternal factors (model 1).  In the next step, subsequent 
measures of maternal anxiety at eight weeks postnatal and eight years were added 
to the model to determine if there are specific effects of the prenatal period 
independent of later anxiety (model 2; see equation 4).  It should be noted that 
maternal anxiety at eight years was used as a measure of trait anxiety.  For analyses 
of the intercept (assessed at age four) it may appear unorthodox to have a backward 
prediction from maternal anxiety at eight years.  The inclusion of this measure as a 
predictor is solely to determine the independence of maternal prenatal anxiety, and 
not to determine if later maternal anxiety can influence SDQ scores at age four. 
Equation 3-4 Latent growth curve model of ADHD-related problems in ALSPAC cohort 
Model 2: 
 i s q | hyper_4@0 hyper_7@1 hyper_9@2 hyper_11@3 hyper_13@4; 
i on a2 a3 a7; 
s on a2 a3 a7; 
q on a2 a3 a7; 
i  on  BW_GA  mat_age  mat_edu  crowd  gest  alc  smk; 
s on  BW_GA  mat_age  mat_edu  crowd  gest  alc  smk; 
q on  BW_GA  mat_age  mat_edu  crowd  gest  alc  smk; 
The latent factors (i, s, q) are derived (|) from the ADHD-related SDQ scores across 
timepoints (hyper_).  Each latent factor is regressed (on) on covariates of interest 
i = intercept, s = slope, q = quadratic, hyper_4 = ADHD related score at age 4, a2 = maternal 
prenatal anxiety at 32 weeks, a3 = maternal anxiety at week 8 postnatal, a7 = maternal 
anxiety at age 8 years 
BW_GA  = birthweight for gestational age, mat_age = maternal age, mat_edu = maternal 
education, crowd = crowding index, gest = gestational age, alc = alcohol use in pregnancy, 
smk = smoking in pregnancy. 
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3.3.6.2 ADHD-related growth curves and maternal anxiety 
The fit indices for this model were acceptable (χ2(140) = 14495.13, CFI/TLI = 
.99/.99, RMSEA = .01, 90% CI: .01-.02).  In males the intercept and slope were 
inversely associated (r = -.21, p<.001) indicating that a higher starting point was 
followed by a decrease in ADHD-related score over time.  The intercept was not 
correlated with the quadratic term.  In contrast the slope and quadratic were strongly 
inversely correlated (r = .92, p <.001).  The strength of this association indicates that 
both factors are indexing the same pattern of growth.  For ease of interpretation the 
slope will be described as the main descriptor of positive and negative change.  The 
quadratic will only be referred to when the positive of negative change is not 
sustained in later assessments.  
In females a similar pattern of association was observed between growth 
factors.  The intercept was modestly inversely correlated with the slope (r = -.19, p = 
.01), indicating that higher scores at age 4 were generally followed by a decline over 
time.  In line with the male model, the slope and quadratic were inversely associated 
indicating that both factors assess similar aspects of change in ADHD-related SDQ 
score (r = -.90, p <.001). 
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ADHD-related problems Males n = 4539 Females n = 4217  
Intercept  Estimate SE p  Estimate SE p 
Prenatal Anxiety (32wks) 0.18
a
 
0.06
b
 
0.02 
0.03 
0.00 
0.02 
 0.18
a
 
0.06
 b
 
0.02 
0.03 
0.00 
0.02 
         
Postnatal Anxiety (8wks) 0.05
 b
 0.03 0.07  0.08
 b
 0.03 0.01 
         
Birthweight for GA  -0.09
 b
 0.02 0.00  -0.08
 b
 0.02 0.00 
         
Maternal age  -0.08
 b
 0.02 0.00  -0.13
 b
 0.02 0.00 
         
Crowding  0.06
 b
 0.02 0.00  - - - 
         
Maternal education  -0.14
 b
 0.02 0.00  -0.18
 b
 0.02 0.00 
Slope  Estimate SE p  Estimate SE p 
Maternal Anxiety (8yrs) 0.11
 b
 0.04 0.00  0.23
 b
 0.05 0.00 
         
Maternal age - - -  0.10
 b
 0.04 0.01 
         
Alcohol in Pregnancy 0.05
 b
 0.03 0.04  - - - 
         
Maternal education 0.06
 b
 0.03 0.08  0.09
 b
 0.04 0.02 
         
Crowding  - - -  -0.08
 b
 0.04 0.04 
Quadratic  Estimate SE p  Estimate SE p 
Maternal Anxiety (8yrs) -0.14
 b
 0.04 0.00  -0.12
 b
 0.04 0.01 
         
Gestational age  - - -  0.08
 b
 0.03 0.03 
Table 3.3.10: Predictors of ADHD-related problem scores across childhood. Prenatal 
anxiety (32wks, shaded grey).  Model ‘a’ contained: Prenatal anxiety (32wks), birthweight 
corrected for gestational age, gestational age, maternal education, maternal age, alcohol 
use in pregnancy, smoking during pregnancy and a crowding index, Model ‘b’ contained 
all variables listed plus Postnatal anxiety (8wks), Maternal anxiety (8yrs). SE = standard 
error, wks = weeks, yrs = years, p = significance level, - = nonsignificant. Note: estimates 
for obstetric, pregnancy related and measures of SES were unchanged between Model ‘a’ 
and Model ‘b’. 
Maternal prenatal anxiety was a significant predictor of the starting point of 
ADHD-related scores (Table 3.3.10).  Accounting for obstetric, pregnancy and SES 
covariates ADHD-related scores at age four increased by approximately 10% for 
each SD increase in maternal prenatal anxiety (Model 1).  Controlling for later 
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measures of maternal anxiety reduced the estimate to approximately 3.5% (Model 
2).  A similar effect of maternal prenatal anxiety was observed in both sexes.  In 
addition to this prenatal effect, maternal postnatal anxiety at eight weeks was a 
significant predictor of the intercept in females, with a trend for a similar effect in 
males.  An increase of one SD in maternal anxiety at this point was associated with a 
similar (3.5%) increase in intercept.  
Maternal prenatal anxiety was not related to the slope or quadratic term in 
males or females, indicating no effect of prenatal anxiety on rates of change in SDQ 
score over time.  In contrast maternal anxiety at eight years was associated with the 
slope.  Although ADHD-related scores decreased over time, maternal anxiety at 
eight years predicted a less rapid decline in ADHD-related score in both males and 
females.  This relationship was strongest in earlier (positive slope) rather than later 
assessments (significant quadratic). 
Replacing maternal anxiety with depression yielded comparable results.  The 
effects of maternal prenatal depression at 32 weeks were restricted to the intercept 
and evident in both males (b = .07, SE = 0.03, p = .01) and females (b = 0.07, SE 
=.03, p 0.01).  
In summary this analysis demonstrates that the effects of maternal prenatal 
anxiety were greatest early in childhood.  These effects are observed in both sexes 
independent of a range of covariates including maternal postnatal anxiety.  Using a 
different methodology these findings replicate those of O’Connor (2002) findings 
increased ADHD-related problems in children exposed to maternal prenatal anxiety.  
Going further these findings indicate that maternal prenatal anxiety determine the 
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initial level of problem behavior but is not directly associated with change in score 
over time.   
3.3.6.3 Other factors and ADHD-related growth curves: 
In males and females BwGa was a significant predictor of the intercept. An 
increase of one SD in BwGa predicted a 5% decrease in ADHD-related scores in 
both sexes.  These findings are in line with previous reports associating lower BwGa 
with increased rates of psychiatric disorders later in development.  Adolescents born 
of very low birthweight (VLBW: <1500g) are at increased risk of any psychiatric 
disorder.  In one study almost half of adolescents born VBLW had a psychiatric 
disorder. One in four reported attention deficits, although few met full diagnostic 
criteria for ADHD (Indredavik et al., 2004).  Similar findings have been reported in 
those born in those born very preterm (<32 weeks) (Indredavik et al., 2010).  The risk 
of behavioural problems, such as attention deficit hyperactivity disorder, is increased 
by 26–40-times in very preterm infants in early childhood, a finding observed cross-
culturally (Saigal and Doyle, 2008).  Importantly in the analyses presented above it is 
birthweight corrected for gestational age which is associated with ADHD-related 
scores.  This may explain the lack of association observed in some studies of 
birthweight and ADHD (Langley et al., 2007). 
Indicators of SES were also associated with ADHD-related growth curves.  In 
both sexes lower levels of maternal education and younger age at pregnancy were 
associated with increases in the intercept.  Similarly, in males higher levels of 
crowding were associated with a higher intercept.  
Unexpectedly maternal education was inversely associated with ADHD-
related score over time (slope).  Rather than a protective effect of increased 
household crowding per se, this effect was a reflection of increasingly weaker 
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association between maternal education and ADHD-related score across time (all r(s)  
≤ -.18, p <.01).  
There was a small but significant effect of maternal alcohol consumption on 
the slope of ADHD-related scores in males.  Higher alcohol consumption in 
pregnancy was also associated with increased ADHD-related scores over time.  
Heavy alcohol use in pregnancy is potential risk factor for ADHD, supported by the 
overlap in attentional difficulties seen in ADHD and FAS.  Previous studies report 
contradictory findings between alcohol use in pregnancy and risk of ADHD (Linnet et 
al., 2003).  A recent large population failed to find a relationship between ADHD and 
alcohol use in pregnancy (Rodriguez et al., 2009).  The positive finding reported here 
should be interpreted with caution given the nature of the data (maternal self-report) 
and limited response categories employed in this study. 
Finally the effect of gestational age on ADHD-related scores in females was 
observed to change over time.  In later assessments increases in gestational age 
were association with higher ADHD-related scores in females.   
Despite a considerable literature, the current study found no significant effect 
of maternal smoking during pregnancy and ADHD-related growth curves.  This 
contrasts with a number of clinical studies reporting consistent association between 
maternal smoking during pregnancy and later risk for ADHD (Froehlich et al., 2009, 
Motlagh et al., 2010). Similarly using a case-control design including first degree 
siblings, Biederman and colleagues found those exposed to smoking during 
pregnancy were almost three times more likely to report symptoms of ADHD relative 
to their unexposed sibling (Biederman et al., 2009).   Two recent studies have 
argued against a link between smoking and ADHD with supportive evidence of a 
genetic basis for this association.  Thapar et al (2009) using a novel IVF based 
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design found no association between ADHD and maternal smoking (Thapar et al., 
2009).  Similarly when symptoms of maternal ADHD were accounted for the link 
between maternal smoking and child ADHD was non-significant (Agrawal et al., 
2010). 
It is difficult to draw any firm conclusions on the relationship between maternal 
smoking and child ADHD from the current data.  The relationship between smoking 
and ADHD may be dose-dependent, something which cannot be tested using the 
binary measure employed in this study.  
3.3.6.4 Conduct problem growth curves and maternal anxiety 
The latent growth curve model of conduct problems across childhood is 
described in equation 5. 
Equation 3-5 Latent growth curve model of conduct problems in the ALSPAC cohort 
Model 2: 
 i s q | cond_4@0 cond_7@1 cond_9@2 cond_11@3 cond_13@4; 
i on a2 a3 a7; 
s on a2 a3 a7; 
q on a2 a3 a7; 
i  on  BW_GA  mat_age  mat_edu  crowd  gest  alc  smk; 
s on  BW_GA  mat_age  mat_edu  crowd  gest  alc  smk; 
q on  BW_GA  mat_age  mat_edu  crowd  gest  alc  smk; 
The latent factors (i, s, q) are derived (|) from the conduct problem scores across timepoints 
(cond_).  Each latent factor is regressed (on) on covariates of interest 
i = intercept, s = slope, q = quadratic, a2 = maternal prenatal anxiety at 32 weeks,  a3 = 
maternal anxiety at week 8 postnatal, a7 = maternal anxiety at age 8 years BW_GA  = 
birthweight for gestational age, mat_age = maternal age, mat_edu = maternal education, 
crowd = crowding index, gest = gestational age, alc = alcohol use in pregnancy, smk = 
smoking in pregnancy. 
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The model fit the data well (χ2(140) = 10510.92, p < .001, CFI/TLI = .99/.99, 
RMSEA = .01, 90% CI: .00-.01). In line with the ADHD-related model there was an 
inverse relationship between the slope and intercept (Males: r(s)  = -0.21, p < 0.001; 
Females r(s)  = -0.19, p <.001) indicating that those with higher scores at age four 
were followed by a general decline over time.  There was no relationship between 
the starting point and quadratic.  Conversely the slope and quadratic were highly 
correlated in both males (r (s) = -0.92, p <0.001) and females (r(s)  = -0.90, p <0.001).  
The strength of this correlation indicates that linear growth is generally maintained 
across timepoints. 
There was a significant effect of maternal prenatal anxiety on the intercept for 
both males and females (Table 3.3.11).  An increase in maternal prenatal anxiety of 
one SD predicted an increase in conduct scores by 15% and over 12% in males and 
females at age four.  This was independent of obstetric and SES-related factors. The 
addition of maternal anxiety at eight weeks (postnatal) and in mid-childhood (age 
eight) to the model reduced this effect somewhat.  Controlling for later maternal 
anxiety an increase of one SD in maternal prenatal anxiety was associated with a 
5% increase in intercept in males.  In females the prenatal effect was absent once 
later maternal anxiety was accounted for.  
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Conduct problems Males n = 4534 Females = 4210 
Intercept  Estimate SE p  Estimate SE p 
Prenatal Anxiety (32wks) 0.21
a
 
0.07
b
 
0.02 
0.03 
0.00 
0.01 
 0.17
a
 
0.04
 b
 
0.02 
0.03 
0.00 
0.15 
         
Postnatal Anxiety (8wks) 
0.08
 b
 0.03 0.00 
 
0.09
 b
 0.03 0.01 
         
Birthweight for GA  - - -  -0.08
 b
 0.02 0.00 
         
Maternal age  
-0.09
 b
 0.02 0.00 
 
-0.04
 b
 0.02 0.06 
  
   
 
   
Crowding   
0.05
 b
 0.02 0.02 
 
0.09
 b
 0.02 0.00 
  
   
 
   
Maternal education 
 -0.08
 b
 0.02 0.00 
 
-0.06
 b
 0.02 0.01 
  
   
 
   
Smoking in Pregnancy 0.10
 b
 0.02 0.00  0.09
 b
 0.02 0.00 
Slope  Estimate SE p  Estimate SE p 
Maternal Anxiety (8yrs) 0.09
 b
 0.04 0.05  0.11
 b
 0.04 0.01 
      
   
Crowding - - -  -0.14
 b
 0.04 0.00 
         
Quadratic  Estimate SE p  Estimate SE p 
         
Maternal Anxiety (8yrs) -0.09
 b
 0.04 0.05  -0.22
 b
 0.06 0.00 
         
Crowding  0.08
 b
 0.04 0.04  0.16
 b
 0.05 0.00 
Table 3.3.11: Predictors of conduct SDQ problem scores across childhood. Prenatal 
anxiety (32wks; shaded grey). Model ‘a’ contained: Prenatal anxiety (32wks), 
birthweight corrected for gestational age, gestational age, maternal education, 
maternal age, alcohol use in pregnancy, smoking during pregnancy and a crowding 
index, Model ‘b’ contained all variables listed plus Postnatal anxiety (8wks), Maternal 
anxiety (8yrs). SE = standard error, wks = weeks, yrs = years, p = significance level, - 
= nonsignificant. Note: estimates for obstetric, pregnancy related and measures of 
SES were unchanged between Model ‘a’ and Model ‘b’. 
There was a significant effect of maternal postnatal anxiety at eight weeks in 
males and females.  An increase of one SD in maternal postnatal anxiety at eight 
weeks increased conduct scores at age for by between 5-6%. 
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Maternal prenatal anxiety did not influence the rate of growth in early (slope) 
or late assessments (quadratic) of conduct SDQ scores in males or females.  In 
contrast maternal anxiety in mid-childhood was positively associated with the rate of 
growth in conduct scores.  This effect was most pronounced in females in earlier 
assessments (demonstrated by a larger negative quadratic term). 
The results described above closely resemble those reported for ADHD-
related scores.  The effects of maternal prenatal anxiety are most pronounced at age 
4.  This finding remained significant after controlling for a range of covariates in 
males but not females. 
The finding that maternal prenatal anxiety predicts conduct SDQ scores at 
age 4 is in line with O’Connor et al., (2002).  In contrast to the study of O’Connor and 
colleagues (2002) the current study does not find an effect of the prenatal period on 
conduct scores in females.  A possible explanation for this finding is the inclusion of 
maternal anxiety at eight years in the current model.  This possibility is supported by 
the finding of a significant independent effect of prenatal anxiety in the intercept in 
females following the removal of maternal anxiety at eight years.  Thus the presence 
of an effect in males, despite the inclusion of maternal anxiety at eight years, argues 
for a stronger effect on the intercept in males. 
In line with the ADHD-related growth curves analysis, maternal prenatal 
depression had a similar effect on estimate of the intercept in males (b = .06, SE = 
0.03, p =.03).  In contrast to anxiety the inclusion of postnatal depression did not 
diminish the effects of prenatal depression in females (b = 0.06, SE = 0.03, p = 0.03).  
As such maternal depression at 32 weeks predicted the intercept in both males and 
females. 
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3.3.6.4.1 Other factors and conduct problem growth curves 
Unlike the findings for ADHD BwGa was only related to the intercept in 
females.  A decrease of one SD in BwGa was associated increased by 
approximately 6%. 
Measures of SES were significantly associated with the intercept in both 
sexes.  Maternal education and levels of crowding were independent predictors of 
the intercept in both sexes.  Lower levels of education and higher levels of crowding 
were associated with an increase in conduct scores at age four.  A similar 
association with lower maternal age was seen in both males and females.   
Finally with regard to intercept, maternal smoking during pregnancy was 
positively associated with scores at age four in both sexes.  Maternal smoking during 
pregnancy was associated with a 7% increase in the intercept.  With the obvious 
limitation regarding cigarette dosage described above, a relationship between 
conduct disorder and maternal smoking has been found previously (Weissman et al., 
1999, Maughan et al., 2004).  Interestingly Maughan et al., (2004) report that this 
relationship is may be confounded by genetic factors promoting maternal risk-taking.  
Once maternal risk-taking was controlled for no association was observed between 
smoking and later risk of conduct disorder in the child. 
Of the additional covariates assessed only household crowding predicted 
rates of change in SDQ score over time in females.  In line with the findings for 
ADHD-related scores in females, the association between crowding and conduct 
score was strongest at age 4 (r(s) = .14, p<.001) however this diminished across 
childhood most notably at age 11 (r(s) = .06, p <.01).  Rather than a protective effect 
of household crowding this slope effect reflects a weakening association between 
crowding and conduct scores in females across childhood.  
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In later assessments the positive association between crowding and conduct 
score increased in strength with a significant effect in both males and females 
(significant quadratic). 
3.3.6.5 Emotional problem growth curves and maternal anxiety 
The latent growth curve model for emotional difficulties across childhood is 
detailed in equation 6. 
Equation 3-6: Latent growth curve model of emotional difficulties in the ALSPAC 
cohort 
Model 2: 
 i s q | emo_4@0 emo_7@1 emo_9@2 emo_11@3 emo_13@4; 
i on a2 a3 a7; 
s on a2 a3 a7; 
q on a2 a3 a7; 
i  on  BW_GA  mat_age  mat_edu  crowd  gest  alc  smk; 
s on  BW_GA  mat_age  mat_edu  crowd  gest  alc  smk; 
q on  BW_GA  mat_age  mat_edu  crowd  gest  alc  smk; 
The latent factors (i, s, q) are derived (|) from the conduct problem scores across timepoints 
(cond_).  Each latent factor is regressed (on) on covariates of interest 
i = intercept, s = slope, q = quadratic, a2 = maternal prenatal anxiety at 32 weeks,  a3 = 
maternal anxiety at week 8 postnatal, a7 = maternal anxiety at age 8 years BW_GA  = 
birthweight for gestational age, mat_age = maternal age, mat_edu = maternal education, 
crowd = crowding index, gest = gestational age, alc = alcohol use in pregnancy, smk = 
smoking in pregnancy. 
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Table 3.3.12 presents the significant predictors of growth factors relating to 
emotional development across childhood.  This model fit the data well (χ2(140) 
=8607.15, p < .001, CFI/TLI = .99/.99, RMSEA = .01, 90% CI: .00-.01).   
In males there was a moderate inverse correlation between the intercept and 
slope (r = -0.35, p <0.001). There was also positive correlation between the intercept 
and quadratic indicating higher scores at 4 were associated with scores in late 
childhood (r = 0.18, p =.03).  Finally there was a highly significant relationship 
between the slope and quadratic term suggestive of linear dependency (r = -0.93, p 
<.001), indicating that the slope and quadratic were indexing the same pattern of 
growth. In females there was no correlation between the intercept and slope, or 
between the intercept and quadratic terms.  This indicates that in scores on the 
emotional subscale at age four were not followed by a significant decrease across 
childhood in females.  Furthermore the correlation between the slope and quadratic 
term (r = -0.87, p <.001) was not as strong as in previous model, indicating a greater 
disparity between linear growth (slope) and scores in later assessments. 
Maternal prenatal anxiety was predictive of significant increases in emotional 
difficulties in both sexes at age 4.  An increase of one SD in maternal prenatal 
anxiety resulted in an increase in emotional difficulties of approximately 28% in 
males and 25% in females.  These effects were independent of obstetric, pregnancy-
related and SES factors.  Controlling for later assessments changed these estimates 
somewhat, with an increase of one SD in maternal prenatal anxiety predicting an 
increase of 14% and 13% in male and females SDQ scores at age four.   
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Emotional problems  Males n = 4539   Females n = 4217  
         
Intercept  Estimate SE p  Estimate SE p 
Prenatal Anxiety (32wks) 0.26a 
0.13 b 
0.02 
0.03 
0.00 
0.00 
 0.25
 a 
0.12 b 
0.03 
0.03 
0.00 
0.00 
         
Postnatal Anxiety (8wks) 0.12 0.03 0.00  0.10 0.03 0.00 
         
Birthweight for GA  -0.05 0.02 0.03  - - - 
         
Maternal age  -0.05 0.02 0.01  -0.08 0.02 0.00 
         
Crowding  -0.06 0.02 0.01  - - - 
         
Slope  Estimate SE p  Estimate SE p 
Prenatal Anxiety (32wks) 0.08a 
- b 
0.03 
- 
0.02 
- 
 0.09
 a 
- b 
0.04 
- 
0.03 
- 
        
Maternal Anxiety (8yrs) 0.14 0.04 0.00  0.23 0.05 0.00 
         
 Quadratic  Estimate SE p  Estimate SE p 
Prenatal Anxiety (32wks) 0.09a 
- b 
0.02 
- 
0.02 
- 
 -
a 
- b 
- 
- 
- 
- 
        
Maternal Anxiety (8yrs) -0.14 0.05 0.00  -0.22 0.06 0.00 
Table 3.3.12: Significant predictors of emotional problems scores across 
childhood. Prenatal anxiety highlighted in grey. Model ‘a’ contained: Prenatal 
anxiety (32wks), birthweight corrected for gestational age, gestational age, 
maternal education, maternal age, alcohol use in pregnancy, smoking during 
pregnancy and a crowding index, Model ‘b’ contained all variables listed plus 
Postnatal anxiety (8wks), Maternal anxiety (8yrs). SE = standard error, wks = 
weeks, yrs = years, p = significance level, - = nonsignificant. Note: estimates for 
obstetric, pregnancy related and measures of SES were unchanged between 
Model ‘a’ and Model ‘b’. 
Maternal anxiety in the postnatal period was also associated with increased 
emotional difficulties at age 4.  An increase of one SD in maternal postnatal anxiety 
was associated with increases of 13% and 10% in males and females respectively. 
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Maternal prenatal anxiety predicted steeper increases in emotional difficulties 
over time in both males and females (Model 1).  This was associated with a small but 
significant decrease in later assessments in males but not females (Model 1).  When 
additional measures of maternal anxiety were added to the model these effects 
disappeared indicating a stronger effect of postnatal anxiety on the slope and 
quadratic term (Model 2). 
Maternal anxiety at eight years was associated with increases in emotional 
difficulties over time.  This effect persisted across assessments (no difference 
between slope and quadratic terms) indicating a lasting effect of maternal anxiety on 
emotional difficulties. 
In summary, in line with ADHD-related and conduct growth models, maternal 
prenatal anxiety had the strongest effect on the intercept in emotional problem 
growth models.  
Replacing maternal anxiety with depression gave somewhat different results.  
While the prediction from maternal prenatal depression at 32 weeks was significant 
for the intercept the estimates were lower in both males (Estimate (b) = 0.09, SE = 
.03, p <.01) and females (Estimate (b) = .08, SE = .03, p =.01).  As such the effects 
of maternal prenatal anxiety appear stronger than for those of maternal depression 
for emotional difficulty scores at age 4.  
 Maternal anxiety at age 8 was associated with greater increases in emotional 
difficulties across time an effect sustained to age 13. For all the SDQ subscales 
assessed maternal anxiety at eight years was associated with increased difficulties 
across childhood.  This finding is in agreement with a vast literature highlighting 
maternal mental health as a risk factor for child emotional and behavioural 
difficulties.  Mesman et al (2009) have reported on the effects of maternal 
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psychopathology and child externalising behaviour using growth curve analysis.  
Maternal psychopathology predicted higher starting point and a less rapid decline in 
externalising behaviours in children age 2-5years (Mesman et al., 2009).  The data 
presented above concur with the findings of Mesman et al (2009).  Both studies 
report an overall decrease over time in externalising behaviours however maternal 
anxiety/psychopathology lessens this decline.   
In a series of reports from the Office of National Statistics (ONS) Ford et al., 
(2007) report maternal distress as a significant predictor of child emotional and 
behavioural outcome in children aged 4-15years (Ford et al., 2007).  A follow-up 
study using data from a third ONS survey indicates maternal mental health is a risk 
factor for persistent emotional or behavioural disorder (Clements et al., 2008).   
3.3.6.5.1 Other factors and emotional problem growth curves 
Maternal age was a significant predictor of the intercept in both males and 
females. For every one SD increase in maternal age the emotional difficulties at age 
four fell by approximately 5% in males and 8% in females.  As such maternal age 
was found to predict the intercept for all problem subscales. These findings suggest 
that younger maternal age may be a non-specific risk factor for emotional and 
behavioural difficulties evident from childhood.   
A significant effect of BwGa was observed in males but not females.  A 
decrease of one SD in BwGa predicted an increase in emotional difficulties of 5% in 
males at age 4.  In contrast higher levels of household crowding predicted a 5% 
decrease in emotional scores at age 4 in males.  There were no other significant 
predictors of growth factors related to emotional problems.   
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3.3.6.6 Growth curves and high levels of maternal 32 week prenatal anxiety 
 The previous sets of analyses have demonstrated that a linear increase in 
maternal prenatal anxiety predicts a higher SDQ score at age four in the ALSPAC 
cohort.  A subgroup of interest is those children born to mothers with high levels of 
anxiety.  While one may predict these individuals will have a higher intercept (from 
results above) it is unclear what profile of growth would be associated with these 
individuals given the lack of association between prenatal anxiety and both the slope 
and quadratic terms.  To describe the specific growth curves for children born to 
anxious women the cohort was split into four groups, males and females exposed to 
low and high maternal prenatal anxiety.  High anxiety was defined as maternal 
anxiety scores above the 85th percentile.  Using these groupings it was possible to 
describe the developmental trajectory for children born to highly anxious women 
(Figure 3.3.4). 
As expected for ADHD-related, conduct and emotional difficulties children 
born to women with high prenatal anxiety had significantly higher scores at age 4 
(Figure 3.3.4).  Even after controlling for all covariates males and females from the 
high prenatal anxiety group remained higher on ADHD-related scores across 
childhood to age 13.  A similar pattern was observed for conduct scores in males. 
Males from the high anxiety group started were reported as having 50% higher 
scores both at the age 4 and 13 assessments.  In females this effect was most 
pronounced at age 4 with the group differences diminishing when additional 
covariates were entered into the model (Figure 3.3.4). 
Emotional difficulties were also higher in children from the high prenatal 
anxiety group.  Females exposed to high prenatal anxiety were rated as having the 
greatest number of emotional difficulties.  For both males and females the greatest 
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group differences were observed at age 4.  In both males and females those 
exposed to high prenatal anxiety emotional difficulties were approximately 36% 
higher.  These group differences were evident across the study period with a small 
but significant decrease in group differences at age 13.  In males this was due to 
decreasing scores in the high prenatal anxiety group.  In females the reduced group 
differences were explained by a small but significant decrease in emotional 
difficulties at age 13 in the high anxiety group versus a similarly small but significant 
increase in emotional scores in the low prenatal anxiety group. 
In summary, children exposed to high levels of prenatal anxiety are 
demonstrating increased rates of emotional and behavioural difficulties.  These 
effects of prenatal anxiety are greatest at age 4, but can persist to at least age 13 
and are independent of a range pre and postnatal confounds. 
 Figure 3.3.4: Emotional and behavioural growth curves in
maternal prenatal anxiety in the top 15% (broken lines) versus controls (solid lines).  Top panels (grey) are unadjusted.  Bo
adjusted for maternal anxiety at 8 weeks, 8years, pregnancy, obstetric, SES covariates.
ADHD-related: 
Hi anx Male (n=710) Lo Anx M (n=3808) 
Hi Anx F (n=684) Lo Anx F (n= 3546) 
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 males (blue) and females (red) from the ALSPAC cohort 
 
Conduct: 
Hi anx Male (n=715) Lo Anx M (n=3819) 
Hi Anx F (n=681) Lo Anx F (n= 3529) 
Hi anx Male (n=
Hi Anx F (n=68
grouped by 
ttom panel 
Emotional: 
716) Lo Anx M (n=3823) 
6) Lo Anx F (n= 3581) 
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3.4 Conclusion 
The analyses presented above illustrate the effects of maternal prenatal 
anxiety on child emotional and behavioural development.  The regression models 
demonstrate that maternal prenatal anxiety is a risk factor for higher problem scores 
at age 13 in both sexes across each problem scale.  Going further this study used 
growth curve modelling to determine how maternal prenatal anxiety affects child 
emotional and behavioural development across childhood.  Across all subscales a 
consistent finding was that maternal prenatal anxiety had the greatest effect on the 
initial levels of problem behaviour.  Grouping participants based on maternal anxiety 
demonstrated that such differences at age four were maintained across childhood 
and into adolescence.   
In general the growth curve models explained approximately 10-15% of the 
variance in the intercept (SDQ scores at age 4).  At a population level maternal 
prenatal anxiety was independently associated with small but consistent increases in 
the intercept.  Although a small effect, children born to the top 15% of anxious 
mothers had the highest SDQ scores at each assessment.  As such this potentially 
modifiable risk factor becomes is of clinical importance particularly for the most 
anxious women and their children. 
These findings are in line with a number of previous studies reporting higher 
rates of emotional and behavioural difficulties in early childhood (O'Connor et al., 
2002, O'Connor et al., 2003, Van den Bergh and Marcoen, 2004).  Overall the effects 
of maternal prenatal anxiety were independent of a range of covariates and generally 
larger than the effects of maternal depression.  The novel contribution of this work is 
to show that these effects extend at least into early adolescence. 
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The findings related to ADHD-related problem scores at age 13 are in line 
with a number of studies (Van den Bergh et al., 2005,2006, Clavarino et al., 2010).  
In a series of cross sectional studies van den Bergh reports that maternal prenatal 
anxiety predicts symptoms of externalising behaviours.  More specifically, in 
adolescence maternal prenatal anxiety was associated with greater impulsivity and 
attentional problems most notably in males (van den Bergh et al., 2005, 2006).  In 
contrast the current study finds an effect of the prenatal period in both sexes 
however this may be due to a substantially larger sample in the current study (N = 53 
versus N = 8756).   
The use of growth curve modelling revealed that maternal prenatal anxiety 
had the strongest effect on the initial level of ADHD-related problem scores.  No 
significant effect of maternal prenatal anxiety on the rate of change in ADHD-related 
score was observed.  Despite this, children born to the women with higher prenatal 
anxiety ratings (top 15%), had higher levels of ADHD-related problem scores at age 
4, and this difference was maintained across childhood.  This is in line with a recent 
study from a large prospective birth cohort in Australia has shown that maternal 
prenatal anxiety is predictive of persisting attention problems from age five to age 
fourteen.  Children exposed to higher levels of maternal prenatal anxiety were three 
times more likely to report attention problems in adolescence (Clavarino et al., 2010).  
As such the results of the current analyses replicate those of Clavarino and 
colleague (2010).  Collectively these data indicate that maternal prenatal anxiety is a 
risk factor for ADHD-related symptoms until at least early adolescence. 
Overall the findings outlined above provide evidence of a specific prenatal 
effect, increasing risk of ADHD-related score in childhood through to adolescence.  
This finding supports the notion of in utero programming by maternal prenatal 
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anxiety.  In contrast, Rice and colleagues (2009), using an IVF model described 
previously, propose that such an association may be explained by genetic 
inheritance and levels of current maternal anxiety.  The authors base this conclusion 
on the findings that maternal prenatal stress was predictive of child ADHD risk only 
in genetically related mothers and their children.  This possibility cannot be ruled out 
in the absence of a genetic control. However the results from the current analyses 
are independent of maternal postnatal anxiety. Furthermore the findings of Rice et 
al., (2009) may be explained in the context of a gene by environment interaction.  It 
is more likely that a gene which interacts with maternal prenatal stress to confer a 
specific vulnerability for ADHD will be shared between genetically similar mother and 
child.  The lower rates of ADHD in the non-related pair may simply reflect the 
absence of this susceptibility gene.  Such a possibility remains to be determined.  
Also in line with previous work is the finding of increases in conduct scores at 
age 13 in relation to maternal prenatal anxiety (Barker and Maughan, 2009).  The 
current study finds that maternal prenatal anxiety is an independent predictor of child 
conduct score, in both males and females.  Using maternal depression for these 
analyses yielded similar, but less marked results.  As such the findings are 
comparable to those of Hay et al., (2010) who report a greater number of antisocial 
behaviours in children exposed to prenatal depression (Hay et al., 2010). Similarly 
the results of the current analysis extend the findings of Barker and Maughan (2009), 
who report persisting effects of maternal prenatal anxiety on child conduct problems.  
The inclusion of a later assessment of maternal anxiety (eight years) in the current 
analyses provides a more stringent test of this effect and demonstrates the robust 
nature of this prediction.   
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A finding also relevant to the studies discussed above was that maternal age 
was a significant predictor of conduct problems.  This is of interest given the findings 
of the Nurse-Family partnership.   
The Nurse-Family partnership model provides pre and postnatal support for 
high-risk, mothers, often single parents, teenage mothers or from low SES 
background (Olds et al., 1998).  This is one of the few interventions in pregnancy 
which has been shown to be clinically effective.  Antisocial behaviour and risk of 
criminality from adolescents born to mothers in the intervention arm was reduced by 
50% (Olds et al., 1998).  The data from growth curve analysis and regression 
analyses described earlier in the chapter indirectly support the findings of Olds et al., 
(1998).  In both analyses younger maternal age was associated with increased 
levels of conduct scores, a risk factor for later criminal behaviour.  Given the success 
of this intervention in relation to maternal age, it would be of interest to determine if a 
similar clinical benefit could be gained from reducing maternal anxiety.  Indeed now 
may be an opportune time to assess this given that a UK version of the Nurse family 
partnership (titled the Family-Nurse Partnership) is now underway (Billingham, 2007) 
The findings from the growth curve analysis for conduct problem scores were 
comparable to that of ADHD-related scores.  Maternal prenatal anxiety predicted a 
greater number of conduct problems score at four, which can be maintained through 
to age 13.  This result is of interest given the findings of Odgers and colleagues 
(2007).  In a longitudinal analysis from age seven to 26 years in a large prospective 
cohort, four trajectories of conduct problem scores emerged. Participants reporting 
high scores at aged four through to adolescence, termed the life-course persistent 
group, had a significantly greater health burden as adults (Odgers et al., 2007).  The 
prevalence of mental health problems was approximately four times higher in the life-
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course persistent group relative to participants reporting low conduct scores across 
the study period.  Interestingly physical health was also impaired in this group.  
Participants from the life-course persistent group health reported the lowest 
subjective ratings of physical health, the highest levels of C-reactive protein (a 
marker of inflammation) and highest risk for coronary heart disease.  Furthermore 
the group with the second highest rates of mental and physical health problems were 
those participants whose conduct scores increased from age 13 to adulthood.  
Placing the results of the current study in the context of the findings from Odgers and 
colleagues indicates that the persisting effect of maternal prenatal anxiety on child 
conduct score may have a lasting impact on adult physical and mental well-being. 
At age 13 maternal prenatal anxiety predicted emotional difficulties in both 
males and females.  The results of the current analysis are in line with previous work 
in this cohort which showed an effect of prenatal anxiety at four and seven years of 
age (O’Connor et al., 2002, 2003).   The results of the current analyses are of 
interest given the evidence that anxiety disorders can manifest at a very early age.  
Similarly Pawlby and colleagues (2009) report that exposure to maternal depression 
in utero is a significant predictor of later depression in adolescence (Pawlby et al., 
2009).  The results of Pawlby and colleagues (2009) are based on a small 
predominantly female sample (Total n = 18; 14 female).  Given the overlap between 
findings for maternal anxiety and depression in this study, the results of the current 
analyses provide support for Pawlby and colleagues findings.  Furthermore the 
current study indicates that maternal prenatal anxiety predicts later emotional 
problems in both sexes.   
Maternal prenatal anxiety predicted a higher intercept for emotional difficulties 
at age four.  This adds to a literature reporting the antecedents of anxiety disorders 
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are evident in infancy.  Kagan et al (1999) found children with highly reactive 
temperaments at age four months were significantly more likely to report an anxiety 
problem when assessed again at age seven (Kagan et al., 1999).  Indeed a number 
of studies report negative effects on temperament in children exposed to maternal 
prenatal stress/anxiety (Austin et al., 2005, Gutteling et al., 2005, Brand et al., 2006, 
Davis et al., 2007).  The results of Kagan and colleagues suggest that such effects 
may predispose to emotional difficulties, such as anxiety problems, early in 
childhood.  
The effects of maternal prenatal anxiety described by the growth curve 
analysis are of interest given the stability of emotional difficulties across childhood.  
Over a three year period Clements et al., (2008) report that 30% of children reporting 
an emotional problem at time one still reported a problem three years later.  Indeed 
over this period the severity of such problems increased (Clements et al., 2008). 
Similarly Ashford and colleagues (2008) report that the risk of an internalising 
problem at age 11 is almost four times more likely in children who report an 
emotional problem between ages four and five.  As such it is perhaps not surprising 
that the effects of maternal prenatal anxiety observed at age four persist across 
childhood and into adolescence. 
The results presented in this section illustrate the enduring effects of maternal 
prenatal anxiety on child development.  Maternal prenatal anxiety was found to be an 
independent risk factor for child SDQ outcome.  Collectively these findings highlight 
the role the maternal prenatal emotional state plays in the long-term emotional and 
behavioural development of the child.   
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4 Chapter 4: Maternal prenatal anxiety 
and programming of the 
Hypothalamic Pituitary Adrenal (HPA) 
axis 
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4.1 Background  
Within the context of fetal programming the HPA axis is of central importance 
(Harris and Seckl, 2010).  The HPA axis is proposed to act as a mediator and a 
target for the effects of prenatal stress/anxiety.  Exposure of the fetus to excess 
maternally-derived glucocorticoids is posited as a programming mechanism which 
then leads to altered HPA function in the offspring (Harris and Seckl, 2010).  This 
resetting of the HPA axis is one mechanism which may underpin the association 
between prenatal stress/anxiety and a range of adverse outcomes (Charil et al., 
2010). 
Strong evidence that the HPA axis can be ‘programmed’ by exposure to 
prenatal stress/anxiety comes from animal studies.  In different species and stress 
paradigms, the association between prenatal stress and altered HPA function is well 
established (Weinstock et al. 2005, Pryce et al., 2010).  The specific direction of 
altered function (high versus low cortisol/corticosterone) often depends on the timing 
or nature of the stressor employed.  Similarly, some species and strains of rodents 
are more sensitive than others.  However, a consistent finding is that both basal and 
stress-responsive levels of cortisol/corticosterone are sensitive to maternal prenatal 
stress, particularly in females (Weinstock, 2007).  Such effects may be mediated by 
impaired negative feedback due to the reduced expression of hippocampal GR seen 
in stress-exposed animals (Koehl et al., 1999).   
An additional strength of animal studies is the possibility to disentangle pre- 
from postnatal effects through the use of cross-fostering.  A recent study 
demonstrates that cross fostering can ameliorate some of the adverse behavioural 
outcomes associated with prenatal stress.  In contrast, this manipulation had no 
181 
 
effect on the high corticosterone levels seen in these animals, indicating a persistent 
effect of the prenatal environment on HPA axis function (Del Cerro et al., 2010).   
 The clinical literature on prenatal programming of the HPA axis is in its 
infancy.  A number of studies report an association between prenatal stress/anxiety 
and the stress response to vaccinations (Gutteling et al., 2004) and to psychological 
stressors such as the ‘Still-face’ procedure in infants (Tollenaar et al., 2010, Grant et 
al., 2009).  More supportive evidence comes from later in childhood where prenatal 
anxiety in late pregnancy has been found to predict higher cortisol levels at waking in 
10 year olds (O'Connor et al., 2005).  Only one prospective study to date has shown 
an association between maternal prenatal anxiety (12-22 weeks gestation) and basal 
levels of cortisol in adolescents (Van den Bergh et al., 2008).  Higher levels of 
prenatal anxiety were associated with a higher waking value and a less steep decline 
across the day (Van den Bergh et al., 2008).  Huizink et al. (2008) report elevated 
morning cortisol (average time 11am) in twins born following the Chernobyl disaster.  
Finally, a study in young adults found no differences in the cortisol diurnal profile in 
relation to (retrospectively collected) maternal prenatal stress. Group differences 
emerged only in relation to a psychosocial stress task where lower baseline levels in 
the prenatal stress group were followed by a sharper increase in cortisol relative to 
controls (Entringer et al., 2009).  In summary, few prospective studies have 
established whether the effects of prenatal stress/anxiety have a lasting effect on the 
function of the HPA axis.  Of those studies reporting a positive association between 
maternal stress/anxiety and child HPA axis function, samples have often been small 
and focused mainly on childhood when the HPA axis is functionally immature 
(Gunnar et al., 2009b). 
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The clinical relevance of the findings described above comes from the 
association between dysregulation of the HPA axis and a number of mental health 
disorders such as depression, schizophrenia and bipolar disorder (Watson et al., 
2004, Lopez-Duran et al., 2009, Vreeburg et al., 2009, Valeria et al., 2010).  More 
specifically a state of hypercortisoleamia is observed in approximately 50% of 
patients with major depression. Interestingly, successful pharmacological treatment 
of depression is associated with a normalisation of cortisol levels (Pariante and 
Lightman, 2008).  HPA axis dysfunction has also been described in patients with 
remitting depression (Vreeburg et al., 2009).  Moreover, an elevated CAR in 
adolescence is reported to be a premorbid risk factor for later depression (Adam et 
al., 2010). The association between depression and HPA axis function is further 
strengthened by the high levels of depression observed in Cushing’s patients 
(Michaud et al., 2009).  Thus, determining if prenatal stress/anxiety can influence the 
regulation of the HPA axis becomes a topic of real clinical relevance.  
In addition to maternal prenatal stress/anxiety a number of obstetric, 
psychosocial and developmental factors have been associated with the function of 
the HPA axis. Size at birth has shown some association with the function of the HPA 
axis.  In adults a quadratic relationship has been reported between size at birth and 
the cortisol stress response (Kajantie et al., 2007).  The lowest cortisol levels were 
observed in the lowest and highest birthweight groups. In children there is some 
evidence for sex-specific effects. One study reports that small size at birth is 
associated with an elevated stress response in males only. An association between 
small size at birth and morning cortisol levels was seen in females (Jones et al., 
2006).  These positive associations are in contrast to a large study of 10-12 year 
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olds which found no association between birthweight and salivary cortisol levels 
(Rosmalen et al., 2005). 
Prematurity is an additional obstetric outcome associated with the HPA axis.  
An elevated CAR was observed in a group of 8-14yr old former preterm children 
relative to controls (Buske-Kirschbaum et al., 2007). In addition to these obstetric 
outcomes, low SES and early adversity have also been found to predict elevated 
cortisol in children (Lupien et al., 2001, Saridjan et al., 2010).  
Other factors which may influence the HPA axis include sex of participant and 
menarche-status in females (Kunz-Ebrecht et al., 2004, Oskis et al., 2009).  Taken 
together, prenatal stress/anxiety, obstetric, socioeconomic and developmental 
processes can influence the function of the HPA axis.  Maternal prenatal anxiety is 
correlated with many of these predictors such as low SES, birthweight and 
gestational age. Given such associations, it is important to determine if there is an 
independent effect of prenatal stress/anxiety on the function of the HPA axis.   
4.2 Aim and hypothesis 
The aim of the current section is to study the determinants of the diurnal 
profile of cortisol in 15 year olds, including the CAR. 
4.2.1 Primary hypothesis  
1. There will be a significant positive correlation between maternal prenatal 
anxiety and diurnal levels of cortisol in their adolescent offspring. 
4.2.1.1 Secondary hypothesis 
a) Maternal prenatal anxiety will predict higher waking cortisol in 
adolescence. 
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4.3 Methods 
4.3.1 Participants and procedure 
Participants were drawn from the previously described ALSPAC cohort (See 
section 2.2.1).  Approximately 3,000 participants attending an ALSPAC age 15 clinic 
were approached for this study (Figure 4.3.1). Participants who agreed to take part 
were given full instructions and provided with a saliva sampling pack. This pack 
contained 12 saliva sampling tubes (salivettes).  Participants were instructed to 
provide saliva samples at waking, 30 mins post-waking, after school and before bed 
to capture the diurnal profile of salivary cortisol. Participants recorded the times of 
each sample on a daily record sheet.  All samples were assayed for saliva cortisol 
using a commercially available immuno-assay (Salimetrics, UK) (see section 2.4.1). 
A total of 1,035 participants returned saliva sampling packs (Figure 4.3.1). 
The following exclusion criteria were then applied: 1) twin or multiple pregnancies, 2) 
gestation <32 weeks, 3) birthweight <1500g, 4) greater than one hour time difference 
between waking and 30 minutes post waking sample, 5) cortisol values outside the 
normal range (mean +/- 4SD). Following these exclusions, a total of 899 participants 
(403 males, 496 females) aged between 15-17years (average age:15 years 4 
months) remained in the cohort.  A small number of participants (N = 67) provided 
samples on just one day.  Mean cortisol levels across sampling days could not be 
generated for these participants, a final sample of 832 (375 males: 457 females) is 
used for such analyses.  
 
 Figure 4.3.1:  Flow chart of participation in the current study of HPA axis function in 
the ALSPAC cohort at age 15
 
4.3.2 Maternal data 
All maternal measures of obstetric outcomes, sociodemographic and 
psychometric data were collected as described previously (Section 
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2.3.1
 
).   
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4.3.3 Attrition 
There was some evidence of selective attrition within this sample (Table 4.4.1, 
page: 190).  Children providing cortisol data come from a subgroup of mothers who 
were significantly less anxious in pregnancy.  These mothers were also less anxious 
at two of the additional 5 assessments of maternal anxiety. Similarly, mothers from 
the cortisol subgroup reported less depression scores across all but one assessment 
(8 months postnatal).  These effects were modest but most marked for maternal 
prenatal anxiety and depression at 18 and 32 weeks.   
Missing data were more likely on children born to younger mothers with lower 
levels of education and higher levels of crowding (Table 4.4.1). Similarly, children 
from the cortisol subgroup were less likely to have been exposed to maternal 
smoking during pregnancy (Table 4.4.1). In terms of obstetric outcomes there was a 
significant difference in gestational age and birthweight between groups, with longer 
gestations and larger babies more characteristic of the cortisol subgroup.  When 
corrected for gestational age the difference in birthweight was non-significant.  
4.3.4 Analysis plan 
All data were checked for normality using P-P plots.  Cortisol data was 
skewed but normalised following ln transformation.  
A notable feature of cortisol data is its marked inter-individual (i.e., between-
individual) and intra-individual (i.e., within-individual, as across day or time of day) 
variation.  As yet no consensus has been reached on how best to analyse cortisol 
data; accordingly, we employed a variety of methods and sought convergence 
across analytic approaches.  Typically correlations, multivariate analysis of variance 
(MANOVA) and regression models are used often using group averages across 
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sampling points (Hruschka et al., 2005).  Associations between covariates of interest 
and ln transformed cortisol data were tested using Spearman rank order correlations.  
To formally test for significant main effects on the cortisol diurnal profile (i.e., multiple 
occasions within each individual) MANOVA analyses were used.  Finally, a 
multivariate linear regression model was built to test for independent effects of 
predictors of interest.  These analyses were carried out using SPSS version 18 
(SPSS, UK).  In addition to these approaches for descriptive and hypothesis-testing 
analyses, we employed two additional techniques, cluster analysis and multilevel 
analysis.  Because they are less commonly used in studies of cortisol they are 
described briefly in the next paragraphs. 
4.3.4.1 Cluster analysis of cortisol data 
Cluster analysis is an exploratory data analysis tool and can use a number of 
algorithms to determine similarity between data-points (Jain et al., 1999).  Cluster 
analysis can be used to discover structures within cortisol data-grouping participants 
with similar cortisol diurnal profiles into groups or “clusters.”’  As such, cluster 
analysis is a data driven or ‘bottom-up’ form of data analysis (Jain et al., 1999).  
Using this analytical approach, Lasikiewicz et al. (2008) describe two distinct clusters 
of cortisol profiles in their study of adults and metabolic risk factors.  The cluster 
associated with the highest number of metabolic risk factors had a blunted cortisol 
diurnal profile (Lasikiewicz et al., 2008).  More specifically, the Ward linkage method 
of cluster analysis uses the variance in data to determine which patterns of data 
points are grouped together (Ward, 1963).  Each data point is plotted in a three 
dimensional space, points that fall closest together are grouped together.  It is then 
possible to assess if a predictor of interest is more closely associated with one 
group/cluster using chi-square tests of distribution.  In the context of this study, the 
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mean cortisol across days 1-3 represent the data patterns and the clusters are 
formed of participants with the most similar cortisol profiles. Cluster analysis was 
used as an exploratory technique to determine if there was a cortisol diurnal profile 
which showed a strong association with maternal prenatal anxiety.  Cluster analysis 
and subsequent chi-square testing were carried out in SPSS version 18 (SPSS, UK).  
4.3.4.2 Multilevel modeling  
Cortisol data in this design has a nested structure.  Samples are provided at 
multiple points during the day (within day variance), often across a number of days 
(between day variance) and from multiple participants (between individual/group 
variance).  Multilevel modelling is an example of such an analysis which is suited to 
data with a nested structure (Goldstein et al., 2002).  As discussed by Hruschka et 
al. (2005), multilevel modelling (MLM) assumes the variance in data can be 
partitioned at different levels.  It is proposed that the total variance in cortisol data 
can be attributed to one of three levels: 1) time of measurement 2) between-day and 
3) between-individual (Figure 4.3.2).  An important aspect of MLM is the ability to 
explore fixed and random effects.  Conventional analyses, such as linear regression, 
determine if a predictor variable relates to an outcome of interest (fixed effect).  In 
addition to determining the fixed effect, MLM determines if this effect varies from 
participant to participant (random effect).  Secondly, MLM can be used to model 
cortisol data forming parameters relevant to the cortisol diurnal profile rather than 
just testing associations with mean levels at a given point.  In the current study three 
parameters were tested for association with covariates of interest; these were 1) the 
intercept (waking level) 2) the CAR 3) the slope of the diurnal profile.   
In support of the use of MLM, Hruschka et al. describe an association 
between cortisol diurnal profiles and aggressive behaviour; a relationship not seen 
 when using group means.  Another example of MLM comes from the work of Adam 
et al. (2006, 2010).  The authors describe the contribution of prior day loneliness on 
the magnitude of the CAR (Adam, 2006, Doane and Adam, 2
Multilevel modelling was used in this study to characterise the relationship 
between maternal prenatal anxiety and the cortisol diurnal profile.  Model fitting 
proceeded in three stages.  First, a basic model containing the three parameters of 
interest (intercept, CAR and slope) and time of waking was constructed (Model 1).  
Subsequently, obstetric and sociodemographic data were added to this model 
(Model 2).  Measures of maternal anxiety from pregnancy, at 8 weeks post
and at 8 years post-partum, were added to the final model (Model 3).  Finally, all 
predictors of interest were regressed on the intercept, CAR and slope.  All MLM 
analyses were carried out in MLwin version 2.21.  
Figure 4.3.2:  Proposed multilevel (hierarchical) model for variance in cortisol data.
 
189 
010).   
 
-partum 
 
 
190 
 
4.4 Results  
4.4.1 Descriptive statistics 
There were a higher proportion of females in the cortisol subgroup (Table 
4.4.1).  These participants were on average one month younger than the remainder 
of the ALSPAC cohort.  Other significant differences included birthweight, which was 
higher, and gestational age, which was longer in the cortisol subgroup.  No 
significant difference in maternal age was observed. However, mothers of the 
cortisol samples reported higher levels of academic achievement and lower levels of 
crowding. Similarly mothers of children in the cortisol sample reported less smoking 
during pregnancy.  
Table 4.4.1:  Participant and maternal characteristics for those taking part in the 
current study (cortisol subgroup) versus the remainder of the ALSPAC cohort 
(Total cohort). Significant group differences are denoted as follows †p for trend 
<.07, *p<.05, **p<.01, ***p<.001.  group differences tested using t-tests and chi-
square test for continuous and categorical outcomes respectively. Note the 
assessment tool for maternal anxiety changed at the age 8year assessment to 
the Spielberger trait anxiety inventory (STAI), yrs = years, mths = months, wks = 
weeks. 
 Cortisol  subsample 
(N = 899) 
Total cohort 
(N = 10, 472) 
Sex of participants: Females/ %  ***496/ 55% 5206 (50%) 
Age in years (SD) ***15.4  (.29) 15.5 (.35) 
BMI  21.4  (3.5) 21.5 (3.60) 
Birthweight (g)  *3467 (490) 3405 (556) 
Corrected for GA: 1.00 1.00 
191 
 
Table continued Cortisol  subsample 
(N = 899) 
Total cohort 
(N = 10, 472) 
Gestation age (weeks)  ***39.6  (1.5) 39.4 (1.9) 
Maternal age 28.5 (4.4) 27.7 (4.8) 
Crowding index*** 
(No. of people/No. of rooms) 
  
≥0.5 420/ 47% 4176/ 40% 
>0.5 - 0.75 290/ 32% 2957/ 28% 
>.75-1.0 142/ 16% 1741/ 17% 
>1 26/   3% 527/ 5% 
Missing 21/  2% 1071/ 10% 
Maternal education***   
CSE/Vocational 157/   18% 2462 /24% 
O-Level  323/ 36% 3243 /31% 
A-Level/Higher degree 402/ 44% 3576/ 33% 
Missing = 17/ 2% 1191/ 12% 
Smoking during pregnancy***   
No 797/ 89% 7958/ 76% 
Yes 93/ 10% 1678/ 16% 
Missing 9/ 1% 836/ 8% 
Continued over 
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Table continued Cortisol  subsample 
(N = 899) 
Total cohort 
(N = 10, 472) 
Alcohol use during pregnancy   
<1 glass per day 779/ 87% 8517/ 81% 
>1 glass per day 110/ 12% 1071/ 10% 
Missing 10/ 1% 884/ 9% 
Ethnicity   
White 840/ 93% 8654/ 83% 
Other 32/ 4% 426/ 4% 
Missing 27/ 3% 1392/ 13% 
Maternal psychometric data   
Maternal anxiety   
Prenatal (18 wks) 
Missing 
4.38 (3.22) 
62/7% 
***4.88 (3.52) 
2909/ 29% 
Prenatal (32 wks) 
Missing 
4.62 (3.50) 
50/ 6% 
**5.05 (3.58) 
2826/ 27% 
Postnatal (8 wks) 
Missing 
3.16 (3.05) 
40/ 4% 
3.37 (3.28) 
2823/ 27% 
Postnatal (8 mths) 
Missing 
3.48 (3.34) 
41/ 5% 
3.58 (3.31) 
2977/ 28% 
Maternal (2 yrs) 
Missing 
3.54 (3.03) 
64/ 7% 
*3.77 (3.31) 
3582/ 34% 
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Table continued Cortisol  subsample 
(N = 899) 
Total cohort 
(N = 10, 472) 
Maternal (3 yrs) 
Missing 
4.33 (3.36) 
66/ 7% 
**4.68 (3.52) 
3861/ 37% 
Maternal (STAI) (8 yrs) 
Missing 
38.95 (8.92) 
153/ 17% 
39.32 (9.11) 
5169/ 49% 
Maternal depression   
Prenatal (18 wks) 
Missing 
6.15 (4.39) 
52/ 6% 
***6.82 (4.78) 
2782/ 27% 
Prenatal (32 wks) 
Missing 
6.30 (4.87) 
33/ 4% 
***6.94 (5.03) 
2629/ 25% 
Postnatal (8 wks) 
Missing 
5.54 (4.49) 
32/ 4% 
**5.97 (4.71) 
2721/ 26% 
Postnatal (8 mths) 
Missing 
5.16 (4.72) 
46/ 5% 
5.30 (4.62) 
2962/ 28% 
Maternal  (2 yrs) 
Missing 
5.25 (4.32) 
60/ 7% 
*5.64 (4.73 
3487/ 37%) 
Maternal  (3 yrs) 
Missing 
5.72 (4.80) 
64/ 7% 
**6.19 (4.99) 
3867/ 37% 
Maternal  (8 yrs) 
Missing 
5.64 (4.85) 
113/ 13% 
*6.08 (5.21) 
4828/ 46% 
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4.4.2 The cortisol diurnal profile at age 15 
 
Figure 4.4.1:  Salivary cortisol diurnal profile (days 1-3) in the ALSPAC cohort. Mean 
cortisol values (+SD) are presented in bold (n = 832). * = significant difference 
between day 1 and 2 p = .01, # = significant difference between day 1 and 3 p <.001. 
 
Figure 4.4.1 describes the diurnal cortisol profile for the current cohort. A 
marked cortisol awakening response (CAR) was followed by declining levels 
throughout the day (F = 2784.45, p < .001 n = 832). On average cortisol levels 
increased by 3.64nmol/L from waking to time-point 2 (t = -23.30, p <.001, n = 850).  
An increase of 25% (1.83nmol/L) or greater was observed in 75% of the cohort.  In 
contrast, 12% of the cohort showed an opposite pattern with declining cortisol levels 
to time-point 2.  As illustrated by Figure 4.4.1, marked inter-individual variation was 
observed for each time-point across the day. 
* # 
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Despite a similar overall pattern there was a significant difference in waking 
cortisol concentrations across days (F= 7.80, p <.001).  This was due to lower 
waking cortisol levels at day 1 relative to day 2 (t = -2.68, p = .01) and day 3 (t = -
4.45, p <.001).  There was no significant difference in waking cortisol between day 2 
and day 3. 
4.4.3 Determinants of the diurnal profile: time of sampling 
Time of awakening and sample collection times can affect the diurnal cortisol 
profile (Okun et al., 2009, Stalder et al., 2009). 
Table 4.4.2 gives the sampling times for the cohort across days one to three.  
A small but significant difference in waking times across sampling days was 
observed (F = 4.01, p = .02).  This was explained by later waking times on day 3.  
Similarly, there was a significant difference in collection of the bedtime samples 
across days (F = 5.43, p = .02), this was attributable to later collection times on day 
three.  There were no significant differences in sample collection times for the post-
waking (+35mins) or after school (+10hr) samples. 
Table 4.4.2:  Wake and sample times days 1-3.  Data are presented as mean and 
standard deviation. mins = minutes, hrs = hours. Significant differences across days 
tested use one-way ANOVA denoted as follows *p < .05. 
Day *Wake (Sample 
1) 
+30 mins (Sample 
2)  
After school 
(Sample 3) 
*Before Bed 
(Sample 4) 
1 7:04 (30) +35m (7) +10hr (67)  +15hr (57) 
2 7:04 (27) +35m (8) +10hr (64) +15hr (55) 
3 7:07 (30) +35m (8) +10hr (65) +15hr (61) 
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A consistent finding across days was a modest association between time of 
waking and the magnitude of the CAR.  Earlier waking was associated with an 
enhanced CAR.  This association was strongest on day three (r(s) = -.11, p <.01) but 
comparable with day 1 (r(s) = -.09, p =.01) and day 2 (r(s) = -.08, p =.04).  In line with 
these observations, wake time on day 1 was correlated with the concentration of 
cortisol in sample 1 (r(s) = .08, p <.03), indicating higher salivary cortisol in samples 
collected at later times.  This correlation weakened progressively from day 2 (r(s) = 
.06, p = .09) to day 3 (r(s) = .05, p =.17).  There were no other significant within day 
correlations between sample collection time and cortisol concentrations.  
4.4.4 Day to day and within variation in diurnal cortisol 
Individual measures of cortisol were correlated across days 1-3 (Table 4.4.3).  
In general, morning samples showed the strongest degree of association across the 
days.  The strongest correlation was observed for saliva samples given at timepoint 
two, coinciding with peak cortisol concentrations.  Despite the stronger degree of 
association between morning samples, the CAR, by definition a function of morning 
samples, was modestly correlated across days. Similarly, small but significant, 
correlations were observed for afternoon and evening cortisol samples.   
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Table 4.4.3:  Day to day correlation (Pearson r) of Ln transformed cortisol data.  All correlations ***p< .001, CAR = cortisol awakening 
response. 
 
 
 
 
 
 
 
Table 4.4.4:  Within day correlations (Pearson r) using mean ln transformed cortisol data. * p < .05, **p<.01, ***p <.001 
             
Ln Cortisol 
Day 1- 2***       Day 2-3***       Day 1-3***       
Wake +30m +10hr Bedtime Wake +30m +10hr Bedtime Wake +30m +10hr Bedtime 
Wake  
r (p) =  0.44 
   
0.46 
   
0.37    
(n) (741) (678) (687) 
+30m  
0.54 
   
0.52 
  
 0.52   
(685) (599) (637) 
+10hr   
0.30 
   
0.31 
 
  0.31  
(700) (612) (623) 
Bedtime    
0.24 
(689)    
0.21 
(611) 
   0.31 
(620) 
CAR 
CAR1-2 
 
 
CAR2-3 
 
 
CAR1-3 
 
 .25 (643) .32 (568) .27 (601) 
Mean Ln Cortisol 
Wake +35min +10hr Bedtime CAR 
Wake r (p) = - .50*** 
(850) 
.25*** 
(872) 
.18*** 
(867) 
-.44*** 
(850) (N) 
+35min 
 
 .29** 
(851) 
.12** 
(850) 
.56*** 
(850) 
+10hr  .41** 
(872) 
.05 
(886) 
Bedtime  -.07* 
(883) 
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Within day correlations were assessed using sample means across days 1-3.  
The CAR was found to be largely independent from afternoon and evening samples 
(Table 4.4.4).  As expected, the CAR was highly correlated with morning levels, 
however, no association was observed with afternoon cortisol levels.  Similarly, only 
a weak marginally significant correlation with late evening levels was found.  This 
lack of association provides supportive evidence that the CAR is a distinct 
component for the cortisol diurnal profile. 
4.4.5 Sex differences in the cortisol diurnal profile 
There is mixed evidence for a sex difference in cortisol levels in adults 
(Pruessner et al., 1997, Kudielka and Kirschbaum, 2003).  In younger age-groups 
the data are similarly inconsistent (O'Connor et al., 2005, Rosmalen et al., 2005).  A 
recent study from the Netherlands reports no sex effect on the cortisol diurnal profile 
in adolescents of a comparable age to the current study (Bouma et al., 2009).  In 
marked contrast, a significant sex difference across the day was observed in the 
current cohort (F = 18.11, p < .001)(Figure 4.4.2).  Significant differences were 
observed across each time point.  This was a large effect size (Cohen δ = 0.57) with 
approximately 30% (2.90 nmol/L) higher cortisol levels seen in females at timepoint 
two.  Given this marked sex difference, particularly for morning samples, sex-specific 
analyses were carried out. 
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Figure 4.4.2:  Sex differences in the cortisol diurnal profile. Data are presented as 
mean and standard deviation.  Significant groups differences tested using a repeated 
measures anova are denoted as follows **p <.01, ***p<.001. Note for clarity of 
presentation error bars are directed down (males) and up (females).  
 
A significant main effect of sex was observed across all days (Day 1: F = 
10.64, p <.001, n = 319 Males, 375 Females; Day 2: F = 7.08, p <.001, N = 277 
Males, 322 Females; Day 3: F = 5.20, p <.001, n = 250 Males, 268 females).  On day 
1 this sex difference was restricted to sample 2 (Figure 4.4.3).  On subsequent days 
significant differences in both the waking and post-waking samples were observed.  
Sex differences in the afternoon and evening were less marked.  Significant 
differences emerged in the afternoon on day 3 with a trend for significant differences 
in the evening samples on day 2 and 3.  These group differences were not related to 
time of waking or sampling on either of the three days. 
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In line with the findings described above, the CAR was significantly different 
between males and females across days.  This difference was most apparent on day 
1 (Figure 4.4.3).  Interestingly, the CAR appeared to decrease across days 1-3.  This 
effect was significant in females (F = 12.00, p <.001, n = 285) attributable to the 
larger CAR on day 1 versus days 2 (t = 3.68, p <.001, n = 354) and day 3 (t = 4.85, p 
<.001, n = 319).  There was no significant difference between the CAR on day 2 and 
3.  Despite a mean decrease no significant differences in the CAR across days was 
found in the male group.   
To summarise, significant sex differences were found in the cortisol diurnal 
profile.  These effects were most apparent in post-waking samples (sample 2), a 
consistent finding across days.  These analyses also found that the first day of 
sampling was associated with fewer sex differences.  On subsequent sampling days 
sex differences emerged at multiple time points. In males and females the CAR 
appeared to decrease across days. More detailed analyses revealed this to be a 
significant main effect in females only.  Taken together, these data indicate that sex 
and day of sampling can affect the cortisol diurnal profile.   
 
 Figure 4.4.3: Boxplots of cortisol data days 1
(red boxes). Significant sex differences are denoted as follows *p <.05, **p<.01, ***p<.001.
* ** 
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202 
 
4.4.6 Factors which influence the HPA axis: Age and BMI 
There was no significant association between age of participant and cortisol 
levels at any point during the day.  Similarly, there was no correlation between 
current BMI and the cortisol diurnal profile. 
4.4.7 Puberty 
There was no association between cortisol at any timepoint and markers of 
pubertal developmental in males.  In females there was an inverse correlation 
between menarche status and post-waking cortisol levels (r (s) = -.12, p = .02, n = 
342).  Postmenarchal females had higher significant cortisol levels at timepoint 2 
(Figure 4.4.4).  The effects of menarche status was specifically associated with 
timepoint 2 (F = 4.23, p = .04, n = 342).  Interestingly, a comparison of premenarchal 
females with males showed no between group differences for any of the timepoints 
assessed (F = .24, p = NS, n = 327).  There were no group differences in relation to 
times of waking or sample collection between groups.  
 
Figure 4.4.4: Menarche status and the cortisol diurnal profile. *p =.04. 
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4.4.8 Indicators of SES and the cortisol diurnal profile 
There was no correlation between crowding and any cortisol sample.  
Similarly there was no correlation between maternal age or education or composite 
measure of maternal SES and cortisol at waking through to afternoon levels.  
However, both maternal age and education were significantly associated with cortisol 
measures at bedtime (Maternal age r(s) = -.07, p = .03, n = 883; maternal education 
r(s) = -.10, p < .01, n = 869).  Given that maternal age at pregnancy and levels of 
education are inter-correlated (r(s) = .26, p < .001, n = 817) the independence of 
these effects were tested using partial correlations.  Controlling for maternal age did 
not significantly change the association between maternal education and bedtime 
cortisol (partial r = -.09, p =.01, n = 816).  However, controlling for maternal 
education did affect the correlation between cortisol at bedtime and maternal age 
(partial r = -.06, p = .10, n = 816), indicating an independent, albeit small, association 
between maternal education and bedtime cortisol.  To illustrate the effect of maternal 
education on the cortisol diurnal profile, participants were grouped into high and low 
levels of maternal education (Lower: O-level equivalent or below and Higher: A-level 
and above) (Figure 4.4.5).   
There was a significant main effect of maternal education on the overall 
cortisol diurnal profile (F = 3.52, p =.02, n = 819).  This effect was accounted for by 
differences in levels of cortisol at bedtime (F = 11.66, p = .001), but no other point 
(Figure 4.4.5).  Mean levels of cortisol were on average 32% higher in the less 
educated group (Higher education mean: 1.01nmol versus Lower education mean: 
1.32 nmol/L).This relationship was similar in males and females with no interaction 
between maternal education and sex of participant (F=.65,p=.64,n=819).  
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Figure 4.4.5:  Maternal education level and the cortisol diurnal profile. ***p<.001 
 
4.4.9 Ethnicity 
This population was predominantly white.  The limited number of participants 
(n = 32) from ethnic minority groups prohibited a definitive comparison of the cortisol 
diurnal profile in white versus non-white groups.   Overall there was a trend inverse 
association between ethnicity and waking cortisol (r(s) = -.06, p = .08, n = 848).  
There was no main effect of ethnicity on the cortisol diurnal profile (F = 1.35, p = NS, 
n = 809), however, a specific effect was observed for waking cortisol (F 5.31, p = 
.02).  Non-white participants were found to have lower cortisol on waking (Mean 
6.20nmol/L, SD: 3.10) relative to the rest of the cohort (Mean: 7.53nmol/L, SD: 3.55).  
205 
 
This effect was not due to a higher proportion of males or differences in time of 
waking between white and non-white groups. 
4.4.10 Early life predictors of HPA axis function 
The previous analyses indicate that sex, menarche and maternal education 
are related to the diurnal cortisol profile.  In this section early life factors including 
maternal mood in pregnancy are considered. 
4.4.11 Smoking and alcohol use during pregnancy   
There was no correlation between maternal smoking during pregnancy and 
any of the cortisol measures, in males or females.  Overall there were modest 
inverse associations between maternal alcohol use in pregnancy and cortisol levels 
at waking (r(s) = -.09, p = .01, n = 871) and at 35 minutes post-waking (r(s) = -.08, p = 
.02, n = 853).  Splitting the cohort by sex revealed that maternal alcohol use was 
correlated with morning levels in females only (waking: r(s) = -.09, p = .04, n = 481; 
+35 minutes: r(s) = -.12, p = .02, n = 472).  No such effects were seen for morning 
samples in males, however, there was an association between alcohol use in 
pregnancy and evening levels (r(s) = .14, p < .01, n = 395).  No relationship with the 
CAR was observed in males or females.    
A MANOVA analysis indicated a trend for alcohol use in pregnancy on the 
diurnal profile in males (F = 2.20, p = .07, n = 370) with a specific effect on evening 
levels (F = 3.76, p = .05).  In females there was no significant main effect of alcohol 
use in pregnancy on the diurnal profile (F = 1.61, p = .17, n = 453).  In light of these 
results alcohol use, but not smoking, during pregnancy was retained as a covariate 
in later multivariate analyses.  
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4.4.12 Birthweight, gestational age, and the diurnal cortisol 
profile 
Low birthweight and prematurity have been associated with both basal and 
stress-induced cortisol levels in adults (Kajantie et al., 2002, Kajantie et al., 2007).  
There was no significant association between birthweight and cortisol at any time 
during the day in the whole sample (Table 4.4.5).  There was trend inverse 
correlation between birthweight and cortisol at time-point 2.  Gestational age 
correlated with both morning cortisol samples.  This relationship indicated higher 
cortisol levels in those born from shorter pregnancies. 
 
Table 4.4.5 Spearman r (s)   correlations between obstetric outcomes and mean ln 
cortisol across the day. † p ≤ .10, *p < .05, **p<.01. 
 
A repeated-measures MANOVA test was used to test if gestational age was 
independently associated with the cortisol diurnal profile.  A significant main effect of 
gestational age (F = 3.00, p = .02, n = 832) but not birthweight (F = 1.01, p = NS, n = 
832) was found.  Gestational age, independent of birthweight, was significantly 
associated with cortisol at waking, and in the afternoon with a trend for a main effect 
at the post-waking sample.  There was no evidence for sex differences in this 
relationship.      
Ln Cortisol Wake +35mins +10 hrs Bedtime CAR 
 Gestational age r (s) = 
(N) 
-.09** 
(881) 
 
-.07* 
(863) 
-.03 
(885) 
.01 
(883) 
.018 
(850) 
 Birthweight -.01 
(881) 
-.06† 
(863) 
.02 
(885) 
-.00 
(883) 
-.03 
(850) 
207 
 
The results described above are based on birthweight and gestational age 
measured as continuous variables.  To further explore the role of birthweight and 
gestation age on the cortisol diurnal profile, established clinical categories were 
used.  Relaxing our a priori exclusion criteria revealed 1% (n = 7) of the cortisol 
cohort was born <1500g, while 3.5% (n = 32) were born <2500g.  A similarly small 
proportion of participants were born premature.  Less than 1% (n =6) were born 
below 32 weeks while approximately 4% (n = 33) were born below 37 weeks.  Given 
the very small sample size, an analysis of the effects of very low birthweight or 
extreme prematurity and diurnal cortisol is not feasible.  These extreme cases were 
combined with cases born <2500g and 37 weeks respectively.  A multivariate 
analysis of these categorical predictors found no independent main effect of either 
gestational age or birthweight.  Interestingly, the interaction between these terms 
was significant (F = 2.85, p= .02, n = 844) with an effect on cortisol levels at 
timepoint 2 (F = 6.70, p = .01).  These differences were most marked for those born 
of low birthweight with different lengths of gestation (Figure 4.4.6).  Low birthweight 
was associated with both higher and lower cortisol at the post-waking sample 
depending on gestational age at birth.   A comparison of the CAR between the two 
groups revealed significant intergroup differences (t = -2.77, p = .05) with an average 
CAR of 6.10 nmol/L in the preterm/low birthweight group versus 3.40 nmol/L in the 
term/low birthweight group.   
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Figure 4.4.6 An interaction between gestational age and birthweight in relation to 
salivary cortisol at 35 minutes post-waking.  Data are presented as mean and 
standard deviation significance level ***p = .001 (from MANOVA model). 
 
4.4.13 Maternal anxiety and depression and the cortisol diurnal 
profile 
Table 4.4.6 describes the relationship between maternal anxiety and 
depression from pregnancy to age 8 and the cortisol diurnal profile.  Maternal 
prenatal anxiety at 18 weeks was the only maternal measure which was associated 
with multiple cortisol measures.  Overall there was a weak association between 
maternal prenatal anxiety at 18 weeks and cortisol at 35 minutes post-waking and in 
the afternoon.  A trend association was observed for this prenatal measure of anxiety 
and cortisol levels at waking.  All of these associations were inverse, increasing 
maternal anxiety was associated with decreasing cortisol levels.   
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Of the remaining assessments, only maternal anxiety in the early postnatal 
period (8 weeks) showed an association with the diurnal profile.  With respect to this 
portion of the diurnal profile, maternal anxiety was positively correlated with cortisol 
at bedtime. 
Two assessments of maternal depression were found to be significantly 
correlated with cortisol at time-point 2.  Maternal depression at 18 weeks (prenatal) 
and again 2 years postpartum were both inversely associated with the post-waking 
cortisol sample.  This association between maternal depression cortisol at timepoint 
2 was supported by trend associations for later maternal depression at 3 and 8 years 
postpartum.  There were trend associations between maternal depression at 32 
weeks (prenatal) 3 and 8 years post-partum and the CAR.  Given the literature from 
animal studies on sex-specific effects of prenatal stress, the association between 
prenatal anxiety and the cortisol diurnal profile was assessed for males and females.  
In males there were no significant correlations between maternal prenatal anxiety or 
depression and any of the cortisol measures.  In contrast, maternal prenatal anxiety 
and depression showed significant associations with cortisol in post-waking samples 
in females.  Anxiety early in pregnancy showed a significant inverse association with 
cortisol at 35 minutes post-waking (r(s) =-.14, p <.01, n = 440) with a trend for similar 
association with anxiety at 32 weeks.  Depression early in pregnancy was also 
inversely associated with post-waking cortisol (r(s) = -.14, p <.01, n = 448); the 
association was diminished but marginally significant later in pregnancy (r(s) = -.09, p 
=.05, n = 460).  Given these findings sex differences were formally tested using 
MANOVA.   
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Maternal Anxiety Maternal Depression 
 Prenatal Postnatal Prenatal Postnatal 
Ln Cortisol  18 wks 32 wks 8 wks 8 mths 2yrs  3 yrs 8yrs 18 wks 32wks 8 wks 8 mths 2 yrs 3 yrs 8 yrs 
Wake r(s) = -0.06† 0.00 -0.03 -0.05 -0.04 -0.05 -0.04 -0.04 -0.01 -0.02 -0.01 -0.01 -0.04 -0.03 
 (n) (819) (833) (841) (840) (820) (817) (732) (829) (849) (849) (835) (823) (819) (773) 
+35minutes -.08* -0.04 -0.04 -0.03 -0.04 -0.05 -0.06 -.08* -0.05 -0.05 -0.03 -0.07* -0.06† -0.07† 
(805) (815) (826) (824) (803) (803) (718) (812) (833) (835) (819) (807) (805) (754) 
+10 hrs 
  
-.07* -0.05 0.00 0.02 -0.02 -0.02 -0.03 -0.05 -0.05 -0.02 0.00 -0.01 -0.04 -0.05 
(824) (836) (845) (844) (822) (822) (736) (834) (853) (853) (839) (826) (824) (775) 
Bedtime (+15hrs) 
  
0.02 0.03 .08* 0.06 0.00 -0.03 0.00 0.02 0.03 0.05 0.02 0.03 -0.04 -0.03 
(825) (837) (843) (844) (823) (820) (736) (835) (854) (851) (839) (827) (822) (776) 
CAR 
  
-0.03 -0.06 -0.01 0.01 -0.02 -0.02 -0.02 -0.06 -0.06† -0.05 -0.03 -0.06† -0.05 -0.06† 
(792) (804) (813) (811) (792) (791) (709) (799) (820) (822) (806) (795) (793) (745) 
Table 4.4.6 Maternal anxiety and depression from pregnancy to age 8 and the cortisol diurnal profile in adolescents at age 15. Data are presented as 
correlation coefficients (Spearman r). †p for trend ≤ .09, *p< .05. wks = weeks, mths = months, yrs = years 
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There was evidence for an interaction between maternal anxiety at 18 weeks 
and sex of participant (F = 2.30, p = .06, n = 779).  This interaction was most 
apparent for cortisol levels at waking (F =4.33, p = .04) and post-waking samples (F 
= 7.50, p <.01).  A similar trend for a sex-specific effect was observed for maternal 
anxiety at 32 weeks and both assessments of prenatal depression.  In light of these 
findings, analyses were carried out grouping males and females separately. 
These analyses were carried out using cut-offs for maternal anxiety and 
depression.  Participants born to mothers with anxiety scores above the 85th 
percentile were compared to the rest of the cohort.  For depression maternal 
depressive scores (>13 on the EPDS) were used as the grouping variable.  Analyses 
were conducted using both these predictors as continuous or dichotomous variables 
with largely comparable results.  The results of analyses using the dichotomous 
predictors are presented below.  Figure 4.4.7 illustrates the sex-specific effects of 
maternal prenatal anxiety and depression the cortisol diurnal profile.   
There was a significant main effect of maternal prenatal anxiety at 18 weeks 
and the diurnal cortisol profile in females (F = 2.99, p = .02, n = 424).  Specific 
effects were found at waking (F = 5.45, p = .02) and at 35 minutes post-waking (F= 
8.75, p <.01).  In contrast, there was no main or specific effect of maternal anxiety at 
32 weeks on any measure of cortisol.  Similarly, there were no significant effects 
found in males for anxiety at either time-point.  
A similar pattern of results emerged for maternal depression.  A significant 
main effect of maternal depression early in pregnancy was observed on the cortisol 
diurnal profile (F = 3.72, p = .01 n = 432).  This was attributable to significantly lower 
cortisol in both morning samples (Waking: F = 5.45, p = .02; 35mins post-waking: F = 
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7.79, p = .01).  In later pregnancy maternal depression had a marginally significant 
effect on the overall cortisol profile (F = 2.34, p = .05, n = 442).  Depression at this 
timepoint did not influence waking cortisol levels but was associated with decreased 
level at 35 minutes post-waking (F = 6.53, p = .01).  No significant effects of maternal 
depression were found in the male group.   
Maternal anxiety at 8 weeks was the only postnatal anxiety assessment which 
had a significant main effect on the diurnal cortisol profile (F = 2.48, p =.04, n = 435).  
In keeping with the prenatal findings, maternal postnatal anxiety was associated with 
waking (F = 6.05, p = .01) and 35 minutes post-waking cortisol levels (F = 5.58, p 
=.02). 
With respect to maternal depression a significant main effect for maternal 
depression at 3 years (F = 3.78, p <.01, n = 425) and 8 years post partum (F = 2.51, 
p = .04, n = 405) was observed.  Specific effects on the cortisol diurnal profile were 
found for cortisol in the post-waking sample (3 years assessment: F = 9.70, p <.01; 8 
year assessment: F = 6.68, p = .01). 
4.4.14 Multivariate analyses of maternal prenatal 
anxiety/depression and HPA axis function 
The analyses presented above report significant main effects for early life 
factors and the diurnal cortisol profile at age 15.  To determine if these effects are 
independent a multivariate model was constructed.  
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Figure 4.4.7 Maternal prenatal anxiety/depression and the diurnal cortisol profile in males (blue) and females (red).  Participants are 
grouped based on maternal ratings of anxiety (top 15%; dashed lines)  and depression (score >13 EPDS) at 18 and 32weeks.  Data 
from  MANOVA analyses,  *p < .05, **p <.01. Cort = cortisol, Hi = High, Lo = low, anx = anxiety, Dep = depression, m = minutes, hr = 
hours.
* 
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A repeated-measure MANOVA revealed a significant main effect of maternal 
anxiety at 18 weeks on the cortisol diurnal profile was found in females independent 
of birthweight, gestational age, and maternal education and alcohol use during 
pregnancy (F = 2.95, p = .02, n = 418).  Post hoc follow-up analyses indicated that, 
significant effects of maternal prenatal anxiety were observed on cortisol at waking 
(F = 5.01, p = .03) and at 35 minutes post-waking (F = 8.37, p <.01).   
In males no effect of maternal anxiety on any aspect of the diurnal profile was 
observed.  There was a trend for a main effect of maternal education (F = 2.27, p = 
.06, n = 350) and alcohol use during pregnancy (F = 2.27, p = .06, n = 350).   In line 
with the results described previously, the effect of maternal education was 
specifically on evening cortisol levels (F = 7.18, p <.01).  Similarly, the effects of 
maternal alcohol consumption were due to a significant effect on evening levels (F = 
4.30, p = .04) and a trend for an effect on cortisol at waking (F = 3.43, p = .07). 
The model described above was subsequently used to test the association 
with maternal depression and the cortisol profile.  The effects of maternal depression 
on the cortisol diurnal profile were less strong than maternal prenatal anxiety.  
Controlling for the covariates listed above there was a trend for a main effect of 
maternal depression on the cortisol profile in females (F = 2.21, p = .07, n = 418).  In 
contrast to maternal prenatal anxiety, the effects of maternal depression at 18 weeks 
were restricted to the post-waking sample (F = 7.48, p = .01).   
To test if the effects of maternal anxiety are specific to the prenatal period 
maternal postnatal anxiety (8 weeks) was added to the model.  Maternal anxiety at 
18 weeks remained a significant main effect on the cortisol diurnal profile in females 
(F = 2.38, p = .05, n = 400).  Conversely, there was no main effect of maternal 
postnatal anxiety at 8 weeks (F = 1.27, p = .28, n = 400).  In line with the previous 
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model, maternal prenatal anxiety was most strongly associated with effects on the 
post-waking sample (F = 4.72, p = .03) with a trend for an effect on levels at waking 
(F = 3.81, p = .08).  Subsequently, maternal anxiety at 8 years was added to the 
model to further test the strength of the prenatal effect.  Controlling for both maternal 
anxiety at 8 weeks and 8 years, maternal prenatal anxiety remained a significant 
main effect with a significant effect on cortisol levels at the 35 minute post-waking 
sample (F = 4.43, p = .04), with a trend for an effect on cortisol at waking (F = 3.28, p 
= .07).  In contrast, the addition the effects of maternal prenatal depression were 
abolished by the addition of maternal postnatal anxiety (8 weeks) to the multivariate 
model.  
In summary, maternal prenatal anxiety, independent of a range of covariates, 
is associated with a blunted cortisol diurnal profile, especially at time 2, in females at 
15.  The effects of maternal prenatal anxiety are stronger than maternal depression 
and independent of obstetric, socioeconomic and postnatal assessments of maternal 
anxiety.  In males the current analyses find no evidence of an effect of maternal 
anxiety or depression on basal levels of cortisol.  A more consistent association in 
males was observed between levels of maternal education, alcohol use during 
pregnancy and evening cortisol. 
4.4.15 Multivariate linear regression analyses of the predictors 
of cortisol measures  
 
The MANOVA results demonstrate a significant main effect of maternal 
prenatal anxiety on the female cortisol diurnal profile.  This effect was most 
consistently seen in morning samples.  Regression models were used to determine 
what percentage of the variance in cortisol was due to maternal prenatal anxiety.  In 
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a univariate model prenatal maternal anxiety (18 weeks) predicted 1% and 2% of the 
variance in cortisol at waking (F = 4.36, p = .04, R2 = .01, n = 447) and at 35 minutes 
post-waking respectively (F = 6.87, p = .01, R2 = .02 n = 440) .  The addition of 
covariates, including maternal postnatal at 8 weeks anxiety, weakened the prediction 
of waking cortisol but had little effect on the prediction of lower post-waking levels.  
The final multivariate regression model including gestational age, birthweight, 
maternal education and maternal anxiety at  8 weeks account for  3.3% of the 
variance in cortisol at this time-point (F = 2.80, p = .03, n = 416).  In line with 
previous models no effect was seen in males (Table 4.4.7).  
35 minutes post waking 
FEMALEa MALEb 
Predictor B Beta B Beta Sig. 
Maternal anxiety (18 
weeks) 
-.14 -.09# .06 .04 .45 
Birthweight -.00 -.01 .00 .02 .76 
Gestational age -.03 -.09 -.01 -.03 .67 
Alcohol -.14 -.11* -.04 -.03 .54 
Maternal education .01 .04 .03 .08 .13 
a= Model fit: F = 3.59, p <.01, R2 = .04 (adj 
= .03) 
b= Model fit: F = .60, p = NS, R2 = .01 
(adj < .01) 
# p = .06 using binary predictor, p <.001 using linear predictor of maternal prenatal 
anxiety, independent of maternal postnatal anxiety (p = .96), 
Table 4.4.7  Linear regression of cortisol at 35 minutes post waking. adj = adjusted   
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4.4.16 Cluster analysis 
The next set of analyses uses cluster analysis to identify distinct patterns or 
profiles, which are then subsequently related to explanatory variables such as 
prenatal anxiety. 
 
Figure 4.4.8 Cluster analysis of diurnal cortisol in ALSPAC cohort (Total N = 832) 
 
Figure 4.4.8 describes the results of the cluster analysis.  Five distinct clusters 
emerged with significant differences across all time-points (F = 121.50, p <.001, n = 
832) (see appendix L for information on selection criteria for the final number of 
clusters).  The highest cortisol levels at waking and the largest CARs were found in 
clusters 1 and 5.  Conversely, the lowest waking and post-waking levels were found 
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in members of clusters 3 and 4, while cluster 2 showed similarities to overall mean 
diurnal cohort described previously (Figure 4.4.1; page: 194). 
4.4.16.1 Sex differences across clusters 
To test the validity of the clusters described above the distribution of males 
and females across the clusters was assessed. Given the strong sex effect 
described earlier, sex differences in cluster membership should be expected.  There 
was a significant difference in the distribution of males and females across clusters 
(χ2 = 53.77, p <.001, n =832) (Figure 4.4.9). 
Clusters 1 and 5 had the highest proportion of females and the highest 
morning levels of any cluster, consistent with the sex differences described earlier.  
In contrast, cluster 3 contained the highest proportion of males (61%) and the lowest 
levels of cortisol across the day.  An equal proportion of males and females were 
observed in the remaining clusters (2 and 4). 
4.4.16.2 Ethnicity and cluster membership 
Given the small number of non-white participants spread across cluster 
groups Fishers exact test was used to test for differences in cluster membership and 
ethnicity.  There was some evidence of unequal distribution of non-white participants 
with the highest number of non-white participants seen in cluster 4 (7%) and lowest 
in cluster 1 (<1%)(Fisher’s exact = 11.47, p = .02). 
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Figure 4.4.9:  Males and females are unequally distributed across clusters 
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4.4.16.3 Socioeconomic indicators across clusters  
There was no significant difference in the distribution of crowding levels or 
young maternal age (<20 years) across the clusters.  There was a significant 
difference in the levels of maternal education across clusters (χ2 = 12.15, p =.02, n 
=832).  In clusters 4 and 5 there were twice the number of mothers reporting lower 
levels of academic achievement relative to the remaining clusters.  In support of the 
findings described previously, clusters 4 and 5 have the highest evening cortisol 
levels.   
4.4.16.4 Obstetric and pregnancy factors across clusters 
There were no significant differences with regard to low birthweight or shorter 
gestations across cluster groups.  Similarly, smoking and alcohol use during 
pregnancy were equally spread across clusters. 
4.4.16.5 Maternal prenatal anxiety and cluster membership 
Table 4.4.8 gives the maternal anxiety and depression scores across 
participants grouped by cluster.  The distribution of high maternal anxiety scores was 
assessed across cluster groups.  Maternal prenatal anxiety at 18 weeks showed 
unequal distribution across clusters (χ2 = 12.87, p =.01, n =832).  The largest 
proportion of high-scoring (top 15%) mothers was found in cluster 4. 
This contrasted with the lowest proportion of anxious mothers from 
participants in clusters 1 and 5 (both 12%).  Maternal postnatal anxiety at 8 weeks 
was the only additional assessment of maternal anxiety to show a trend for 
differential distribution across clusters (χ2 = 8.57, p =.07, n =832).  There were no 
significant differences across clusters for maternal depression scores in the pre- or 
postnatal period. 
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In summary, cluster analysis was used as an exploratory, data-driven 
analytical method.  This analysis highlights a marked sex difference with females 
demonstrating a larger CAR.  In contrast cluster four, with the highest rates of 
maternal prenatal anxiety profile showed an atypical cortisol diurnal profile with a 
blunted CAR.  Interestingly a similar number of males and females were observed in 
this cluster which could suggest a similar effect of maternal prenatal anxiety in both 
sexes.  The results from this exploratory form of analysis require formal testing which 
is described in the next section. 
4.4.17 Multilevel modelling 
Multilevel modelling complements but adds to the previous analyses using 
MANOVA and cluster analysis because it makes explicit three core parameters: the 
intercept (waking cortisol level), the CAR (magnitude of response) and the slope 
(change from waking to evening levels).  Neither the MANOVA nor the cluster 
analyses sufficiently distinguishes these parameters.  As a result, the multilevel 
analyses may be viewed as a more powerful test of how predictor variables may 
have distinct effects on adolescent cortisol.  That is, they may predict initial level, the 
CAR, or the slope across the day.  Multilevel modelling, unlike the previous analyses 
(or other approaches such as area under the curve), allows for a specific test of 
these distinct possibilities.  Multilevel modelling also has the advantage that it is able 
to use all available data and does not delete a case if there are any missing data for 
that case.  Importantly these parameters are modelled using all the available data 
from days one to three.  Together with describing the fixed effects of predictors of 
interest (similar to the results presented above) MLM can determine if these effects 
vary among individual participants (random effects). 
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Table 4.4.8:  Maternal anxiety and depression scores across cortisol cluster membership.  Significant differences tested by one-way 
ANOVA are denoted as follows *p < .05, **p<.01. wks = weeks, mths = months, yrs = years. 
Maternal anxiety  Maternal depression 
                      Prenatal Postnatal Prenatal Postnatal 
Cluster No. 
**8 wks **32 wks 8 wks 8 mths 2 yrs 3yrs 8yrs *18 wks 32 wks 8 wks 8 mths 2 yrs 3yrs 8yrs 
 1  Mean 
(SD) 
3.90 
(2.93) 
4.40 
(3.41) 
2.95 
(2.96) 
3.22 
(3.19) 
3.52 
(3.19) 
4.09 
(3.31) 
37.92 
(9.13) 
5.39 
(4.01) 
5.92 
(4.46) 
5.23 
(4.39) 
4.89 
(4.27) 
5.10 
(4.25) 
5.28 
(4.50) 
5.14 
(4.79) 
  2 4.77 
(3.36) 
4.87 
(3.57) 
3.21 
(3.10) 
3.63 
(3.35) 
3.61 
(3.00) 
4.48 
(3.44) 
39.59 
(9.15) 
6.44 
(4.61) 
6.37 
(4.83) 
5.62 
(4.54) 
5.49 
(4.82) 
5.45 
(4.46) 
6.01 
(4.77) 
5.71 
(4.99) 
  3 4.10 
(2.95) 
4.19 
(3.21) 
3.03 
(3.15) 
3.43 
(3.56) 
3.51 
(2.91) 
4.44 
(3.53) 
38.85 
(7.83) 
6.16 
(4.25) 
6.16 
(5.01) 
5.27 
(4.44) 
5.04 
(4.98) 
4.99 
(4.04) 
6.02 
(4.97) 
6.07 
(4.82) 
  4 5.24 
(3.80) 
5.70 
(3.98) 
4.01 
(3.15) 
3.78 
(2.89) 
3.79 
(3.14) 
4.46 
(3.10) 
39.54 
(8.80) 
7.08 
(5.00) 
7.39 
(5.12) 
6.75 
(4.75) 
5.07 
(4.33) 
5.54 
(4.61) 
5.65 
(4.68) 
5.48 
(4.32) 
  5 3.76 
(2.97) 
4.07 
(3.06) 
2.94 
(2.35) 
2.89 
(2.68) 
3.03 
(2.67) 
3.69 
(2.97) 
38.49 
(9.20) 
6.01 
(4.40) 
5.94 
(4.65) 
5.26 
(4.15) 
4.48 
(3.94) 
4.87 
(4.00) 
4.72 
(3.92) 
5.68 
(4.91) 
223 
 
Table 4.4.9 Results from the multilevel analysis of cortisol data in relation to maternal 
prenatal anxiety at 32 weeks.  CAR = cortisol awakening response, Bwt = birthweight, 
wk = week, yr = year. Estimates are derived from Ln transformed data. *p <.05. 
 Fixed Effects 
 
Parameter Model 1 Model 2 Model 3 
Intercept  2.510(.097)  3.882(.382)  3.95(.010) 
 Wake time  -.067(.014)*  -.057(.015)*  -.075(.016)* 
 CAR   .425(.013)*   .456(.375)  .585(.419) 
 Slope   -.109(.003)*  -.189(.034)*  -.182(.038)* 
 Slope
2
   .001(.000)*  .001(.000)*  .001(.000)* 
 Female X Intercept    .106(.029)*  .119(.033)* 
 Female X CAR     .135(.030)*  .143(.033)* 
 Female X Slope    -.003(.003)  -.005(.003) 
Bwt X Intercept      -.329(.083)*  -.314(.090)* 
 Bwt X CAR     .030(.084)  .007(.091) 
 Bwt X Slope     .019(.009)*  .021(.008)* 
 Gestational age X Intercept   -.037(.009)*  -.034(.010)* 
 Gestational age X CAR    -.002(.009)  -.003(.011) 
 Gestational age X Slope   .002(.0008)*  .002(.001)* 
 Crowding X Intercept    -.005(.019)  -.022(.022) 
 Crowding X CAR    -.019(.019)  -.026 (.022) 
Crowding  X Slope    .001(.002)  .002(.002) 
32 wk anxiety X Intercept      .009(.006) 
32 wk anxiety X CAR       -.012(.006)* 
32 wk anxiety X Slope       -.001(.001) 
8 wk anxiety X Intercept       -.010(.007) 
8 wk anxiety X CAR       .004(.007) 
8 wk anxiety X Slope       .001(.001) 
8 yr anxiety X Intercept       -.002(.002) 
8 yr anxiety X CAR       -.002(.002) 
8 yr anxiety X Slope       .000(.000) 
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Random Parameters 
Level 3 (person) 
 Intercept/Intercept .107(.008)*  .092(.010)*  .095(.009)* 
(Between-person variance in Intercept)  
 Intercept/CAR   -.003(.006)  -.004(.006)  -.004(.007) 
 (Co-variance between Intercept and CAR)  
 Intercept/Slope  -.006(.001)*  -.005(.001)*  -.006(.001)* 
 (Covariance between Intercept and slope) 
 CAR/CAR  .040(.008)*  .037(.008)*  .035(.009)* 
(Between-person variance in CAR) 
 CAR/Slope  .000(.000)  -.000(.001)  .000(.001) 
 (Co-variance between CAR and Slope) 
 Slope/Slope  .001(.000)*  .0001(.00001)*  .001(.000)* 
 (Between-person variance in Slope) 
Level 2 (day) 
 Intercept/Intercept .003(.002)  .002(.002)  .002(.002) 
(Between-day variance) 
Level 1 (occasion) 
 Intercept/intercept .150(.003)*  .151(.003)*  .154(.004)* 
 (Within-day variance) 
Model fit (decreasing value indicating better fit) 
-2Xloglikelihood   11465.54   8482.35   7082.89 
 
 Table 4.4.9 describes the results of the MLM analysis of cortisol data.  
Maternal prenatal anxiety was found to be an independent predictor of the CAR.  In 
line with the analyses described previously, higher maternal prenatal anxiety was 
associated with a blunted CAR.  This effect was independent of postnatal anxiety at 
8 weeks and later in childhood at 8 years.  Interestingly, MLM analyses found no 
significant sex difference in relation to the effect of maternal prenatal anxiety and the 
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CAR.  In addition, these effects for maternal anxiety at 32 weeks were comparable to 
those seen at 18 weeks gestation (see appendix M).  In line with previous analyses 
maternal prenatal anxiety predicted a blunted CAR which contrasts with the 
experimental hypothesis which predicted a positive association between prenatal 
anxiety and the cortisol diurnal profile.  Similarly maternal prenatal anxiety did not 
predict higher waking levels in contrast with the secondary hypothesis of this study. 
In line with findings from conventional forms of analysis there were significant 
sex differences in the cortisol diurnal profile.  Females reported higher intercepts and 
a larger CAR but with no sex difference in diurnal slope.   
Also in line with earlier analyses was the finding that the CAR is independent 
from the remainder of the diurnal profile.  Despite significant covariance between the 
intercept and slope there was no significant association between the CAR and 
intercept or slope. 
Both birthweight and gestational age were significantly associated with the 
intercept and slope of the diurnal profile.  There was an inverse association between 
gestational age and the intercept.  Similarly, those born with shorter gestations 
reported flatter diurnal slopes.  In contrast, there was no relationship between 
gestational age and the CAR.  A largely similar pattern emerged for birthweight.  
While there was no association with the CAR, birthweight was inversely associated 
with the intercept and positively associated with the slope.   
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4.4.18 Supplementary analyses 
4.4.18.1 Sleep and the HPA axis 
Sleep has shown some association with the function of the HPA axis.  A 
recent study finds shorter and poor quality sleep is associated with a larger CAR and 
higher diurnal cortisol levels (Raikkonen et al., 2010).  The current study did not 
assess sleep quality or quantity.  However, as 85% of the cohort provided samples 
on consecutive days, prior-day bedtime will relate to sleep duration.  An interesting 
observation from the current analyses is that bedtime on day 1 is correlated with the 
magnitude of the CAR on day 2 (r(s) = .10, p <.01) with later prior betimes being 
associated with a larger CAR.  Similarly, bedtime on day 2 correlates with the 
magnitude of the CAR on day 3 (r(s) = .14, p <.001).  Thus, the association described 
above provides tentative support for the findings of Raikkonen and colleagues.  This 
finding is of particular interest given evidence of disrupted sleep in infants (in this 
cohort) exposed to high maternal prenatal anxiety (O'Connor et al., 2007).  Further 
study of potential interactions between prenatal anxiety, sleep and the function of the 
HPA axis would be of interest.   
4.4.18.2 Early adversity and the HPA axis 
Fetal development may be adversely affected by exposure to a single toxic 
stimulus.  Alternatively, development may be disrupted following the cumulative 
effect of several less noxious factors (Shonkoff et al., 2009). The effect of multiple 
risk factor exposure in early life on the function of the HPA axis is described by 
Ouellet-Morin and colleagues (2008).  In children exposed to higher levels of family 
adversity (low birthweight, maternal education and income, smoking during 
pregnancy and hostile parenting) the cortisol stress response was higher and 
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patterns of reactivity more similar in exposed twins (Ouellet-Morin et al., 2008).  The 
contribution of family adversity to basal functioning of the HPA axis was tested in the 
current study.   
A composite variable was created which included low birthweight (<2500g) 
smoking and alcohol use during pregnancy, low maternal education (<O-level 
equivalent), higher levels of crowding and younger maternal age (<20 years).  Early 
adversity showed a weakly inverse association with 35 minutes post-waking cortisol 
levels (r(s) = -.08, p = .02, n = 827).  In contrast, a stronger positive correlation was 
found between adversity and evening levels (r(s) = .11, p = .001, n = 849).  There was 
an overall main effect of adversity (F = 5.20, p < .001, n = 799) with significant 
effects at +35minutes post waking (F = 5.90, p = .02) and bedtime (F = 11.00, p = 
.001).  Moreover, those with higher levels of adversity were more likely to be 
members of cluster four described previously, in line with the overall pattern of lower 
morning levels and higher evening cortisol (χ2 = 9.92, p = .04, = 799). Despite a 
significant correlation between early adversity and maternal prenatal anxiety (r(s) = 
.09, p = .01, n = 755), partial correlations controlling for maternal prenatal anxiety did 
not change the results described above (+35 minutes (partial) r = -.09, p = .01, n = 
755; Bedtime: (partial ) r = .11, p <.01, n = 755).  As such these data provide 
evidence that the basal function of the HPA axis may be influenced by the 
cumulative exposure to risk factors which alone have a less significant effect. 
4.5 Discussion 
The main findings of this section relate to the determinants of the cortisol 
diurnal profile.  Clear sex differences are reported both for the CAR and the diurnal 
profile.  Secondly, the CAR is a discreet component of the diurnal profile unrelated to 
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cortisol at later timepoints.  Most importantly this study finds maternal prenatal 
anxiety in early pregnancy is a small but significant determinant of the cortisol diurnal 
profile.   
4.5.1 The CAR and the diurnal profile 
The CAR is a well characterised component of the cortisol diurnal profile 
(Fries et al., 2009).   The regulation of the CAR is of interest given the association 
between psychopathology and both a raised or blunted CAR (Chida and Steptoe, 
2009, Fries et al., 2009, Adam et al., 2010).  This study found evidence that the CAR 
is not associated with the function of the HPA axis.  The CAR was not associated 
with cortisol in the afternoon, and only marginally associated with evening cortisol.    
These findings support Clow et al (2009) who state that the CAR may be under 
different control other than that of the HPA axis.  The hippocampus, SCN and 
prefrontal cortex are all possible centres which may regulate the CAR (Clow et al., 
2009). 
An interesting observation from the current analyses was the enhanced CAR 
seen on day 1.  A similar finding has been observed in a group of females studied 
over 12 sampling days.  The magnitude of the CAR appeared to decrease as the 
study proceeded, this could not be explained by state variables nor changes in 
season (Stalder et al., 2010b).  It is tempting to speculate that on day 1, anticipation 
of saliva sampling results in an enhanced CAR while on days 2 and 3 participants 
habituate and the CAR reflect the normal basal state.  This possibility is supported 
by studies which report the largest CAR on days when there are high levels of 
anticipation (e.g. a ballroom dancing competition) (Rohleder et al., 2007, Stalder et 
al., 2010a)  
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  The association between time of sampling and the CAR is well established 
(Kudielka and Kirschbaum, 2003, Okun et al., 2009).  This study found an inverse 
association between time of waking and the CAR.  Participants waking earlier, when 
cortisol is lower, had a larger CAR.  A similar finding has been reported recently in a 
single case study of one participant across a 50 day period (Stalder et al., 2009). 
Also in line with previous work was the consistent finding across days of a 
strong correlation between morning rather than evening cortisol levels.  The findings 
of Wust et al. (2000) indicate that this correlation may reflect a stronger genetic 
component to morning cortisol levels.  Using a twin study design the authors 
conclude that the CAR is moderately heritable, with shared genetic factors 
accounted for 46% of the variance.  More recently similar heritability of awakening 
cortisol has been reported in infant twin-pairs (Ouellet-Morin et al., 2009).  
Interestingly, the concordance between twins for cortisol across the morning period 
was strongest in those exposed to adversity, indicating a possible gene by 
environment effect.   
4.5.2 Sex-specific effects on the cortisol diurnal profile 
There were clear sex differences in the both the CAR and cortisol diurnal 
profile.  The CAR showed the greatest degree of sexual dimorphism consistent 
across study days.  This result is in line with previous reports of sex differences in 
adults (Pruessner et al., 1997, Kunz-Ebrecht et al., 2004).  This result contrasts with 
a previous study in children from this cohort showing no sex differences in the 
diurnal cortisol profile at age 10 years (O'Connor et al., 2005).  Furthermore, the 
current data are in stark contrast to those of Bouma et al (2010) who report no sex 
effect in a large group (n = 650) of 15-17 year olds.  There are two possible 
230 
 
explanations for the contradictory findings.  Firstly, the majority of the sample (66%) 
studied by Bouma et al. were at high risk of various mental health problems.  This 
contrasts with the randomly selected adolescents from a community sample used in 
this study.  Secondly, Bouma and colleagues collected cortisol samples (waking and 
30mins post) on just one day.  In the current study sex differences were most 
apparent on days 2 and 3 it is possible that underlying sex differences are 
attenuated on the first day of sampling.   
The findings related to puberty are of interest given the sex differences 
discussed above.  Females reporting first menses had higher cortisol levels at 
timepoint 2.  It is important to note that this finding requires replication given the 
small sample size (n= 21) of the comparison group in this study.  With this limitation 
in mind, the data presented support findings from Oskis and colleagues.  Comparing 
pre and post-menarchal females the authors report significant differences in the 
CAR.  More specifically, post-menses females had a higher and later morning 
cortisol peak relative to the premenarchal group (Oskis et al., 2009).   Group 
differences emerged only after 30 minutes post waking.  As the average sample 
collection time in the current study was 35 minutes post-waking, our data are in line 
with the results of Oskis et al. (2009).   
There was no correlation between cortisol levels and Tanner stage. This may 
be explained largely by the age of participants included in this study.  Less than 2% 
of females with cortisol data reported pre-early stage pubertal development (Tanner 
stages 1-2).  Similarly, no relationship between Tanner stage and cortisol levels was 
seen in males.  In line with female participants few males reported an early stage of 
puberty.  For male pubic hair development 95% of males in the cortisol subgroup 
had reached mid-late Tanner stage (≥Tanner stage 3).  In line with this, 90% of the 
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male group reported a change in voice.  As such the data from the current study 
indicate that cortisol levels show no significant difference between mid-late Tanner 
stages in males and females (Tanner stages 3-5).   
It is possible that the emergence of sex differences and the dynamic CAR 
observed are evidence of a mature HPA axis.  Adolescence is a period when the 
output of the HPA axis in response to psychosocial stress approaches adult-like 
levels (Gunnar et al., 2009b).  The data from the current study suggests basal 
cortisol levels may be affected in a similar fashion.  Such sex and developmental 
differences are of interest in the context of adolescent mental health.   
Anxiety and depressive disorders increase disproportionately in females 
during adolescence (Zahn-Waxler et al., 2008).  Similarly, higher levels of cortisol 
and a higher CAR are associated with depressive and anxiety-related disorders 
(Greaves-Lord et al., 2007, Pariante and Lightman, 2008, Adam et al., 2010b).  It is 
tempting to speculate that the developmental changes in HPA function described 
here may lead to an increased vulnerability to anxiety/depressive disorders in 
females.  In the absence of concurrent psychiatric data testing such associations is 
not feasible.   
In contrast to the elevated morning cortisol levels seen in females, ethnicity 
was associated with lower cortisol at waking.  The generalisability of this finding is 
limited due to the small size (n = 32) and ill-defined sample of ethnic minorities 
(White versus Non-white).  With these considerable limitations in mind it is 
interesting to compare this finding to those of Hajat et al (2010) and DeSantis et al., 
(2007).  In a large group of adults (n = 935) of different ethnic minorities, Black and 
Hispanic populations had lower waking cortisol (Hajat et al., 2010).  Similarly, 
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DeSantis and colleagues in a cohort of 17 years old adolescents found lower waking 
cortisol levels in African American participants (DeSantis et al., 2007).  In both 
studies group differences emerged in the evening with the highest cortisol levels in 
observed Blacks, lowest in Hispanics and mid-range values in White participants.  
The current study did not find an effect on evening cortisol levels, however, the 
grouping of different non-white ethnicities together could have masked such nuanced 
differences in evening cortisol levels.  The finding from this study indicates that 
already by mid-adolescence ethnic differences in HPA axis function are apparent 
and an important consideration for studies of the cortisol diurnal profile. 
Maternal education was used as a proxy for socioeconomic status and was 
found to be associated with elevated evening cortisol.  This contrasts with a smaller 
study (n = 307, ranging in age from 6-16) reporting higher morning cortisol in lower 
SES in 6-10 year olds, a difference which disappeared by age 16.  In contrast, 
Cohen et al. (2010) in a large study (n = 781) of adults found elevated evening 
cortisol in those reporting low SES.  In this study SES was operationalised as 
number of years spent in education in line with the predictor for the current analyses.  
Similarly, Miller et al. (2009) report higher evening cortisol levels in adults exposed to 
low SES in early life.  Evening levels are thought to be more greatly influenced by 
psychosocial stress (Wust et al., 2000a).  It is possible that the higher levels of 
evening cortisol seen from low SES participants may reflect increased exposure to 
psychosocial stress in this group.  The importance of this finding is highlighted by the 
main findings of Miller et al. (2005, 2009b).  In an interesting study of the molecular 
sequela of low SES the authors report a pro-inflammatory phenotype in those 
exposed to low SES in early life (Miller et al., 2005, Miller et al., 2009b). 
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This study found that lower gestational age was associated with higher 
cortisol at waking.  These results are in line with those of Buske-Kirschbaum et al. 
(2007), who report significantly higher cortisol at waking in former pre-term children 
(aged 8-14).  In addition to these endocrine changes, Buske-Kirschbaum and 
colleagues report a blunted response to an immune challenge in the former preterm 
group (Buske-Kirschbaum et al., 2007).  The current study did not assess immune 
function but it would be of interest to determine the changes to the cortisol profile 
observed in the preterm group associate with altered immune response.   
In this study there was no main effect of birthweight on the cortisol diurnal 
profile.  This contrasts with Jones et al. (2006), who report an inverse correlation 
between birthweight and the peak of cortisol in morning samples of younger females 
(aged 7-9).  One possible explanation for these discrepant findings is age differences 
observed between the two studies.  In support of this possibility is the effect of 
menarche observed in this sample.  Given the younger age of participants described 
by Jones et al. (2006), this developmental milestone may account for some of the 
differences observed between the studies. 
An interesting observation from the current study was the interaction between 
gestational age and low birthweight.  Being born of low birthweight (<2500g) had 
markedly different effects on the cortisol profile depending on the gestational age at 
birth.  As such low birthweight was associated with both higher and lower cortisol in 
the post-waking sample.  This finding has some support from the work of Kajantie et 
al (2002).  Despite a different sample demographic (males and females aged ~70 
years) the authors report largely similar findings.  In those participants born below 39 
weeks there was an inverse association with birthweight and fasting morning cortisol 
levels (8:30-10:00am).  In contrast, in those born at term (>39 weeks) there was a 
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positive correlation with birthweight and fasting cortisol, such that low birthweight 
was associated with lower cortisol levels (Kajantie et al., 2002).  Although the sample 
size used in the current analyses was small these findings give some evidence for 
different cortisol profiles following divergent in utero development.  
4.5.3 Maternal prenatal anxiety and a blunted cortisol diurnal profile 
This is the largest prospective study of its kind, and the first to show an effect 
of maternal prenatal anxiety on the CAR in adolescence.  Maternal prenatal anxiety 
resulted in a blunted cortisol diurnal profile independent of a range of covariates, 
including postnatal anxiety.  This finding was apparent only in females when 
conventional forms of analysis were used.  In contrast, multi-level modelling (MLM) 
with its greater sensitivity, found maternal prenatal anxiety at both 18 and 32 weeks 
affected both males and females.   
The finding that maternal anxiety, from both prenatal assessments, results in 
a blunted CAR and overall lower levels of morning cortisol is in direct conflict with 
evidence from this cohort at a younger age.  In a smaller sample of 10 year olds from 
this cohort (n = 75), maternal prenatal anxiety in later pregnancy was positively 
correlated with the diurnal profile.  Moreover, maternal anxiety specifically predicted 
higher cortisol at waking an association seen more strongly at 32 weeks gestation. 
This result contrasts with the experimental hypothesis and a range of animal studies 
showing elevated cortisol in relation to maternal prenatal stress (Weinstock, 2007, 
Pryce et al., 2010).   
The results of this study also contrast with those of Huizink et al (2008) who 
report elevated morning cortisol in adolescent twins aged 14, indirectly exposed to 
the Chernobyl nuclear disaster during pregnancy (Huizink et al., 2008).  In their study 
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indirect exposure to the Chernobyl disaster during the second trimester accounted 
for 3% of the variance in morning cortisol at age 14 (average time 11:00am) (Huizink 
et al., 2008).  Although the results of the current study account for a similar 
proportion of the variance the prediction is in the opposite direction.  There are a 
number of possible explanations.  Firstly, there was no assessment of maternal 
anxiety in the exposed or non-exposed group.  In addition, the comparison group, 
born one year following the disaster, had significantly lower birthweight (an average 
of 93g difference between twin pairs) and shorter gestations (37.3 weeks versus 
36.9 weeks).  Finally, the cortisol sample collection were not standardised to time of 
waking with considerably more variability in the exposed group (Mean exposed 
group: 8.49nmol/L SD: 19.55 versus 4.94nmol/L SD: 3.97).  Such differences in 
methodology may underlie the conflicting results between the current study and the 
findings of Huizink et al (2008).   
In addition to the results of Huizink et al (2008), the results of the current 
study conflict with those of Entringer et al (2009) who report no effect of prenatal 
stress on the cortisol diurnal profile.  There are a number of possible explanations for 
this conflict.  Firstly, Entringer and colleagues (2009) base their analyses on a 
stress-exposed group of 31 young adults.  This sample may have been 
underpowered to detect the effects reported in the current study.  An additional 
possibility is their use of different life events to operationalise ‘prenatal stress.’  
Examples of ‘prenatal stressors’ included flooding, car accidents, illness of a loved 
one, marital infidelity or paternity denial.  This heterogeneity conflicts with the current 
study which used maternal anxiety as the main index of prenatal stress.  Finally, the 
findings of Entringer et al. (2009) rely on the retrospective collection of data on 
prenatal stress some 25 years post-partum (contrasting with the prospective design 
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of the current study).  Furthermore, the investigators did not collect this data from the 
mothers in question.  Instead, participants were instructed to ask their mothers about 
the stressors of interest.  Given the sensitive nature of some of these stressors 
investigated (paternity denial, marital infidelity etc) underreporting in both 
experimental and control groups may have contributed to the absence of a group 
difference. 
The present analyses are in line with the only other study in mid-adolescence 
of the effects of maternal prenatal anxiety on the cortisol diurnal profile.  This finding 
extends those of Van den Bergh et al. (2008), who report lower awakening and 
higher evening cortisol levels in adolescents exposed to high levels of maternal 
prenatal anxiety between 12-22 weeks (Van den Bergh et al., 2008).  The findings of 
the current analyses and those of Van den Bergh (2008) argue for reduced basal 
morning cortisol in adolescents exposed to maternal prenatal anxiety.  This 
downward reprogramming has support from studies of early life exposure to post 
traumatic stress disorder (PTSD). 
In a cohort of adults born to holocaust survivors with PTSD, lower diurnal 
cortisol levels were observed (Yehuda et al., 2007).  Intriguingly, this effect was 
strongest when the pregnancy occurred closer to the time of trauma exposure.  
Moreover, it was maternal, rather than paternal PTSD, consistent with maternal 
transmission of effect.  A similar pattern of lower cortisol in morning samples has 
been reported in children exposed to 9/11 in utero whose mothers went on to 
develop PTSD (Yehuda et al., 2005).  Similarly, animal models of PTSD show down 
regulation of the HPA axis stress exposure.  Prepurbertal rats exposed to a 
threatening stimulus (cat odour) display significantly lower corticosterone stress 
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responses in adulthood (Bazak et al., 2009) with a potentially mediating role of lower 
hippocampal brain derived neurotrophic factor (BDNF). 
Collectively, these studies provide evidence that the function of the HPA axis 
can be dampened following early stress exposure.  However, such studies occur in 
the context of extreme stress exposure followed by progression to PTSD.  This 
process may have a very different biological underpinning to the effects of maternal 
anxiety assessed in this study.  Furthermore asserting that maternal prenatal anxiety 
results lower basal cortisol directly contradicts the findings of O’Connor et al., (2005).  
An alternative hypothesis, which may explain the apparently contradictory findings, is 
that maternal anxiety can lead to both higher and lower cortisol at different 
developmental stages.   
This possibility is in line with the model proposed by Fries et al (2005).  The 
authors give the examples of PTSD, chronic pain and chronic fatigue as conditions 
associated with hypocortisolism, a state also seen in atypical depression (Anisman 
et al., 1999).  Using an animal model the authors show that higher levels of cortisol 
can result in a state of hypocortisolism in the long term (Fries et al., 2005).  This 
switch from high to low cortisol is proposed as a protective mechanism however an 
over-adjustment results in lower basal cortisol levels.  This model offers a plausible 
biological model to bring the results of O’Connor et al. (2005) in line with those of the 
current study.  
4.5.4 Clinical implications of the current findings 
Maternal anxiety accounted for less than 3% of the variance in the CAR.  It is 
unlikely, but not inconceivable, that such an effect mediates the relationship between 
maternal prenatal anxiety and adverse neurodevelopmental outcomes described 
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previously.  It appears from this study that the basal function of HPA axis and the 
CAR are sensitive to maternal prenatal anxiety but these effects are unlikely to be of 
clinical relevance.  This conclusion does not preclude a role for the HPA axis in 
neurodevelopment.   
Higher levels of cortisol/corticosterone are associated with neural processes 
such as decreased neurogenesis (Barha et al., 2010), synaptogenesis (Afadlal et al., 
2010), and dendritic arborisation (Morales-Medina et al., 2009).  It is plausible that 
maternal prenatal anxiety may have a greater impact on the stress response or more 
central HPA axis functions, however, these possibilities are beyond the scope of the 
current study. 
4.5.5 Limitations 
A major strength of this study was the large sample size and use of a 
prospectively designed cohort with detailed information on a range of covariates.  
Despite these strengths, a number of important methodological concerns should be 
highlighted.  Firstly, no objective measure of compliance was used in this study, 
sample collection times replied on participant self-report.  Sample timing is crucial for 
accurate determination of the CAR (Okun et al., 2010).  Sex differences or group 
differences may simply reflect different levels of compliance.  While this possibility 
cannot be ruled out we found no overall sex or group differences in self-report 
sample collection times.  Okun et al. (2010), using both objective and self-report 
measures of sample collection times, found excellent concordance rates between 
measures.   
An additional limitation is the lack of data on the phase of menstrual cycle 
phase during sampling or the use of oral contraceptives.  There is mixed evidence 
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for the contribution of these factors to the cortisol diurnal profile (Pruessner et al., 
1997, Kudielka and Kirschbaum, 2003, Bouma et al., 2009).  Kudielka et al. (2003) 
suggest these factors have minimal affect on the awakening response. In contrast, 
Bouma et al. (2010) report a blunted CAR in females using oral contraceptives.  It is 
possible that a medication effect may influence the relationship between maternal 
prenatal and the blunted cortisol response seen in females, however, the presence 
of such an effect in males argues against this conclusion. 
This study would have benefited from data on the genetic component of 
cortisol diurnal profile.  The relationship described between maternal prenatal anxiety 
and adolescent cortisol may reflect shared genetic variance.  Arguing against a 
simple genetic transmission is the lack of association between postnatal 
assessments of maternal anxiety and cortisol in adolescence.        
Finally, it is difficult to determine if the changes to the diurnal cortisol profiles 
described here translate to changes at a cellular level.  While cortisol in saliva 
represents the physiologically active portion contained in serum, glucocorticoid 
sensitivity may be different between participants.  The collection of blood samples to 
probe GR sensitivity may have yielded more information about the functional effects 
of the effects described.   
4.5.6 Conclusion 
In conclusion, there are a number of significant determinants of the cortisol 
diurnal profile.  The strongest prediction of the CAR came from maternal prenatal 
anxiety.  In contrast to earlier in development, a downregulation of cortisol is seen 
following exposure to maternal anxiety in utero.  The findings discussed in this 
section make a significant contribution to the literature on fetal programming.  The 
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results indicate that the HPA axis and CAR are sensitive to maternal prenatal anxiety 
at least into adolescence, however, the clinical relevance of these effects are yet to 
be undetermined.  
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5 Chapter 5: Fetal programming and 
the placenta 
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5.1 Background 
 The placenta connects the mother to her fetus.  It is through this filter that 
oxygen, nutrients, hormones and waste products are exchanged supporting fetal 
growth and development.  Placental function is a key determinant of pregnancy 
viability.  This is exemplified in a range of medical disorders of pregnancy where 
compromised placental function can lead to miscarriage (Kaplan, 2008). 
Placental tissue is derived from the trophectoderm, the outer cell layer of the 
blastocyst (Huppertz, 2008).  It is genetically ‘fetal’ and can be used for determining 
chromosomal abnormalities early in pregnancy through chorionic villi sampling.  The 
growth of the placenta precedes that of the fetus. Placental growth is maximal during 
weeks 12-22 slowing towards term (Bleker et al.).  Conversely fetal growth lags 
behind increasing to term.  The positive correlation between placental weight and 
birthweight is a consistent finding across studies (de Paula et al., 2008).  Some 
studies, using a placenta:birthweight ratio, report that this measure is a significant 
predictor of cardiovascular disease in later life (Risnes et al., 2009, Thornburg et al., 
2010).  As such placental growth and development is important for both short and 
long term health outcomes.  
An intriguing aspect of placental function is its contribution to the maternal 
HPA axis.  The placenta secretes CRH during pregnancy (Wadhwa et al., 1997).  
This CRH participates in positive feedback on the maternal HPA axis increasing 
cortisol levels to term.  It is these high levels of cortisol which meet the metabolic 
demands of a growing fetus.  The function of the maternal HPA is important for 
meeting the metabolic demands of pregnancy however fetal exposure to excess 
glucocorticoids compromise fetal development.   The placental enzyme 11β-HSD2 
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regulates the access of maternal cortisol to the fetal compartment, metabolising 
active cortisol to inactive cortisone (Edwards et al., 1993).  It is estimated that 
approximately 90% of maternal cortisol is metabolised by this enzyme resulting in 
10-13 fold lower cortisol concentrations in the fetal compartment (Harris and Seckl, 
2010, Gitau et al., 1998).  As a primary regulator of fetal cortisol exposure placental 
11β-HSD2 is a likely programming mechanism.  
Two fields of research provide supportive evidence that placental 11β-HSD2 
may be a programming vector.  The first comes from clinical studies which illustrate 
that placental 11β-HSD2 is sensitive to physiological changes in the mother.  More 
direct evidence comes from animal studies reporting reduced expression and/or 
function of 11β-HSD2 following maternal prenatal stress. 
A number of clinical studies associate reduced placental 11β-HSD2 or 
increased exposure to glucocorticoids, with adverse obstetric outcomes.  Placenta 
from intrauterine growth restriction (IUGR) and preterm cases show reduced 11β-
HSD2 gene expression and enzyme activity (Shams et al., 1998, Schoof et al., 
2001).  The association between reduced 11β-HSD2 gene expression and IUGR has 
been replicated in a number of studies (McTernan et al., 2001, Dy et al., 2008).  
Similarly a more recent study reports both reduced 11β-HSD2 gene expression and 
placental weight in IUGR cases (Wächter et al., 2009).  Kajantie et al., (2006) 
reported lower 11β-HSD2 activity in placenta from extremely low birth weight 
neonates.  Furthermore lower placental 11β-HSD2 activity levels were associated 
with poorer clinical outcomes, lower Score of Neonatal Acute Physiology (SNAP) 
scores and symptoms of adrenal insufficiency, suggesting a less mature adrenal.  A 
recent study from Chile reports a less consistent pattern of association between 11β-
HSD2 activity and placenta from small for gestational age cases, with reduced 
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enzyme activity only observed in female placentae (Mericq et al., 2009).  It is 
plausible that diminished levels of 11β-HSD2 affects fetal growth.  Supportive 
evidence comes from the rare genetic disorder syndrome of apparent 
mineralocorticoid excess (AME).  AME arises from a dominant negative mutation in 
the HSD211B gene abolishing 11β-HSD2 gene expression and activity (Hammer 
and Stewart, 2006).  Individuals carrying this mutation are born of low birthweight 
and progress to a hypertensive state in adolescence/adulthood.  This occurs due to 
the lack of renal 11β-HSD2 activity which ensures aldosterone, rather than cortisol, 
binds the mineralocorticoid receptor (MR).   
Additional evidence that excess that excess glucocorticoids, or diminished 
11β-HSD2 function, can have lasting effects comes from pregnancies treated with 
multiple course of antenatal steroids (Bevilacqua et al., 2010).  These drugs used to 
ensure fetal lung maturation, are often poor substrates for 11β-HSD2 and readily 
cross the placental barrier.  A recent meta-analysis reports that multiple exposure to 
these steroids during pregnancy resulted in reduced birthweight (Bevilacqua et al., 
2010).   
More evidence that placental 11β-HSD2 is sensitive to maternal physiology 
comes from a number of studies carried out by Clifton and colleagues in the 
University of Newcastle, Australia (Murphy and Clifton, 2003, Murphy et al., 2003, 
Clifton, 2010, Hodyl et al., 2010).  This group’s studies of maternal asthma have 
yielded a number of important findings which are relevant to the study of 11β-HSD2 
function as a programming mechanism.  Firstly 11β-HSD2 activity appears higher in 
placental samples from normal healthy females (Murphy et al., 2003).  Secondly 
11β-HSD2 activity is unchanged with respect to mode of delivery (Murphy and 
Clifton, 2003).  Finally this group also suggest that placental 11β-HSD2 activity is 
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responsive to maternal asthma and betamethsone treatment (Stark et al., 2009) and 
that maternal asthma can reduce capillary volume in the placenta (Mayhew et al., 
2008).     
Taken together the studies described above indicate that 11β-HSD2 may 
have an important role in regulating the amount of maternal cortisol which the fetus 
encounters.  They also demonstrate that 11β-HSD2 gene expression is reduced in 
somatic disorders of pregnancy, however no study to date has examined the effects 
of psychological distress. 
The most compelling evidence that maternal prenatal stress is associated with 
decreased 11β-HSD2 expression and activity comes from animal models.  
Treatment of pregnant dams with the non-specific 11β-HSD inhibitor carbenexolone 
resulted in low birthweight, increased stress responses, anxiety-like behaviour and 
amygdalar GR expression in the offspring (Welberg et al., 2000).  Similarly the 11β-
HSD2 knockout is born low birthweight and demonstrates anxiety like behaviour later 
in development (Holmes et al., 2006).  Recently this group have reported that 
placenta from these knockout mice demonstrate significant pathology with reduced 
weight, and reduced placental glucose transfer (Wyrwoll et al., 2009).   
Additional evidence that placental 11β-HSD2 is important for 
neurodevelopment comes from a study using mice selectively bred for high and low 
anxiety (Lucassen et al., 2008).  Offspring from the high anxiety group display 
reduced placental 11β-HSD2 activity and decreased hippocampal neurogenesis 
relative to the low anxiety mice on the same genetic background.  This finding is 
similar to that of Coe et al (2003) who found decreased hippocampal neurogenesis 
in primates born to prenatally stressed mothers (Coe et al., 2003). 
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From the work of Seckl and colleagues it is clear that pharmacological or 
genetic manipulations which affect 11β-HSD2 function lead to adverse 
biobehavioural outcomes.  The work of Welberg and others (2005) and subsequently 
Marreisse et al (2007) illustrate that maternal stress can have a similar effect on 11β-
HSD2 function.  Using restraint stress in rats Welberg et al (2005) reported that brief 
stress exposure was associated with an increase in 11β-HSD2 activity (Welberg et 
al., 2005).  As 11β-HSD2 is positively regulated by cortisol (corticosterone in 
rodents) this upregulation is plausible (van Beek et al., 2004).  However chronic 
stress was associated with a reduced capacity to upregulate 11β-HSD2 activity.  
Conversely Mairesse et al (2007), using the same strain of rat but a more severe 
form of stressor (restraint +bright light exposure), found that chronic stress was 
associated with decreased expression and activity of placental 11β-HSD2.  The 
offspring from the stress exposure group had smaller adrenals, in line with the 
findings of Kajantie et al (2006) in humans.  Surprisingly despite lower levels of 11β-
HSD2 activity cord blood corticosterone was similar between stressed and control 
groups.  This may point toward a greater contribution from the fetal adrenal in the 
non-stressed group.  
5.2 Aims and hypotheses 
The animal studies described above provide a firm basis on which to base the 
hypotheses to be explored in this section. 
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5.2.1 Primary hypothesis to be tested 
1. Maternal anxiety will be negatively associated with 11β-HSD2 gene 
expression. 
5.2.1.1 Secondary hypothesis 
a. Lower gene expression will be associated with increased 
fetal cord blood cortisol 
5.3 Methods 
Singleton pregnancies from women with no medical known medical disorder 
scheduled for caesarean sections at Queen Charlottes and Chelsea hospital were 
eligible for participation in this study.  One day prior to surgery women attended a 
pre-admission appointment where full informed consent was received from each 
participant.    
5.3.1 Measures 
5.3.1.1 Maternal data/Psychological measures 
Each participant was given a questionnaire to assess sociodemographic, 
pregnancy-related and psychometric data.  The Spielberger State/Trait anxiety 
inventory was sued to assess current or trait-like anxiety respectively (Spielberger et 
al., 1970).  The Edinburgh postnatal depression survey (EPDS), a validated tool for 
the assessment of depression in the prenatal period, was given to assess maternal 
depression (Cox et al., 1996).  Mothers were instructed to take the questionnaire 
booklet home, complete it, and return it the following day.  
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5.3.1.2 Biological samples 
Following surgery whole placenta and fetal cord blood (venous and arterial) 
were collected by the attending midwife.  Intact placenta with no obvious pathology 
were returned to the laboratory, weighed and dissected within one hour of delivery.   
RNA was isolated from placental samples and quantity and quality assessed (see 
methods section for more detail).  Samples with low quality RNA were excluded for 
gene expression analyses (n= 33) resulted in a final sample of forty placenta which 
were assayed for 11β-HSD2 gene expression (n = 40).  The semi-quantitative assay 
provides data on the level of expression of a gene of interest (11β-HSD2) relative to 
a housekeeping gene with stable high levels of expression (L19).  This metric is 
termed ∆Ct with a larger number (greater difference) reflects lower expression of the 
gene of interest.   A further transformation may be applied to the ∆Ct to express 
gene expression in a group of interest (high anxiety group) relative to controls (low 
anxiety group).  This is calculated by subtracting the average ∆Ct of the control 
group from the average ∆Ct of the experimental group (∆∆Ct).  Expressing this value 
using the following formula gives gene expression as fold change: 2-∆∆Ct  (see section 
2.4.3.4 for more details). 
A subsample of these placenta (n=25) were assayed for 11β-HSD2 activity 
(see section 2.4.4.1).  Briefly this assay indexes 11β-HSD2 activity using the 
radiometric conversion of tritiated cortisol to cortisone as an index of enzyme activity, 
units are expressed in nanomoles of product (cortisone) formed per unit protein per 
hour (nm/mg/hr). 
Cord blood samples collected in EDTA-free vacutainers (Becton-Dickson, 
Oxford, UK) and assayed for serum cortisol levels using a commercial enzyme linked 
immuno-sorbent assay (ELISA) (see section 2.4.2).   
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5.3.1.3 Obstetric outcomes 
Obstetric details including indication for section, fetal sex, time of delivery, 
birthweight, gestational age and other relevant information were extracted from 
medical records.   
5.3.2 Analyses 
Prior to statistical analysis all data were tested for normality using P-P plots 
(SPSS version 18.0, UK).  Data which was normally distributed was analysed using 
parametric Pearson product-moment correlations (r(p)) and group differences tested 
using t-tests.  Relationships between non-parametric covariates (e.g. time of day AM 
vs PM) and outcomes of interests were tested using Spearman rank order 
correlations (r(s)).  Placental 11β-HSD2 gene expression data (∆Ct) and activity data 
were normalised after Ln transformation. Chi-square tests were used to determine 
differences in distribution of categorical outcomes (e.g. household income). 
Due to the modest sample size group differences were tested in two ways.  
First a median split was applied to the predictor variable of interest and differences 
tested between the lower and higher anxiety groups.  The following median cut-offs 
were employed: SSAI > 37, STAI > 34, EPDS > 7. Secondly the effects of very high 
levels of maternal anxiety/depression were tested to determine if there was an 
increase in the effects of maternal anxiety on outcomes of interest.  An arbitrary cut-
off was applied to each predictor variables to give comparison group of high 
maternal anxiety/depression with scores in the 90th percentile: SSAI > 55, STAI >50 
and EPDS > 15. 
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5.4 Results  
Table 5.4.1: Maternal characteristics and outcome data for the total cohort (left 
column) compared with the subgroup on which gene expression data was available 
(right column grey shading). Data are presented as mean/median standard 
deviation/range as appropriate. M = male, F = female, Wks = weeks, g = grams, 
SSTAI/SSAI = Spielberger Trait/State anxiety inventory, EPDS = Edinburgh postnatal 
depression survey.*p < .05. 
 Total cohort 
(n = 73) 
Gene expression cohort 
(n = 40) 
Fetal sex n = 37M: 36F 20M: 20F 
Obstetric data   
Indication for section  
Previous C-section 
Breech presentation 
Maternal request 
Low lying placenta 
Previous tear 
Other 
 
52 
10 
3 
1 
2 
5 
 
27 
7 
2 
1 
1 
2 
Gestation in wks 39 (36-41) 39 (38-41) 
*Birthweight g 3394 (388) 3324(369) 
Placental weight g 601 (129) 591 (124) 
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Venous cord cortisol nmol/L 275 (95) 280 (97) 
Arterial cord cortisol nmol/L 244 (110) 262.62 (113.81) 
Time of delivery 12.03 (09:14-18:00) 12.04 (09:14-18:00) 
Maternal characteristics   
Age in years 34.8 (6.0) 34.2 (4.7) 
Parity 1 (0-9) 1 (0-9) 
BMI 24.82 (17.9-38.0) 24.9 (17.9-35.4) 
Smoking currently  
No 
Yes 
 
70 
2 
 
38 
2 
Weekly alcohol intake 
None 
1-5 units per wk 
5-10 units per wk 
 
53 
17 
1 
 
31 
7 
1 
Ethnicity 
Caucasian 
African/Afro-Caribbean 
Indian/Pakistani 
 
58 
4 
2 
 
31 
3 
1 
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Table 5.4.1 describes the women who participated in this study.  The sample 
was mainly Caucasian with one previous pregnancy.  The shaded column describes 
the subgroup on which gene expression data were available.  This group were on 
average 70g lighter at birth but still within the normal range. 
5.4.1 11β-HSD2 gene expression and maternal anxiety 
Higher levels of maternal anxiety were associated with decreased (higher 
∆Ct) placental 11β-HSD2 gene expression (r(p)= .48, p<.01, n = 40: Figure 5.4.1).  
Middle eastern 
Not given 
2 
4 
1 
3 
Household income   
Not given 
<£18,000per annum 
£18,000 < £25,000 
£25,000 < £43,000 
>£43,000  
11 
5 
4 
9 
43 
7 
4 
3 
6 
20 
Psychometric details   
STAI (Trait anxiety) 36.8 (9.5) 37 (9.6) 
SSAI (State anxiety 39.1 (10.3) 40.80 (11.14) 
EPDS (depression) 8.3 (4.9) 8.90 (5.50) 
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Entering maternal anxiety in a univariate regression model indicated that this factor 
accounted for 16% of the variance in 11β-HSD2 gene expression (F = 7.00, p = .01; 
R2 = .16). This finding indicates that across the range of anxiety scores higher 
maternal anxiety is associated with decreased expression of placental 11β-HSD2.  A 
trend toward a similar relationship with maternal state anxiety was observed but did 
not reach statistical significance (r(p) = .26, p = 0.10).  No correlation with maternal 
depression was observed.  
 
Figure 5.4.1 Maternal anxiety and placental 11β-HSD2 gene expression. Gene 
expression data are presented ln transformed ∆Ct where a higher number reflects 
lower expression.  STAI = Spielberger trait anxiety inventory. 
To illustrate the effect of maternal anxiety on placental 11β-HSD2 expression 
two groups of high and low anxiety were formed.  Figure 5.4.2 presents the relative 
fold change in gene expression first using a median split of anxiety (Figure 5.4.2a) 
R
2 
= .16, p =.01 
254 
 
and secondly in the top 10% of anxious women (Figure 5.4.2b). Both were 
significant, a median split based on maternal anxiety revealed an approximate 25% 
decrease in 11β-HSD2 gene expression.  This effect was greater still in the placenta 
from high anxiety (top 10%) pregnancy with a 50% decreased in target gene 
expression relative to less anxious controls. 
 
Figure 5.4.2:  Maternal anxiety and 11β-HSD2 gene expression.  Data are presented 
from a median split (A) and the top 10% of anxious women (B) Anx = anxiety 
5.4.1.1 Sex-specific associations with maternal anxiety 
Previous research indicates that placental 11β-HSD2 enzyme activity may be 
higher in females.  To determine if this occurs at a transcriptional level 11β-HSD2 
gene expression was compared in placenta from males and females.   There was no 
sex difference in target gene expression (t = 0.05, p = .96).  
To test if the effects of maternal anxiety are similar in males and females sex-
specific analyses were carried out (Figure 5.4.3).  A strong association between 
maternal anxiety and decreased gene expression was seen in male (r(p) = .46, p = 
.04) but not female placenta (r(p) = .37, p = .11).  There was evidence for an outlier in 
the female group. The removal of this datum further diminished the relationship 
A. B. 
 between maternal anxiety and 11β
.06, p = .78). As such this study’s primary hypothesis that maternal anxiety would be 
associated with decreased 11β
male group. 
 
Figure 5.4.3:  Maternal anxiety and 11
and females (right).  In females a potential outlier is highlighted (
STAI = Spielberger trait anxiety inven
Using maternal anxiety as a grouping variable the relative fold change was 
calculated for males and females separately.  In males the results were consistent 
with those reported for the overall group.  A median split revealed a significant 
decrease in 11β-HSD2 gene expression in the group with higher anxiety scores (t = 
2.45, p = .03, n = 20).  No significant differences in placental 11β
were seen between females based on maternal anxiety rating irrespective of the 
inclusion of the outlying data
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-HSD2 gene expression in female placenta (r
-HSD2 gene expression was supported only in the 
β-HSD2 gene expression in males (left) 
tory. 
-HSD2 expression 
-point (Figure 5.4.4).     
(p) = -
 
dashed box). 
-
256 
 
 
Figure 5.4.4:  Maternal anxiety (median split and 11β-HSD2 gene expression in males 
(left) and females (right). Anx = anxiety, *p = .03. 
 
5.4.1.2 Other maternal factors and placental 11β-HSD2 gene expression 
No correlations were observed between 11β-HSD2 gene expression and 
maternal smoking, parity, BMI or household income.  
5.4.2 Placental 11β-HSD2 enzyme activity 
Placental 11β-HSD2 activity data was measured in a subgroup of participants 
from the gene expression cohort.  Correlation analysis of enzyme activity and fetal 
sex indicated higher activity in placenta from females (r(s) =.60, p <.001, n = 25).  
Figure 5.4.5 illustrates the sexual dimorphism of placental 11β-HSD2 enzyme activity 
in this sample. This was a strong effect (Cohen’s δ > 1) with approximately 27% 
lower enzyme activity levels in male placenta. 
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Figure 5.4.5:  Placental 11β-HSD2 enzyme activity in male & female placenta. **p < .01 
5.4.2.1 Placental 11β-HSD2 gene expression and enzyme activity 
A decrease in 11β-HSD2 gene expression indicates that maternal anxiety can 
affect gene transcription.  Decreased gene expression may not equate to a 
decrement in placental function.  Initial analyses revealed a significant inverse 
correlation between gene expression and enzyme activity (r (p) = -.40, p = .05, n = 
25). Upon closer inspection this result was dependent on the inclusion the participant 
described as an outlier above.  Despite activity data within an acceptable range 
(within mean +/- 4SD) the anomalously low gene expression in the case adversely 
influenced the overall correlation.  When this participant was excluded no significant 
relationship between gene expression and enzyme activity (r(p) = -.23, p = .28, n = 
24).  Given that the activity data from this case was within acceptable ranges the 
case is included in the analyses of maternal anxiety described below.   
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In line with the results from the gene expression analyses enzyme activity was 
not correlated with maternal socioeconomic factors, smoking or alcohol intake during 
pregnancy. 
5.4.2.2 Maternal anxiety and placental 11β-HSD2 activity 
Transcription of 11β-HSD2 mRNA precedes the production of the functional 
11β-HSD2 enzyme.  Given the strong association between maternal anxiety and 
11β-HSD2 gene expression this relationship was assessed using enzyme activity as 
the outcome of interest. No significant difference in enzyme activity was observed 
when the cohort was split based on median levels of maternal anxiety.  However, at 
higher levels of maternal anxiety (top 10%) a significant difference emerged between 
highly anxious and less anxious groups (Figure 5.4.6).  This analysis indicated that 
high levels of maternal anxiety are associated with a 24% decrease in 11β-HSD2 
enzyme activity.  The modest sample size for this aspect of the study precluded the 
study of sex-specific effects in relation to maternal anxiety and enzyme activity. 
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Figure 5.4.6 Maternal anxiety and placental 11β-HSD2 enzyme activity.  Anx = anxiety, 
lo = low, hi = high. 
5.4.3 Placental weight and maternal anxiety 
Although not an a priori hypothesis the most anxious mothers in this study 
had lighter placentas.  Placenta weights in the most anxious group (90th percentile) 
showed a significant difference (17% reduction) in mean placental weights (Figure 
5.4.7). As there was no significant correlation observed between placental weight 
and current smoking, previous smoking, mother’s number of previous pregnancies or 
number of children, fetal sex or maternal BMI, the effect on placental weight appears 
to be independently associated with maternal anxiety itself.  Despite a significant 
correlation between placental weight and birth weight there was no effect of maternal 
anxiety on birth weight (r = 0.02, p = 0.89, n = 73).  
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Figure 5.4.7 Maternal anxiety and placental weight in low (stripes, left) and 
high (grey, right) anxiety groups. STAI =Spielberger trait anxiety inventory. 
 
The analyses of 11β-HSD2 gene expression indicate that placentae from 
males are more sensitive to the effects of maternal anxiety.  Figure 5.4.8 illustrates a 
similar finding between maternal anxiety and placental weight.  A significant 
decrease in placental weight was observed using both a median split and a 
comparison of placenta from the top 10% of maternal anxiety scores.  No significant 
difference in placental weight was observed in females based on a median split or 
comparing the placenta from high anxiety groups, although there was considerable 
variability in this group. 
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Figure 5.4.8 Maternal anxiety and placental weight in males (top panel, blue) and 
females (bottom panel, red) using a median split (left column) or a comparison of 
those with maternal anxiety scores in the 90th percentile (right column). 
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5.4.3.1 Other factors which influence placental weight  
5.4.3.1.1 Maternal BMI 
Significant positive associations were observed between maternal BMI and 
both placental weight (r(s) = 0.38, p < .01, n = 60) and birthweight (r(s) = 0.31, p = .02, 
n = 60).  In general mothers with a higher BMI had a larger placenta.  An analysis of 
women with BMI in the 90th percentile (BMI >28) revealed a significant increase in 
placental weight of approximately 17% relative to the lower BMI group (t = 2.20, p 
=.03, n = 60).  Despite this relationship between maternal BMI and placental weight 
no direct correlation with cord blood cortisol was observed.  There did not appear to 
be any sex difference in the association between maternal BMI and placental weight 
(males r(s) = .35, p = .05, n =31; Females r(s) = .39, p = .04, n = 29)  There was no 
relationship between maternal anxiety and maternal BMI.  
5.4.3.1.2 Alcohol use during pregnancy 
Maternal alcohol consumption was negatively associated with both placental 
weight and birthweight (Placental weight: r(p)  = -0.38, p = .02; Birthweight r(p)  = -
0.34, p = .03).  An analysis of placental weights from the alcohol exposed group 
indicated a reduction of approximately 19% relative to non-exposed controls (Figure 
5.4.9).  In addition to this placental effect, birthweight was significantly lower in the 
alcohol exposed group relative to controls (Figure 5.4.9).  There was no evidence of 
a sex difference in this effect or any interaction with maternal anxiety.  In line with the 
results of the BMI analyses there was no direct correlation between maternal alcohol 
 use in pregnancy and cord blood cortisol levels.
Figure 5.4.9 Maternal alcohol consumption in pregnancy and placental weight. 
Alco = Alcohol,  ***p <.001
5.4.3.2 Multivariate analysis of the
The analyses presented above indicate that placental weight is associated 
with maternal anxiety, BMI and alcohol use during pregnancy with additional 
evidence of sex-specific effects.  To determine the independence of these predictors 
a multivariate regression model was constructed with placental weight as the 
outcome of interest.  Table 5.4.2 present
significant predictors.  This model accounted for approximately 34% (adjusted 28%) 
of the variance in placental weight (F = 4.55, p = .01, n = 26).  Fetal sex and 
maternal BMI were not independent predictors of p
prediction came from maternal anxiety.  For every score point increase in maternal 
anxiety (20 point range) placental weight decreased by approximately 4g.  Similarly 
in the group reporting alcohol consumption during pregnan
approximately 94g lighter. 
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 predictors of placental weight 
s the results of this analysis highlighting 
lacental weight.  The strongest 
cy placenta were 
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Model fit: R2 = .34 (Adjusted R2  = .28)  
Predictor B β p 
Sex of Fetus 5.793 .023 .87 
Maternal Anxiety (STAI) -4.115 -.343 .02 
Maternal BMI 6.522 .235 .10 
Maternal Alcohol use -93.766 -.340 .02 
Table 5.4.2 Multivariate analysis of factors influencing placental weight. STAI = 
Spielberger trait anxiety. 
5.4.4 Determinants of fetal cortisol exposure 
As expected venous cord blood cortisol was strongly correlated with arterial 
levels (r (p) = .57, p <.001, n = 42).  This correlation was stronger in females than 
males (Males: r (p) = .37, p = .07, n = 21; Females: r (p) = .71, p < .001, n = 21).  
Despite this difference in correlation between venous and arterial samples there was 
no overall sex difference in the concentration of cortisol in either venous (Males: 
Mean: 288nmol, SD = 85nmol; Females mean = 263nmol, SD = 105nmol) or arterial 
samples (Males: Mean = 255nmol, SD = 109nmol; Females 233nmol SD = 
112nmol). 
Time of delivery and diurnal effects on cord blood cortisol 
A factor which may influence fetal cortisol exposure is the diurnal rhythm of 
maternal cortisol.  Cortisol displays a marked diurnal profile with highest 
concentrations in both serum and saliva observed in the morning.  This relationship 
was tested by grouping samples by time of collection: AM versus PM (Figure 5.4.10).  
265 
 
Cortisol concentrations were significantly higher in the venous cord blood of the PM 
groups consistent with greater passage of cortisol across the placenta from AM to 
PM.  A partial correlation revealed that this result was independent of maternal state 
anxiety (partial r = .32, p = .03, n = 43).  Interestingly there was some evidence that 
this effect was strongest in males consistent with lower levels of enzyme activity in 
male placenta (Males AM: 236nmol versus PM: 317nmol, p = .02; Females AM: 
246nmol versus 278nmol, p =.47). 
 
Figure 5.4.10 Cortisol in fetal cord blood (venous) samples grouped by time of 
collection. Cort = Cortisol 
 
5.4.4.1 Other maternal factors and cord blood cortisol 
There was no correlation between cortisol in fetal cord blood samples and 
maternal BMI, ethnicity, parity or alcohol consumption during pregnancy.  Similarly 
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there was no correlation between venous samples and maternal age or household 
income.  Overall there was an inverse correlation between maternal age and cortisol 
in arterial samples (r(p) = -.40, p = .01, n = 46) an effect seen in both sexes and not 
explained by number of previous pregnancies (partial r = -.35, p = .02, n = 43).    
5.4.4.2 Placental 11β-HSD2 and cord blood cortisol 
From a programming perspective a downregulation of 11β-HSD2 is of interest 
as it may increase fetal cortisol exposure in utero.  Maternal cortisol not metabolised 
by 11β-HSD2 would pass into the fetal circulation through the venous blood supply.  
A positive correlation was noted between placental 11β-HSD2 gene expression and 
increased cortisol in venous blood supply in support of this study’s secondary 
hypothesis (Table 5.4.3).  No significant relationship was observed with cortisol in 
arterial cord blood samples and 11β-HSD2 gene expression.  
 
Arterial 
CORT Venous CORT 
11β-HSD2 Gene expression  r(p) 0.27 0.36* 
(N) (28) (29) 
11β-HSD2 activity 
 -.40 
(17) 
-.31 
(15) 
 
Table 5.4.3 Pearson correlation coefficients between 11β-HSD2 gene 
expression and cord blood cortisol *p ≤.05. 
 Figure 5.4.11 Maternal anxiety and cortisol in venous (left) and arterial (right) 
cord blood samples. STAI = Spielberger tra
Given the associations described above the relationship between maternal 
anxiety and cord blood cortisol was assessed (Figure 5.4.11).  There was no 
correlation between maternal anxiety and venous (r 
arterial cord blood cortisol (r 
in this correlation or an association with maternal state anxiety or depression.
5.4.4.3 Placental weight and fetal cortisol exposure
Placental weight was inversely associated with venou
n = 43).  Linear regression analysis established that placental weight accounted for 
16% of the variance in venous cord blood cortisol concentrations and that for every 
10g decrease in placental weight there is a 29.7nmol/
cortisol. As the placental weights ranged from 381
significant difference in venous cord cortisol between placentas below and above the 
mean placental weight (Figure 5.4.12). No significant corre
arterial cortisol concentrations (
suggested.  
R
2 
= .01, p =.52
it anxiety 
(p) = -.09, p = .53, n = 49) or 
(p) = -.01, p = .93, n = 46).  There was no sex difference 
 
s cord blood (r
l increase in venous cord blood 
-932g, this would result in a 
lation was found with 
r (p)= -0.25, p = 0.10, n = 46,), although a trend is 
 
R
2 
= .01, p =.89
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(p) = -.40, p .01, 
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Figure 5.4.12 Placental weight dividing using a median split (578g) and cortisol 
concentrations in venous cord blood samples. 
5.4.4.4 Multivariate analysis of fetal cortisol exposure in venous cord blood 
The analyses presented above indicate that gene expression, enzyme 
activity, placental weight and time of day are all associated with fetal cortisol 
exposure.  In a univariate solution 11β-HSD2 enzyme activity was not a significant 
predictor of cortisol in (venous) cord blood and was excluded from the multivariate 
model. The final model included placental 11β-HSD2 gene expression, placental 
weight, fetal sex and time of delivery.  This model was significant and accounted for 
approximately 26% of the variance in venous cortisol concentrations (F = 3.32, p = 
.03, Adjusted R2 = .26, n = 27).  Placental weight alone was the only significant 
predictor of venous cortisol concentrations.  A 10g decrease in placental weight was 
predictive of an increase of 32nmol in venous cortisol levels (B = -.32, β = -.39, p = 
.05).  There was a trend for deliveries in the afternoon to be associated with an 
 269
increase of 68nmol relative to morning deliveries (B = 68.0, β = -.35, p = .06). 
Placental 11β-HSD2 gene expression and the sex of the fetus were not independent 
predictors of venous cord blood cortisol in this model.  The addition of maternal 
anxiety worsened the fit of the model and was not a predictor of cord blood cortisol.  
Given the small sample size sex specific regression models were not feasible. 
5.5 Discussion 
The main finding from these analyses is that the placenta is sensitive to 
maternal anxiety and is a likely programming vector.  Maternal anxiety was 
associated with decreased gene expression, enzyme activity and reduced placental 
weight.  Similarly reduced gene expression and lower placental weight were 
associated with increased cord blood cortisol.  The possibility that these effects may 
be sex-specific is intriguing but such results require replication in a larger sample. 
The results demonstrate a significant inverse correlation between maternal 
trait anxiety and 11β-HSD2 expression.  Placenta from the top 10% of anxious 
mothers were shown to have significantly reduced placental 11β-HSD2 expression.  
Thus, the data support the first hypothesis that 11β-HSD2 gene expression will be 
reduced in response to maternal anxiety.  
This result is consistent with the study of Lucassen et al. (2008) who 
demonstrated lower placental 11β-HSD2 activity in rats selectively bred for high 
anxiety.  It is also consistent with the study by Mairesse et al. (2007) demonstrating 
significant reductions in placental 11β-HSD2 mRNA levels and activity in response to 
chronic restraint stress imposed on pregnant dams.  The current analyses indicate a 
dose response effect of maternal anxiety with decreasing gene expression with 
increasing maternal anxiety.   
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There was some evidence that the effect of maternal anxiety on 11β-HSD2 
expression was sex-specific.  Although not hypothesized maternal anxiety was found 
to affect placenta from males but not females, despite similar levels of maternal 
anxiety in both groups.  This sex difference was only evident in relation to 
heightened maternal anxiety, as basal levels of gene expression were comparable in 
both sexes.  This is in line with Mericq et al., (2010) who report no sex differences in 
basal 11β-HSD2 gene expression in placenta from small, appropriate or large for 
gestational age neonates.  The possibility that sex differences emerge in relation to 
maternal anxiety is a novel finding in the clinical literature of 11β-HSD2 but has 
indirect support from the animal studies described.  Mairesse et al (2007) report only 
on the placenta form male fetuses and find a significant effect of maternal stress on 
11β-HSD2 expression.  Similarly Wrynoll et al (2008) and Holmes et al (2006) use 
only males to describe the significant placental pathology and behavioural phenotype 
observed in 11β-HSD2 knockout mice.  Also in agreement are data from Mueller and 
Bale (2008) who report greater vulnerability of males in relation to early prenatal 
stress (Mueller and Bale, 2008).  While the authors did not study 11β-HSD2 they do 
report gene expression profiles which are sex-specific with the greatest effects in 
male (Mueller and Bale, 2008).  In contrast the only carried out in mice which reports 
the effects of prenatal stress on placental 11β-HSD2 in both sexes, finds a significant 
reduction in females but not males (Pankevich et al., 2009), however stress during 
early gestation was the focus of this research. 
As such the data from this study are in line with findings from preclinical 
studies of stress later in pregnancy.  Further study in both human and animal models 
will determine if the mechanisms observed in males are similar in females. 
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This is the first study in humans investigating the effect of maternal anxiety on 
placental 11β-HSD2 expression. However, it is consistent with another study in 
humans by Glover et al. (2009) which showed increased permeability of the placenta 
to maternal cortisol in response to maternal anxiety (as would be expected with 
decreased 11β-HSD2 expression) by demonstrating a positive correlation between 
maternal plasma and amniotic fluid cortisol concentrations in highly anxious women.  
The data on placental 11β-HSD2 activity are limited to a small subsample in 
this study.  As such these data require cautious interpretation.  Despite this limitation 
high levels of maternal anxiety were associated with decreased 11β-HSD2 activity.   
This finding extends previous work in clinical samples to suggest that enzyme 
activity is sensitive by both psychological stress as well as somatic medical 
disorders. A significant sex difference between male and female placenta was also 
observed replicating the findings of Murphy and colleagues (2003).  This finding is of 
interest from two perspectives.  Firstly, females are at lower risk of adverse obstetric 
outcomes such as miscarriage and neonatal death (Zetterström et al., 2008).  There 
is some evidence that following natural disasters, terrorist attacks and high levels of 
maternal stress there is an increase in the female to ale ratio of live births (Bruckner 
and Catalano, 2007, Obel et al., 2007, Bruckner et al., 2010).  In general there is an 
overall improved survival rate for females born preterm relative to their male 
counterparts (Swamy et al., 2008). The work of Kajantie et al (2003, 2006) indicates 
that placental 11β-HSD2 enzyme activity is correlated with illness severity in low 
birthweight neonates (Kajantie et al., 2003, Kajantie et al., 2006).  The finding that 
placental 11β-HSD2 enzyme activity is sexually dimorphic may provide some 
explanation for the improved outcomes seen in female neonates.  A related point is 
that many of the outcomes associated with prenatal stress show a sex bias towards 
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males e.g. schizophrenia, ADHD and autism.  This study has demonstrated that 
placental 11β-HSD2 enzyme activity is sensitive to maternal prenatal anxiety. 
Although speculative it is possible that lower basal levels of enzyme activity 
combined with further lowering of enzyme activity in response to maternal anxiety 
could provide an explanation for the disproportionate effects of prenatal stress 
effects seen in male relative to female children. 
The relevance of the findings described above is underscored by animal 
studies.  Reduced 11β-HSD2 expression and activity have been associated with 
increased anxiety like behavior in the offspring (Holmes et al. 2006).  Similarly 
decreased levels of enzyme activity are associated with changes in receptor 
expression in key brain sites and central processes such as neurogenesis (Waddell 
et al., 2000, Lucassen et al., 2009). 
In humans Räikkönen et al. (2009) demonstrated that inhibition of 11β-HSD2 
activity (as a result of maternal liquorice consumption) was associated with poor 
cognitive development and behavioural problems in the children born (Räikkönen et 
al., 2009) and altered stress hormone levels (Räikkönen et al., 2010) . Thus, the 
decrease in placental 11β-HSD2 expression seen in this study in response to 
maternal stress (in the form of trait anxiety) is of clinical relevance and may be 
associated with a range of adverse biobehavioural outcomes in the child. 
This study found higher levels of maternal anxiety were associated with 
decreased placental weight.  This finding was of interest given the strong correlation 
between placental weight and cord blood cortisol, in line with Mericq et al., (2009).  
That increased placental exposure to glucocorticoids could bring about a decrease in 
placental weight is suggested in animal models where maternal administration of 
 273
glucocorticoids during late gestation is associated with a 7% and 34% reduction in 
mouse and rat placentas respectively (Hewitt et al., 2006, Baisden et al., 2007).  The 
resulting correlation between placental weight and venous cortisol suggests a 
decreased filtering capacity of a smaller placenta.  
The current analyses demonstrate a significant inverse correlation between 
placental 11β-HSD2 gene expression and venous cord blood cortisol concentrations. 
Thus, the results support the final hypothesis of increased venous cord blood cortisol 
concentrations in response to decreased placental 11β-HSD2 expression. As venous 
cord blood cortisol concentrations are the best indicator of fetal exposure to maternal 
glucocorticoids, these results suggest that decreased 11β-HSD2 expression results 
in increased permeability of the placental barrier to maternal cortisol.   
 Our results are consistent with those in animal models showing increased 
transfer of maternal glucocorticoids in response to a decrease in placental 11β-
HSD2 (Betram and Hanson 2001). In addition, our results are similar to those in pre-
eclamptic pregnancies where placental 11β-HSD2 expression is inversely associated 
with cord blood cortisol (McCalla et al., 1998).  
The results of the multivariate analyses indicate that the relationship between 
11β-HSD2 expression and cord blood cortisol is not independent of placental weight.  
Given that both placental weight and 11β-HSD2 expression are sensitive to maternal 
anxiety it is possible that there is an interaction between both outcomes.  This 
possibility is supported by animal studies which describe both reduced gene 
expression and placental weight in relation dietary manipulations (Liang et al., 
Langley-Evans et al., 1996).  A formal test of this association is not possible in the 
current study but would be an interesting future direction for such research. 
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   This study provides the first clinical evidence that maternal anxiety can affect 
placental function and lead to increased fetal cortisol exposure.  As described above 
the study is limited primarily due to its small sample size.  An additional limitation is 
the scope to extrapolate these findings to other samples.  All placenta were collected 
from women undergoing elective C-sections.  While advantageous for accurate 
sample collection limiting recruitment to this specific group may bias the findings of 
this study.  In support of the recruitment strategy are the findings of Murphy and 
Clifton (2003) who report no effect of type of delivery on placental 11β-HSD2 mRNA 
levels or activity.  Interestingly this study reports a significant reduction in placental 
11β-HSD2 activity from 38-40 weeks.  In routine clinical practice C-sections are 
carried out at 39 weeks, the limited range of gestational ages in this study may have 
strengthened the results of this study. 
An additional limitation of this study is the absence of a measure of maternal 
cortisol.   Such a measure would allow the ratio of maternal:fetal cortisol ratio to be 
calculated.  This metric would determine if the placental effects described above 
result are functional or if they occur in response to a net increase in maternal cortisol 
in anxious women.  There is mixed evidence that maternal cortisol increases in 
response to stress/anxiety with one report only showing effects in the evening, 
beyond the time of sample collection in this study (Obel et al., 2005).  Furthermore 
the lack of correlation observed between maternal anxiety and fetal cortisol suggests 
that rather than causing a net increase in maternal fetal cortisol, maternal anxiety is 
acting on the placenta in a way which in turn regulates fetal exposure to cortisol and 
other programming factors.   
With these limitations in mind the placental effects described above provide 
supportive evidence for the placenta as a potential programming mechanism.  To 
 275
establish if such altered placental function is a bona fide programming mechanism 
the future neurodevelopment of these children should be assessed. 
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6 Chapter 6:  Discussion 
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6.1 Main findings 
The maternal emotional state across childhood is known to have a profound 
effect on child development (Clements et al., 2008).  This thesis explored the 
maternal emotional state during pregnancy in the context of fetal programming.  
Animal studies, and an increasing number of clinical studies in children, demonstrate 
an effect of maternal prenatal stress or anxiety on biobehavioural outcomes in the 
offspring.  The current study makes a contribution to the literature in several ways.  
Firstly, the effects of maternal anxiety are shown to persist to age 13 in a large 
prospectively designed cohort.  Furthermore maternal prenatal anxiety has been 
found, for the first time, to predict a blunted CAR in adolescence.  Finally a potential 
placental programming mechanism is shown to be associated to maternal prenatal 
anxiety, a finding previously only demonstrated on rodents.  Taken together these 
findings lend support to the concept in utero programming of both behavioural and 
biological outcomes in adolescence and describe a potential mechanism by which 
this may occur. 
Maternal prenatal anxiety at 32 weeks gestation was a significant risk factor 
for emotional/behavioural problem scores in both males and females at age 13.  This 
is in line and extends the findings of O’Connor et al., (2002, 2003) from age 7 to age 
13.  Importantly, at age 13, an increase of one SD in maternal prenatal anxiety at 32 
weeks was associated with increases ranging from 4-13% in problem scale scores. 
Moreover these findings were independent of maternal postnatal anxiety providing 
evidence for a specific prenatal effect.  This study also supports work from the 
ALSPAC cohort finding maternal prenatal anxiety was associated with persistent 
conduct problems to age 13 (Barker and Maughan, 2009).  The current study 
extends the findings of Barker and Maughan to include ADHD-related and emotional 
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problems.  Thus maternal prenatal anxiety is associated with all the problem scales 
assessed and evident in both males and females.  These findings indicate that the 
effects of maternal prenatal anxiety are unremitting and evident until at least early 
adolescence.   
The growth curve analyses used in this study describe how maternal prenatal 
stress affects the pattern of emotional/behavioural development across childhood.  
Males were rated higher than females for ADHD-related and conduct problem 
scores.  These higher scores declined more slowly in males than in females across 
childhood.  In contrast there was a trend for females to have higher levels of 
emotional difficulties at age 4.  Emotional problem scores increased in females over 
time at a faster rate than males.  These models replicate well-established sex 
differences in externalising/internalising behaviours (Zahn-Waxler et al., 2008). 
However, the novel contribution of these analyses is the sex-specific patterns of 
growth observed across childhood.   
Further analyses of these growth curves revealed a significant effect of 
maternal prenatal anxiety at 32 weeks.  Maternal prenatal anxiety predicted 
increases in problem scores early in childhood, increasing initial levels of emotional 
and behavioural difficulties at age 4.  This is in line with previous work within this 
cohort (O'Connor et al., 2002, O'Connor et al., 2003) and consistent with a range of 
studies in children (Talge et al., 2007).  Using maternal history of prenatal anxiety as 
a grouping variable revealed that group differences at age 4 are generally 
maintained across childhood and into adolescence.  This is the first study to report 
on the persisting effects of maternal prenatal anxiety across multiple assessments 
from childhood to early adolescence.  Furthermore this study has found that the 
persisting effects of maternal prenatal anxiety on child emotional and behavioural 
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development are likely to be mediated through high initial levels of problem 
behaviour. 
Having established that child emotional/behavioural development is sensitive 
to maternal prenatal anxiety the focus of this study turned to biological outcomes.  A 
biological mechanism which may underlie the association between maternal prenatal 
anxiety and adverse neurodevelopmental outcomes in the child is the 
reprogramming of the fetal HPA axis.  Animal work shows strong evidence that 
prenatal stress/anxiety gives rise to altered function of the HPA axis in offspring 
across the lifespan.  These changes in function of the HPA axis often co-occur with 
distinct behavioural phenotypes.  
Maternal prenatal anxiety, at 18 or 32 weeks, was associated with lower 
cortisol in post-waking samples leading to a blunted CAR.  Using conventional forms 
of analyses this effect was observed only in females in line with animal research 
showing a greater sensitivity in females (Weinstock, 2007).  In contrast the use of 
MLM, an analysis which accounts for the nested structure of cortisol data, showed 
effects on the CAR in both males and females.  This finding, of reduced cortisol, 
conflicts with a range of studies in younger and smaller samples showing elevated 
cortisol in relation to prenatal stress/anxiety (Gutteling et al., 2004, O'Connor et al., 
2005, Huizink et al., 2008).  In contrast the data are in line with one study in a similar 
age group showing lower cortisol at waking in relation to high maternal anxiety in 
early gestation (Van den Bergh et al., 2008), although no assessment of the CAR 
was reported in this study. 
  The blunted CAR reported here has been observed in syndromes such as 
PTSD, atypical depression, chronic fatigue and chronic pain (Fries et al., 2005).  The 
 280
cause of this cortisol suppression shown in the current study is unknown.  Regulation 
of the HPA axis occurs at many levels.  A blunted CAR may reflect reduced 
biosynthesis of cortisol due to reduced levels of ACTH or CRH.  In contrast over-
secretion of ACTH or CRH could downregulate target receptors having a ‘knock-on’ 
effect on cortisol levels.  Alternatively an enhanced sensitivity to CRH and resultant 
pituitary-mediated negative feedback, or enhanced cortisol negative feedback 
mediated by hippocampal GR may explain the current observation.  Arguing against 
the latter explanation are rodent studies showing reduced expression of hippocampal 
GR in stress exposed offspring (Henry et al., 1994, Koehl et al., 1999).  A functional 
assessment of the HPA axis in the current cohort may help elucidate the cause of 
this blunted CAR.  
An important consideration in relation to the blunted CAR reported in this 
study is the size of this effect.  The analyses presented here indicate maternal 
prenatal anxiety accounts for less than 3% of the variance in the CAR.  From the 
MLM analyses the difference in CAR equates to approximately 0.5nmol/L.  It is 
difficult to determine if this is a functionally relevant effect.  In their study of maternal 
prenatal anxiety Van den Bergh et al., (2008) report a mean difference in waking 
cortisol of 1.7nmol/L between adolescents born to normal versus anxious mothers.  
Interestingly the effect of maternal prenatal anxiety on the overall diurnal profile was 
found to mediate the association between maternal anxiety and depression in their 
female children.  As such, relatively small differences in mean cortisol levels, as 
seen in the current study, may be associated with adverse outcomes in adolescence.  
As discussed above the current study does not provide a holistic description of the 
HPA axis but rather end-point measurements. It is also unknown if the 
concentrations seen in saliva reflect those in target tissues and cells.  The availability 
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of concurrent psychiatric data would clarify the relationship between a blunted CAR 
and emotional/behavioural development.  With this obvious limitation in mind it 
seems appropriate to conclude that maternal prenatal anxiety is modestly associated 
with the CAR in adolescence but the functional relevance of this effect remains to be 
determined.  
The focus of this aspect of the study was to determine the relationship 
between maternal prenatal anxiety and the cortisol diurnal profile. However a 
number of additional findings emerged.  In this study the CAR was found to be 
independent of the underlying cortisol diurnal profile consistent with previous work 
(Clow et al., 2009, Stalder et al., 2009).  The dissociation seen between cortisol and 
ACTH in the pre-awakening suggest the CAR may regulated by more than just the 
HPA axis (Born et al., 1999).  Clow and colleagues (2009) propose that adrenal 
sensitivity to ACTH can be modulated by sympathetic activity (Clow et al., 2009).  
Interestingly sympathetic tone is increased in PTSD, Chronic fatigue and chronic 
pain, all of which have been associated with a blunted CAR (Fries et al., 2005).  No 
assessment of the sympathetic system was undertaken in the current study. 
However a number of animal studies show this stress system is also sensitive to 
maternal prenatal stress (Weinstock et al., 1998, Igosheva et al., 2007).    
This study found a strong sex-effect on the CAR.  Perhaps relatedly, a larger 
CAR was observed in post-menarchal females. This finding is in line with a previous 
study in pubertal females (Oskis et al., 2009).  The underlying mechanism explaining 
such sex and menarche-related differences is unknown but the role of female sex 
hormones seems intuitive.  A study of ovariectomised peri-pubescent rats provides 
support for the role of female sex hormones in regulating corticosterone levels 
(Evuarherhe et al., 2009).  As adults, treatment of ovariectomised animals with 
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estrogen (17β-estradiol) significantly increased basal corticosterone levels relative to 
cholesterol treated controls (Evuarherhe et al., 2009).  The findings of this study 
provide a plausible explanation for both the sex difference and effect of menarche 
seen in this study.  
Collectively the studies described above provide new evidence on the 
relationship between maternal prenatal anxiety and long-term biobehavioural 
outcomes in the child.  Firstly maternal prenatal anxiety was found to have lasting 
effects on child emotional/behavioural development.  Secondly, maternal prenatal 
anxiety was found to predict aspects of neuroendocrine function in adolescence, with 
less marked effects than behavioural outcomes.  The final aspect of the thesis 
sought to determine how such effects may be mediated in pregnancy.     
Higher levels of maternal anxiety were associated with decreased gene 
expression of the glucocorticoid barrier enzyme 11β-HSD2 in human placenta.  This 
effect was observed in the total cohort but a significant sex-interaction revealed 
marked effects in males but not females.  This result is consistent with the study by 
Lucassen et al. (2008) who demonstrated lower 11β-HSD2 expression and activity in 
rats selectively bred for high anxiety.  It is also consistent with the study by Mairesse 
et al. (2007) who report significant reductions in placental 11β-HSD2 mRNA levels 
and activity in response to chronic restraint stress imposed on pregnant dams.  
Importantly in both studies only the placenta from male offspring were characterised.  
In contrast the only study to report on the effects of prenatal stress on placental 11β-
HSD2 in both sexes, finds a significant reduction in females but not males 
(Pankevich et al., 2009). These very discrepant findings of Pankevich et al., (2009) 
may explained by 1) the use of a different stress paradigm (variable unpredictable 
stress) 2) a different timing of exposure (early stress: days1-12) 3) the use of a 
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different species (mice versus rat).  As such the findings of the current studies are 
consistent with studies of prenatal stress towards term in the rat, while the findings of 
Pankevich et al., (2009) indicate that stress exposure earlier in pregnancy may have 
opposite sex-specific effects.   
This is the first study in humans investigating the effect of maternal anxiety on 
placental 11β-HSD2 expression. However, it is consistent with Glover et al. (2009) 
who showed that the correlation between maternal and fetal cortisol grew stronger 
with increasing maternal anxiety (Glover et al., 2009). Further support of a 
relationship between maternal anxiety and placental function was found from 
analysis of placental 11β-HSD2 activity. In line with the gene expression data, lower 
levels of activity were seen in the most anxious women.   
From the current study it is not possible to determine if cortisol levels are 
higher in more anxious women, although previous works shows only a modest 
support for this association (Sarkar et al., 2006).  From the current data it appears 
increased permeability of the placenta may be a more likely mechanism.  This 
possibility is strengthened by the inverse association between placental 11β-HSD2 
expression and cortisol in cord blood samples. 
Given that maternal cortisol levels are approximately 10-13 fold higher than 
those of the fetus (Gitau et al., 1998) a decrease in placental of 11β-HSD2 activity of 
the magnitude described in this study (24%) would effectively double the (maternally 
derived) cortisol in the fetal compartment.  Collectively these data provide tentative 
evidence for the ‘exposure to excess maternal glucocorticoids’ hypothesis of fetal 
programming.   
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An important caveat to the argument outlined above is that despite a 
correlation between gene expression and cord blood cortisol, there was no 
significant difference in cord blood cortisol levels between high or low maternal 
anxiety groups.  While this finding is surprising it is not unprecedented.  In their study 
of women undergoing amniocentesis Glover and colleagues found no significant 
differences in amniotic fluid cortisol concentrations between high and low anxiety 
groups (Glover et al., 2009).  Similarly Clifton (2005) reports that despite large sex 
differences in placental 11β-HSD2 activity there is little evidence for sex differences 
in cortisol from the fetal cord (Clifton, 2005).  Additional support comes from Kajantie 
et al., (2006) who again showed lower levels of 11β-HSD2 activity without an 
increase in cord blood cortisol.   
In rodents studies a similar pattern emerges.  Mairesse et al., (2007) report no 
significant differences in fetal cord blood corticosterone levels despites lower 
placental expression and activity levels.  Similarly in the 11β-HSD2-/- knockout 
model, despite a complete absence of this gene, cord blood corticosterone levels  
were comparable to control levels (Holmes et al., personal communication).  
An explanation for this apparent paradox comes from the work of Kajantie et 
al., (2006).  Extremely low birthweight neonates born with lower levels of placental 
11β-HSD2 displayed symptoms of adrenal insufficiency.  It is possible that higher 
exposure to maternal cortisol throughout gestation delays the maturation of the fetal 
adrenal resulting in lower output at term.  This is also supported by rodent studies 
which report adrenal hypotrophy in animals with low, or no placental 11β-HSD2 
activity respectively (Mairesse et al., 2007, Holmes et al., 2006).  The lack of 
difference in cord blood cortisol between high and low anxiety group may reflect two 
differing fetal contributions to the level of cord blood.  While this possibility is highly 
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speculative and requires further study, it suggests the fetal adrenal function may 
serve as a proxy marker for in utero cortisol exposure. 
Placental weight was inversely correlated with fetal cord blood cortisol in both 
sexes, in line with a previous report (Mericq et al., 2009).  In this study of 
programming mechanisms placental weight thus emerged as a potential outcome of 
interest.  To the author’s knowledge this is the first study in humans to report an 
inverse association between placental weight and maternal prenatal anxiety.  This 
effect was restricted to males, although the numbers were small, and so this must be 
treated with caution.   There is some supportive evidence for such a sex-specific 
reduction in placental size.  In a detailed stereological analysis a significant sex 
interaction was observed in placenta exposed to maternal asthma during pregnancy.  
Males born to asthmatic mothers had significantly reduced capillary volumes relative 
to females and controls.  The authors suggest that the higher levels of 11β-HSD2 
activity seen in female placenta may protect from the anti-proliferative effects of 
glucocorticoids on target tissue (Mayhew et al., 2008).  This possibility may extend to 
the results of the current study in which sex differences in basal enzyme activity 
were observed while maternal stress was associated with reduced 11β-HSD2 
expression.  Collectively reduced expression and activity may contribute to the sex-
specific reduction in placental weight in males but not females.  This association 
between 11β-HSD2 function and placental weight is supported by the findings of 
Wyrwoll et al., (2009) using the 11β-HSD2-/- model and Liang et al., (2010) in an 
alcohol exposure paradigm.  
Placental weight and birthweight were reduced in women who reported 
alcohol use during pregnancy.  This has been reported in a number of studies of 
alcoholic mothers and FAS (Burd et al., 2007).  Interestingly, unlike maternal 
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prenatal anxiety, the associated between alcohol use and placental weight was 
observed in males and females.   
An alternative explanation is that there is shared genetic variance between 
maternal risk-taking and regulation of placental weight.  As such the outcome is not 
mediated by exposure to alcohol but represents a gene-gene interaction (Linnet et 
al., 2003).  Arguing against this idea are rat studies where the genetic background of 
the animal is controlled.  In such models ethanol exposure alone is sufficient to 
reduce both placental and fetal weight (Liang et al., 2010).    
A reduction in placental weight due to maternal alcohol use is of interest given 
the correlation between placental weight and cord blood cortisol.  The results from 
the current study indicate that alcohol use during pregnancy may have a direct effect 
on the developing fetus (Hellemans et al., 2010) but may also indirectly increase 
fetal cortisol exposure through its action on placental weight.  
The placental weight findings described above may also be relevant to health 
outcomes in later life.  Reduced placental weight has been associated with increased 
risk of cardiovascular disease (Thornburg et al., 2010) and reduced white matter 
integrity in the brain in later life (Shenkin et al., 2009). 
In summary, this thesis provides evidence of a lasting effect of maternal 
prenatal anxiety on biobehavioural outcomes in the child.  These data support the 
concept of in utero programming by the maternal emotional state.  Finally, in an 
attempt to determine how such effects are mediated, the role of the placenta as a 
programming mechanism was explored.  This study provides prelimnary evidence 
that the placenta may be sensitive to maternal prenatal anxiety and may act as a 
programming vector.     
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6.2 Limitations 
There are a number of limitations in the three studies (Study 1-3) described 
above which warrant discussion. 
Firstly there was evidence of selective attrition in the ALSPAC cohorts (Study 
1and 2).  In general participants in these studies were born from women reporting 
less anxiety and depression, smoking and alcohol use during pregnancy.  In addition 
these mothers reported higher rating of SES.   
Similarly in study 1 the participants included in these analyses at age 13 
reported less emotional and behavioural problems earlier in childhood than the rest 
of the cohort.  As such the sample used for the current analyses may not be 
representative of the overall cohort, or of a ‘normal’ UK community sample.  With this 
limitation in mind it is likely that the effect of maternal prenatal anxiety on child 
development and HPA axis function are an underestimate given the selective 
attrition of the most anxious mothers and the most problematic children.  
An additional limitation pertinent to the ALSPAC cohort is the poor 
representation of ethnic minority groups in this cohort.  It is difficult to extrapolate the 
findings in this study to populations with greater ethnic diversity.  This is most 
relevant for ALSPAC-based studies in which White participants make-up greater 
than 90% of the cohort.  As such the current findings are applicable to White mothers 
and their children.   
An important consideration for this study is the reliance on data collected 
through maternal self-report.  In the ALSPAC studies mothers alone provided ratings 
of their child’s behaviour.  There is some evidence that anxious or depressed 
mothers are more likely to report higher rates of behavioural problems in their 
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children (Najman et al., 2000).  This could result in an artefact of more anxious or 
depressed women rating their child as more troublesome.  In contrast recent data 
from a large study of behavioural problems using both maternal and child report 
found no effect of maternal anxiety on maternal ratings of child behaviour but a small 
significant effect of maternal depression (van der Toorn et al., 2010).  The use of 
multi-informant formats or clinical interviews for data collection would have lessened 
any possible effect of maternal bias. 
An important limitation for the ALSPAC studies listed above is the lack of 
concurrent SDQ data at age 15. This data would have facilitated a meditational 
analysis to determine if the blunted CAR reported here mediates an association 
between maternal prenatal anxiety and child problem behaviour.  In the absence of 
this data it can be concluded that maternal prenatal anxiety is associated with both 
outcomes. However no association between emotional/behavioural development and 
HPA axis function can be established.   
The availability of genetic data would have strengthened the conclusions from 
the studies of child behaviour and HPA axis function.  While the current study 
controlled for potential postnatal confounds, and reports independent effects of the 
prenatal period, no assessment of the genetic contribution to child development was 
made.  For emotional and behavioural development a number of genes have been 
found to interact with an adverse early environment predisposing to later depression 
(Caspi et al., 2003) or anti-social behaviour (Thapar et al., 2005, Taylor and Kim-
Cohen, 2007).  To date there have been no comparable genetic studies relating 
prenatal exposures to later emotional and behavioural outcomes.  Such a study 
would make a valuable contribution to the programming field. 
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In line with criticism described above the genetic contribution to HPA axis 
function was not assessed in the current study.  This is despite good evidence that 
the CAR has a moderate genetic component (Wust et al., 2000a).  Indeed as 
discussed in Section 1.9.4 (page 59) there are a number of genes contribute to the 
function of the HPA axis and CAR.  The availability of such data would have 
strengthened the conclusions drawn by this study.    
A major limitation of Study 3 is the sample size used for analyses.  In addition 
to the small sample there were missing data for some of the outcomes of interest.  
This was particularly relevant for the placental 11β-HSD2 gene expression and 
activity assays and cord blood analysis.  Despite a larger total cohort (N = 73) gene 
expression data was available on only 40 participants, while activity data was 
available on fewer still (25/73).  Poor RNA quality was the main cause reason for 
such exclusions.  In addition, the timeframe of the current study limited the number 
of activity assays completed.  Finally cord blood samples were not always collected 
or available for all participants.  Reasons for this included insufficient volume and 
failure to collect experimental samples.  As such the results presented here are 
preliminary and should be interpreted with caution.  Recruitment is on-going which 
will facilitate a replication in a larger sample.  However due to the time constraints of 
the current study the currently available data are presented here. 
An additional limitation is the timing of sample collection.  All placenta 
samples were collected at term following a clinically indicated C-section.  Given that 
11β-HSD2 mRNA and protein have a half-life of 12 and 21 hours respectively, the 
data on gene expression and activity is a snapshot at a very specific point in time 
(Atanasov et al., 2007, Sharma et al., 2009).  It is difficult to infer what effect 
maternal prenatal anxiety has on gene expression and enzyme activity at earlier 
 290
points in pregnancy.  One possibility would be to recruit women undergoing 
Chorionic Villi Sampling (CSV), in which a placental sample is collected in early 
gestation for the testing of chromosomal abnormalities, and follow-up to term.  The 
collection of placenta samples at term would allow a comparison 11β-HSD2 
expression and activity at an early and late stage in placental development.  A 
drawback of this hypothetical design would be the use of a single sample of 
placental tissue from early gestation which contrasts with multiple biopsies taken at 
term in this study.   
A related issue is the use of cord blood samples at term.  In line with the 
placental data the cortisol in these samples provided an index of cortisol exposure at 
one timepoint.  Fetal blood sampling is increasingly rare in clinical practice. However 
the availability of such samples would considerably strengthen the current study.  
With this in mind it is of interest that the strongest association with gene 
expression and enzyme activity was with maternal trait anxiety.  Women in this study 
were all due to undergo a surgical procedure within 24 hours.  It is conceivable, 
given the data on mRNA and protein stability, that maternal state anxiety would have 
the greatest effect on gene expression and activity.  Despite higher state anxiety 
scores, the strongest prediction came from maternal trait anxiety.  Thus it is tempting 
to speculate the mechanism regulating 11β-HSD2 expression and activity is 
relatively stable.  If this is the case then the lower levels of gene expression and 
enzyme activity observed at term may reflect similarly lower levels earlier in 
gestation. However this possibility requires further study.  
A final limitation which applies to all of the findings described above is their 
generalizability to other measures of psychosocial stress.  In general maternal 
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anxiety was the strongest predictor of child biobehavioural development.  A similar 
but less consistent pattern emerged for maternal prenatal depression.  Similarly in 
Study 3 maternal trait anxiety, but not state anxiety or depression, was most strongly 
associated with placental data.  It is unknown if these findings extend to other 
measures of prenatal stress such as pregnancy specific anxiety or stressful life 
events.  Both of these assessments have shown an association with child outcome 
(Gutteling et al., 2006, Bergman et al., 2007, Buss et al., 2009).  The failure to 
include such assessments in a battery of questionnaires precludes a direct 
comparison between different types of stress and their respective effects on the 
child.   
6.3 Contribution to science 
This study provides new evidence that maternal prenatal anxiety has a lasting 
effect on child development.  A number of findings from this thesis make a novel 
contribution to the developmental origins literature.  In addition data from these 
studies are relevant to the fields of child development, psychoneuroendocrinology 
and placental function. 
To the author’s knowledge this is the first study with multiple longitudinal 
assessments to show the effects of maternal prenatal anxiety persist from 4 to 13.  
Previous analyses have often been cross-sectional or carried out over shorter 
timeframes (O'Connor et al., 2002, O'Connor et al., 2003, Laplante et al., 2004, 
Laplante et al., 2008).  The growth curve analyses provide evidence for a distinct 
developmental trajectory for children exposed to maternal prenatal anxiety. 
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More generally, these analyses demonstrate that patterns of emotional and 
behavioural development are highly sex specific, differing in both initial levels of 
problem behaviour and rates of change over time.  
It is important to place these findings in the context of the recent ONS survey 
of child mental health in the UK.  The children with the highest problem scores at age 
15 were those children scoring high at age 13 (Clements et al., 2008).  Importantly in 
a study of adults with a psychiatric disorder approximately half had reported a mental 
health problem by age 15 (Kim-Cohen et al., 2003).  Thus the persistence of problem 
scores related to maternal prenatal anxiety becomes an issue of clinical importance 
both for the individual and those tasked with public health spending.  
Study 2 is the largest prospective study of maternal prenatal anxiety and the 
cortisol diurnal profile in adolescence.  The finding of a blunted CAR in relation to 
maternal prenatal anxiety is novel.  In line with the behavioural findings there is 
evidence for a distinct cortisol diurnal profile in children exposed to maternal prenatal 
anxiety.  The cluster analysis describes an atypical, blunted cortisol diurnal profile in 
children born to more anxious women.  Support for a blunted CAR was also provided 
from MANOVA and MLM analyses and was independent of obstetric and postnatal 
confounds.   
The effects of maternal prenatal anxiety on the CAR are small.  However, 
these group differences observed are somewhat comparable to a previous study of 
cortisol at waking (Van den Bergh et al., 2008). It is difficult to conclude that such 
small effects are of substantial clinical relevance and generally mediate the effects of 
prenatal anxiety on behavioural outcomes, although they may well be important in a 
subgroup.  The involvement of the HPA axis may yet prove an important mediator 
 293
but this will need to be assessed using functional methodologies.  As such a 
contribution of this study may be to widen the scope of future studies beyond salivary 
cortisol.   
A more general contribution of this study is to the study of the HPA axis in 
adolescence.  A significant sex difference in the cortisol diurnal profile at age 15 was 
observed, contrasting with a previous report in similarly aged adolescents (Bouma et 
al., 2009).  This was most marked for the CAR.  This replicates a similar finding in 
adults demonstrating a larger CAR in females (Kunz-Ebrecht et al., 2004).  A role for 
menarche is suggested by the significant difference between pre and post-
menarchal females reported in the current study.  Given the disproportionate 
increase in anxiety and depressive disorders in adolescent females this biological 
phenomenon may be of clinical relevance (Zahn-Waxler et al., 2008). 
This study also provides preliminary support for ethnic differences in the 
cortisol diurnal profile.  In line with two other sources non-white participants had 
lower waking cortisol (DeSantis et al., 2007, Hajat et al., 2010).  Similarly the finding 
that the CAR is independent from the underlying diurnal profile replicates previous 
work (Stalder et al., 2009).   
From a fetal programming perspective this is the first clinical study to draw 
associations between maternal prenatal anxiety and human placental 11β-HSD2 
expression and activity.  Although restricted to males this is the first evidence that 
maternal psychological functioning may affect aspects of placental function.  Also 
novel is the finding that maternal prenatal anxiety is associated with reduced 
placental weight.  The finding that placental weight is correlated with cord blood 
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cortisol, and maternal alcohol use supports previous work (Burd et al., 2007, Mericq 
et al., 2009). 
These findings are of interest as they demonstrate an effect of maternal 
prenatal anxiety independent from the postnatal environment.  In longitudinal 
analyses it is often difficult to determine if an effect is specifically ‘prenatal’ given the 
important role of the postnatal environment.  Large epidemiological studies (Study 1-
2) provide the resources to control for relevant confounds giving statistically 
independent estimates of prenatal effects.  However demonstrating that there is an 
effect of maternal prenatal anxiety evident at birth adds strength to the in utero 
programming hypothesis.  Characterising the neurodevelopment of these children 
thus becomes an important next step to determine the relevance of these findings for 
the field of fetal programming. 
Collectively these findings represent a tripartite study of fetal programming.  
The long term effects of maternal prenatal anxiety have been found to affect child 
behaviour and biology into adolescence.  The final study described in this thesis 
highlights altered placental function as a promising programming target sensitive to 
maternal prenatal anxiety.  In sum this thesis provides novel evidence for fetal 
programming by maternal prenatal anxiety.  
6.4 Future directions 
The current study (Study 1) indicates that impairments associated with 
maternal prenatal stress/anxiety persist across childhood.  However as discussed 
above the age of data collection and the use of a non-diagnostic assessment limits 
the clinical relevance of these findings.  The Development and Wellbeing 
Assessment (DAWBA) is an instrument which generates clinician-rated diagnoses 
 295
(Goodman et al., 2000a).  A logical follow-up study to those described above would 
assess if maternal prenatal anxiety results in a greater number of clinical diagnoses, 
or alternatively if such effects are sub-clinical and perhaps additive to postnatal life 
events.  This is particularly relevant as the adolescents are now aged 17, a stage 
when the prevalence of psychiatric disorders is approaching adult-like levels (Zahn-
Waxler et al., 2008).  Demonstrating an association between maternal prenatal 
anxiety and persistent neurodevelopmental disorder would strengthen the clinical 
relevance of this subject. 
The blunted CAR associated with maternal prenatal stress provides the basis 
for a number of future studies.  Firstly, lower CAR cortisol levels have been 
associated with a number of syndromes such as atypical depression, PTSD, chronic 
pain and fatigue (Fries et al., 2005).  Fries and colleagues suggest that unifying 
these conditions is a symptom triad of enhanced stress, sensitivity, pain and fatigue.  
As such assessing these features in the current cohort would be informative.  Such a 
study would show if the cortisol diurnal profile associated with maternal anxiety 
confers a vulnerability for the disorders listed above. 
A related study would determine the nature of this blunted CAR.  A functional 
probe of the HPA axis using a DEX/CRF test and a synthetic ACTH (synacthen) 
challenge may determine which aspect of HPA axis drive or feedback is impaired.  In 
parallel the use of imaging to assess adrenal volume may make a novel contribution 
to the study of maternal prenatal anxiety and aspects of HPA axis function.   
A related study would involve the imaging of the pituitary.  A number of 
studies have shown an association between pituitary volume and risk or presence of 
psychopathology (Pariante et al., 2004, Reisch et al., 2010). No study to date has 
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characterised pituitary volume in relation to maternal prenatal anxiety.  Dependent 
on the functional assessments described above, pituitary volume may prove to be 
sensitive to maternal prenatal anxiety.  
As described above a limitation of the current study was the lack of genetic 
data.  However, genotyping of a number of candidate genes is underway.  In addition 
to the genes already described earlier, BDNF may also be of interest.   In a rat model 
of PTSD attenuated corticosterone responses to stress are associated with reduced 
hippocampal BDNF (Bazak et al., 2009).  Interestingly a recent study has reported 
an association between the salivary cortisol in the evening and polymorphisms in the 
BDNF gene (Vinberg et al., 2009).  
As stated above a major limitation of the current study was a small number of 
ethnic minority participants in this sample.  Of relevance to the study of the HPA axis 
there is good evidence that the CRH gene shows strong ethnic differences (Shimmin 
et al., 2007).  Such genetic differences may be functionally relevant with evidence 
that, at least in pregnancy, that CRH and cortisol levels are significantly lower in 
African-American women (Glynn et al., 2007, Chen et al., 2010).  Given the lower 
levels of cortisol seen in the small sample of non-white participants in the current 
study it would be of interest to replicate this finding in a larger group, and determine 
which aspect of HPA axis function mediates this effect.  Subsequently examining if 
such changes give rise to increased levels of psychopathology in certain ethnic 
minorities would be of interest.   
The role of ethnicity may also prove of interest to studies of fetal 
programming.  There is good evidence that migrants and individuals of Afro-
Caribbean origin living in the UK are at greater risk of psychosis-related disorders 
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(Coid et al., 2008) .  Interestingly schizophrenia has shown some association with 
prenatal stress most notably exposure to famine in the prenatal period or the death 
of a spouse (van Os and Selten, 1998, Khashan et al., 2008).  It would be of interest 
to determine if the effects of prenatal stress were additive, independent or otherwise 
in Ethnic minority groups.  Conversely, British Indian children are found to have 
lower levels of eternalising behaviours, even in lower levels of SES, relative to their 
White-British peers (Goodman et al., 2010).  It would of interest to determine if this 
resilience extends to maternal anxiety during pregnancy. 
The long term effects of the prenatal environment have been the focus of the 
current study; however the postnatal environment is an important consideration for 
further studies.  There is strong evidence from rodent models that postnatal maternal 
care can have lasting effects on the biobehavioural development of the offspring.  
Lower levels of maternal care give rise to stable, epigenetically programmed, 
changes to the function of the HPA axis (Weaver et al., 2004).  Offspring from a low 
maternal care background display increased stress responses and delayed recovery, 
mediated by reduced expression of hippocampal GR.  Intriguingly prenatal stress 
can affect maternal care, whereby females previously characterised as high carers 
give rise to offspring with HPA axis dysregulation typical of a low maternal care 
background (Champagne and Meaney, 2006).  Furthermore a recent study 
demonstrates that parenting, indexed by mother/infant attachment style, moderates 
the association between prenatal cortisol exposure and child cognitive development.  
Children observed to have a secure attachment style were buffered against the 
adverse effects of higher in utero cortisol exposure. (Bergman et al., 2010). 
The importance of the postnatal environment is further highlighted by studies 
of environmental enrichment.  Providing postnatal stimulation through environmental 
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enrichment can buffer against the adverse effects of maternal prenatal restraint 
stress in rodents (Morley-Fletcher et al., 2003, Welberg et al., 2006).  In combination 
these studies place a strong emphasis on mother-infant interaction and the postnatal 
environment in moderating the negative effects of prenatal stress.  Assessing 
patterns of maternal care would be a potentially informative future study.  This would 
be especially pertinent to the participants of study 3, given the current age of 
participants (~1 year old).  
Study 3 provides the first human evidence that maternal prenatal anxiety is 
associated with reduced placental 11β-HSD2 expression and activity.  This novel 
contribution to the clinical literature on programming mechanisms requires further 
study.  In particular it is important to characterise the molecular pathways which may 
mediate this effect.  There are a number of plausible candidates.  Firstly, maternally 
derived catecholamines may reduce 11β-HSD2 expression (Sarkar et al., 2001).  In 
human trophoblast cell lines treatment with noradrenaline decreased 11β-HSD2 
mRNA levels (Sarkar et al. 2001).  It appears more likely that noradrenaline may be 
the principal stress-related mediator or reduced 11β-HSD2 expression given the 
finding that cortisol positively regulates gene expression (van Beek et al., 2004).   
A role for epigenetic regulation of 11β-HSD2 is supported by recent work from 
Baserga and colleagues (2010).  In a rat model of IUGR discreet binding sites of the 
promoter region of renal 11β-HSD2 were found to be hypermethylated (Baserga et 
al., 2010).  These patterns of methylation were sex-specific. Importantly these 
pattern of methylation occur in the context of reduced 11β-HSD2 expression at birth 
and through to adolescence (day 21).  This work makes a significant contribution to 
the programming literature.  It demonstrates that 11β-HSD2 is sensitive to maternal 
manipulations and has lasting effects on gene expression. Secondly it demonstrates 
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how the same manipulation can result in sex-specific effects at a gene level.  
Studying the epigenetic regulation of placental 11β-HSD2 may yield an insight into 
the sex-specific association between maternal prenatal anxiety and gene expression. 
An additional avenue for future research is the relationship between maternal 
immune function and placental 11β-HSD2 expression.  More specifically in cell 
culture models the inflammatory cytokines tumor necrosis factor (TNF)-α and inter-
leukin 1β (IL1β) downregulate 11β-HSD2 expression and activity (Chisaka et al., 
2005).  There is some evidence that psychosocial stress can increase these 
inflammatory markers and may be relevant to the pathophysiology of depression 
(Miller et al., 2009a).  There is emerging evidence of similar correlation between 
maternal mooed and levels of proinflammatory cytokines in pregnancy (Christian et 
al., 2009).  Exploring maternal immune status as a potential regulator of placental 
11β-HSD2 may be an important future study. 
The role of noradrenaline is underexplored in relation to fetal programming.  
As well as the regulation of 11β-HSD2 transcription described earlier, noradrenaline 
may have more direct effects on uteroplacental blood flow.  Treatment of rodent 
placenta with noradrenaline (within physiological ranges) resulted in vasoconstriction 
of uterine vessels (Segal and Wang, 2008).  In line with this Teixeira and colleagues 
report maternal anxiety to be associated with uterine artery resistance (Teixeira et 
al., 1999), although this was not found in another study (Harville et al., 2008).  
Interestingly, mild to moderate chronic decrements in uteroplacental blood flow 
significantly reduce placental weight in a sheep model of placental insufficiency 
(Lang et al., 2000).  Collectively these studies highlight the importance of maternal 
sympathetic drive, or circulating noradrenaline on uteroplacental perfusion.  It is yet 
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to be determined if maternally derived noradrenaline has a long term effect on child 
development. 
The association between maternal prenatal anxiety and placental weight is 
novel.  An important next step will be to repeat this a larger sample and, if replicated, 
determine how maternal prenatal anxiety can affect placental growth.  As mentioned 
above potential interactions with 11β-HSD2 appear a plausible mechanism.  In the 
rodent 11β-HSD2-/- model significantly reduced amino acid transfer co-occurs with 
reduced placental weight.  It is possible that reduced nutrient intake to the feto-
placental unit may affect both placental and fetal growth.  Similarly in the absence of 
11β-HSD2 high levels of corticosterone may drive differentiation of placental tissues 
(Malassiné and Cronier, 2002). 
 An alternative mechanism is disruption to the Insulin-like growth factor (IGF) 
axes.  In humans placental weight is positively associated with IGF-1, IGF binding 
protein 3 (IGFBP-3), IGF-2 and inversely correlated with IGFBP-1 in cord blood 
samples (Ong et al., 2000).  Animal studies provide plausible mechanisms which 
could link prenatal stress/anxiety and disruption to components of the IGF axes.  
An interaction between synthetic glucocorticoids and the IGF axes is reported 
by Baisden et al., (2007).  Prenatal dexamethasone (DEX) treatment resulted in 
significantly lighter placenta in the exposed group.  A microarray of placental tissue 
from the treatment group revealed that DEX treatment downregulated a number of 
genes including growth promoting IGFBP-3 (Baisden et al., 2007).  Similarly 
treatment of rodent placental tissue with corticosterone results in decreased IGF-2 
expression (Fowden and Forhead, 2009). 
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More direct evidence for a role of maternal prenatal stress on the IGF axes 
comes from Mueller et al., (2008).  In their study of prenatal stress, IGFBP-1 which 
negatively regulates the action of IGF-1 was upregulated in placenta from male 
offspring.  The authors do not report placental weights in this study. However 
prenatal stress in early gestation resulted in a distinct biobehavioural phenotype in 
male offspring.  Stress-exposed males displayed increased anxiety and depressive-
like behaviour, increased stress responses and reduced glucocorticoid receptor 
expression in the hippocampus. 
Of additional relevance are findings related to the methylation of the promoter 
region of IGF-2.  Exposure to famine in the peri-conceptual stage resulted in 
decreased methylation of the IGF-2 promoter (Tobi et al., 2009).  Interestingly a 
similar sex specific pattern emerges between methylation of the IGF-2 promoter and 
brain weight in males (Pidsley et al., 2010).  Putting these finding together with the 
animal studies described above, studying the IGF axes in the current sample would 
help determine if this pathway mediates the association between maternal prenatal 
anxiety and placental weight. 
The data from the study of the placenta finds marked effects of maternal 
prenatal anxiety in relation to placental function in males but not females, although 
again this needs replicating in a larger sample. This sex difference is surprising given 
some evidence that female are more responsive to maternal physiology (Clifton, 
2005).  Indeed from a programming perspective the current study offers little insight 
into potential mechanisms in females.  The findings of Baserga et al., (2010) 
highlight that an identical manipulation (IUGR) can give rise to the same outcome via 
different molecular pathways.  It is possible that the females in this study are not 
resilient to the effects of maternal prenatal anxiety. However it seems more likely that 
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the effects of prenatal anxiety on placental function are less marked or occur through 
a different mechanism.  Such a mechanism remains to be elucidated in future 
studies. 
The ultimate goal of this research is to determine how maternal prenatal 
anxiety affects neurodevelopment and how best to intervene.  The current study 
provides encouraging evidence for the involvement of the placenta.  However it 
remains unknown if the altered placental function described here leads to adverse 
child outcomes.  To address this question the children from the current cohort are 
being assessed at age one.  Although this work falls beyond the timeframe of the 
current thesis, the outcome of these assessments will determine the importance of 
the changes in placental function described in this thesis.  
Finally, in the long-term, the study of the transgerational effects of maternal 
prenatal anxiety would be of interest.  There is some good evidence from dietary 
manipulation models that programming effects demonstrate transgenerational 
transmission mediated by epigenetic changes in gene expression (Dunn et al., 
2010).  The children from the ALSPAC study, now aged 17, will provide a unique 
resource to test this in a clinical sample during their reproductive years.  A 
comprehensive study of mothers, their daughters, sons and grandchildren would 
provide a good test of transgenerational effect of maternal prenatal anxiety.   
6.5 Concluding remarks 
Higher rates of emotional and behavioural problems were observed in 
children born to more anxious women.  Later in adolescence, higher rates of 
maternal prenatal anxiety were associated reduced cortisol output.  These 
consequences of maternal prenatal anxiety may stem, in part, from changes to 
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placental function.  From a biological perspective the question remains; why should 
such changes occur?  As this thesis began with a description of developmental 
plasticity it seems appropriate to place the findings of the current study in such a 
context. 
There are a number of speculative explanations for the finding described 
above.  In the context of life history stage, high levels of maternal prenatal anxiety 
may lead to a premature transition in development (e.g. in brain maturation) which 
has long-term maladaptive consequences.  In anuran amphibians, a drying pond can 
act as a catalyst for premature metamorphosis from a marine to terrestrial 
phenotype.  The trade-off for survival is smaller body size in adulthood and less 
reproductive success (Crespi and Denver, 2005).  In a similar manner maternal 
prenatal anxiety may promote premature maturation of specific neural structures 
which gives rise to less than optimal outcomes later in development.  This 
perspective would view the outcomes described above as maladaptive 
consequences of a developmental process.   
An alternative possibility is that the outcomes associated with prenatal 
anxiety/stress are adaptive but context dependent (Glover, in press).  High levels 
prenatal stress/anxiety may signal to the fetus to prepare for a threatening or 
dangerous environment.  The subsequent outcomes of ADHD, conduct disorder or 
emotional problems, such as anxiety, may constitute beneficial adaptations.  The 
constantly shifting attention (ADHD), aggressive behaviour (conduct disorder) or 
greater threat sensitivity (anxiety) may all prove adaptive if living under fear of attack.  
In contrast, in today’s civilised society such outcomes are maladaptive and may 
hinder academic and personal development (Glover, in press).  This perspective 
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argues that the effects of maternal prenatal anxiety are adaptive processes but ill-
suited to a mismatched environment. 
Despite such differences in perspectives a unifying concept between both is 
the concept of a ‘trade-off’.  Adapting the organism for one environment comes at a 
cost when exposed to a different setting.  This is exemplified in a rodent model 
similar to the low/high maternal care paradigm described previously (DeVries et al., 
2007).  In this model, handled rats generally have ‘optimal’ HPA axis function with 
lower basal levels of corticosterone and a blunted stress response, which quickly 
return to baseline.  These changes are mediated by increased hippocampal GR 
expression (DeVries et al., 2007).  The ‘trade-off’ becomes apparent when these 
animals are exposed to a model of stroke.  Corticosterone levels increase 
dramatically and remain chronically high over a period of days.  Handled animals 
with their ‘optimal’ HPA axis function succumb to the excitotoxic effects of elevated 
corticosterone, with an increased infarct size and greatest functional impairment.  In 
contrast, non-handled animals, exposed to higher daily levels of corticosterone, have 
a more favourable outcome in this specific context relative to their handled 
littermates (DeVries et al., 2007). 
In a sombre conclusion Ellison (2005) states that in the context of trade-offs 
‘health’ may never be truly obtainable, however ill-health will result from an inter-play 
between an individual’s risk-factors and the prevailing environmental conditions 
(Ellison, 2005).   
To conclude, this thesis provides evidence of a lasting effect of maternal 
prenatal anxiety on child development.  The perspectives outlined above may partly 
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explain why such effects are observed.  From a public health perspective the 
importance shifts to how such outcomes can be prevented. 
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 Appendices 
7.1 Appendix A:  Participant information sheet (Study 3)
Participant information sheet for those recruited for Study 3 (Maternal prenatal 
emotional state and placental function)
 
 
Amendment 2 version 1 22 February 2010   REC No: 
Patient Information Sheet 
Study Title: Prenatal stress and possible effe
You are invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please 
take time to read the following information carefully. You are free t
take part and your treatment will not be affected by your decision. 
The purpose of the study.
We are conducting a study to look at t
on the development of the child. There is good evidence that 
anxious or depressed during pregnancy this can affect the outcome of the 
pregnancy. However not all children are affected, most are not. We would like to 
understand more about what makes some children more vulnerable to stress and 
some more resistant. We want to compare the effect of different kinds of stress that 
may be experienced during pregnancy on the function of the placenta.  We will 
assess how you are feeling by asking you to fill in 5 questionnaires that are widely 
used for assessing mood. We will also ask for a sample of your placenta to assess 
whether it may provide a barrier to the passage of cortisol from you to the child. 
Why have I been chosen?
We are approaching all healthy women in the antenatal clinic who are about
an elective caesarean. If you have a medical condition or are expecting twins you will 
not be included. 
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cts on the child 
o decide not to 
 
 
he effect of stress exposure during pregnancy 
if a mother is stressed, 
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What will happen if I take part? 
We will ask you to fill in five simple questionnaires today. This will take about 30 
minutes.  
If we identify that you are feeling unusually stressed, anxious or depressed and may 
benefit from talking to someone after you have had the baby, we will share this with 
you and suggest possible sources of help. We will contact your GP about this only 
with your consent.  He/she will be able to refer you to the appropriate health 
professional in your area.  
• At delivery you will be asked to donate your placenta. This is delivered after your 
baby and is normally discarded. Data will be collected on your baby’s delivery details 
and birth weight. 
• With all the tissues collected, from the placenta, after donation, as with all tissue 
donations, you will lose all entitlement to them. They will be used only for the 
specified tests and then destroyed. No serious communicable disease (especially 
HIV and Hepatitis B) testing is to be done.  Any genetic variations we will look at are 
responsible for subtle changes in stress responses, have no clinical relevance and 
are only useful for research purposes. The tests will be anonymised. It will not 
therefore be possible to identify the results with any specific individual.  
• When your infant is a year old we will ask you to come to QCCH with your child. 
The appointment will take between one hour and two hours, depending on how 
quickly your child settles in.  We will carry out a variety of simple tests of your child’s 
development (e.g. placing blocks in a cup, response to an automated toy dog) You 
will be with your child at all times. We will film the proceedings. The DVD is made so 
that your child’s actions and interactions can be studied later. You will be free to see 
the film yourself at any time and to ask for it to be erased. Otherwise only members 
of the research team will see it. During the project the discs are stored in a locked 
cupboard in a secure building. At the end of the project when all the data has been 
analysed the discs will be destroyed. You will also be asked to collect samples of 
saliva from your child to measure stress hormone levels. During the session, with 
your help the researcher will obtain a saliva sample from your child to look at the 
genes that might be regulating your child’s stress hormone levels. You yourself will 
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be asked to fill in questionnaires about how you are feeling and about your child’s 
development.  
If your child’s development at this time gives cause for concern we will share this 
with you and ask your permission to contact your GP and Health Visitor.   
Will my taking part in this study be kept confidential? 
All information collected about you during the course of the research will be kept 
strictly confidential. It will be stored in a locked cabinet in a secure building. Only the 
research team will have access to it. Responsible individuals from the Trust and 
Imperial College may need to access your notes and study data, and those of your 
child, for audit purposes. Any information about you which may leave the hospital will 
have your name and address removed so that you cannot be recognised from it. 
Some data from this project may be analysed outside the UK  as this is part of a 
Europe-wide study. With your permission your GP will be informed of your 
participation in the study and will also be sent a copy of the information sheet. We 
hope to have the results of this research in about 3 year’s time, and will publish it 
then. However you will not be identifiable as an individual. 
What are the benefits of taking part? 
There is no direct clinical benefit from taking part in the study. However the study will 
help us understand more about different types of stress and their effect on the child, 
about why some mothers and babies are more susceptible than others and whether 
this may be controlled by particular genes.  
What are the disadvantages/risks of taking part. 
We do not believe that there are any disadvantages in taking part.  
What if something goes wrong? 
Imperial College London holds insurance policies which apply to this study.  If you 
experience harm or injury as a result of taking part in this study, you may be eligible 
to claim compensation without having to prove that Imperial College is at fault.  This 
does not affect your legal rights to seek compensation. If you are harmed due to 
someone’s negligence, then you may have grounds for a legal action.  Regardless of 
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this, if you wish to complain, or have any concerns about any aspect of the way you 
have been treated during the course of this study then you should immediately 
inform the Investigator  Professor Vivette Glover on 020 7594 2159.The normal 
National Health Service complaint complaints mechanisms are also available to you.  
If you are still not satisfied with the response, you may contact the Imperial College 
Clinical Research Governance Office.   
Your choice. 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. A 
copy of the consent form will be filed in your notes and for this reason we need your 
permission to access your hospital records. If you decide to take part, you are still 
free to withdraw at any time without giving a reason. This will not affect the standard 
of care you receive. Please feel free to contact us at any time if you require further 
information. 
The research is funded by The Medical Research Council and is part of a wider 
Eurostress Project 
The study is sponsored by Imperial College. 
The study has received a favourable opinion from the Brompton Harefield and NHLI 
Research Ethics Committee: REC number: 08/H0708/126 
Thank you for reading this. If you need any more information about the study please 
contact Diana Adams or Laura Freeman at any time on 020 7594 2159 or 020 7594 
2188. 
 
Amendment 2 version 1: 22/02/2010 
   
 
 7.2 Appendix B:  Participant consent form sheet (Study 3)
Below is the consent form and give to part
prenatal emotional state and placental function).
 
 
 
 
 
REC number (08/H0708/126) 
 
 
 
 
The participant should complete the whole of this sheet 
 
The study has been explained to me by:
Prof/Dr/Mr/Mrs/Ms 
______________________________________________________
 
Please tick each statement as it applies to you
 
I confirm that I have read and understood the information sheet for the above 
study, and have had the opportunity to ask questions. 
 
I understand what is required from me to participate in this study.
 
I am willing to fill in questionnaires about h
icipants taking part in Study 3 (Maternal 
 
PARTICIPANT CONSENT FORM
Study title: Prenatal stress and possible 
effects on the child 
Study number:  
Study centre: Queen Cha
Chelsea Hospital 
 
 
 
 
 
ow I am feeling  
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rlotte’s and 
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I agree to donate my placenta at the time of my delivery 
 
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving reason, and without my medical care being affected. 
 
 
I understand that my records may be accessed by members of the research 
team as well as by responsible individuals from Imperial College and Trust for 
audit purposes only.  
 
I agree to my GP being notified of my participation, and that If we have any 
concerns we will ask your permission to contact your GP. 
 
 
I agree that, if possible, my infant and I will come back when my infant is one 
year old for a simple assessment of his/her development.  
 
 
Signed: ________________________________________      Date 
:___________     
 
 
NAME IN BLOCK CAPITALS 
____________________________________________ 
 
 
 
Investigator’s signature ____________________________     Date 
:___________     
 
 
NAME IN BLOCK CAPITALS 
___________________________________________ 
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7.3 Appendix C:  The Crown Crisp Experiential Index 
(CCEI) anxiety subscale (Study 1-2) 
The anxiety subscale of the CCEI is outline below which was used to assess 
maternal anxiety in studies 1 and 2 from pregnancy to three years postpartum.  
Despite a 4 item response category, items below were recoded to give a maximum 
score of 16.   
 
Please indicate the way you feel at this stage in your pregnancy. 
[1 = Very Often, 2 = Often, 3 = Not very Often, 4 = Never] 
 
1) Do you feel upset for no obvious reason? 
2) Do you sometimes feel panicky? 
3) Do you feel strung-up inside? 
4) Do you ever have the feeling you are going to pieces? 
5) Have you felt as though you might faint? 
6) Do you feel uneasy and restless? 
7) Do you worry a lot? 
8) Do you have bad dreams which upset you when you wake up? 
 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
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7.4 Appendix D: The Spielberger Trait Anxiety inventory 
(STAI) (Study 1-3) 
The STAI was used to index maternal anxiety in studies 1 and 2 when 
children were aged 8.  Similarly this assessment was used in Study 3 to assess 
maternal prenatal anxiety prior to C-section. 
 
Below are a number of statements which you may use to describe yourself. Please 
indicate if you think these apply to you. Each statement applies to how you generally 
feel. 
 
  Almost 
never 
Sometimes Often Almost 
always 
21
. 
I feel pleasant     
22
. 
 
I feel nervous and restless     
23
. 
I feel satisfied with myself     
24
. 
I wish I could be as happy as others  
seem to be 
    
25
. 
I feel  like a failure     
26
. 
I feel rested     
27
. 
I am "calm, cool and collected"     
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28
. 
I feel that difficulties are piling up so that I 
cannot overcome them 
    
29
. 
I worry too much over something that 
really doesn't matter 
    
30
. 
I  am happy     
31
. 
I have disturbing thoughts     
32
. 
 I lack self-confidence     
33
. 
 I feel secure     
34
. 
I make decisions easily     
35
. 
I feel inadequate     
36
. 
I am content     
37
. 
Some unimportant thought runs through 
my mind and bothers me 
    
38
. 
I take disappointments so keenly that I 
can't put them out of my mind 
    
39
. 
I am a steady person     
40
. 
I get in a state of tension or turmoil as I 
think over my recent concerns and 
interests 
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7.5 Appendix E:  The Edinburgh Postnatal depression 
Survey (EDPS) (Study 1-3) 
This assessment was used to assess feeling of depression in women in all studies. 
For ease of interpretation the scores for each question are given to the right hand 
side. 
Please indicate the way you feel at this stage in your pregnancy.  Thinking about 
Your feelings in the past week please underline the statement which best describes 
how you felt: 
I have been able to laugh and see the funny side of things: 
As much as I always could 1 
Not quite so much now 2 
Definitely not so much now 3 
Not at all 4 
I have looked forward with enjoyment to things: 
As much as I ever did 1 
Rather less than I used to 2 
Definitely less than I used to 3 
Hardly at all 4 
I have blamed myself unnecessarily when things went wrong: 
Yes, most of the time 1 
Yes, some of the time 2 
Not very often 3 
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No never 4 
I have been anxious or worried for no good reason: 
No, not at all 1 
Hardly ever 2 
Yes, sometimes 3 
Yes, often 4 
I have felt scared or panicky for no very good reason: 
Yes, quite a lot 1 
Yes, sometimes 2 
No, not much 3 
No, not at all 4 
 
Things have been getting on top of me: 
Yes, most of the time 1 
Yes, sometimes 2 
No, hardly ever 3 
No, not at all 4 
 I have been so unhappy that I have had difficulty sleeping: 
Yes, most of the time 1 
Yes, sometimes 2 
Not very often 3 
No, not all 4 
I have felt sad or miserable: 
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Yes, most of the time 1 
Yes, quite often 2 
Not very often 3 
No, not at all 4 
I have been so unhappy that I have been crying: 
Yes, most of the time 1 
Yes, quite often 2 
Only occasionally 3 
No, never 4 
The thought of harming myself has occurred to me: 
Yes, quite often 1 
Sometimes 2 
Hardly ever 3 
Never 4 
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7.6 Appendix F: The Spielberger State Anxiety inventory 
(SSAI) (Study 3) 
The SSAI was used to index maternal anxiety study 3 to assess maternal 
prenatal anxiety prior to C-section.  
Below are a number of statements which you may use to describe yourself. Please 
indicate if you think these apply to you. Each statement applies to how you feel at 
the present moment. 
 
 Doesn’t  
apply  
Applies  
a bit  
Moderately  
applies  
Certainly  
 applies  
a) I feel calm      
b) I feel secure      
c) I feel tense      
d) I feel strained      
e) I feel at ease      
f) I feel upset      
g) I am presently worrying over  
possible misfortunes  
    
h) I feel satisfied      
i) I feel frightened      
j) I feel comfortable      
k) I feel self-confident      
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l) I feel nervous      
m) I am jittery      
n) I feel indecisive      
o) I am relaxed      
p) I feel content      
q) I am worried      
r) I feel confused      
s) I feel steady      
t) I feel pleasant      
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7.7 Appendix G: The Strengths and Difficulties 
questionnaire (SDQ) (Study 1) 
The SDQ assessment used in Study 1 is described below.  The problem scales 
(ADHD-related, Conduct and Emotional) are the focus of this study appear in a box 
below. 
The precursor to the question was: 
Please think how your child has been in the past 6 months with possible responses 
of not true (0), somewhat true (1) or certainly true (2). 
 
Prosocial: 
She has been considerate of other people’s feelings  
She has shared readily with other children (treats, toys, pencils etc.)  
She is helpful if someone is hurt, upset or feeling ill  
She is kind to younger children  
She often volunteers to help others (parents, teachers, other children)  
 
ADHD-related: 
She has been restless, overactive, cannot stay still for long  
She is constantly fidgeting or squirming  
She is easily distracted, her concentration wanders  
She thinks things out before acting (reversed) 
She sees tasks through to the end, has good attention span (reversed) 
 
Emotional symptoms: 
She has often complained of headaches, stomach aches or sickness  
She has many worries, often seems worried  
She is often unhappy, down-hearted or tearful  
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She is nervous or clingy in new situations, easily loses confidence  
She has many fears, is easily scared  
 
Conduct problems: 
She has often had temper tantrums or hot tempers  
She is generally obedient, usually does what adults request (reversed) 
She often fights with other children or bullies them  
She often lies or cheats  
She steals from home, school or elsewhere  
 
Peer problems: 
She is rather solitary, tends to play alone  
She has at least one good friend (reversed) 
She is generally liked by other children (reversed) 
She is picked on or bullied by other children  
She gets on better with adults than with other children  
 7.8 Appendix H: Participant sali
(Study 2) 
In Study 2 participants were requested to record the time at which each 
sample was taken.  This information sheet was returned together with the saliva 
samples and used to determine time of awakening and the time difference between 
sample 1 and sample 2. 
.
va sampling record form 
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 7.9 Appendix I: Placental dissection proforma (Study 3)
Each placenta was processed using a standard placental proforma to ensure 
accuracy and consistency in sample collection.
Date: 
Time of delivery 
 Gross placental weight 
Remarks: 
 
 
 
Checklist Day 1: 
Samples on dry ice to -80 
Samples in RNA later to fridge 
Biopsy in formalin 
Blood samples (Sera) to -80 
Clean area 
Tissue waste to yellow bin/cold room 
Birthweight 
Indication for section 
Apgar  
1 min: 
5 mins: 
 
 
Study ID 
Time completed 
 Excess 
 
Checklist Day 2: 
RNA samples to -80
 
Biopsy to 70% EtOH
 
Congenital abnormalities
Other comments 
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initials 
Sex  
 Total 
 
 
  
 
 374
7.10 Appendix J:  Spearman correlations between maternal depression and child SDQ 
score 
Males ADHD-related SDQ score Conduct SDQ score Emotional SDQ score 
Maternal Depression  4yrs 7yrs 9yrs 11yrs 13yrs 4yrs 7yrs 9yrs 11yrs 13yrs 4yrs 7yrs 9yrs 11yrs 13yrs 
18 wks prenatal  r (s) .137
**
 .126
**
 .130
**
 .131
**
 .132
**
 .141
**
 .146
**
 .124
**
 .103
**
 .148
**
 .166
**
 .178
**
 .215
**
 .217
**
 .175
**
 
N 4221 3639 3298 2992 3016 4261 3712 3274 3003 3013 4270 3740 3329 3011 3017 
32 wks prenatal  r (s) .161
**
 .141
**
 .145
**
 .124
**
 .155
**
 .155
**
 .158
**
 .151
**
 .115
**
 .162
**
 .156
**
 .156
**
 .215
**
 .210
**
 .173
**
 
N 4368 3765 3393 3079 3096 4407 3843 3372 3094 3094 4420 3873 3428 3100 3097 
8 wks postnatal  r (s) .160
**
 .149
**
 .164
**
 .127
**
 .152
**
 .152
**
 .162
**
 .143
**
 .109
**
 .130
**
 .169
**
 .192
**
 .215
**
 .217
**
 .197
**
 
N 4291 3699 3328 3021 3047 4326 3768 3306 3037 3044 4335 3805 3360 3041 3048 
8 mths postnatal  r (s) .166
**
 .147
**
 .157
**
 .143
**
 .141
**
 .170
**
 .180
**
 .144
**
 .118
**
 .150
**
 .173
**
 .198
**
 .209
**
 .196
**
 .187
**
 
N 4238 3664 3292 2987 3002 4274 3738 3278 2998 2999 4285 3772 3330 3005 3003 
2 years  r (s) .187
**
 .169
**
 .201
**
 .148
**
 .160
**
 .197
**
 .183
**
 .186
**
 .121
**
 .172
**
 .174
**
 .198
**
 .227
**
 .205
**
 .191
**
 
N 4117 3579 3196 2909 2946 4148 3644 3179 2922 2943 4159 3677 3230 2931 2947 
3 years  r (s) .178
**
 .165
**
 .178
**
 .151
**
 .157
**
 .196
**
 .188
**
 .183
**
 .127
**
 .161
**
 .180
**
 .173
**
 .212
**
 .193
**
 .168
**
 
N 4070 3510 3142 2850 2888 4101 3573 3118 2861 2884 4114 3605 3172 2866 2888 
8 years  r (s) .152
**
 .188
**
 .193
**
 .184
**
 .169
**
 .167
**
 .215
**
 .219
**
 .150
**
 .184
**
 .177
**
 .201
**
 .245
**
 .251
**
 .202
**
 
N 3250 3091 2955 2711 2720 3274 3151 2928 2715 2717 3278 3173 2975 2725 2720 
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Females ADHD-related SDQ score Conduct SDQ score Emotional SDQ score 
Maternal Depression  4yrs 7yrs 9yrs 11yrs 13yrs 4yrs 7yrs 9yrs 11yrs 13yrs 4yrs 7yrs 9yrs 11yrs 13yrs 
18 wks prenatal r (s) .155
**
 .181
**
 .158
**
 .162
**
 .171
**
 .156
**
 .144
**
 .121
**
 .143
**
 .155
**
 .135
**
 .163
**
 .177
**
 .179
**
 .174
**
 
N 3918 3413 3136 2921 2957 3947 3496 3176 2924 2959 3942 3493 3188 2944 2961 
32 wks prenatal r (s) .168
**
 .149
**
 .154
**
 .170
**
 .168
**
 .155
**
 .117
**
 .134
**
 .158
**
 .156
**
 .149
**
 .167
**
 .173
**
 .194
**
 .189
**
 
N 4064 3555 3262 3043 3070 4095 3635 3296 3034 3072 4092 3636 3319 3066 3074 
8 wks r (s) .170
**
 .160
**
 .153
**
 .177
**
 .178
**
 .169
**
 .119
**
 .124
**
 .156
**
 .152
**
 .170
**
 .167
**
 .186
**
 .194
**
 .191
**
 
N 3978 3502 3212 3002 3020 4011 3582 3246 2990 3023 4006 3584 3264 3021 3024 
8 mths postnatal   r (s) .183
**
 .196
**
 .192
**
 .186
**
 .178
**
 .182
**
 .154
**
 .134
**
 .154
**
 .157
**
 .169
**
 .192
**
 .207
**
 .172
**
 .186
**
 
N 3947 3464 3173 2960 2973 3977 3543 3203 2955 2976 3973 3542 3224 2986 2976 
2 years  r (s) .183
**
 .196
**
 .209
**
 .194
**
 .188
**
 .186
**
 .154
**
 .132
**
 .142
**
 .159
**
 .170
**
 .194
**
 .199
**
 .174
**
 .197
**
 
N 3844 3371 3097 2898 2913 3869 3451 3126 2885 2916 3869 3457 3148 2917 2916 
3 years  r (s) .183
**
 .177
**
 .170
**
 .185
**
 .183
**
 .190
**
 .168
**
 .155
**
 .154
**
 .175
**
 .187
**
 .216
**
 .199
**
 .193
**
 .198
**
 
N 3783 3315 3013 2833 2854 3811 3392 3038 2826 2857 3809 3394 3059 2854 2857 
8 years  r (s) .159
**
 .199
**
 .213
**
 .200
**
 .198
**
 .183
**
 .184
**
 .175
**
 .152
**
 .177
**
 .157
**
 .235
**
 .248
**
 .216
**
 .220
**
 
N 3135 3007 2894 2684 2694 3160 3072 2924 2673 2696 3155 3070 2942 2699 2698 
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7.11 Appendix K: P-P plot of the standardized residuals 
from SDQ models 
 
Figure 7.11.1 Standardised residuals plot of ADHD-related (top) conduct (middle) and 
emotional (bottom) SDQ scores 
 7.12 Appendix L: C
analysis of cortisol data
The coefficient of linkage was 
described the cortisol diurnal profiles observed in the 
7.12.1).  This coefficient indexes
clusters together.  As the number of clusters used to describe 
the amount of error increases.  Given that there was little change in error between a 
range of clusters (Cluster 10
selection was based on the fulfilment of two additional selection criteria 1) adequate 
sample size in each cluster and 2) the presence of a sex difference in the cortisol 
profiles already established from earlier analyses in this thesis.
Figure 7.12.1 Coefficient of linkage describing the change in error as the number of 
clusters used to describe the range of cortisol profiles decreases
indicates the final number of clusters used fo
oefficient of linkage and cluster 
 from the ALSPAC cohort
used to determine how many clusters 
ALSPAC cohort (Figure 
 the amount of error associated with
the data
-Cluster 4) a five cluster solution was selected.
 
. Grey highlighting 
r the current analyses. 
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best 
 combining 
 decreases 
  This 
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7.13 Appendix M: Multilevel model of cortisol data 
including maternal prenatal anxiety at 18 weeks 
Results from Multilevel Analysis of Cortisol Data: 18 Week Prenatal Anxiety. Bwt = birthweight, 
*p<.05 
       Fixed Effects 
Parameter   Model 1  Model 2  Model 3 
Intercept   2.510(.097)  3.877(.376)  4.143(.430) 
Level 1 (adolescent) 
 Wake time  -.067(.014)*  -.056(.015)*  -.070(.017)* 
 CAR   .425(.013)*  .387(.371)  .659(.425) 
 Slope   -.107(.003)*  -.192(.033)*  -.197(.038)* 
 Slope
2
   .001(.000)*  .0005(.0002)*  .001(.000) 
 Female      .106(.029)*  .103(.033)* 
 Female X CAR     .129(.030)*  .148(.033)* 
 Female X Slope    -.003(.003)  -.004(.003) 
Bwt     -.326(.083)*  -.333(.090)* 
 Bwt X CAR     .036(.085)  .030(.091) 
 Bwt X Slope     .019(.008)*  .022(.008)* 
 Gestational age     -.037(.009)*  -.040(.011)* 
 Gestational age X CAR    -.001(.009)  -.005(.011) 
 Gestational age X Slope   .002(.0008)*  .002(.001)* 
 Crowding     -.005(.014)  -.008(.016) 
 Crowding X CAR    -.002(.015)  .005(.017) 
Crowding X Slope    .001(.001)  .002(.002) 
18 wk anxiety       .002(.006)  
18 wk anxiety X CAR      -.015(.006)* 
18 wk anxiety X Slope      -.001(.001) 
  8 wk anxiety       -.010(.007) 
8 wk anxiety X CAR      .004(.007) 
8 wk anxiety X Slope      .001(.001) 
8 yr anxiety       -.006(.007) 
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8 yr anxiety X CAR       -.005(.007) 
8  yr anxiety X Slope      .000(.001) 
     
Random Parameters 
Level 3 (person) 
Model 1  Model 2  Model 3 
 Intercept/intercept .107(.008)*  .092(.001)*  .093(.009)* 
 Intercept/CAR   -.003(.006)  -.004(.006)  -.003(.007) 
 Intercept/Slope  -.006(.001)*  -.005(.001)*  -.006(.001)* 
 CAR/CAR  .040(.008)*  .037(.008)*  .035(.009)* 
 CAR/Slope  .000(.000)  -.000(.001)  .000(.001) 
 Slope/Slope  .001(.000)*  .0001(.00001)*  .001(.000)* 
Level 2 (day) 
 Intercept/intercept .003(.002)  .002(.002)  .003(.002) 
Level 1 (occasion) 
 Intercept/intercept .150(.003)*  .151(.003)*  .154(.004)* 
-2Xloglikelihood  10889.30  8544.25 
 7008.55 
Decreasing loglikelihood indicates a better model fit 
 
 
